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Abstract
In the United States, the number of major limb amputees is predicted to exceed
several million in the coming decades. For those amputees using a prosthesis, their
quality of life (QoL) is often modulated by residuum limb problems resultant from its
use. Multiple factors preclude quality evidence-based medicine (EBM) research in the
field of prosthetics, leading to greater health risk from prosthetic prescription ambiguity.
Positive social change is integral to good QoL; studies support administrative healthcare
(AHc) as useful to support such, especially in the absence of EBM. This study utilized
Veterans Healthcare Administration (VHA) AHc data to discriminate determinants of
residual limb skin problem severity (RLSPS), relative to the artificial limb configuration
(ALC) used through a retrospective, longitudinal study of a cohort of U.S.Veteran
dysvascular amputees. The dataset was derived from multiple archival VHA AHc
databases from which 279 Cohort members were identified who underwent amputation
surgery during the fiscal year (FY) 2007 were dispensed a prosthesis, and had clinical
records through FY 2011. ICD-9-CM and HCPCS codes were used to identify categories
of RLSPS and ALC, respectively, with generalized estimating equations modeling to
identify likelihood associations of parameters. Derivation of the study cohort dataset was
encumbered by data integrity issues and coding system limitations; significant
associations were detected for RLSPS with chronic obstructive pulmonary disease,
substance use disorder, and major depressive disorder, regardless of the ALC dispensed.
The findings support the utility of an amputee-prosthesis AHc database to drive product,
policy, and medical decisions toward an improved QoL for this vulnerable population.
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Chapter 1: Introduction to the Study
Background
Etiology and Epidemiology of Acquired Limb Loss
Relevant literature and health statistics suggest a continuing, increasing
prevalence of individuals in the United States with lower extremity acquired limb loss
(Ziegler-Graham, MacKenzie, Ephraim, Travison, & Brookmeyer, 2008). Collectively,
sources indicate three primary reasons account for this rise: (a) a rising incidence and
subsequent prevalence of diabetes mellitus with associated foot complications, (b) an
aging population with a high risk of peripheral arterial disease (PAD), which includes
critical limb ischemia, and (c) injuries due to vehicular accidents,
occupational/recreational incidents, and military events and practices (Dillingham,
Pezzin, & MacKenzie, 2002; Limb Loss Resource Center, 2012.)
Although acquired limb loss incidence has decreased significantly since 1996
(185,000 amputations annually), in 2005, more than 71,000 major limb amputations were
performed annually, with approximately 70% involving the lower extremities and
approximately 30% involving the upper limbs (Limb Loss Resource center, 2012). Of the
lower extremity amputations, the majority (65%) were due to diabetic complications and
other dysvascular diseases; the remainder were a consequence of trauma or cancer (Limb
Loss Resource Center, 2012)
Over the next 45 years, the number of persons living with the loss of a limb is
expected to rise from 1.6 million in 2005, to an estimated 2 million in 2007, to 3.6
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million in 2050 (Ziegler-Graham et al., 2008). Most such amputations will likely be due
to dysvascular conditions (diabetes and PAD), with population totals increasing from less
than 1 million in 2005 to 2.3 million in 2050 (Ziegler-Graham et al., 2008).
Living with Limb Loss
Acquired limb loss is indiscriminant of gender, ethnicity, or socio-economic
status, although it is frequently related to a disease or condition that is associated with
any of these factors. The loss of a limb exacts on-going lifestyle and quality of life
outcomes, regardless of etiology or demographics. (Christensen, Ipsen, Doherty, &
Langberg, 2016; Dillingham, Pezzin, & MacKenzie, 2002).
Whereas the younger person, who more typically experiences a trauma-acquired
limb loss, may be able to return to an active lifestyle and pursue their former recreational
and occupational activities, the older individual with dysvascular acquired limb loss may
be less fortunate. These individuals are given a 30-day post-operative mortality rate
ranging from 15 % to 30%, depending on the level of amputation (Dillingham, Pezzin, &
Shore, 2005; Ephraim, Dillingham, Sector, Pezzin, & Mackenzie, 2003; Feinglass et al.,
2001; Mayfield et al., 2001). In general, within 5 years of the index amputation, second
amputation and mortality rates increase with age, more proximal amputation, and poorer
health status, especially for those with comorbid cardiovascular disease (CVD), renal
failure, pulmonary disease, and systemic infection or sepsis (Aulivola et al., 2004;
Dillingham et al., 2005; Feinglass et al., 2001; Mayfield et al., 2001).
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Many persons living with limb loss are faced with restricted use of their artificial
limb due to surgical consequences, residual limb complications, disease comorbidities,
and/or additional injuries. Overall, it is estimated that nearly 25% of lower limb amputees
will forego their artificial limb in lieu of a wheelchair, most often due to chronic pain
(musculoskeletal and phantom limb), hypersensitivity, poor skin resiliency of the residual
limb, poor prosthetic socket fit or artificial limb prescription, costs, and the psychological
and physical exertion required to ambulate with an artificial limb (DePalma et al., 2002;
Desmond, Gallagher, Henderson-Slater, & Chatfield, 2008; Desmond & MacLachlan,
2002; Dudek, Marks, Marshall, & Chardon, 2005; Legro et al., 1999). Emotionally, not
only must the amputee contend with the depression and grieving process associated with
losing a major limb, but in concert with such, they are faced with adapting to a new body
image (with and without an artificial limb) as well as a potentially new way of life
(Coffey, Gallagher, Horgan, Desmond, & MacLachlan, 2009). They may need to
consider changes in their choice or status of employment, level of independence, and an
increased awareness or monitoring of their overall health (Boutoille, Feraille, Maulaz, &
Krempf, 2008; Desmond & MacLachlan, 2002; Gallagher, 2004; Uustal, 2009). Further,
the individual’s coping strategies (such as avoidance behavior, denial, problem-solving
skills) seem to be at the heart of their ability to adapt to the loss of a limb and acceptance
of an artificial limb (Desmond & MacLachlan, 2006b). Maladaptive coping behaviors
(such as drug/alcohol consumption), greater disability, poorer social functioning, and loss
of functional independence may exacerbate artificial limb use as result of difficulties in
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psychological adjustment (Callaghan, Condie, & Johnston, 2008; Desmond &
MacLachlan, 2006a; Desmond & MacLachlan, 2006b; Livneh, Antonak, & Gerhardt,
1999).
The Artificial Limb
The artificial limb prescription is based on multiple factors and significantly
impacts the potential user’s future, to include, beyond mere mobility: employment, selfimage, socialization, health care costs, subsequent numerous treatment visits, and the
expenses associated with the provision, maintenance, repair, or replacement of an
artificial limb (Dillingham et al., 2005; Zidarov, Swaine, & Gauthier-Gagnon, 2009).
Subsequently, multiple competing factors drive the prescription of an artificial limb and
hinge on a meaningful evaluation of the prospective user (DePalma et al., 2002).
Consideration must be given to the amputee’s needs, goals, functional abilities (both
cognitive and motor), learning capacity, health status and accommodations upon
discharge, health care accessibility, and social/emotional support (DePalma et al., 2002;
Kerkovich, 2004; Nelson et al., 2006; Zidarov et al., 2009). These concerns reflect not
only the potential needs of the artificial limb user, but also offer insights for the physician
and prosthetist as to the most appropriate artificial limb configuration to be prescribed
and provided. In most cases, it is the patient’s surgeon or physiatrist who prescribes the
artificial limb, to include the type of foot, suspension system, and socket material; it is the
prosthetist who crafts the socket, recommends specific components, assembles and aligns
the artificial limb, and trains the user on use and care of the limb (DePalma et al., 2002;
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DeLisa & Kerrigan, 1998).
Typically, when the site of surgery has healed sufficiently, the patient begins
physical therapy with a temporary artificial limb—a limb that is designed to
accommodate their immediate needs, not their ultimate goals (DePalma et al., 2002;
DeLisa & Kerrigan, 1998). For the next 6 to 12 months, the residual limb may go through
significant changes in size and shape as it continues to heal and as the patient trains with
their temporary artificial limb, gradually increasing their mobility and endurance
(DePalma et al., 2002; G. W. Bosker, CPO, personal communication, January 2011). At
the point of residual limb stabilization, a definitive artificial limb is configured, one that
is designed to accommodate the patient’s near and ultimate goals (DePalma et al., 2002;
DeLisa & Kerrigan, 1998).
The modern artificial limb is comprised of multiple prescribed components that in
combination describe the function and performance of the entire unit. The basic
transtibial artificial limb is composed of (from the bottom up): a prosthetic foot, a multior single-axis ankle, pylon, a handcrafted socket, and a suspension system that works to
keep the leg on and in place over the residual limb (DePalma et al., 2002; G. W. Bosker,
CPO, personal communication, January 2011). Commercially, there is a significant
prosthetics–orthotics device industry with a vast array of component makes and models
having varying marketed functions and capabilities (DePalma et al., 2002; G. W. Bosker,
CPO, personal communication, January 2011). For example, the transtibial artificial limb
may include a prosthetic foot structured of materials that give it specific mechanical
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qualities and/or contain sensors that help mediate its use; the suspension system may be
as simple as Velcro belts and wraps or as sophisticated as a Vacuum Assisted Suspension
System (VASS) (DePalma et al., 2002; Mak, Liu, & Lee, 1994). All such products are
considered Class II medical devices by the U.S. Food and Drug Administration (FDA)
and thus are exempt from FDA approval beyond premarketing notification. Clinical trials
are not required, although manufacturers are asked to report serious adverse events that
they learn about (2012).
Of the components used to configure an artificial limb, a well-fitted, well-crafted
prosthetic socket is essential, as it is this part of the artificial limb that forms the interface
between the mechanical aspects of the prosthesis with the human residual limb (Ferguson
& Smith, 1999; Mak, Zhang, & Boone, 2001). The socket is typically handcrafted,
although computer aided design–computer aided manufacture (CAD-CAM) techniques,
which are used to improve fit, standardize materials and methods, and ultimately reduce
cost and production time are being increasingly explored (Rogers et al., 2007; Collins,
Karmarkar, Relich, Pasquina, & Cooper, 2006; Mak et al, 2001; Sewell, Noroozi,
Vinney, & Andrews, 2000)
Regardless, the socket is the one component of the entire artificial limb that,
because of its customized fit to an individual’s residual limb, cannot be mass produced
(Ferguson & Smith, 1999). Thus the fit and comfort of the socket is primarily dependent
on the skill and expertise of the prosthetist, but may be complicated by the shape and
length of the residual limb (DePalma et al., 2002). Beyond the skill of the prosthetist, it is
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generally accepted (although not systematically investigated) that a poorly prescribed or
configured artificial limb will exacerbate the human/mechanical interface supplied by the
socket, resulting in excessive discomfort, a compromised residual limb, and user
frustration (DePalma et al., 2002; Legro et al., 1999; Mac et al., 1994).
Research Trends in the Field of Artificial Limb Function, User Outcomes
To date, based on literature review, most research conducted regarding persons
living with limb loss and the use of an artificial limb has been focused on gait and
balance biomechanics, functional capacity, energy cost, and patient satisfaction as
measured by varying questionnaires and survey tools. While there is an abundance of
case reports on residual limb complications, given the nature of scientific publication
practices, most are about an unusual condition or circumstance (Meulenbelt, Geertzen,
Dijkstra, & Jonkman, 2007). Little attention has been given to the incidence or
prevalence of common residual limb complications in relation to artificial limb
configurations or components, despite implications thereof and significant rates of reamputation and patient dissatisfaction (Dudek et al., 2005; Meulenbelt, Dijkstra,
Jonkman, & Geertzen, 2006). Additionally, there is a dearth of literature on long-term
effects of artificial limb use (after more than 1 year), to include the associated
psychosocial conditions, barriers, and implications of living with limb loss (Desmond &
MacLachlan, 2002; Gallagher, 2004).
Most studies addressing issues of artificial limb use, outcomes, or design are of
moderate methodological design and have small case numbers, unique populations, and
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short follow-up periods (less than 6 months) (Iezzoni, 2004). Very few randomized
control trials have been conducted, in part due to the nature of the study population, but
also due to the fact there are few (if any) standardized measures or outcomes that are
universally accepted or easily quantified (Meulenbelt et al, 2006).
Subsequently, population-based, comprehensive, and objective information that
facilitates the development of universal prescription guidelines, identification of adverse
patterns of patient outcomes, geographic or ethnic influences, and the monitoring of
artificial limb costs, usage, availability and/or marketing influences, is seriously
encumbered (Iezzoni, 2004). As such, there is a need to exploit alternative means of
facilitating the analysis and dissemination of objective, outcomes-based (patient/artificial
limb) results that may fill informational gaps associated with anecdotal evidence and the
experiential knowledge of the practitioner. In short, there is a need to promote, facilitate,
and disseminate evidence-based clinical information regarding the person living with
limb loss and the use of an artificial limb, as a means to improve relative health care
practices.
Alternative Artificial Limb-Outcomes Research Resources
In those cases where conducting a clinical trial may be unfeasible or unethical,
many disciplines have turned to the development of a high-quality clinical database
(HQCD) as a means for consolidating evidence-based medicine in a systematic,
consolidated manner (Arlet et al., 2008). An HQCD is typically a relational database that
focuses on an intervention and the related patient outcome. It allows for the generation of
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large samples that improve statistics, promote generalizability of analyses, and allow for
subgroup identification to include the aggregation of rare cases and/or interventions for
study (Black, 1997). In the United States, a database of this sort does not exist for the
field of prosthetics/limb loss.
In the absence of an appropriate HQCD (or to facilitate the development of such),
a healthcare administrative database may serve as a viable alternative. Though broad in
scope and without direct clinical information beyond diagnosis and procedural codes, a
healthcare administrative database is a proven and effective tool for calculating
population disease incidence/prevalence and/or health service practices (Boyko,
Koepsell, Gaziano, Horner, & Feussner, 2000; Hlatky, 1991; Nordio, Antonucci, Feriani,
Inio, & Marchini, 2009). Further, when a healthcare administrative database is linked to a
systematic patient follow-up with outcomes directly related to medical coding, what
emerges is a tool not dissimilar to an HQCD. Though such a tool would likely prove
highly valuable for the clinical decision-maker for identifying those factors that strongly
predict good or poor outcome, the concept is as yet untested (Iezzoni, 2004). It is
projected that this is due in part to the lack of an amputee/prosthetics surveillance or
monitoring system, the lack of a universally accepted and obtainable outcome measure,
and to a highly prolific and profitable prosthetics industry.
To this end, the Veterans Health Administration (VHA), with its rich history in
information technology, may provide a viable source for such patient/artificial limb
outcomes analysis. The VHA has maintained a National Patient Care Database (NPCD)
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since 1976 that contains patient care information in the form of ICD-9 codes, procedure
codes, V-codes, and HCPCS codes, as well as certain demographic information (Murphy,
Cowper, Seppala, Stroupe, & Hynes, 2002). The database is derived from regional
applications supported by the Veterans Health Information Systems and Technology
Architecture (VISTA), an integrated, interactive information technology set of
applications and tools that support healthcare system-wide security, device access, datasharing, and communications (Brown, Lincoln, Groen, & Kolodner, 2003). A key
application supported by VISTA is the Computerized Patient Record System (CPRS),
which provides much of the medical coding (for example, ICD-9-CM and CPT codes)
associated with each patient’s facility inpatient stay or outpatient visit (Boyko et al.,
2000; Brown et al., 2003; Murphy et al, 2002). Currently, the NPCD represents the
medical care of over 8 million veterans in the United States, and this number is growing
(Department of Veteran Affairs, 2010).
Additionally, since 2000, the VA’s Prosthetics and Sensory Aids Service (PSAS)
has maintained a unique database: the National Prosthetic Patient Database (NPPD), of
which data is transmitted via the Orthotic WorkLoad (OWL) or the Prosthetics Software
Package (PSP) applications, also integrated with VISTA (Werner, 2010). With a
developmental intent to provide a means to monitor the VA’s Prosthetic Service, as well
as to be a source of artificial limb prescription practice information for clinicians, the
NPPD is a compilation of prosthetic and orthotic provision records acquired from VA
facilities across the nation—a roll-up of all prosthetic, orthotic, and sensory aids
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transactions performed per patient visit per fiscal year (Downs, 2000; Pape, Maciejewski,
& Reiber, 2001). Further, as of 2005, the NPPD has been significantly improved,
evaluated, and made more easily integrated with other VA administrative databases,
including the NPCD (Smith, Su, & Phibbs, 2010). Therefore, the longitudinal tracing of
factors and patient outcomes associated with artificial limb component provision has
been significantly facilitated and is encouraged by VHA leadership.
To this end, recent strides have been made by investigative leaders in the field of
amputee care to develop a National Amputee Registry within the VHA system (G.
Reiber, personal communication, August 2012). It is believed that this level of
surveillance will, at the least, simplify the identification of patterns of outcomes and will
facilitate the development of prescription guidelines and reduction of prescription
ambiguity for the practitioner, as well as provide manufacturers with greater
insight/evidence for improved design and marketing information, ultimately benefiting
the artificial limb user (Downs, 2000).
Problem Statement
For the individual living with limb loss and an artificial limb, their success and
quality of life is often modulated by residual limb problems resultant from artificial limb
use. Normal and excessive biomechanical forces (e.g., pressure, friction, shearing, and
torques) are generated at the interface of the artificial limb socket and the users residual
limb, setting up conditions adverse for normal tissue growth and healing. Excessive heat
and sweat facilitate bacterial and fungal growth, undue pressures can lead to soft tissue
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damage or calluses, friction and shearing is often related to blistering, and all such effects
have a deleterious effect on the integrity of the skin, thereby increasing the risk for
infection and non-use of the artificial limb (Bui, Raugi, Nguyen, & Reiber, 2009; DeLisa
& Kerrigan, 1998; Dudek et al., 2005; Meulenbelt et al., 2006; Meulenbelt et al., 2007).
Further, it is not uncommon for persons having difficulty making adjustments
following amputation to report bouts of depression, feelings of hopelessness, grief, low
self-esteem, fatigue, anxiety, and sometimes suicidal ideation (Singh et al., 2009;
Williams et al., 2011). For those who also suffer from peripheral vascular disease or
diabetes, such emotions and their associated behaviors may confound the artificial limb
use because their condition is associated with compromised circulation and poor healing
capacity in the residual limb. Depending on the severity of such complications, artificial
limb use may be restricted, minimized, or terminated. Re-amputation of the same limb
may be required, or death may ensue due to sepsis originating from residual limb tissue
infection (Centers for Disease Control and Prevention [CDC], 2004). With the current
and projected continued rise in the numbers of individuals with diabetes, peripheral
arterial disease, and co-morbidities associated with aging, the present and pending
population of persons living with acquired dysvascular below-knee amputations will
correspondingly increase (Ziegler-Graham, et al., 2008).
While it is generally accepted among amputee care practitioners that artificial
limb components and characteristics (such as prosthetic feet, sockets, and socket
suspension systems) can and do impact residual limb skin integrity/condition, there is
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little to no evidence-based clinical research that directly assesses such a relationship, with
or without the consideration of influence of mental health disorders as a complicating
factor (Desmond & Maclachlan, 2002, Dudek et al, 2005; Meulenbelt et al., 2006;
Meulenbelt et al., 2007).
Without evidence-based outcomes research, this population will remain especially
vulnerable for poor quality of life, in conjunction with excessive medical care and costs,
due to inappropriate artificial limb prescriptions that are based on biased industry
marketing and/or anecdotal information, rather than on objective clinical data.
An extensive literature search on evidence-based medical research in the field of
prosthetics, revealed three key factors hindering the practice: (a) currently, no amputee–
artificial limb surveillance or monitoring is established or practiced among the general
public in the United States, and thus comprehensive data collection on the matter is
seriously encumbered and limited to specific sites (hospitals) or centers; (b) large clinical
trials of artificial limb components are not required or truly feasible; and (c) suitable
prospective studies are hindered by rapidly changing and expensive artificial limb
technology. However, the VHA, with its rich history in national patient care databases,
offers a viable alternative solution. Although untested to date, a dataset derived from the
integration of VHA healthcare administrative database subsets, and relevant to patients
with acquired limb loss and a dispensed artificial limb, may provide meaningful
evidence-based information useful toward lessening artificial limb prescription
ambiguity, while promoting positive healthcare and patient outcomes. Further, analysis of
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such a dataset may prove highly resourceful by identifying those variables most relevant
for future surveillance.
Nature of the Study
Purpose
The purpose of this study was to address the utility of VHA administrative
healthcare records to discriminate determinants of residual limb skin outcomes relative to
the artificial lower limb configuration prescribed, as a source of information toward the
potential development of a suitable amputee-artificial limb database and future
surveillance system.
Utilizing subsets from two health care administrative databases maintained by the
VHA (the National Patient Care Database and the National Prosthetics Patient Database),
this study derived an integrated dataset representative of a cohort of veterans having
undergone a transtibial amputation for dysvascular complications during fiscal year (FY)
2007 (October 1, 2006 through September 30, 2007), subsequently provided with an
artificial limb prior to the end of FY 2007, and then followed through FY 2010, or a
maximum of 3 years. A more thorough description of the cohort, derivation of the
integrated dataset, and definitions of the outcome variable, residual limb skin problem
severity (RLSPS), covariate conditions, and independent variable artificial limb
configuration (ALC) is provided in Chapter 3.
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Objectives
As detailed more completely in Chapter 3, a significant component of the study
was dedicated to the compilation and derivation of the study dataset that linked patient
care data with their dispensed artificial limb configuration, to include categorization of
the ALCs and definition of the outcome variable. This dataset then formed the foundation
and source for the study’s primary objective. However, while not an Objective per se, the
development of this dataset is key not only to the epidemiological questions at hand, but
also in addressing the potential for a similarly derived database as an informatics tool in
the development of an amputee-care surveillance system. Thus, aspects of the dataset
itself warrants discussion based on the study’s findings.
Primary Objectives
Statistical analysis of the refined dataset and identification of the patterns and
trends of the cohort with regard to artificial limb provision and subsequent RLSPS
(categorical) outcomes.
Research Questions and Hypotheses
The research questions that follow were derived from a literature review of
artificial limb prescription trends and recommendations, residual limb complications of
artificial limb use, and healthcare informatics.
As elucidated in Chapter 2, multiple factors contribute to residual limb skin
problems in conjunction with the use of an artificial limb. This study addressed aspects of
two categories of those factors: mechanical and behavioral, although the two categories
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are not mutually exclusive, as both involve exacerbation of the existing residual
limb/artificial limb interface. Mechanical factors are those in which skin problems are the
consequence of continued biomechanical forces (for example, friction, pressure, and
shearing) acting on traumatized skin tissue, and thus pertain primarily to the ALC
utilized. Behavioral factors are those in which a similar exacerbation exists, but is driven
by the actions of the user (for example, poor self-care or disease management,
activity/ambulation level, treatment non-compliance). Therefore, the following research
questions focused on both mechanical and behavioral factors as main effects or
covariates.
Finally, because the study dataset was comprised of a selected subset of extant
data that was uncertain in quality (the NPPD), containing the independent variable that is
characterized but yet to be indexed or categorized; because the subsequent dataset was
rich in clinical information (the NPCD); and because such a systematic and long-term
assessment of amputee outcomes relative to specific artificial limb configurations and
components has not yet been reported, a veritable new knowledge base was established.
As such, the research questions and hypotheses reflect the exploratory nature of this
retrospective observational study, and the dataset and cohort warrants current and future
characterization (for example, cohort age ranges, mortality rates, rates of artificial limb
components and configurations dispensed, frequencies of specific residual limb skin
conditions; an accounting of nonsensical data or invalid values, and case
matching/linking complications).
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RQ1. Do categories of RLSPS differ with ALC/component? (Mechanical main
effect)
Null Hypothesis (H01). RLSPS categories (frequency and type) will not differ
significantly on the basis of the ALC or component dispensed.
Alternative Hypothesis (Ha1). More severe RLSPS (such as ulcers) will be
significantly more frequent among ALC Categories of higher function or technical
sophistication and will be least for low function, low technically sophisticated
configurations (Ha1a); over 50% of all the cohort members will have at least one less
severe RLSPS category treated during the 3 year follow-up period, regardless of the ALC
dispensed to them (Ha1b).
RQ2. Using the Region of Veterans Integrated Service Network (VISN) where
the artificial limb was dispensed as a proxy for the prosthetist responsible for crafting the
socket and configuring the artificial limb, do categories of RLSPS (frequency and type)
differ with ALC and the responsible prosthetist? (Mechanical as covariate)
Null Hypothesis (H02). RLSPS categories (frequency and type) will not differ
between Regions, regardless of ALC dispensed.
Alternative Hypothesis (Ha2). Significantly more “severe” category RLSPS will
be noted among cohort members with higher function or more technically sophisticated
ALC, regardless of the responsible prosthetist.
RQ3. Do categories of RLSPS (frequency and type) differ relative to a comorbid
condition diagnosis to include major depressive disorder (MDD), post-traumatic stress
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disorder (PTSD), or substance use disorder (SUD) during the three-year follow-up
period? (Behavioral main effect)
Null Hypothesis (H03). Cohort members with a diagnosis of MMD, PTSD, or
SUD will not differ in RLSPS categories (frequency or type) than members of the cohort
with no such diagnosis.
Alternative Hypothesis (Ha3). Cohort members with a diagnosis of MMD will
have fewer severe residual limb skin problems and fewer residual limb skin problems
treated overall, as compared to those members with no such depression diagnosis
(HA3a); cohort members with a diagnosis of PTSD or SUD will have significantly more
(in frequency) RLSPS (such as ulcers) than those members without PTSD or SUD, but no
significant difference in frequency of less severe RLSPS compared to those cohort
members with no such diagnosis (HA3b).
RQ4. Do categories of RLSPS (frequency and type) differ significantly with ALC
and a diagnosis of a comorbid condition to include MDD, PTSD, or SUD? (Interaction
effect, mechanical by behavioral factors)
Null Hypothesis (H04). RLSPS categories relative to ALC will not differ for
cohort members with a diagnosis of MDD, PTSD, or SUD, compared to cohort members
with similar ALC artificial limbs and no such diagnoses.
Alternative Hypothesis (Ha4). Cohort members with a diagnosis of PTSD or SUD
and an artificial limb of high function or technical sophistication will have significantly
more “severe” residual limb skin problems (such as ulcers) than all other cohort members
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(Ha4a); cohort members with a diagnosis of MDD and a lower function or less
technically sophisticated artificial limb configuration will have significantly fewer
“severe” residual limb problems than all other cohort members (Ha4b).
Theoretical Basis
The goal of most epidemiological studies is to infer causation, specifically to
reveal unbiased relationships between exposures and outcomes (morbidity/mortality).
Most outcomes are consequent of multiple factors—a web of interactions that define a
cause or condition. Causal relationships can be considered as necessary, sufficient, or
probabilistic conditions. If a necessary condition can be identified and controlled, the
harmful outcome can be avoided (Phillips & Goodman, 2004).
To this end, the informatics model and the evidence-based medicine model are the
means toward unbiased, objective information; the biopsychosocial model offers the
necessary, sufficient, or probabilistic condition; and the practice-based evidence model
provides a framework with which to explore causal relationships.
The informatics model. The informatics model is a simplistic way to
conceptualize such a potentially complex process. It consists of three essential parts:
“data, information, and knowledge, arranged hierarchically, with data at the base of the
model providing the basis for establishing information and leading, in turn, to the
potential generation of knowledge.” (Georgiou, 2002). Within this model, data take on
the character of facts or observations, which have little or no meaning. The data are
placed in context and managed accordingly, becoming useful information, which can
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then be further synthesized with social, economic, and even political contributing
influences, to be ultimately disseminated as knowledge (Georgiou, 2002). The
significance and fundamentals of the informatics model are demonstrated in the section
“Surveillance, Informatics, and the Amputee” in Chapter 2. Further, it is this informatics
model that forms the basic concepts underlying evidence-based medicine, converging
with its principles, aims, and tasks, particularly in regard to transforming data and
information into evidence-based knowledge.
Evidence-based medicine. Evidence-based medicine (EBM) became a feature of
medical and health care planning in the 1990s, being partly driven by significant
advances and accessibility in information technology to include health informatics
(Charles, Gafni, & Freeman, 2011). It may be defined as a process of using the best
evidence to make decisions on care for patients—a process of decision-making that
incorporates best practice medicine; external, related scientific evidence; and social,
economic, and cultural factors that influence a patient’s quality of life, morbidity and
mortality (Borg & Sunnerhagen, 2008; Sackett, Rosenberg, Gray, Haynes, & Richardson,
2007). The paradigm incorporates clinician expertise as “evidence” derived through
patient interactions, field specialty, and education; related external scientific evidence
ranging from the basic sciences of medicine, to mechanical/electrical engineering, to the
computational and communication sciences (IT); as well as patient input, communication,
and education (Borg & Sunnerhagen, 2008; Georgiou, 2002; Sackett et al., 2007).
Perhaps the most important component of evidence-based medicine however is
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patient-centered clinical research that utilizes randomized control trials, especially those
that challenge the accuracy, power, safety, and efficacy of diagnostic tests, prognostic
tools, and therapeutic, rehabilitative, and preventive regimens (Sackett et al., 2007).
Because the randomized control trial—especially the systematic review of several
randomized control trials or the meta-analyses thereof—typically promotes greater
validity and reliability but less bias, it has become the gold standard for judging whether
a treatment does more good than harm (Sackett et al., 2007). Examples of the
significance of evidence-based medicine, specifically through the use of clinical or health
care administrative databases, are presented in the section “To Build a Better Database or
Not” in Chapter 2.
The practice-based evidence model. To meet the requirements of the evidencebased medicine paradigm, there has been a trend toward using newer methodological and
statistical design techniques to better accommodate the unique practice and patient
population characteristics of rehabilitation medicine and similar specialties (Iezzoni,
2004; Groah et al., 2009; Charles et al., 2011).
For example, a variant of the prospective observational cohort design (a gold
standard for many epidemiologic health studies) is the practice-based evidence (PBE)
model. The PBE model basically seeks to systematically categorize patient interventions
to determine which interventions are most strongly associated with outcomes, taking into
account a large number of patient characteristics that may also be influential (Groah et al.,
2009). The label practice-based evidence is rather self-explanatory as the model/design is
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focused on actual medical practice. It utilizes hypotheses and inclusion criteria that are
general (with more specific hypotheses being developed and tested as associations are
warranted), selection criteria are broad and designed to maximize generalizability and
external validity, and data collected includes an array of patient characteristics that may
account for the outcomes observed: demographic and socioeconomic profiles, comorbid
conditions, and functional status (Groah et al., 2009). These characteristics are then
controlled for through the use of multivariate statistical analyses (Groah et al., 2009;
Iezzoni, 2004). “PBE aims to place greater emphasis on real-world practice and behavior
to determine which patient characteristics and interventions are associated with better
outcomes” (Groah, et al., 2009, 945).
In many cases, the clinical epidemiologist, grounded in the informatics model and
under the umbrella of evidence-based medicine, will turn to alternative data sources when
a randomized control trial is inappropriate or not feasible, a prospective cohort study too
costly or complex to manage, or pre-existing data is to be synthesized into useful
information and evidence (for example, literature systematic reviews or meta-analyses)
(Georgiou, 2002; Groah et al., 2009; Sackett et al., 2007). The study presented in this
dissertation is an example of such a situation and therefore, in keeping with the evidencebased medicine paradigm, the informatics model, and the practice-based evidence cohort
framework, this study is based on a retrospective cohort design utilizing VHA national
databases containing patient demographics and extensive clinical histories in the form of
medical, clinical, and billing codes. While the ultimate goal (as per the informatics model
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and evidence-based medicine paradigm) may be to produce evidential knowledge, such is
outside the scope of the study. Instead, the intent is to merely collect data and manipulate
it with multivariate statistics in the context of prosthetics intervention, culminating in
useful information that may prove as evidence in future studies. As such, these theoretical
models, in combination, drive the purpose and exploratory nature of the study and
support all 4 research questions and hypotheses.
The biopsychosocial model. When psychiatry was challenged as a legitimate
branch of medicine in the 1970s, the field was criticized for failing to follow the medical
model that posited a purely molecular explanation of all disease processes (Wilson, 1993;
Freedman, 1995). In 1992, G. L. Engel defended the need to include psychological and
social factors in considering the diagnosis and treatment of both physiologic and
psychiatric disease, using the examples of diabetes and schizophrenia to illustrate the
importance of “a biopsychosocial model which includes the patient as well as the illness”
(Engel, 1977, 133). This model has been further embraced in multiple other medical care
models, including those specific to chronic disease and self-management, especially
diabetes (Rakovec-Felser, 2011; Zinszer, Mulhern, & Kareem, 2011).
More recently, Fischer and colleagues (2005) posit a “Resources and Support
Self-management” model that is based on two key premises: that an individual’s behavior
(and subsequent decision-making) is strongly influenced by their physical and social
environment, and that their perspective regarding their circumstance and resource
availability is central to disease control and quality of life, basically coming full-circle to
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Engle’s initial theory (Fisher et al., 2005; Goodman, Yoo, & Jack, 2006).
Therefore, as exemplified in the section “Living with Limb Loss” in Chapter 2
and under the mantel of these models and theories, it is believed that patient
psychological status (as indicated by a diagnosis of MDD or PTSD), and behavioral
factors such as SUDs, with direct and indirect influence from socio-demographic factors
(age, gender, marital status, being subject to medical care co-payments), will cause
variations in their maintenance of disease self-management, to include care of their
residual and artificial limbs (Hypotheses 3 and 4).
Definition of Terms
CPRS: Computerized Patient Record System. The VHA’s electronic medical record
system, a component of VISTA (Brown et al., 2003).
Current Procedural Terminology (CPT) codes: CPT codes are numbers assigned to every
task and service a medical practitioner may provide to a patient, including
medical, surgical, and diagnostic services, primarily for billing purposes
(American Medical Association [AMA], 2013). They are developed, maintained,
and copyrighted by the American Medical Association. CPT coding is similar to
ICD coding, except that it identifies the services rendered rather than the
diagnosis. There are 3 types of CPT codes: Type I has six categories: (a)
Evaluation and Management, (b) Anesthesia, (c) Surgery, (d) Radiology, (e)
Pathology and Laboratory, and (f) Medicine (AMA, 2013). Type II codes have to
do with “performance measurement” and are distinguished by being alphanumeric
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rather than strictly numeric (as Type I codes are) (AMA, 2013). Type III codes
have to do with emerging technologies and all end with the letter “T” (AMA,
2013). A further discussion of CPT codes is provided in Chapter 2.
Dysvascular: Dysfunction or failure of the vascular circulatory system, to include
peripheral arterial disease (PAD), diabetes mellitus, and peripheral vascular
disease (PVD) (Dillingham et al, 2005)
General Estimating Equations: General Estimating Equations (GEE) are amultivariate
statistical modeling method considered more robust than General Linear modeling
for it accommodates non-continuous dependent variables, a Poisson distribution,
and the dependent variable need not be linearly linked to the
independent/predictor variable (Garson, 2008, 2011a).
HCPCS codes: Healthcare Common Procedure Coding System—A standard code
developed by the Centers for Medicare & Medicaid Services (CMS) for
reimbursement purposes. The U.S. Food and Drug Administration (FDA)
forwards information on durable medical equipment (DME) applications to the
CMS. CMS then assigns the item an HCPCS code. These are frequently referred
to as “L-codes” or “billing codes” (Centers for Medicare & Medicaid Services
[CMMS], 2012).
ICD-9-CM codes: The International Classification of Diseases, 9th Revision, Clinical
Modifications. ICD-9-CM is a standardized classification of disease, injuries, and
causes of death, by etiology and anatomic location. The combined information is
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assigned a unique, searchable, six-digit number, allowing various national and
international stakeholders to exchange information. ICD codes are maintained by
the World Health Organization (Centers for Disease Control and Prevention
[CDC], 2012).
Intact limb: In the case of the unilateral lower limb amputee, that limb which has not
undergone any amputation, although it may lack peripheral sensation (as in
diabetic peripheral neuropathy), or be arthritic, or have other musculoskeletal
problems that may compromise its use. Frequently this limb is also referred to as
the sound limb.
Major Depressive Disorder (MDD): Major depressive disorder, diagnosed by structured
psychiatric interviews and specific diagnostic criteria, is present in 5-13% of
Veterans seen by primary care physicians. Depression is a major cause of
impaired quality of life, reduced productivity, and increased mortality. Social
difficulties are common (for example, social stigma, loss of employment, marital
break-up). Depressive symptoms include depressed mood, loss of interest in most
activities (anhedonia), significant change in weight or appetite, insomnia or
hypersomnia, decreased concentration, decreased energy, inappropriate guilt or
feelings of worthlessness, psychomotor agitation or retardation, and suicidal
ideation. Symptoms must persist for at least two weeks (The Management of
MDD Working Group, 2009). The ICD-9-CM codes used are listed in Appendix
B, Table B15.
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Medical SAS Dataset: The VHA Medical Statistical Analysis System (SAS) Datasets are
national administrative data for VHA-provided health care. The datasets include
provided health care information primarily for Veterans, but also for nonVeterans such as employees and research participants. The datasets are provided
in SAS format by fiscal year (October 1 - September 30), and are extracted from
the National Patient Care Database (NPCD). They include: VA inpatient care
(four datasets); VA outpatient care (two datasets); VHA extended care (four
datasets); VA inpatient short stay (less than 24 hours) observation care (four
datasets); and health care provided for Veterans outside the VA with VA funding
(four datasets) (VA Information Resource Center (VIReC), 2012b). In all of the
Medical SAS Datasets, each patient has a unique identifier referred to as the
scrambled SSN, which is a formula-based encryption of the individual's Social
Security Number. The identifier is consistent for a given patient across datasets
and fiscal years.
NPCD: National Patient Care Database. This is maintained by the U.S. Veterans
Administration. The NPCD is an Oracle database maintained at the Austin
Information Technology Center (AITC) on a Unix platform (VA Information
Resource Center (VIReC), 2012b). It is the VHA's centralized data warehouse
that receives patient visit and encounter data from VHA clinical information
systems across the VA system. It is updated daily and contains such information
as: patient demographics, facility type and location, visit dates, ICD-9-CM codes,
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procedure and/or surgery codes, provider codes, and so forth. Since 1980, data
from this database has been made available as annual medical SAS datasets
(VIReC, 2012b).
NPPD: National Prosthetic Patient Database. Maintained by the U.S. Veterans
Administration Prosthetic and Sensory Aids Service Strategic Health Care Group
(PSAS). It is an Access relational administrative database comprising orthotic,
prosthetic and sensory devices dispensed to Veterans nationwide (Downs, 2000).
Data fields include visit dates, prosthetics provision, repair or replacement
information, product identification (cost, type, and so forth), and contractor (VA
Information Resource Center (VIReC), 2012a).
OPCF: Outpatient Care File: a subset of the VA’s NPCD. Each outpatient data record
represents one date of service for one outpatient, either as a visit or an event.
Visits on a single day to multiple clinics, laboratories, and treatment programs are
captured. Outpatient care is reported in terms of diagnoses (ICD-9-CM codes) and
procedures (CPT codes) (VIReC, 2012b).
Peripheral Arterial Disease (PAD): See “dysvascular” definition. Basically a collapse of
artery blood vessels.
Peripheral Vascular Disease (PVD): See “dysvascular” definition. Similar to PAD but
not limited to arterial blood vessels; PVD may include breakdown of venous
vessels.

29
Post Traumatic Stress Disorder (PTSD): Chronic post traumatic stress disorder
(symptoms lasting more than three months after exposure to trauma) can appear
alone (presenting with common symptoms of PTSD) or other co-occurring
conditions (persistent difficulties in interpersonal relations, mood, chronic pain,
sleep disturbances, somatization, and profound identity problems) or psychiatric
disorders (meeting DSM criteria for another disorder, such as substance abuse,
depression, and anxiety disorder). It is typically characterized by low energy,
memory problems, an inability to focus on work or daily activities, indecision, ,
irritability, agitation, anger, or resentfulness; emotional numbness, withdrawal,
disconnection from others, spontaneous crying, despair, or hopelessness; extreme
protectiveness or fear for loved ones; inability to face certain aspects of the
trauma, avoidance of activities, places, or persons associated with the traumatic
event (The Management of Post-Traumatic Stress Working Group, 2010). The
ICD-9-CM codes used are listed in Appendix B, Table B16.
Prosthetic foot: An artificial, mechanical foot component. These are typically categorized
into five groups as defined by their functional design: SACH (solid ankle
cushioned heel), multiaxis, dynamic response, dynamic response–multiaxis, and
hybrid/microprocessor (DePalma et al., 2002.
Prosthesis: Another word for an artificial limb.
Region: Regions represent four virtual divisions and the distribution of the VISNs as
determined and established by the Office of Information Technology (OIT) VHA
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Central Offices, 2013. They may be loosely described in geographical terms:
Region 1 - Northwest and Western U.S, Region 2 - North- and South-Central U.S.
(includes Texas), Region - Eastern Mid-West and Southern U.S. (includes Ohio),
and Region 4 - Mid-Atlantic and Northeast U.S. (includes Washington
DC/Maryland). It should be noted that a single VISN may cover areas in multiple
states.
Residual Limb: That part of an extremity that remains intact after amputation.
Socket: Refers to that prosthetic component that fits over the residual amputated limb and
serves as the interface between the mechanical components of the artificial limb
and the human tissue. It is typically hand-crafted and customized to the patient’s
residual limb (DePalma et al., 2002).
Substance Use Disorder (SUD): Substance use disorder includes conditions and
disorders of unhealthy alcohol use ranging from risky use, problem drinking,
harmful use and alcohol abuse, to alcoholism and alcohol dependence. It is
defined as the maladaptive use of substances (drugs or alcohol) leading to
clinically significant impairment or distress, typically manifested by at least three
of the following behaviors within a 12 month period: persistent desire or inability
to control use of the substance, significant time spent obtaining, using, or
recovering from the substance; social, occupational, or recreational activities are
sacrificed in lieu of use of the substance; and substance use persists despite
knowledge and evidence of its harmful effects (The Management of SUD
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Working Group, 2009). The ICD-9-CM codes used are listed in Appendix B,
Table B17.
Suspension system: A component of the artificial limb and of various types, the sole
purpose of which is to facilitate the fit and hold of the socket and artificial limb
over the residual amputated limb (DePalma et al., 2002).
Transfemoral amputation: a lower extremity amputation below the hip and above the
knee. It transects the femur and also is frequently referred to as an “above-knee
amputation”.
Transtibial amputation: an amputation of the lower extremity, below the knee but above
the ankle that transects the tibia /fibula. It also is frequently referred to as a
“below-knee amputation.”
V-codes: Visit codes identify occurrences of medical encounters related to circumstances
other than a disease or injury and are also used to report problems or factors that
may influence present or future care. The V-code is a supplemental classification
of ICD-9-CM and includes categories V01–V89 (CDC, 2012).
VISN: Veterans Integrated Systems Network. Regional offices of the Veterans
Administration that oversee the budgets and employment of over 163 VHA
facilities (Boyko et al., 2000).
VISTA: Veterans Health Information Systems and Technology Architecture, the core of
the VHA’s information technology system (Brown et al., 2003).
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Assumptions and Limitations
There were two primary assumptions maintained throughout this study analysis:
(a) that the data provided and used for analysis was reliable and valid, and (b) that the
prosthetic socket provided to the Veteran amputee was of good quality and design.
Data reliability and validity. Health care coding used in most administrative
databases (for example, ICD-9-CM, CPT, HCPCS codes) are prone to random and
systematic error resultant of physician judgment, communication failures, and/or coding
procedures. Therefore, they may not reflect precisely an individual’s disease condition or
appropriate treatment procedure (van Walraven & Austin, 2012). The VHA, through its
dependence on the VISTA and electronic medical record system (CPRS), has taken
significant steps to reduce this potential for error. Data that comprise both the NPCD and
NPPD are derived from roll-up applications from all VISNs, of which there are 23 across
the nation. Each VISN receives data from various facilities under its direction, and each
facility is responsible for compiling and maintaining its own administrative electronic
records (Boyko, et al., 2000).
The primary source of data for the NPCD is CPRS, the electronic medical record
system utilized by the VHA. It has features specific to each VISN, but the data features
and dictionary are standardized across all VISNs (Brown, et al., 2003). At the time of the
patient "encounter" or visit, the physician is responsible for selecting the appropriate
treatment (CPT) or diagnosis (ICD-9-CM) code from selection boxes as part of their
signed progress note or consult. However, the selection of these codes is prone to
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multiple sources of error to include: poor communication between the patient and
clinician leading to inaccurate decisions; the clinician’s depth (or lack thereof) of
knowledge and training regarding ICD9-CM and CPT codes or field of medicine, leading
to the use of more generic codes over a more precise definition; and pressures of patient
workload leading to fatigue and case confusion or inaccuracy (O'Malley et al., 2005).
Ultimately these codes reach professional medical coders who, based on a review of all
the pertinent medical information, assign a “principal diagnosis” (as defined by the
Uniform Hospital Discharge Data Set—UHDDS), as well as a principal treatment code
and, in the VHA, up to 14 additional diagnostic codes and 7 procedure codes in a
patient’s day, for those cases that required multiple evaluations, therapeutic interventions,
extended care or monitoring, and diagnostic procedures such as laboratory and imaging
(O'Malley et al., 2005). The degree of accuracy of the selection of these codes, which are
eventually rolled-up from the various facilities and VISNs into the VHA’s national
administrative database, is dependent on the skill, training, and experience of the coders
who are, in turn, dependent on the clinician’s code selections for accurate information
regarding a patient’s condition and care.
Similarly, the NPPD is a roll-up of fields from the Prosthetics Software Package
(PSP) which has recently (as of FY 2010) been upgraded and includes the Orthotics
Workload (OWL) application (G. W. Bosker CPO, personal communication, January
2013). The PSP is integrated with six other Vista applications including: PSAS (the
Prosthetics and Sensory Aids Service—Central office); IFCAP (Purchasing/Supply
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services); Consult Tracking (prosthetic purchases are resultant of consultation requests
from other services); CPRS, Patient Care Encounters (for purposes of patient and
clinician workload tracking); DSS (Decision Support Service, which is responsible for
vendor contracts); and billing (Werner, 2010). They are integrated through an exchange
of data via Vista which allows for the direct transference of data rather than merely
copies of files, thereby limiting another source of systematic error. Similar to CPRS
notations, for every patient encounter with the Prosthetics–Orthotics Service, there is an
accounting of that visit via various menus and associated electronic forms, including one
for purchasing prosthetic devices (Werner, 2010). The software application provides lists
of items (device model and make), as well as edit fields to provide additional information
for the vendor, including a specific model or type (Werner, 2010). To complete the
transaction, the practitioner selects the status of the device (initial, repair, replacement, or
spare) as well as the corresponding HCPCS code that is provided based on the item
selection (Werner, 2010).
With such controls to minimize communication and systematic error, one can
only assume that, for both CPRS and PSP, the selection made by the practitioner was
correct and appropriate. The NPCD has been and is regularly evaluated for validity and
reliability, and found to attain levels of over 90% validity (Murphy et al., 2002).
However, the NPPD, being a fairly new database, has not yet undergone similar
reliability and validity testing, although it has been utilized for multiple published
works— to include a comparison of artificial limb distribution frequencies across VISNs
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and between VA and commercial providers (Downs, 2000), an estimation of total
prosthetics spending across a selection of VISNs in FY 1999 (Render, Taylor, Plunkett,
& Nugent, 2003), some wheelchair type distribution and costs comparisons during FY
2000-2001 (Hubbard et al., 2007), and a determination of clinical characteristics
associated with artificial limb prescription for the elderly amputee (Kurichi et al., 2007).
M. L. Smith and colleagues conducted and published an evaluation of the NPPD in 2010
in which they compared an accounting of outpatient and inpatient visits (as recorded in
the NPCD) related to the Prosthetics–Orthotics Service with an accounting of device
delivery dates as specified in the NPPD. They determined that while the number of
devices delivered (as determined by Type II CPT codes) was significantly greater than
the corresponding number of related visits, this could be explained by the fact that a
single clinical outpatient or inpatient visit (as per the NPCD) could amount to multiple
devices delivered (as per the NPPD) (Smith et al, 2010). Additionally, as per an
accounting of visits and visit dates, the authors determined that there was a 40–60%
discrepancy between clinic visit dates and the VA mandated delivery date of 14 days post
request; however, again, this discrepancy may be due to the availability of devices, types
of devices dispensed (for example, artificial limbs must be custom fabricated), and
manpower issues (Smith et al., 2010). For the proposed study, this discrepancy is fairly
irrelevant as the intent is to merely note and account association frequencies between
artificial limb configurations and components with the presence or absence of categorized
residual limb problems.
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Finally, in this study, CPT codes and/or ICD-9-CM codes were used to define
residual limb status, based on the procedure (or diagnosis) required to treat a residual
limb related problem. The intent of such coding is to provide uniform information. As the
focus of the study is on patient outcome and not on healthcare service, an assumption was
maintained that different residual limb problems require different treatment procedures,
and thus different CPT codes or combinations thereof, and that the CPT codes for service
were reflective of actual patient outcomes.
A further discussion of the NPCD and NPPD database structures is provided in
Chapters 2 and 3; further definitions of CPT, ICD-9-CM, and HCPCS codes are found in
Chapter 2, as well as a listing of codes of interest in Chapter 3 and Table 3.
Prosthetic socket craftsmanship. As stated in the Background section of this
chapter and further described in Chapter 2, the fit of the prosthetic socket has direct
bearing on the residual limb's condition. A poorly crafted socket may cause not only pain
and discomfort for the amputee, but may also exacerbate forces and frictions exerted on
the residual limb, leading to residual limb breakdown of skin and soft tissue (Ferguson &
Smith, 1999). While not all prosthetists associated with the VHA may be licensed in their
particular state of residence, all are certified by the American Board of Certification and
thus are trained in the fit and manufacture of prosthetic sockets. (G. W. Bosker CPO,
personal communication, January 2011). Therefore, this study assumes that all prosthetic
sockets provided are fitted and crafted to the best of the ability of the prosthetist, but that
the craftsmanship may vary between prosthetists on the basis of experience and/or skill;
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that any ensuing residual limb problems are due to artificial limb configurations
concurrent with medical comorbidities, and/or the patient’s living conditions
(independent or assisted, single or married), but not due specifically to poor
craftsmanship of the socket.
Each VISN station represents multiple VHA facilities and/or prosthetists (the
VHA also frequently contracts with prosthetists in the local economy) (G. W. Bosker
CPO, personal communication, January 2011). The study tracked patients over a threeyear period, during which time the patient may have moved, or the prosthetist supervising
their artificial limb provision may have changed, even within a VISN. For the purposes of
this study, it was assumed that the patients being followed and remaining within a
particular VISN was treated by the same prosthetist and skill level.
A unique population. While the VHA national databases provide significant case
numbers to support statistical power, characteristics of its patient population are unique
and thus not necessarily generalizable to the non-military or general public
More specifically, the Veteran population seeking health care from the VHA is
over 90% male, predominately of low socio-economic status, and of a racial mix that is
not representative of the current United States population rates (Mayfield et al., 2000;
Department of Veteran Affairs, 2010). For example, the 2010 U.S. Census reported the
following statistics: 69.1% of the population reported being White, 12.1% reported being
Black, 3.96% as Asian, 12.5% reported being Hispanic, 0.7% reported being American
Indian/Alaskan Native, and 0.2% reported as being “other”
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(http://www.census.gov/popfinder/2010)/. In contrast, the Veterans Administration
reported for 2009 a population that was 79.3% White, 11.3% Black, 1.3% Asian, 5.8%
Hispanic, 0.8% American Indian/Alaskan Native, and 1.3%”other (Department of
Veteran Affairs, 2010). Further, especially for the service-connected Veteran amputee,
health care costs are significantly lower than those in the private sector, likely influencing
the number of visits and/or severity of condition, as well as the configuration of the
artificial limb provided. In fact, for individuals with service-connected medical
conditions, there is a VHA directive that they receive “best practice” and “state-of-theart” artificial limbs and prosthetic devices (DePalma et al., 2002, The Rehabilitation of
Lower Limb Amputation Working Group, 2007). Such devices would likely be cost
prohibitive for similar individuals in the non-military, general public.
The dysvascular amputee. As discussed in Chapter 2, acquired limb loss
consequent of dysvascular complications is frequently characterized by issues not shared
by limb loss from other etiologies. Most significant of these is a high one-year mortality
rate and re-amputation of the same or contralateral limb. It is primarily for these two
reasons that a decision was made that the cohort under study have undergone transtibial
amputation during the same fiscal year. Relative to this decision however, one might
argue that limitations of the study include: (a) all the artificial limb users will be
inexperienced and thus more prone to complications (or not); (b) findings will not be
necessarily generalizable to the proven successful long-term artificial limb users; and (c)
the study population (dysvascular amputees) does not lend itself to activity levels that
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truly challenge the efficacy of some artificial limb configurations and thus may bias the
results (for example, fewer residual limb problems because of less activity, not because
of the artificial limb configuration).
A novel dataset. Another limitation of the study is related to the uncertain
validity and reliability of the NPPD. A study that investigates the actual configuration of
an artificial limb has yet to be reported or published, although a study of wheelchair type
(lightweight, motorized, or standard) has, and suggests study feasibility (Hubbard et al.,
2007). Nonetheless, a limitation of this study is its retrospective database study design as
opposed to a prospective observational study. Given this methodology, it is not feasible
to confirm artificial limb configurations, fully appreciate a cohort member’s residual limb
outcome, or measure the extent to which they actually utilized their artificial limb. As
noted under “Assumptions,” the medical codes being utilized are reflective only of a
cohort member’s actual condition. A CPT code describes the treatment, but not the actual
problem; some skin wounds may not warrant an ICD-9-CM code, or a physician’s
selection of either code may be imprecise. None of the patient codes were validated with
a chart review or abstraction, and were thus limited to database accuracy. Further, there is
no standardized or universally agreed-upon patient outcome to associate with artificial
limb use (a matter discussed further in Chapter 2), and thus the use of medical coding
may be considered to be a limitation of the study because its value as an outcome
measure of artificial limb usage is untested and speculative.
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The scope of the study. This study was a descriptive analysis of a cohort of
Veterans identified in the NPCD as having undergone a transtibial amputation between
October 1, 2006 and September 30, 2007 (FY 2007). Utilizing this same database, the
cohort was followed for three sequential years: FY 2007, FY 2008, FY 2009, and FY
2010. Given the seriousness of the comorbid dysvascular etiology underlying their
amputations, some cohort members did not survive the observation period. Only
mortality rates as ascertained from this database were calculated and thus did not include
deaths outside VHA facilities, nor from other databases such as the Beneficiary
Identification and Records Locator System (BIRLS) utilized to confirm a cohort
member’s death (Dominitz, Maynard, & Boyko, 2001)
Some cohort members may have been “lost” due to unaccounted death, before or
after receiving their definitive artificial limb; or because further health care was sought
outside the VHA system; or because use of the artificial limb was abandoned. This study
did not address the lost cohort member beyond an accounting of relevant episodes such as
residual limb problems (to include surgical revision), changes in artificial limb
configurations, or discharge due to death during the three-year observation period.
The cohort was also tracked over the same time period through the NPPD in order
to identify dates of artificial limb provision and component replacement. Although
several other artificial limb components are necessary or may improve performance (for
example, pylons and rotators), for the purposes of this study, the identification of
prosthetic artificial limb components was limited to categories of prosthetic feet and
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socket suspension systems. For example, as discussed in Chapters 2 and 3, a single make
and model of prosthetic foot may require several HCPCS codes but be representative of a
particular category of prosthetic foot (such as a multiaxis foot or a dynamic response
foot) (G. W. Bosker CPO, personal communication, January 2011)
The categories of prosthetic feet are relatively arbitrary and typically based on
function, but also generally accepted by the prosthetics community. To simplify data
analysis, this study endeavored to categorize artificial limb components into such
accepted categories rather than examine individual makes and models of components, as
to do so is beyond the scope of the study. Later studies may focus on other artificial limb
components, or specific component makes and models. Additionally, it is beyond the
scope of this study to ascertain whether or not a dispensed artificial limb is abandoned by
the cohort member.
Finally, the follow-up period of three years was determined on the basis of data
availability. As noted under “limitations,” the NPPD is a relatively new and not-yet
validated database. In 2005 significant software upgrades were made to improve its
reliability. A FY 2007 cohort was selected to allow for these database improvements, but
subsequently limited the follow-up period. Nonetheless, literature suggests that the
average durability for a transtibial artificial limb is 5 years, but the typical user’s
accommodation period is six months to one year (Datta, Vaidya, & Alsindi, 1999;
DePalma et al., 2002; TheRehabilitationofLowerLimbAmputationWorkingGroup, 2007).
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It is not clear if a longer follow-up period would reveal more meaningful information, but
this may be considered for future studies.
While a major thrust of this study was to develop a framework for a useable and
meaningful amputee-artificial limb database derived from administrative health care
records with standardized coding systems, the value of the epidemiological analysis used
to “test” the derived database is not to be discounted. As revealed by multiple reports,
few studies have used a systematic approach to assess artificial limb use outcomes, and
even fewer have applied such an approach to residual limb skin problems (Bui et al.,
2009; Collins et al., 2006; Meulenbelt, et al., 2006). As discussed previously, multiple
factors have led to such a dearth of research, not the least of which has to do with the
sheer complexity of artificial limb use, both in terms of mechanics of the artificial limb
itself and the user’s state of health (mental and physical). Given such complexity and the
dynamic interrelationships therein (especially in light of the biopsychosocial model), it
was felt that an analysis of the user’s demographics, outcomes, and artificial limb used
would not suffice or add any truly useful information to the existing body of knowledge.
However, and by the same token, (that is, the complexity of the subject matter), a simple
but robust analysis would provide more useable information than a more structurally
complex approach (such as regression analysis), given the vagrancies and limitations of
the data sources.
For these reasons, the epidemiological analysis of this study employed
multivariate analysis modeling (via General Estimating Equations – GEE), was limited to
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only two components of an artificial limb (the prosthetic foot and the socket suspension
system) in relation to a single binomial outcome (a medically coded residual limb skin
condition categorized as “severe” or “less severe”) and potentially modulated by the
behavior of the user as suggested by medically coded and diagnosed comorbid conditions
to include depression, PTSD, or SUD. Despite these scope limitations, the findings from
the epidemiological analysis successfully addressed some major issues to include: (a)
information as to the viability of medical coding relative to artificial limb devices and
patient conditions as a tool for future studies, (b) identify trends in artificial limb
component dispensed to Veterans across VISNs that may prove useful for future VHA
leadership Quality Assurance/Quality Improvement evaluations, and (c) perhaps more
importantly, offer insight and add to the body of knowledge regarding the significance of
comorbid conditions and mental health status toward the long-term successful use of a
lower extremity artificial limb, especially in light of the artificial limb components used.
In conclusion, this study was intended only to lay the methodological and
descriptive analysis foundation for future studies that may seek predictive relationships
regarding artificial limb configuration and patient outcome. Such studies should,
logically, lead to improved prescription and/or design and clinical guidelines, as well as
provide support for the establishment of an amputee care surveillance system or registry.
Significance of the Study
While the purpose and methodology of this study is fairly simplistic, the driving
factors behind the investigation are not.
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Today's society of capitalism and marketing has influences that reach deep into
the medical and health care industries. The field of prosthetics is not immune to these
influences and is further not open to governmental control such as by the FDA
Subsequently, marketing information is a prime source (if not the only source) for many
practitioners and prosthetists, because objective, evidence-based outcomes are not easily
accessible.
Marketing information provided for artificial limb components and prosthetic
devices is typically not based on generalizable, objective, or long-term evidence-based
measures of user outcomes, but rather on manufacturer design and selected study results.
Further, manufacturers of such devices are faced with the high cost of development,
materials, and production, coupled with a rather small niche market, and thus, they have
minimal incentive/resources to conduct large scale, randomized, control trials, which are
typically a source for objective, evidence-based information.
Unfortunately, unlike a pair of shoes, it is not a simple matter to exchange one
artificial limb for another, nor does the typical artificial limb user have any prior
experience, so most are dependent on the decisions and recommendations of their
practitioner. Many times, those decisions and recommendations are based on ambiguous,
if not biased, evidence, and the results thereof are borne by the patient in the form of
further complications, health risks, and costs. Consequently, given an artificial limb, 25%
of the intended users will ultimately choose to abandon it and, in the case of the lower
extremity amputee, this means a significant loss of mobility, independence, and
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socialization, although many resort to using a wheelchair with its own set of barriers and
issues (van der Linde et al., 2004). Clearly, in the field of prosthetic devices and
components, evidence-based practice recommendations are needed that go beyond
personal experience and anecdotal evidence.
Without objective outcome measures of artificial limb acceptance and usability, it
is very difficult for practitioners to make the best possible decisions and
recommendations for their patients. For example, an artificial limb design that will
function well for a young active individual will likely be totally inappropriate for an older
less active user, and vice versa. Marketing practices may not make such a differentiation,
claiming instead that technological advances have led to the development of a more “lifelike” limb, without the benefit of objective evidence to support its properties, limitations,
or conditional considerations. A practitioner, then, may rightly or wrongly prescribe such
an artificial limb on the basis of significantly biased information, patient persuasion, and
the presumption that more advanced technology must be better, which is a logically
seductive concept. Such a decision may put the patient at undue risk, and also may
ultimately be considered fraudulent in regard to medical care costs and insurance
coverage. In fact, more and more, insurance companies, including Medicare and
Medicaid, are requiring objective evidence to support billing and payment practices (G.
W. Bosker CPO, personal communication, January 2011). It is therefore hoped that the
findings of the study will help the practitioner/prosthetist to overcome marketing
influences and capitalistic tendencies in the prescription of prosthetic devices, by
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providing objective evidence of artificial limb component impact on residual limb
outcomes for the lower extremity amputee.
This small step away from marketing and commercialism is one step toward
social justice for a very vulnerable population, the amputee, and any move towards social
justice is a move towards positive social change. Albeit small and incremental, this move
toward social justice is relative to many, not just in regard to racial or gender disparity,
but more towards that which governs disabled persons. Regardless of an individual’s socalled disability, it should be the goal of the healthcare and medical system to not merely
diagnose and treat the individual, but to selflessly facilitate their community integration,
good health, and any necessary lifestyle change—the same care that is expected by any
able-bodied individual. Countering or supporting relative marketing information, through
the acquisition, evaluation and/or dissemination of objective evidence-based outcomes—
the basis of translational and comparative effectiveness research—is key to such
facilitation.
More specifically and relative to lower extremity amputees, this move towards
social justice will help to ensure that any individual receiving a prosthetic device that
does not require FDA approval can be assured that the device will cause minimal
subsequent harm, that any ensuing costs are minimal, that the device is appropriate for
their condition, and that there is unbiased evidence to support such claims. To this end, it
is hoped that this study will begin to lay the foundation for the development of a patient
prosthetic high-quality clinical database through demonstration of its potential value.
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While an administrative healthcare database (such as those to be used in this study) may
be an imperfect tool for assessing patient outcome, it nonetheless is an eloquent tool for
describing trends and patterns relative to patient care and diagnosis. Areas of more
defined research may be identified, leading to more focused and efficacious human
research or, as in the case of this study, better device design and manufacture. It is further
hoped that the results from this study will inspire prosthetic manufacturers, prescribing
practitioners, patients, and their prosthetists, to more carefully consider the
appropriateness of an artificial limb component, rather than just considering its state-ofthe-art status or its high-tech qualities
Summary
It is well understood that the primary purpose of an artificial limb is to restore
function, but function should not be at the cost of pain and/or residual limb complications
(DeLisa & Kerrigan, 1998). It is also understood that rarely is any one artificial limb
component solely responsible for such complications, but rather it is one of several
factors, to include the individual’s demographics, their health status (physical and
mental), socket fit/craftsmanship, and influences from other components (DePalma et al.,
2002; Desmond & MacLachlan, 2002)
Nonetheless, this study is believed to be one of the first of its kind as it takes
advantage of large case numbers in national databases maintained by the VHA (2,321
unique new major lower limb amputations in FY 2009; personal communication: L.
Copeland, PhD February20, 2010) to examine patient outcomes relative to artificial limb
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devices, as well as focusing on long-term residual limb outcomes rather than more
immediate artificial limb functionality, or subject/patient measures.
The ensuing chapters further articulate the need for such a study, characterize the
cohort/population, and provide detail regarding the compilation of the integrated dataset
and subsequent descriptive statistical analysis plan.
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Chapter 2: Literature Review
Outline of the Chapter
This chapter will highlight the literature by providing background information
about the key components of the research study: the amputee population, their artificial
limbs, outcomes, and methods of research relative to the field of prosthetics and the
amputees. As such, emphasis is placed on the epidemiology of the dysvascular lower
limb amputee, artificial limb components suitable for a transtibial amputation, factors
driving and contributing to the prescription thereof, and outcomes, both physical and
psychosocial, faced by an individual utilizing a lower extremity artificial limb.
Additionally, a brief discussion of the practices of evidence-based medicine (EBM) and
its limitations in the realm of rehabilitation medicine (specifically prosthetics) is
presented, leading to a discussion of alternative methodologies such as practice-based
evidence (PBE) and healthcare database analysis specific to the VHA. In conclusion, the
long term goals and objectives of this research study are presented as a means to define
the relevance and importance of this research study, both medically/clinically and
socially.
Review Strategy
Given the breadth and novelty of the study, literature searches were conducted
topically, but with overlapping terms. An initial keyword search utilizing the Ovid search
engine was conducted with the terms artificial limb or prosthesis, prescription or
guidelines, amputee or amputation, limited to human studies, English text, and as of 1996
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(to find the most relevant literature and current prosthetics), in an effort to ascertain what
literature was available pertaining to artificial limb prescription guidelines. No articles
were found in Medline and/or EBM Cochrane Reviews, so the search terms were
modified to explore literature available on amputee outcomes, prosthetics research, and
amputee databases, registries, or repositories. Of note, using the above designated limits,
only one article was found for the keywords amputee and outcomes, and two (though not
sufficiently relevant) for the terms amputee and database (none for amputee plus the term
registry or repository). Further, on the matter of amputation epidemiology, the search
terms amputee, amputation, acquired limb loss, epidemiology, and statistics were used in
various combinations using both the Ovid and PubMed search engines and were limited
to those articles with abstracts, English text, and published as of 1991. For topics related
to psychological and/or social issues, databases were expanded to include PsychInfo,
Social work abstracts, and Ovid HealthStar. Finally, references of relevant review
articles, and original papers were also examined for additional titles of interest. Citations
of articles published before 2005 were also searched for, in an effort to identify updated
findings of relevant topics.
This strategy was repeated for the main topics of the proposal: the epidemiology
of lower extremity amputation, dysvascular amputation (complications of PAD, PVD,
and diabetes), artificial limbs for the transtibial amputee, risk factors and barriers
following amputation, psychosocial issues for the amputee, evidence-based medicine
practices and methods, healthcare administrative records in research, and VHA healthcare
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national databases. While many original papers and journal articles were reviewed or
read for context and general background, only those original articles of particular topical
relevance and specific to the United States population and health care system were
selected as reference material for this study. Most articles were retrieved as full text from
online sources.
Certain websites were accessed that provided direct information or served as
portals to publications of interest. Websites of particular note include: Amputee Coalition
of America–National Limb Loss Resource Center (http://www.amputeecoalition.org/nllic_about.html),VA Information Resource Center
(http://www.virec.research.va.gov), National Center for Veterans Analysis and Statistics
(http://www.va.gov/VETDATA/index.asp), Centers for Disease Control and Prevention
(CDC)—Diabetes (http://www.cdc.gov/diabetes/statistics/complications_national.html),
and National Institute of Diabetes and Digestive and Kidney Diseases
(http://www2.niddk.nih.gov/).
The Etiology and Epidemiology of Dysvascular Limb Loss
Overview
Limb loss is indiscriminant of gender, age, race or socio-economic status, but it is
frequently closely associated with lifestyle and disease patterns among disparate
population groups (Dillingham et al., 2002). There are four
primary etiologies of limb loss, of which cancer, traumatic accident, and dysvascular
disease are the most common and are responsible for cases of “acquired limb loss” or true
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amputation (Limb Loss Resource Center, 2012). Such afflicted individuals describe the
predominance of artificial limb users, particularly for the lower extremities. Limb loss
due to congenital causes and birth defects are the least common and typically do not
require amputation, but such persons are frequently practiced and uncomplicated users of
artificial limbs (Limb Loss Resource Center, 2012).
Cancer is the third most frequent etiology for acquired lower limb loss, with a
2005 estimated prevalence of “13,000 persons or approximately 72% of all cancer-related
amputations” (Ziegler-Graham et al., 2008). Of the various cancers, osteosarcoma is the
most frequent cause for amputation. Whenever possible, the affected limb is salvaged
such that only the cancerous bone and marginal tissue are removed, and may involve the
replacement of a limb joint rather than limb amputation. Depending on the location of the
tumor and level of amputation, use of an artificial limb is quite practical and successful
(Bacci et al., 2003).
Limb loss due to trauma is the second most frequently occurring etiology and
accounts for the predominance of upper extremity amputations (Limb Loss Resource
Center, 2012). The 2005 prevalence estimate for major lower limb traumatic amputations
was 106,000 or 15% of all trauma-related amputations estimated for that year (ZieglerGraham et al., 2008). Traumatic amputations usually result directly from occupational
hazards and motor vehicle or recreational accidents. Natural disasters, war, and terrorist
attacks can also cause traumatic amputations and explain sudden increases or decreases in
worldwide incident rates (DePalma et al., 2002). However, a “traumatic amputation” is
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not limited to the individual who suffers a severed limb consequent of the causes
mentioned. Serious burns (chemical, radiation, fire, and so forth) are a contributing
factor, as such patients are susceptible to compartment syndrome in which there is a
significant interstitial tissue fluid imbalance. In such cases, the fluid imbalance leads to
muscle necrosis that, when uncontrolled and substantial, may necessitate amputation over
limb salvage (DePalma et al., 2002; Li, Liang, & Liu, 2002; Sandnes, Sobel, & Flum,
2004).
In the United States and most developed nations, amputation due to dysvascular
diseases is the most common. More specifically, as derived from the National Health
Interview Survey between 1988 and 1996, approximately 82% of all nonfederal hospital
discharges for amputations annually were due to dysvascular disease complications, for
example: critical limb ischemia due to peripheral arterial disease (PAD), peripheral
vascular disease (PVD), complications of foot ulcers among persons with diabetes and
PAD, and joint or bone infection (Centers for Disease Control and Prevention [CDC],
2006). In 2005, Ziegler-Graham et al., estimated that 504,000 persons were living with
the loss of a major lower limb due to dysvascular disease complications (nearly five times
that for traumatically acquired limb loss), accounting for nearly 60% of all lower limb
amputations (Ziegler-Graham et al., 2008).
Generally speaking, incident rates for lower extremity amputations are nearly four
times more common than upper extremity amputations, and diabetic/dysvascular
amputations are at least twice as common as traumatic amputations (CDC, 2006;
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Dillingham et al., 2002). Persons in the 65–74 year age group represent the largest group
of new amputees (although individuals over the age of 75 are twice as likely to undergo
amputation) and, across all age groups, men are 15% more likely to undergo an
amputation than women (Dillingham et al., 2002a; Ephraim et al., 2003). While the
predominance of persons living with limb loss may be White, the risk of amputation is
three times greater among Black, and approximately 1.5 times more likely among
Hispanics. Age, diabetes and heart disease, smoking, lack of exercise, and lack of proper
nutrition are, as well as barriers to preventive and primary health care, postulated to be
contributing risk factors for the loss of a limb and observed disparities (Dillingham,
Pezzin, & Mackenzie, 2002b; Ephraim, Dillingham, Sector, Pezzin, & MacKenzie, 2003;
Resnik & Borgia, 2004).
Acquired Limb Loss Due to Dysvascular Diseases
Amputation subsequent to peripheral vascular diseases (PVD) is a common
occurrence among the more developed nations as well as being age-related and primarily
of the lower extremities. While individuals with PVD or peripheral arterial disease (PAD)
may also experience loss of foot sensation, more often the complaint is of limb pain and
weakness (Steffen, Duprez, Boucher, Ershow, & Hirsch, 2008). Medication, vascular
bypass surgery, and angioplasty/stents are the first line of treatment, but ultimately
amputation is required to remove potentially gangrenous and painful extremities
(Osterman, 1992; Steffen, et al.,2008). The primary explanation for high PVD rates
revolves around a growing elderly population and the concordant rise in both diabetes
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and PAD. In fact, in 1996 there were an estimated 10 million persons living in the United
States with a diagnosis of PAD (diabetes-related or otherwise), of which about 129,000
required in some level of amputation, equating to about one out of every 2,000 persons
being an amputee (Criqui, 2001).
Of the dysvascular conditions, diabetes and diabetic complications account for the
largest proportion of below-knee amputations, typically subsequent to foot ulceration and
infection (Adler, Boyko, Ahroni, & Smith, 1999; Davis, Norman, Bruce, & Davis, 2006;
Ephraim et al., 2003; Mayfield, Reiber, Maynard, Czerniecki, & Sangeorzan, 2004;
Rayman, Krishnan, Baker, Wareham, & Rayman, 2004; Reiber, Lipsky, & Gibbons,
1998). In fact, by 2005 estimates, approximately 70% of persons with dysvascular-related
acquired limb loss were also recorded as having comorbid diabetes, with this percentage
reducing to approximately 60% by 2010 (CDC, 2014). Further, it is likely that nearly
85% of the estimated 359,000 major limb amputations among this population were
preceded by a foot ulcer (CDC, 2011a; Ziegler-Graham, et al., 2008).
One of the complications of diabetes is neuropathy and, when in the presence of
poor microvascularization, an individual is particularly prone to foot ulceration (CDC,
2011a; Reiber & Raugi, 2005). Individuals with this condition cannot feel pressure points
or “hot spots” on their feet, and thus do not adjust their gait and foot fall patterns
accordingly to protect the injured tissue. Without regular visual inspection of their feet,
these pressure sores go undetected, tissue breaks down and ulcers form, providing an
entrance for infection (Reiber & Raugi, 2005). The big toe, first and second metatarsal
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heads, fourth and fifth metatarsal heads, and heel (in order of frequency) are those
regions of the foot most prone to ulceration (Adler et al., 1999; Izumi, Satterfield, Lee, &
Harkless, 2006; Reiber et al., 1998). Typically, symptoms of peripheral neuropathy will
manifest themselves within 10 to 20 years of diabetes onset—and even sooner, with
uncontrolled glucose levels (CDC, 2011a; CDC, 2014). It is also estimated that
approximately 25% of individuals with limb loss due to diabetes will undergo reamputation, typically due to complications of the residual limb, or ulceration and
infection of the intact, contralateral foot (CDC, 2011a; Davis, et al., 2006; Dillingham, et
al., 2005; Izumi, et al., 2006).
For Blacks, the risk of dysvascular lower limb acquired limb loss is estimated to
be 1.5 to 3.5 times that of non-Hispanic Whites, while for Hispanic Americans the risk is
estimated to be 1.5 times greater than their White counterparts (CDC, 2011a). These
variations in rates among racial and ethnic groups may be attributed, in part, to
differences in the prevalence of underlying disease (for example, the prevalence of
diabetes among Blacks is 1.8 times greater than that of Whites), but regardless, the
incidence of diabetes-related amputation in men is two to three times greater than that in
women, irrespective of age, race, ethnic origin, or nationality (CDC, 2011a; Dillingham,
et al., 2002b).As such, the difference in limb loss rates between men and women is likely
more a reflection of society behavior norms and expectations for men versus that of
women, particularly in the realm of health and healthcare self-management (Ephraim et
al., 2003; Jack, 2004; Tudiver & Talbot, 1999).
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Limb Loss Current Trends and the Future
Typically, incidence and prevalence rates offered regarding limb loss or
amputation are derived from multiple sources, the most commonly used being hospital
discharge records, results of the National Health Interview Survey (NHIS), or the Health
Care Utilization Project National Inpatient Sample (HCUP-NIS). However, as of 1996,
national estimates of persons living with limb loss (acquired or otherwise) became
increasingly difficult to acquire due to the discontinuation of “triggering” and relevant
questions in the NHIS (Ziegler-Graham et al., 2008). Given no other national monitoring
or surveillance system for limb loss, and in an effort to provide more current relevant
statistics, Ziegler and colleagues (2009) calculated limb loss estimates for 2005 with
projections for 2050 (Ziegler-Graham et al., 2008).
Rate estimates were based on historical patterns of age-specific and sex-specific
limb loss incidence rates, mortality, and relative risk rates by race and ethnicity, as well
as incidence patterns of underlying disease etiologies of limb loss (for example: PAD,
cancer, diabetes and diabetes complications, and so forth). Utilizing census data, nonfederal hospital discharge records, and established algorithms, the authors constructed
estimates of limb loss prevalence by age, race, gender, and limb loss, anatomical level,
and etiology (see Table 1 for examples of their findings). However, the derived estimates
do not include VHA amputation records, reported to account for nearly 10% of all
amputation-related discharges in a given year, nor do they include amputations resulting
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from armed conflicts or any other cause for which military personnel were treated in a
military hospital (Dillingham et al., 2002b; Ziegler-Graham et al., 2008).
Despite an obvious under-counting of cases, the 2005 estimated prevalence for
acquired limb loss amounted to 1.6 million persons, an increase of 10% from the 1996
estimate of 1.3 million (Ziegler-Graham et al., 2008). These estimates represent all levels
and most causes of acquired limb loss from fingers and toes to upper and lower major
limb amputations, due to cancer, dysvascular disease, diabetic complications, and noncombat trauma. Further, for 2005, Ziegler-Graham estimated that 33% were amputations
of the major lower limbs, 42% were over the age of 65 years, 65% were men, and 42%
were non-White. Given present and projected population trends, the authors further
estimated that by 2050, the prevalence rate would double to over 3.6 million persons, be
proportionally more Hispanic, and would be driven by an aging population, extended life
expectancies, and associated age and ethnic dysvascular disease/diabetic patterns.
Given such projections, policies are obviously needed that provide for effective
access to artificial limbs, assistive devices, and appropriate health and prosthetic services.
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Table 1
Past and Predicted Prevalence Rates of Persons Living with Limb Loss
Etiology
1996
2005
2020
2050
All etiologies
1,286,000
1,568,000
2,213,000
3,627,000
Traumatic
Unavailable
704,000a
906,000
1,326,000
a
Cancer
Unavailable
18,000
22,000
29,000
Dysvascular
Unavailable
846,000a
1,285,000
2,272,000
(PAD &
diabetes)
Dysvascular
Unavailable
592,000a
899,000
1,667,000
(diabetes only)
Note. From “Estimating the prevalence of limb loss in the United States: 2005 to 2050,”
by Ziegler-Graham, K., MacKenzie, E. J., Ephraim, P. L., Travison, T. G., &
Brookmeyer, R, 2008, Archives of Physical Medicine and Rehabilitation, 89(3), p. 425.
Copyright © 2008 American Congress of Rehabilitation Medicine and the American
Academy of Physical Medicine and Rehabilitation Published by Elsevier Inc.
Reprinted with permission.
2005 prevalence estimates of persons living with the loss of a lower limb [by etiology:
dysvascular (PAD & diabetes)—504,000; dysvascular (diabetes only—359,000;
trauma—106,000; cancer—13,000.]
Living with Limb Loss
Limb loss for any individual is not a simple matter. It is physically and mentally
and even socially challenging, regardless of one’s age, gender or ethnicity. The loss of
even a single toe may affect one’s balance; the loss of a finger may be socially unsettling.
The loss of a major limb has profound effects including one’s ability to work or to
maintain a job, to care for oneself or another, to pursue recreational interests, and to
maintain a good quality of life (Coffey, Gallagher, Horgan, Desmond, & MacLachlan,
2009; Gallagher, 2004). The loss of a major lower limb inhibits one’s mobility and is
often characterized with long-term pain from phantom limb sensations, osteoarthritis of
overused or stressed joints, chronic low back pain, and the risk of re-amputation
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(Desmond et al., 2008; Dudek et al., 2005; Ephraim, MacKenzie, Wegener, Dillingham,
& Pezzin, 2006; Flood et al., 2006; Gallagher, 2004; Legro et al., 1999).
While an artificial limb provides the promise of a return to a previous lifestyle, it
is nothing like a “real” leg or arm. All artificial limbs are biomechanically inefficient
compared to one’s own natural limb, to the point that many amputees, frustrated with
these inefficiencies and complications, will choose to forgo its use. It is estimated that
nearly 25% of major lower limb amputees will forgo their artificial limb in lieu of
crutches or a wheelchair (Legro et al., 1999). In fact, even the competitive athlete,
especially the above-knee amputee, will compete with an artificial limb, but often will
use a wheelchair otherwise (Karmarkar et al., 2009). The common explanations for such
behavior are: physical demands required to ambulate, environmental barriers, overall
comfort, and even social acceptance Karmarkar et al., 2009). It has been suggested that
since the passage of the Americans with Disabilities Act, wheelchairs have gained
significant social acceptance, perhaps more so than artificial limbs (Hubbard et al., 2007).
It could be argued, however, that the continuing physical and social barriers faced
by many individuals with acquired limb loss, are not due to a lack of interest or effort on
the part of the artificial limb component manufacturers, but that the cost of such
components is in itself a barrier. In fact, in the United Kingdom, a study revealed such to
be the case, although the UK does not use a system of classification like that of Medicare
in the US (Sansam, O'Connor, Neumann, & Bhakta, 2014). Nonetheless, based on
Medicare billing codes and reimbursements, an artificial limb is surprisingly expensive,
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ranging from approximately $600 for the simplest and least sophisticated below-knee
artificial limb, to nearly $10,000 for the most technically sophisticated version configured
with state-of-the-art components (G. W. Bosker CPO, personal communication, January
2011). Further, over the past decade, significant advances in artificial limb technology
and materials have led to a vast array of components and some fairly profitable
manufacturers and marketers (for example, Otto Bock Health Care USA, one of the more
prominent prosthetics manufacturers)
(http://www.ottobock.com/cps/rde/xchg/ob_us_en/hs.xsl/12952.html).
Some of this growth is driven by the increase in numbers of traumatic amputees
consequent of the Middle East—United States war tactics, and the Department of
Defense efforts to return such Wounded Warriors to their pre—injury status with the
option of remaining on active duty (Bilmes, 2007). Given, in part, such a demand for
heightened and accelerated artificial limb engineering, current state-of-the-art prosthetic
technology is approximately six times more expensive than prosthetic technology used in
2000 (Bilmes, 2007; Kerkovich, 2004).
While it seems that “providing the best for our war Veterans” has been a driving
force behind new artificial limb technology and even, perhaps, greater social acceptance,
there is, in addition, a rising prevalence of limb loss due to dysvascular complications
(Downs, 2000; Ziegler-Graham et al., 2008; CDC, 2011a).
Ethically, every individual who loses a major limb should have at least the option
of a “state-of-the-art” artificial limb. However, not only is this cost prohibitive, but also
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there are no prescription guidelines based on evidence-based medicine to help
practitioners and patients ascertain which device will serve that individual best. Instead,
marketing information, anecdotal evidence, insurance company directives, and expert or
experiential knowledge provide the basis for these decisions and, by their nature, the
decisions are biased, if not unfounded. Nonetheless, considerable research is ongoing
regarding the benefits of these latest devices, the associated biomechanics, and even
patient satisfaction. Typically, though, such research does not lend itself to the standards
of evidence-based medicine, due to the small sample size and moderate design, nor is
there a measureable, reliable and consensual outcome measure in the field. However, one
outcome remains constant: if the artificial limb causes pain and/or is uncomfortable or
difficult to use, the amputee will not use it. And, if the residual limb that interfaces with
the artificial limb is compromised, the amputee will likely not be able to utilize the
artificial limb temporarily or even permanently. Particularly in the case of the
dysvascular amputee, a compromised residual limb may even be life threatening.
The Dysvascular Lower Limb Amputee
Surgery—limb salvage or amputation? Peripheral arterial disease (PAD) is the
primary etiology for dysvascular limb loss and is a significant characteristic of diabetes.
While not every individual diagnosed with PAD will also have diabetes, with or without
a comorbid diagnosis of diabetes, PAD is initially treated with diet, exercise and
medication (Steffen et al., 2008). As lipid deposits build and blockage of the peripheral
vascular system continues, neuropathy may set in, as well as poor healing of tissue. Foot
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ulcers may develop providing a portal for infection, or the blockage of main vessels may
engender tissue necrosis or gangrene (Jude, Oyibo, Chalmers, & Boulton, 2001; Steffenet
al, 2008).
Typically, prior to such grave conditions, the vascular surgeons may perform
angioplasty, vessel by-pass surgeries, or even place stents in the major arteries of the
lower limb to improve circulation and prevent necrosis or gangrene. It is not uncommon
for individuals with severe PAD to undergo multiple by-pass or stent surgery in an effort
to maintain and control critical limb ischemia (Steffen et al, 2008). However, at some
point, the resting pain may become so intense or the threat of sepsis or gangrene so great
as to necessitate amputation (Steffen et al., 2008). Upon making such a decision, the
surgeon will perform the amputation at a point just above the evidence of good healthy
tissue and blood flow, at the same time attempting to maintain as long a residual limb as
possible (DePalma et al., 2002). The simple consideration as to whether or not the
patient has potential as an artificial limb user will also dictate the course of a surgery:
how best to secure muscle flaps, the shape of the residual limb so as to best fit an
artificial limb, how much fat padding to leave at the distal end of the residual limb—
considerations that influence the fit and comfort of an artificial limb (Butler et al., 2014;
DePalma et al., 2002; Hakimi, 2009; Pinzur, Gottschalk, Pinto, & Smith, 2008; Randon,
Deroose, & Vermassen, 2003).
Surgery outcome is varied given the complexity of the underlying disease for the
dysvascular patient. Amputation as a consequence of diabetes is typically indicative of
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prolonged disease and/or poor glycemic control (CDC, 2011a; CDC, 2014b). PAD is of
course closely associated with other vascular problems such as heart disease,
hypertension and renal failure (Criqui, 2001). Both are complicated by poor circulation
and wound healing such that recovery from surgery and inpatient stays may be anywhere
from weeks to months (Jude et al., 2001. Given the fragility of many such patients,
mortality rates are high and, for many, discharge is due to death (Criqui, 2001; Jude et al.,
2001; DePalma et al., 2002).
Mortality. Mortality due to amputation is very rare, but rather indicative of the
severity of an underlying disease, especially diabetes. Further, mortality rates among such
populations are typically presented as 30-day or one-year mortality rates, and reports vary
due to a lack of national measures regarding limb loss. Hence many rates reflect single
hospital sites and small samples that may be biased by surgeon preference or even
hospital care accessibility.
In any case, persons who undergo amputation due to diabetic complications tend
to be younger, and subsequently die younger, than their non-traumatic dysvascular
counterparts (Dillingham et al., 2002a). For the dysvascular amputee, survival outcomes
tend to worsen with advancing age, proximal amputation level, renal disease, and
cardiovascular, cerebrovascular, and peripheral vascular disease (Aulivola et al., 2004;
Mayfield et al., 2004; Roberts et al., 2006). Among the non-traumatic dysvascular
amputees, 30-day mortality rates for the transtibial amputee range from 5.6% for patients
in a tertiary hospital and academic medical center (Aulivola et al., 2004), to 7.0% among
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a cohort of Veterans as of 1998 (Mayfield et al., 2000), to as high as just over 12% in a
study conducted by Cruz and colleagues (2003) among a population of Veterans with
below-knee amputation of unspecified etiology (Cruz, Eidt, Capps, Kirtley, & Moursi,
2003). Heart problems, wound infection, and pneumonia were the most frequent
complications associated with 30-day mortality rates, whereas one-year and five-year
survival rates were significantly influenced by the presence of diabetes and/or end-stage
renal disease, reducing survival rates by 20% to 50% at five years post-surgery (Aulivola
et al., 2004; Feinglass et al., 2001; Mayfield et al., 2001).
Rehabilitation—from the temporary to the definitive artificial limb. If the
patient’s overall health condition will allow, the goal is to get the patient up and standing
with a temporary artificial limb as soon as possible. To do so speeds up the process of
“shaping” the residual limb to best accommodate an artificial limb, to build the patient’s
balance confidence, and to begin accepting and accommodating to the pressure from the
artificial limb (Payne & Marks, 2003). For example, a psychologist may work with the
patient prior to surgery to deal with present and future depression. Physical therapy even
before receiving a temporary artificial limb will work to strengthen the intact limb and to
encourage stretching of hip muscles and knee joints to prevent contractures
(Rehabilitation of Lower Limb Amputation Working Group, 2007). Compression hose
are placed on the residual limb to prevent excessive swelling and again to help “shape” it
(Nawijn, van der Linde, Emmelot, & Hofstad, 2005; Smith, McFarland, Sangeorzan,
Reiber, & Czerniecki, 2003; The Rehabilitation of Lower Limb Amputation Working
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Group, 2007). As soon as healing of the wound permits, the patient destined to receive an
artificial limb is fitted with a “temporary” artificial limb. The components of the
temporary limb may be the same as what will configure the definitive limb, or it may be
comprised of components equal to the patient’s current stage of rehabilitation (The
Rehabilitation of Lower Limb Amputation Working Group, 2007).
During this period of adaptation, the residual limb undergoes considerable and
notable changes: swelling, then shrinking in size, as the wound continues to heal and
mature; some muscles atrophy as others develop; and tissues shift internally in response
to external pressures. All this creates a shape to the residual limb that will ultimately
dictate the design and fit of the definitive artificial limb socket (Butler et al., 2014;
DePalma et al., 2002; Smith, et al., 2003). Typically, a patient is transitioned from the
temporary to definitive artificial limb when the wound is mature, and these changes in the
residual limb have stabilized, a process that may take anywhere from three months to a
year (DePalma et al., 2002). For some, the definitive artificial limb may be only for
cosmetic purposes, may serve only to assist in transitions (that is, from sitting to standing,
but not really for walking), may be suitable and safe only for maneuvering in the
household, or may be an artificial limb that can accommodate varied terrains and impact
forces such as those generated during sport activities. These outcomes, however, depend
on multiple factors, to include the health status of the individual, level of insurance
coverage, their physician’s and prosthetist’s perceived capabilities, and, of course, the
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patient’s personal goals and beliefs (Abrahamson, Skinner, Effeney, & Wilson, 1985;
DePalma et al., 2002; Sansam, O'Connor, Neumann, & Bhakt, 2014; aUustal, 2009).
Patient and practitioner goals. Key to the successful artificial limb prescription is
the evaluation of the amputee: the amputee’s needs, goals, functional ability (both
cognitive and motor), health status, and living conditions upon discharge (DePalma et al.,
2002; Desmond & MacLachlan, 2002; Nelson et al., 2006; Sansom et al., 2014). In most
cases such an evaluation is accomplished with a team approach, the team being
comprised of a physiatrist, the surgeon, a social worker, psychologist, physical therapist,
and the prosthetist (DePalma, et al., 2002; The Rehabilitation of Lower Limb Amputation
Working Group, 2007; Sansom et al., 2014). Further, the psychological component of the
amputee’s recovery is complex. It involves changes in body-image, self-esteem, cultural
and religious belief systems, grief, fear, and the prospect of both minor and major
lifestyle change (Desmond & MacLachlan, 2002; Flood et al., 2006). In the end, the best
the patient’s team can hope to accomplish is to prepare and set up the patient for success
rather than failure. This is one of the key reasons why “prescription guidelines” are so
important, for while it is true that each patient is an individual case and requires a level of
customization, artificial limb prescription guidelines would go far to focus the field and
help practitioners distinguish what is a realistic from an unrealistic goal, without ignoring
or denying the patient’s input (Sansom et al., 2014).
Functional levels and other concerns. The perceived and measured functional
level of the amputee is key to artificial limb prescription. Their functional level at the
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time of amputation helps determine their course of rehabilitation with and without an
artificial limb (Cumming, Barr, & Howe, 2006; DePalma et al, 2002; The Rehabilitation
of Lower Limb Amputation Working Group, 2007). It also provides a measureable
guideline for artificial limb configuration prescription (Nelson, et al, 2006; The
Rehabilitation of Lower Limb Amputation Working Group, 2007; van der Linde et al.,
2004).
In general, functional levels are dependent upon several factors, among them the
overall physical condition of the amputee. The functionality the amputee will have
following surgery is dependent on the level of amputation; other orthopedic,
cardiovascular, respiratory conditions; and vascular problems (particularly PVD); as well
as any sensory loss or neurological issues (DePalma et al., 2002; Nelson, et al, 2006;
Cruz al., 2003). Moreover, an amputee’s functional level or potential thereof is not
limited to their physical condition. Also involved are aspects of their emotional and
cognitive abilities (an understanding of their situation), as well as their activity level,
degree of motivation, vocation, age, and the presence, or lack thereof, of a support system
made up of family and friends (Cumming et al., 2006; DePalma et al., 2002; Desmond &
MacLachlan, 2002; Livneh et al., 1999).
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There are five functional levels (K0–K4) that are used to establish a functional
level for the amputee:
K0–The amputee does not have the ability or potential to ambulate or transfer
safely without assistance, and an artificial limb does not enhance their quality of
life or mobility;
K1–The amputee does not have the potential for ambulation, but may benefit
from an artificial limb to assist in transitions and transfers with minimal to no
assistance;
K2–The amputee has the ability or potential to be an independent household
ambulator, able to walk short distances over level terrain and in limited
community environments;
K3–The amputee has the ability or potential to be an independent ambulator, able
to walk longer distances over un-level terrain (curbs, outdoor terrains, hills, and
so forth) and at more than one cadence;
K4–The amputee has the ability or potential for ambulation with an artificial limb
that exceeds the basic ambulation skills, exhibiting high impact, stressor energy
levels, typical of the demands of active adults, or athletes (DePalma et al., 2002).
Many private insurance companies base their determinations of what artificial
limb component they will provide coverage for on the patient’s assessed functional level
(Cigna Health Care, 2010). Typically, the functional level of the patient is determined by
their physician, physical therapist, or kinesiotherapist, and the prosthetist (DePalma,
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2002; The Rehabilitation of Lower Limb Amputation Working Group, 2007; Uustal,
2009).
Artificial Limb Prescription
As indicated previously, each member of the patient’s medical team may
contribute to the patient’s artificial limb prescription, particularly in terms of whether or
not the patient is a good candidate for such a device, and in determining the patient’s
previous, present, and potential functional level. For the dysvascular major lower limb
amputee, a surprising number will not benefit from an artificial limb, at least not at the
K3–K4 level. Nearly 60% of such individuals will not progress beyond the K2 level and a
fairly rudimentary artificial limb, primarily because of the complications associated with
their underlying disease (Smith et al., 2003; Uustal, 2009). Ambulation with an artificial
limb takes considerable stamina, strength, and motivation. An individual whose PAD has
progressed to the point of limb amputation is typically aged, with cardiovascular
problems that will not support physical exertion (Criqui, 2001; Uustal, 2009). For the
individual with diabetes, many are dealing with similar problems as well as renal
complications and vision loss (diabetic retinopathy) (CDC, 2004). However, for the
remaining 40%, especially those of a younger age and reasonable glycemic control, an
artificial limb may prove truly beneficial by helping them to maintain an exercise level
necessary for the continued control of diabetes (Chitragari, Mahler, Sumpio, Blume, &
Sumpio, 2014).
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For the dysvascular transtibial amputee, while the tissue at the point of
amputation may be healthy, the natural progression of the disease will ultimately
compromise the vascular health of the residual limb. Thus, a key aspect of the artificial
limb prescription should perhaps revolve around not only comfort and mobility for the
amputee, but also protection of the residual limb.
The importance of a good socket fit. A well-fitted, well-crafted prosthetic
socket is essential as it is this part of the artificial limb that forms the interface between
the mechanical aspects of the artificial limb with the human residual limb (Fergason &
Smith, 1999). In this capacity, the socket fit is responsible for minimizing undue
biomechanical forces, providing necessary support and protection of the residual limb, as
well as providing a means to connect the artificial limb’s mechanical parts to the living
residual limb (Butler et al., 2014; (Chitragari et al., 2014; Ferguson & Smith, 1999;
Rogers et al., 2007). A poorly-fitted socket, no matter how good the remaining artificial
limb components may be, will likely lead to patient discomfort, skin irritation of the
residual limb from friction, undue swelling from circulation constriction, and additional
physical effort to maintain balance or to ambulate (Butler et al., 2014; Fergason & Smith,
1999; Sewell et al., 2000).
The socket is typically handcrafted by the prosthetist, and is the one component of
the entire artificial limb that, because of its customized fit to an individual’s residual
limb, cannot be mass produced. Even though computer aided design/computer aided
manufacture (CAD-CAM) techniques are used as a means to improve fit, standardize
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materials and methods, and ultimately reduce cost and production time, this manner of
socket manufacture has only very recently been embraced by the field with the advent of
3D printers, and the resultant socket is still dependent on the expertise and skill of the
prosthetist (Fergason & Smith, 1999; Sewell et al., 2000; Rogers et al., 2007; G. W.
Bosker CPO, personal communication, March 2016).
The socket is typically made of a hard carbon fiber or plastic material with a
smooth exterior and internal topography to accommodate bony structures of the residual
limb, particularly the knee (Chitragari et al., 2014; Ferguson & Smith, 1999; Sewell et al.,
2000; G. W. Bosker CPO, personal communication, January 2011). There are three
primary designs: the patella tendon bearing socket (with or without a liner); the patellar
tendon bearing supracondylar; and the total surface bearing socket (Chitragari et al.,
2014; DePalma et al., 2002; Ferguson & Smith, 1999). The decision regarding which
socket type to employ is typically dependent on the shape and condition of the residual
limb, the potential functionality of the artificial limb (for transfers only or for high impact
activity), the cost and insurance coverage, and the suspension system to be utilized
(DePalma et al., 2002; Fergason & Smith, 1999; Sewell et al., 2000).
The socket suspension system. There are three main types of socket suspension
systems: differential pressure system (suction/vacuum assist systems), anatomical
suspension system, and cuff suspension (DePalma et al., 2002). The suction and vacuum
assist systems tend to be preferred by the more active amputee as they fit closely to the
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residual limb and hence provide the best control of the artificial limb (Chitragari et al.,
2014; G. W. Bosker CPO, personal communication, January 2011).
Differential pressure suspension systems are quite popular. For example, in those
cases where the residual limb is prone to swell and shrink during the day or where
additional padding is needed for comfort, the amputee may use a pellite, silicon,
urethane, or mineral gel liner over their residual limb. The liner has a small pin-locking
mechanism near its base that fits into the socket. The locking mechanism serves to ensure
a connection with the socket during periods when the fit is not quite as air-tight
(Chitragari et al., 2014; DePalma et al., 2002). It should be noted that a residual limb for
the transtibial amputee may change in girth up to 15% throughout the day, depending on
the level of activity (Nawijn et al., 2005). Also, scars or bumps on the residual limb may
prevent perfect airtightness within the socket, which is a primary reason to use a liner that
will shape itself to fill the gaps between the residual limb and socket wall, while
providing cushioning over bony areas (Chitragari et al., 2014; G. W. Bosker CPO,
personal communication, January 2011).
Another popular differential pressure suspension system is the vacuum assisted
suspension system or VASS. The VASS incorporates a small pump in the pylon of the
artificial limb that assists in maintaining the temporary vacuum, actually creating a
negative pressure that more or less pulls the residual limb into the socket (Klute et al.,
2011).
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While these “differential pressure” suspension systems are very popular, they are
also the most expensive types and are not suitable for all amputees. They require a certain
level of understanding of their operation so as to detect when they are not working
properly. Also, if not properly donned, they can cause significant harm to an already
compromised residual limb of the dysvascular amputee (Chitragari et al., 2014; DePalma
et al., 2002; Laferrier & Gailey, 2010; Meulenbelt et al., 2007).
The anatomical suspension systems are achieved through the contouring of the
inside of the socket wall to fit over bony protuberances (femoral epicondyles) of the
amputee’s residual limb. It is especially effective for those persons with short residual
limbs and those that require a little more medial-lateral stability of the knee (transtibial
amputations only) (DePalma et al., 2002). Another variation includes shaping of the
inside socket wall over the patella. In either case, the socket veritably hangs in position
and provides a modicum of increased stability, but at the cost of greater flexibility.
Nonetheless, this system is less expensive than the differential pressure system and is
suitable for the K2-K3 ambulator (DePalma et al., 2002; Laferrier & Gailey, 2010).
The third form of socket suspension is basically a cuff or strap that can be
wrapped around the limb above the socket and then attached to a waist belt. It is the most
inexpensive system and the least complicated, and able to accommodate significant
volume changes of the residual limb (DePalma et al., 2002). Unfortunately, it is also
associated with pistoning of the residual limb within the socket, which can lead to skin
irritation and blistering. However, because of its simplistic design, it is often prescribed
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for the household ambulator (functional level K2) or when an artificial limb is used
primarily for transitions from sit to stand and stand to sit (DePalma et al., 2002; van der
Linde et al., 2004). Because such individuals do not typically walk for long periods,
pistoning is kept to a minimum and the harmful potentials of this type suspension system
are kept in check.
The prosthetic foot. There are five main types of prosthetic feet: solid ankle
cushion heel (SACH), single axis, multi-axis, dynamic response, and hybrid dynamic
response/multi-axis feet (DePalma et al., 2002; Versluys et al., 2009). The purpose of the
various designs and types of prosthetic foot are to perform human-like functions with
inanimate materials. When the foot does not act properly or animatedly enough, the rest
of the body must compensate to remain balanced. It is this compensation that creates the
undue biomechanical forces to act on the residual limb through the limb-socket interface
(Chitragari et al., 2014; DeLisa & Kerrigan, 1998; Soares, Yamaguti, Mochizuki,
Amadio, & Serrao, 2009; Versluys et al., 2009).
SACH feet were developed in the 1950s and remain the simplest design, the least
expensive, relatively lightweight, and the most reliable feet that are clinically accepted.
There are no moving parts, which makes the foot very durable and suitable for the
individual limited to walking. It is comprised of a cushioned heel to absorb forces at heel
strike, a webbed keel for stability during stance, and a molded sole for “roll over,” as the
person’s weight shifts from the heel to the toe in preparation for swinging the leg forward
(Chitragari et al., 2014; Versluys et al., 2009).

76
Single axis prosthetic feet are those that allow for rapid foot flat at heel strike
(unlike the SACH foot) and thus provide greater stability, especially for the individual
who has an unstable artificial limb such as those using cuff and belt suspension (DePalma
et al., 2002; Versluys et al., 2009). They also allow the foot to accommodate uneven
terrain, but only in one direction (anterior/posterior). Unfortunately, the foot is relatively
heavy, less durable, noisy (because of moving parts), and also more costly than the
SACH foot (DePalma et al., 2002).
The multi-axial foot adds an additional axis of motion (inversion/eversion) and
thus makes it more suitable for varied terrain than the single-axis foot. This particular
type of foot may have the multi-axis feature built in or an actual multi-axis ankle built
onto the foot, such as a SACH foot (a SACH foot with a multi-axis ankle then becomes,
and is billed as, a multi-axial foot) (Hofstad, Linde, Limbeck, & Postema, 2004). The
multi-axial foot is typically prescribed for the K2 or above ambulator, but is more costly,
heavier, and requires accommodation and training for safe use (Chitragari et al., 2014;
DePalma et al., 2002).
Dynamic response/energy storing feet have a plastic spring keel that provides a
“dynamic responsiveness,” giving a more life-like feel during stance and push-off
(Versluys et al., 2009). There are numerous dynamic response feet, all having a variation
on the material, placement, and responsiveness of the keel (Hafner, Sanders, Czerniecki,
& Fergason, 2002). More responsiveness usually equates to more potential energy
release, making it easier to move the foot and artificial limb. These types of feet are
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suitable for the more aggressive ambulator (K3–K4), including runners, but are typically
expensive, and require an accommodation (getting accustomed to it) for the user
(DePalma et al., 2002).
The hybrid multi-axis-dynamic response foot combines the best features of both
types and is considered, as of 2009, to be state of the art. They come the closest in
function to replacing the anatomical foot and often incorporate materials and designs, to
include microprocessors, to mediate their functional capacity (Chitragari et al., 2014;
Versluys et al., 2009). As such, they are most suitable for the high-functioning amputee,
but even so, require an accommodation period. They are also typically the most
expensive of prosthetic feet and require the most maintenance (DePalma et al., 2002).
Putting the parts together. While the surgeon and physiatrist may devise the
artificial limb prescription, it is the Prosthetist who actually builds the artificial limb and
consequently is frequently relied upon to assist in, if not define the specifics of that
prescription (G. W. Bosker CPO, personal communication, January 2011). An artificial
limb is not something that is ordered from a catalogue the way a pair of shoes are. Rather,
components are assembled that, in combination, will most effectively meet the needs of
the user.
A typical lower limb prosthesis is comprised (from the bottom up) of a prosthetic
foot (with or without multi-axis functions), the pylon, prosthetic socket, suspension
system, and cosmetic features. Given a well-constructed socket, the remainder of the
artificial limb components are bolted together and attached to the base of the socket. The
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amputee then dons the artificial limb, stands, and takes a few steps to test the alignment
and the position of the foot relative to the socket. While the manufacturer will suggest
starting alignment positions, it is through the trained eye of the prosthetist and feedback
from the amputee that a good alignment is achieved (G. W. Bosker CPO, personal
communication, January 2011). A good alignment is essential to promote the most
efficient gait possible for the amputee, and to minimize undue biomechanical forces on
the residual limb (Butler, et al., 2014; DePalma et al., 2002; Soares et al., 2009).
All these components, except for the socket, are produced by competitive
prosthetic manufacturers such as Ohio Willowood, Hanger, and Otto Bock, who
subsequently provide extensive marketing influences on the prosthetists, physicians, and
amputees (G. W. Bosker CPO, personal communication, January 2011). As stated on the
FDA website “Medical Device Exemptions 510(k) and Good Manufacturing Practices
(GMP) Requirements,” “Part 890 – Physical Medicine Devices”.
External limb prosthetic component; external limb orthotic component; and
external assembled lower limb prosthesis are exempt from FDA approval and GMP
requirements, including premarket approval. Only general recordkeeping and compliance
files are required. (U.S. Food and Drug Administration [FDA], 2012).
Subsequently, components are typically “bench-tested” by the manufacturer but
no randomized clinical trials are conducted, although biased trials occur as companies
“test” their products on core volunteers (G. W. Bosker CPO, personal communication,
January 2011).
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Life with a Transtibial Artificial Limb
Typically, it takes six months to a year for an amputee to feel fully confident
while using their artificial limb (G. W. Bosker CPO, personal communication, January
2011). “Balance confidence” is a driving factor and lack of it can impede success, even if
the amputee has never fallen (Miller, Deathe, Speechley, & Koval, 2001). One of the
unspoken aspects of normal gait is its “automaticity:” the sense that it just happens, with
minimal thought or concentration. In a study by Gauthier-Gagnon, Grise, & Potvin
(1999) where a five-year follow-up survey using the Prosthetic Profile of the Amputee
was used for a study of nearly 400 transtibial and transfemoral amputees, the loss of
automaticity of gait was a significant factor contributing to their use or disuse of their
artificial limb (Gauthier-Gagnon, Grise, & Potvin, 1999). Unfortunately, balance
confidence and automaticity of gait are not always achieved, even after years of
ambulation with an artificial limb and, as previously mentioned, are often a consequence
of poor artificial limb alignment or prescription (Butler et al, 2014; van der Linde et al.,
2004).
Many barriers, both social and physical, exist for even the successful amputee
with an artificial limb. Physically, the use of a lower extremity artificial limb demands
considerable additional energy as well as coordination. The inefficiencies of the artificial
limb require gait and balance compensations that frequently put unnatural forces and
torques on other body segments, the negotiation of ramps and stairs become more
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complicated and fatiguing, and even walking over uneven terrain will significantly
challenge an already compromised balance system (Soares et al., 2009).
Psychosocial factors and their implications. Many factors contribute to the
successful use of an artificial limb, not the least of which is the emotional/psychological
status of the user, a matter that is closely interwoven with the physical adaptations
required. A component of rehabilitation for the new amputee involves not just the
attainment of independence in activity, but also socialization, because that is key to
overall health and well-being. In fact, prior to and immediately following surgery, the
patient undergoes psychological evaluation and treatment for depression (Singh et al.,
2009). Also, during the rehabilitation process and training in the use of an artificial limb,
occupational, physical and social work therapies are incorporated into the program (The
Rehabilitation of Lower Limb Amputation Working Group, 2007; Zidarov et al., 2009b).
Emotionally, not only must the amputee contend with the depression and grieving
process associated with losing a major limb but, in concert with such, they are also faced
with adapting to a new body image (with and without an artificial limb) as well as a
potentially new way of life. They may need to consider changes in their choice or status
of employment, level of independence, and an increased awareness or monitoring of their
overall health (Boutoille et al., 2008; Desmond & MacLachlan, 2002; Gallagher, 2004;
Uustal, 2009). Further, attitudes about living with an artificial limb will vary from person
to person. Given the same conditions and artificial limb, one individual may view having
an artificial limb as an asset, a means to perform certain physical tasks and social roles,
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while another may consider the artificial limb inhibitory, an inability to perform certain
physical functions and social roles (Desmond & MacLachlan, 2002). It is not uncommon
for persons having difficulty making such adjustments to report bouts of depression,
feelings of hopelessness, grief, low self-esteem, fatigue, anxiety, and sometimes suicidal
ideation (Williams et al., 2011; Roberts et al., 2006). Further, the individual’s coping
strategies (such as avoidance behavior, denial, problem-solving skills) seem to be at the
heart of their ability to adapt to the loss of a limb and acceptance of an artificial limb
(Coffey et al., 2009). Maladaptive coping behaviors (such as drug/alcohol consumption),
greater disability, poorer social functioning, and loss of functional independence may
exacerbate artificial limb use as result of difficulties in psychological adjustment
(Callaghan et al., 2008; Desmond & MacLachlan, 2006a; Livneh et al., 1999).
Unfortunately, compared to the amount of research literature available regarding
artificial limb biomechanics or physical rehabilitation of amputations, little is available
on psychosocial, demographic, and other factors impacting living with a disability
(Desmond & MacLachlan, 2002). Nonetheless, Darnall and colleagues (2005) published
an article containing a current literature review and results of a survey regarding
psychosocial issues faced by a lower extremity amputee. From their literature review, the
authors noted that for the inpatient dysvascular lower limb amputee, significant
depression prevalence ranged from 29% to 54%, while outpatient lower limb amputees’
prevalence of significant depression ranged from 21% to 35%, amounts not very different
from those found for spinal cord injury patients, chronic pain patients, and persons with
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diabetes (Darnall et al., 2005). Further, it has been reported that adults who experienced
social discomfort, limited social interaction, or unsatisfactory social support related to
their amputation were at greater risk for depressive symptoms (Desmond & MacLachlan,
2006a; Gallagher, 2004; Remes et al., 2010; Singh et al., 2009). Considering that
amputation-specific pain is associated with functional limitations and decreased activity,
for the lower limb amputee this means greater difficulty attaining satisfactory social
interaction and thus greater risk for depression (Boutoille et al., 2008; Desmond et al.,
2008; Gambassi, 2009).
The actual study conducted by Darnall and colleagues confirmed many of these
reports. They derived their study population from a survey database maintained by the
Amputee Coalition of America from 1998 to 2000. Stratifying their population by limb
loss etiology (dysvascular, trauma, and cancer), 914 persons were identified as eligible
(meeting- inclusion/exclusion criteria), and consented to participate in a computerassisted telephone interview (Darnall et al., 2005). The population was fairly evenly
distributed across etiologies and included both upper and lower limb, as well as bilateral,
amputees. The phone interview conducted by trained personnel included the Center for
Epidemiologic Study Depression Scale (CES-D 10-item) which asks subjects to rate the
frequency of symptoms over the previous week for pain incidence (of the residual limb,
back or phantom limb), as well as including questions regarding characteristics of the
amputation, socio-demographics, and mental health status (Darnall et al., 2005).
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Ultimately, the study population was predominately White, male, with a high
school education, mean age of 55 years with at least two comorbid conditions, not poor,
and mostly lower limb amputees that were, on average, 4.5 years post-surgery (Darnall et
al., 2005). It should be noted that the original database was derived from a web-based
survey on the ACA website, which may explain the “middle-America” profile of the
population. These were persons who had easy access to a computer, unlike many in the
poverty or below-poverty range. Analysis of the survey data revealed the prevalence of
significant depressive symptoms to be 28.7%, not unlike that reported for amputee
outpatients (see above). Following logistic analyses, the risk factors for depression
among the population included being between 18 and 54 years of age, being divorced or
separated, living at the near-poverty level, having comorbid conditions, being somewhat
bothered or extremely bothered by back pain and phantom limb pain, and having residual
limb pain (Darnall et al., 2005). Of the sample reporting significant depressive symptoms,
over 67% reported not needing mental health services, suggesting some level of
maladaptive coping such as denial or selective social separation (Darnall et al., 2005;
Desmond & MacLachlan, 2006; Livneh et al., 1999).
Further evidence of the link between depression and limb loss is reported by
Williams and colleagues (2011) in a study conducted to ascertain the relationship
between a diagnosis and treatment for depression, diabetes, and incidence of major
(transtibial, transfemoral) and minor (toes, partial foot) amputations among a cohort of
U.S. Veterans. A retrospective analysis of over 530,000 Veterans was conducted that
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examined the amputation rates between those diagnosed with diabetes and being treated
for depression, versus those diabetics not requiring or receiving treatment for depression.
(Williams et al., 2011). The mean follow-up period was 4 years, during which time there
was a 33% increase in major limb amputation for those being treated for depression
compared to those not diagnosed or treated for depression (Williams et al., 2011). A
similar relationship did not exist for minor amputations. What is somewhat surprising is
that this increase occurred despite treatment (as per anti-depressant prescription records),
leading one to question treatment effectiveness or perhaps patient compliance. It is
possible that the difference in minor and major limb amputations relative to depression is
as reflective of disease (diabetes) progression, as it may be to the level of depression.
Additionally, coping mechanisms and stressors associated with the amputation and
subsequent residual limb management may influence an amputee’s willingness to reexpose themselves to the stressors during clinic visits, whether visits are to the
prosthetist, the psychologist, or the physical therapist, and thus influence their clinic
attendance (Desmond & MacLachlan, 2006). Also, many people will be reluctant to seek
mental health help simply on the basis of the stigma associated with such (although this
trend has been shifting over the past decade) (Golberstein, Eisenberg, & Gollust, 2008).
All in all, this study clearly demonstrates that depression due to amputation is not limited
to the inpatient, but is a real factor for many amputees, surely impacting their quality of
life beyond the limb loss itself, and potentially throughout their lifetimes.
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Finally, in a prospective study specific to lower limb dysvascular amputees and
conducted by Coffey and colleagues (2009), 38 participants with diabetes-related lower
limb amputations, recruited from two limb-fitting centers in the United Kingdom,
completed three psychological self-report assessments: the Trinity Amputation and
Prosthesis Experience Scales; the Hospital Anxiety and Depression Scale; and the
Amputation Body Image Scale—Revised. Although the study sample was fairly small,
the homogeneity of the population affords the results sufficient power. As such, the most
noteworthy finding was the relationship between body image and depression. While the
authors noted that over 18% of the study population scored above the normal range for
depression and anxiety, even nearly four years post amputation, it is also known that a
strong association between depression and diabetes exists, regardless of any limb loss due
to diabetic complications (Coffey et al, 2009; Singh et al., 2008). Some even suspect that
this association is hormonal in basis (Lustman & Clouse, 2007). Nonetheless, among this
study population, body image disturbance was strongly correlated with both depression
and anxiety and, although causality cannot be inferred, it is quite suggestive that the level
of depression detected is not solely a consequence of the underlying disease—that the
loss of one’s limb may have a profound effect on the psychological well-being of the
amputee. Further, it is not surprising that there should be an increase in anxiety levels, for
not only must one be concerned with controlling their disease, but now, as an amputee,
they are faced with environmental and social barriers, as well as the constant vigilance
required taking care of their residual and artificial limbs.
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For any amputee, but especially for the dysvascular amputee, care of the residual
limb and artificial limb requires self-discipline, diligence, and considerable self-care to
remain ambulatory and healthy- not totally inconsistent with the “chronic care model”
(Zinszer et al., 2011). It is up to the user of the artificial limb to care for their residual
limb with proper hygiene practices, and to recognize problems such as undue soreness or
redness, and to adjust their artificial limb wearing schedule accordingly, basically to
prevent residual limb breakdown (G. W. Bosker CPO, personal communication, January
2011). It is also typically up to the person living with limb loss and utilizing an artificial
limb to note when the artificial limb is not working properly. For example, the amputee
would need to note when the suspension system is failing, or when an additional pair of
stump socks are needed to improve the socket fit due to temporary changes in the residual
limb fluid retention. When sent home with a lower extremity artificial limb, the amputee
is instructed on how to maintain it and what signs of failure to look for, and what to do
(DePalma et al., 2002; The Rehabilitation of Lower Limb Amputation Working Group,
2007). In fact, in a study by Larner, van Ross, & Hale (2003), the authors determined that
success with an artificial limb was fairly “site specific” (that is, the more proximal the
amputation, the less successful the artificial limb user), and that learning and memory
capacity was more important than emotional stability, as well as being the most
significant predictor of success. Memory and learning capacity becomes particularly
relevant in regard to the ability to retain instruction such as that which would be
necessary to don and doff an artificial limb, in particular the more sophisticated socket
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suspension systems, such as the VASS described previously in this chapter. The study
also indicated that someone with a mild case of dementia might still be able to use an
artificial limb, albeit of simple design and function (Larner et al., 2003).
The consequences of poor disease/limb self-management and care. Whereas
primary prevention for diabetes revolves around healthy eating, moderate exercise, and
diabetes awareness, the preferred method of diabetes treatment is the incorporation of
self-management, where the individual is responsible for daily monitoring of blood
glucose levels, medication compliance, foot inspection, weight control, and regular
clinical visits (Funnell et al., 2011). In most cases, “self-management” is clinician driven
and, although effective, may be fraught with numerous environmental barriers for the
amputee (such as treatment costs, medical care access, and a lack of effective diabetes
education) (Ephraim et al., 2006; Gallagher, O'Donovan, Doyle, & Desmond, 2011).
The point is, the dysvascular amputee with comorbid diabetes—even PAD—must
contend with matters of daily self-management and care. For the amputee, the same
barriers, including both economic and individual motivational, may preclude
participation in diabetes education, foot care management programs, and regular clinical
visits necessary to maintain the function of their artificial limb or health of their residual
limb (Ephraim et al., 2006; Gallagher et al., 2011). Failure to do so may lead to serious
consequences, not the least of which is chronic residual limb pain, infection, and the
inability to use the artificial limb or, ultimately, re-amputation.
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The risks of reamputation. Re-amputation, most often within five years of the
index amputation, is not uncommon and is typically a factor of health complications,
especially PVD and diabetes (Dillingham et al., 2005; Izumi et al., 2006). Most often,
undue biomechanical forces and/or poor fitting artificial limbs cause the residual limb’s
integrity to break down, or poor vascularization (especially in combination with poor
sanitation) engenders gangrenous tissue (Bui, Raugi, Nguyen, & Reiber, 2009;
Meulenbelt et al., 2007). Additionally, there is a significant risk of amputation of the
contralateral limb, due either to the bilateral nature of PAD and critical limb ischemia, or
tissue breakdown, foot ulceration, and infection subsequent to a greater dependency on
the intact limb with associated biomechanical changes (Izumi et al., 2006; DeLisa &
Kerrigan, 1998).
In a study by Izumi, Satterfield, Lee, & Harkless (2006) the likelihood of reamputation among a population of diabetic dysvascular amputees was determined to
increase with time, reaching estimates of over 60% five years post index (initial)
amputation. While the actual period before re-amputation was dependent on the level of
amputation, the highest incidence occurred within six months of the operation (Izumi et
al., 2006). In their 10-year observational study, the authors also determined that reamputation of the same (ipsilateral) limb occurs in 14% of those individuals with a
transtibial or transfemoral index amputation (Izumi et al., 2006). Additionally, for those
persons with a unilateral transtibial or transfemoral amputation, it was estimated that
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within five years there was a 50% likelihood they would undergo some level of
amputation of the contralateral (non-amputated) limb (Izumi et al., 2006).
To contrast, Dillingham, Pezzin, and Shore (2005) conducted an analysis of
approximately 71,300 Medicare beneficiaries, of which 3,565 lower limb amputees
secondary to dysvascular disease were identified. In this study, 74% of the study sample
had comorbid diabetes. Of these, 26% underwent a re-amputation (of either the ipsilateral
or contralateral limb) within the one-year study period, suggesting a much higher reamputation rate than that presented by Izumi and colleagues (Dillingham et al., 2005;
Izumi et al., 2006). Further, about 16% of all Medicare beneficiaries with a dysvascular
amputation secondary to diabetes died before age 65, a rate 2.5 times that of non-diabetic
dysvascular amputees, and costs associated with caring for beneficiaries with a
dysvascular amputation exceeded $4.3 billion yearly (Dillingham et al., 2005). Table 2
provides additional comparisons between the non-diabetic dysvascular and diabetic
dysvascular amputees.
In summary, the two studies suggest that (a) the diabetic amputee tends to be
younger at the time of their index amputation and first re-amputation, and die at a
younger age than the non-diabetic dysvascular amputee, (b) the prevalence of single or
multiple re-amputations was significantly greater among the diabetic dysvascular
amputees, suggesting greater medical care costs, and (c) while the diabetic dysvascular
amputee may have died at a younger age, they survived for a longer period of time
following their index amputation, again suggesting a higher burden of medical care costs.
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However, neither of these studies gives any real suggestion as to why re-amputation rates
are higher among the diabetic dysvascular amputees other than to suggest greater
comorbid diagnoses (Dillingham et al., 2005). Perhaps the younger age of the diabetic
amputee is also indicative of a more active individual, one more likely to remain mobile
with an artificial limb, and thus put their residual limb more at risk for complications, and
causing their contralateral limb to bear more biomechanical forces.
Table 2
Reamputation Rates among Dysvascular Amputees
Group
Index
Progress to
Progressed
At least one
1 year
transtibial
transfemoral
to bilateral reamputation mortality
with
rate
revision
All
81.3%
9.4%
9.4%
77%
35.5%
dysvascular
With
80.0%
9.3%
10.5%
75.4%
34.0%
comorbid
diabetes
Non-diabetic
85.4%
9.6%
5.0%
83.3%
41.5%
Note. From “Reamputation, mortality, and health care costs among persons with
dysvascular lower-limb amputations,” by Dillingham, T. R., Pezzin, L. E., & Shore, A.
D., 2005, Archives of Physical Medicine and Rehabilitation, 86(3), p. 484
Copyright © 2005 American Congress of Rehabilitation Medicine and the American
Academy of Physical Medicine and Rehabilitation Published by Elsevier Inc.
Reprinted with permission.
Skin problems associated with the residual limb. For the dysvascular amputee,
the residual limb is particularly vulnerable to skin problems, primarily due to its inherent
poor healing capacity resultant of poor circulation. Poor circulation leads to poor
oxygenation of tissue, poor inflammatory responses, and poor tissue growth stimulation
such that the skin is unable to recover sufficiently from insults (Guo & Dipietro, 2010).
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These so-called insults may be biologically or mechanically induced, such as from
friction, pressure, shear forces, heat, moisture, or foreign bodies present at the residual
limb/artificial limb socket interface (Butler et al., 2014; DeLisa & Kerrigan, 1998;
Roberts et al., 2006). For example, the residual limb within the socket may experience
undue friction from pistoning of the residual limb within an ill-fitting socket and
suspension system. Excessive sweating consequent of the materials comprising the socket
can lead to blistering, and infection from non-hygienic conditions (Bui et al., 2009; Butler
et al., 2014; Meulenbelt et al., 2007). Also, allergic reaction to the materials that are used
to make the socket, suspension systems, liners, sleeves, and socks are not uncommon
(Meulenbelt et al., 2006). Many times, these problems are resolved with the application
of a topical ointment or powder and with restricted use of the artificial limb. However,
when such problems persist or consistently reoccur, consideration is given to the fit,
alignment, or appropriateness of the artificial limb, as well as to the health status, disease
progression, and self-management practices of the patient (G. W. Bosker CPO, personal
communication, January 2011).
Regardless of the skin condition or its cause, the danger lies in the residual limb’s
inability to heal rapidly and the formation of ulcers, which then serve as portals to
infection (Mayfield et al., 2004; Meulenbelt et al., 2006; Salawu, Middleton, Gilbertson,
Kodavali, & Neumann, 2006). The infection (osteomyelitis or sepsis) is the primary
reason for limb surgical revision and re-amputation. It is also one of the four primary
causes of death for the dysvascular amputee, along with heart failure, renal failure, and
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pneumonia/pulmonary failure, all of which, it should be noted, are also closely associated
with diabetes and PAD, and not necessarily with amputation (Feinglass et al., 2001;
Mayfield et al., 2001).
In a six-year retrospective chart review of outpatient lower extremity amputees,
Dudek, Marks, Marshall and Chardon (2005) determined that 26.7% of the residual limbs
examined were noted to have had at least one ulcer treated. Overall, 47% of the cases
were treated for some skin problem: irritation 17.6%, inclusion cysts 15.0%, callus
11.4%, verrucous hyperplasia 8.9%, blister 6.6%, fungal infection 4.9%, cellulitis 2.1%,
and “other” 6.8% (Dudek et al., 2005). The population examined was predominately male
(77%) with a mean age of 58 years; 66% were transtibial amputations and 19%
transfemoral, with the majority of the amputations being due to PVD. In their analysis,
the authors found that being a younger amputee, having any amputation level other than
transfemoral, being employed, being a community ambulator, and not using any other
gait aid beyond a single point cane were traits of the amputees most likely to incur a skin
problem (Dudek et al., 2005). Interestingly, the authors also noted that having a comorbid
diagnosis of PVD decreased the likelihood of developing a skin problem. They went on
to attribute this finding to a reduced activity level among such persons (as compared to
those without PVD), ultimately concluding that more active amputees have an increased
risk of skin problems (Dudek et al., 2005). This, then, suggests that at the crux of most
residual limb skin problems is excessive biomechanical forces acting on the residual limb
at the residual limb–artificial limb interface, although the authors found that neither the
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type of socket nor suspension system for the transfemoral or transtibial amputee
significantly increased or decreased the likelihood of developing a skin problem (Dudek
et al., 2005).
Of note, most, if not all, of the amputees in the study received their artificial limbs
and care from the same group of prosthetists associated with the outpatient clinic where
the study was conducted (Dudek et al., 2005). The most commonly provided socket
suspension system for the transtibial amputees was the anatomical type of suspension
(supera-condylear) with a patellar tendon bearing socket; approximately 11% utilized a
vacuum (pin-lock) suspension with a patellar tendon bearing socket (a brief description of
these suspension systems is provided in this chapter) (Dudek et al., 2005). The authors
provided no further analysis to associate the incidence of ulcers or skin problems relative
to the presence or absence of PVD and a particular socket suspension type, nor did they
take into consideration the type of prosthetic foot utilized. Given that the population
likely received similar practitioner care, it is fairly safe to assume that poor alignment of
the artificial limb was not a significant contributing factor to the etiology of the skin
problems, but a question remains as to whether or not certain artificial limb
configurations are more prone to incur skin problems than others, regardless of the
activity level of the user. Such an analysis would go far to define prescription guidelines
for the person living with limb loss.
Residual limb conditions other than ulcers may be less life-threatening but are
equally responsible for preventing the use of an artificial limb. For example, neuromas or
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aggravated nerve bundles at the site of the residual limb may become so painful as to
prevent wearing a socket; osteoarthritis of the knee, hip or back can be so painful as to
prevent ambulation; loss of bone density is also not uncommon but typically is associated
with the long term traumatic amputee (DePalma et al., 2002). However, an individual
who loses a limb to trauma, “recovers,” and then develops PAD or diabetes, suffers the
same problems as any similarly diagnosed individual who loses their limb to
complications thereof (DePalma et al., 2005; G. W. Bosker CPO, personal
communication, January, 2011).
Clearly the residual limb is highly vulnerable and at the crux of many issues faced
by the person living with limb loss. In fact, from a survey conducted by Legro, et al.
(1999), it was determined that among a diverse population of 92 lower limb amputees,
artificial limb fit, ability to walk with the artificial limb, avoidance of blisters or sores on
the residual limb, and avoidance of rashes on the residual limb were the most important
factors they associated with the use of an artificial limb. Since residual limb health (for
example, skin problems, swelling, pain, sweating) affects the fit of the artificial limb, it is
not surprising that residual limb health is of high priority for the person living with limb
loss. The authors suggest that improved education as to the care of the residual limb, as
well as more regular and “finely tuned” visits with a practitioner may be a means to
resolve the issue (Legro et al., 1999). Unfortunately, for many, medical care access is a
barrier, and the additional visits add to health care costs (Ephraim et al., 2006; Legro et
al., 1999). Perhaps an alternative is to further explore residual limb outcomes relative to
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specific artificial limb configurations and components, in an effort to determine those that
act best to ameliorate harmful biomechanical forces acting on the residual limb. Given
such evidence, practitioners may be in a better position to prescribe an artificial limb
configuration that is least likely to promote skin problems, and most likely to promote
physical activity.
Artificial limb failure and repair. As noted above, a key factor or concern for
residual limb breakdown is the fit and alignment of the artificial limb. Results can be
pistoning of the residual limb within the socket and the potential for blistering from
friction, occlusion of blood flow from a socket that is too tight, an allergic skin reaction
to socket or suspension system materials, or inefficient ambulation (Butler et al., 2014;
Fergason & Smith, 1999). In other words, an artificial limb that is not well maintained
sets up the amputee for failure, such as poor, inefficient gait; joint pain; residual limb
compromise; and an overall reduced quality of life (Chitragari et al., 2014; DeLisa &
Kerrigan, 1998).
In a study by Datta, Vaidya, & Alsindi (1999), the authors conducted a detailed
retrospective review of a cohort of 104 transtibial and transfemoral amputees. The
purpose was to identify patterns of “prosthetic episodes:” how often and what sort of
repair or maintenance was required of an individual’s artificial limb over a 10-year
period. The patients on average needed 5.54 visits per year when all age groups were
considered together, 6.42 visits per year for the 15-60 year age group, and 4.8 visits per
year for the 60+ age group (Datta et al., 1999). Overall, the amputees in the study on
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average needed about one new prosthesis and one new socket every two years, one major
repair every five years, and about two same-day repairs per year (Datta et al, 1999).
However, the authors concluded that the actual frequency of repairs or artificial limb
replacements was truly unique to the individual and dependent on multiple factors, to
include different levels of amputation, degree of artificial limb use (activity level), type
of componentry used, and availability of services (Datta et al., 1999).
Conclusion and Future Prospects
The naïve observer watching a lower limb amputee walk through a parking lot or
through a grocery store may not appreciate all that that person has gone through or
continues to go through. For the dysvascular amputee, the goal to live a full and
productive life is challenged given a five-year mortality rate of 50%, and psychological
and physical issues that press even the strongest body and soul (Dillingham et al., 2005;
Coffey et al., 2009; The Rehabilitation of Lower Limb Amputation Working Group,
2007). Despite human ingenuity, we have yet to cure diabetes or PVD. The disease’s
progression can be controlled or slowed with diligence and discipline, but it cannot be
cured and, as long as there are dysvascular diseases, there will be limb loss. As long as
there is limb loss, there will be matters of psychological and physical adjustment.
Human ingenuity also has yet to build a better artificial limb. Engineers and
scientists have come closer with microprocessor components, special designs, and special
materials, but in regard to the socket-residual limb interface—to create seamlessness
between mechanical parts and the human body—this goal has yet to be achieved (Mak et
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al., 1994; Sewell et al., 2000). Osteointegration of a socket to a residual limb, the in vitro
or in vivo regeneration of limbs, as well as limb transplants are techniques being
researched to improve functionality for the amputee, but all are plagued with problems of
chronic infection, medication issues, or rejection (Mak et al., 1994; Brandacher et al.,
2009).
Whether due to purely mechanical influences (for example, poor socket fit,
artificial limb alignment, or component design) or behaviorally induced (for example,
poor hygiene, issues of self-management, or emotional status), the residual limb for the
lower extremity amputee is vulnerable and at risk, for it is being required to perform in a
manner for which it was not designed (Boutin, Pathria, & Resnick, 1998). Given known
limitations, the question becomes how best to overcome certain barriers, while at the
same time pressing the boundaries of our skills and knowledge.
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Surveillance, Informatics, and the Amputee
The Current Monitoring System
Surveillance is a key component of public health for it serves as a means to
monitor the progress of a disease, program, or population. It includes the “systematic
collection, analysis and interpretation of health data for purposes of improving health and
safety” (http://www.cdc.gov/niosh/topics/surveillance/). Data derived from a surveillance
system is powerful for it transcends opinion and politics, being objective in nature, and
thus highly useful for the dissemination of health information. However, when performed
selectively, or within a narrow framework, it can prove to be biased or skewed, and thus
become more a case of health care marketing than public health surveillance.
Nonetheless, when conducted on the basis of individual activities, public health
surveillance takes on the function of patient screening or monitoring. On this level, the
goal of such surveillance is early detection of disease or dysfunction, followed by
appropriate interventions to prevent further exacerbation of the condition (Boyko et al.,
2000; O'Carroll et al., 2003). At this point, surveillance likely becomes increasingly
relevant to the clinician or practitioner for it tends to focus on more specific
characteristics of the population and condition in question.
An extensive search of the available literature and Internet resources has revealed
that no coordinated surveillance or monitoring program exists for limb loss in the United
States, except for that conducted by state health departments for Emergency Medical
Services (EMS), or from limited research studies of hospital discharge records or health

99
insurance beneficiaries. Such is understandable given the relatively low incidence of
major limb loss (relative to incidence rates for major life-threatening conditions such as
diabetes, cancer, and infectious disease), the complexity and variation of the condition,
and the likely high cost–benefits ratio a concerted surveillance effort would require
(Groah et al., 2009). However, as suggested previously, with a prevalence rate of 1.6
million persons living with limb loss in 2005 and a potential rate of 3.6 million in 2050,
perhaps surveillance specific to the limb loss condition should be developed (ZieglerGraham et al., 2008). Such a system would potentially provide information useful in the
development of artificial limb prescription guidelines, patient therapy standards, and costeffective rehabilitation practices, as well as providing stakeholders’ (including
manufacturers’) insights into the real needs (instead of perceived needs) of the individual
living with limb loss.
The CDC diabetes model. In the case of limb loss, the benefits of surveillance
are demonstrated by the monitoring of the incidence and prevalence of diabetes, with the
subsequent accounting of acquired limb loss due to diabetic complications (a subset of
CDC’s National Diabetes surveillance). As of 2005, the Centers for Disease Control and
Prevention estimated there were 20.6 million adults living with diabetes (approximately
9.6% of the total U.S. population over the age of 20 years), but by 2010, this number had
increased to 25.7 million or approximately 11.3% of the U.S. population (CDC, 2011b).
By 2012, while the actual number of adults with diabetes continued to increase to 29.1
million people, the percentage of such persons in the U.S. population decreased to 9.3%
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(CDC, 2014). The latest available statistics derived from hospital discharge records
indicate approximately 82,000 lower limb dysvascular amputations in 2002, 71,000 in
2004, about 65,700 in 2006, and approximately 44,000 in 2010the decline being
attributed to improved diabetic foot care and management, improved glucose control
methods, and a heightened awareness from extensive diabetes education programs—a
blending of clinical care and self-management improvements (CDC, 2011a; CDC, 2014;
Dillingham, 2002; Reiber & Raugi, 2005; Ziegler-Graham, 2008;). However, for 2010,
44,000 amputations indicates those directly related to diabetes, while a larger number of
73,000 lower limb amputations were performed in persons diagnosed with diabetes ,
likely a reflection of a growing, aging population (CDC, 2014). Of note, the data reported
in these estimates are derived from self-reported responses to national surveys such as the
2005-2008 National Health And Nutrition Examination Survey, United States Census
Statistics, 2007–2009 National Health Interview Survey, Indian Health Service, National
Patient Information Reporting System, state or local level Behavioral Risk Factor
Surveillance System, and various study groups and research groups (CDC, 2011).
Obviously, there is no accessible specific database from which to derive information to
explore the actual limb loss condition.
The British model. While such a system does not yet exist in the United States,
some countries that practice forms of socialized medicine, such as Great Britain,
Australia, and The Netherlands, maintain national databases that benefit both the artificial
limb user and the health care provider. For example, in the British Society of
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Rehabilitation Medicine (BSRM) Working Party Report on Amputee and Prosthetic
Rehabilitation Standards and Guidelines (2003), patient care steps—pre-surgical,
surgical, post-surgical, wound healing, physical therapies, physician requirements,
therapy access, artificial limb prescription, and accessibility to health care facilities—are
all outlined and categorized as required/must, recommended/should or suggested. The
overall objective of the work is to establish a basis for the provision of a service of
excellence to the amputee population with equity of access throughout the UK. (British
Society of Rehabilitation Medicine [BSRM], 2003). The targeted population includes not
only the person with limb loss, but also the clinicians, practitioners, therapists, and even
artificial limb manufacturers. The various recommendations, standards, and guidelines
were and are based on evidence derived from previous BSRM Working Party Reports,
research literature and reviews, as well as on the consultation and consensus of experts in
the field of amputation and artificial limb rehabilitation (BSRM, 2003). Of note, clearly
stated in the standards and guidelines and as its own surveillance measure, the various
Prosthetic and Amputee Rehabilitation Centers (PARCs) of the British Health System are
strongly recommended (“should”) to collect, maintain, and provide statistical data
relative to amputee rehabilitation and prosthetics to the National Amputee Statistical
Database (NASDAB) (BSRM, 2003). To be included in this data is that specifically
related to trends in artificial limb prescription and patient functional outcomes.
A stated goal of the BSRM’s standards and guidelines for data collection and
analysis (surveillance) is to serve as a means to audit the service practices and outcomes
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of the PARCs as well as to provide future and present evidence of patient outcomes
(BSRM, 2003). It is this sort of surveillance that is lacking in the United States and
potentially contributes to the high healthcare costs and questionable quality of life for the
amputee.
However, in a study by Sansam, O'Connor, Neumann, & Bhakta (2014), 23
clinicians were interviewed from 4 different amputee rehabilitation centers. Those
interviewed included physicians, prosthetists, physical therapist, and specialty nurses.
In the UK, not unlike the US) the process whereby an individual’s artificial limb
prescription is determined, is generally influenced by the clinical observations, training
and experience of the treating team, the difference being that in the US, that decision is
also often driven by health insurance coverage and classifications. In the UK, there are
several national and international guidelines on amputee rehabilitation and, while they all
include “the need for a patient centered, multidisciplinary assessment to establish each
individual’s needs and goals”, they do not specify how the decision of whether to provide
a prosthesis or what components to choose should be made (Sansom et al., 2014).
Analysis of the interviews identified four thematic factors when considering an artificial
limb prescription: the patient’s estimated outcome (ability to learn how to use an artificial
limb and their predicted activity level), the complexity of the case (patient attributes,
success with early walking aids, and social support), the patient’s choice (mediated by
family influence, clinician management of patient expectations, and patient goals), and
barriers to prescribing (budget limitations, component availability, and risk of the
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patient’s ultimate aversion to the artificial limb (Sansom et al., 2014). As indicated
previously in this chapter, these same themes are present for the team prescribing an
artificial limb in the US, the primary difference being the influence of insurance coverage
(if any). Of particular note, of the four rehabilitative center clinicians interviewed, only
one center and team actually used any form of prescription guidelines, and the guidelines
were ones they derived themselves (Sansom et al., 2014). This same center claimed
greater confidence and success in their artificial limb prescription process although any
assessment of such was beyond the scope of the study (Sansom et al., 2014).
Nonetheless, in conclusion, the authors stressed the importance of including all four
factors in any clinical artificial limb prescription algorithm or guideline, noting the
paucity of research on patient motivation and the implications of psychosocial factors
(Sansom et al., 2014). However, this study presents another issue, that the problem as to
the best artificial limb to provide a patient, resides not only with patient compliance, cost,
and expert knowledge and practice,, but also with the provision and acceptance of
evidence- based material by the practitioner as guidelines were available but not used
and/or recreated to meet the knowledge base of the clinicians using the guidelines
(Cicerone, 2005; Groah et al., 2009; Sansom et al., 2014). Perhaps with the availability of
a system of surveillance, monitoring, and standards and guidelines in place, the person
living with limb loss can be set up for success, as those various stakeholders involved
have greater access to less biased information, greater accountability, and greater insight
for future research and development.
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Meaningful Evidence
One of the primary benefits of a database specific to people living with limb loss
(such as the British National Amputee Statistical Database [NASDAB]) is the ability to
utilize objective data in large case numbers and identify patterns and trends of the data
therein. This practice becomes particularly valuable when the data includes not only
cross-sectional data useful for the calculation of incidence and prevalence rates, but also
an outcome measure indicative of some interventional measure. The best outcome
measures are those that can be applied with universal acceptance, can be easily
standardized or quantified, and are sufficiently relative to bear meaning (Arlet et al.,
2008; Black, 1997; Borg & Sunnerhagen, 2008; Deathe et al., 2009). Such an approach is
particularly important for the clinical decision-maker that may be looking to an analysis
of the database to identify factors that strongly predict good or poor patient outcome.
To date, most lower extremity prosthetic outcome measures have been related to
gait and balance biomechanics, functional capacity, energy cost, and patient satisfaction
(as measured by varying questionnaires and survey tools) (Meulenbelt, et al., 2006).
While useful for describing the functional capacity of the artificial limb user, the
mechanics of the artificial limb itself, or overall user performance, these outcome
measures are not universal (not easily obtained, especially in large case numbers), not
well standardized, and, though relative to the condition, are limited in scope and meaning
for the patient or clinical decision-maker. Interestingly, the impact of various artificial
limb components on the integrity of the residual limb has not been extensively
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researched, specifically such outcomes as skin irritation, ulceration, infection, and/or
surgical revision; these are conditions that are classified by standardized, universally
accepted CPT and ICD-9-CM codes, and that have direct impact on the amputee and their
use of an artificial limb (Bui et al., 2009; Dudek et al., 2005). Instead, the relevant
literature tends to focus on case studies that report rare or unusual conditions rather than
focusing on more common conditions, and few relate such conditions to the artificial
limb configuration in use (Meulenbelt, Dijkstra, Jonkman, & Geertzen, 2006; Meulenbelt
et al., 2007). Nonetheless, a few studies have reported the findings of extensive literature
searches specific to skin disorders of the residual limb and offer various models of
categorization based on morphology or presumed etiology, for example: mechanical
forces, foreign bodies, concurrent disease, or occlusion (Bui et al., 2009; Butler et al.,
2014; Meulenbelt et al., 2006).
Recognizing the need to better understand the relationship between artificial limb
use and residual limb skin problems, Meulenbelt, Geertzen, Jonkman, & Dijkstra (2009)
surveyed over 2,000 lower limb amputees, representing 75% of the amputee population
in the Netherlands. The purpose of the study was to identify determinants of residual limb
skin problems, as determined by a self-designed questionnaire that consisted of a series of
open questions and multiple choice questions intended to assess the “domains:”
demographics, characteristics of the amputation and prosthesis, activity level of the
amputee, residual limb and prosthesis hygiene, and skin problems (Meulenbelt, Geertzen,
Jonkman, & Dijkstra, 2009). Since the researchers did not actually examine the
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participants’ residual limbs, they defined their outcome variables as “suspicious”, such
as, suspicion for eczema, suspicion for mechanically-induced skin problems, suspicion
for skin problems caused by occlusion, and suspicion for skin problems caused by PAD
(Meulenbelt et al., 2009). Stepwise backward logistic regression was then utilized to
identify the determinants of skin problems.
Forty percent of the individuals to whom surveys had been mailed subsequently
responded with completed questionnaires (respondents were significantly younger than
those who did not complete or return the questionnaire) (Meulenbelt et al., 2009). Most
respondents were men (62%), nearly half were transtibial amputees, another third were
transfemoral amputees, and 42% had acquired limb loss due to trauma, with only 28%
due to dysvascular complications (although the authors stated that nearly 94% of all
amputations in the Netherlands were due to PVD complications) (Meulenbelt et al.,
2009). Most of the respondents were unemployed and relatively inactive (walked less
than 500 meters/day), half used a liner with their socket suspension system, and yet 82%
of the respondents reported skin problems and 63% reported more than one. Most were
pressure ulcers (57%), infection accounted for another 35%, and 57% stated they could
not wear the artificial limb temporarily because of the skin problems (Meulenbelt et al.,
2009). Such findings tend to lead one to question the premise that activity level, and
therefore mechanical forces acting on the residual limb, is the primary cause behind
residual limb skin problems.
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From their regression analysis, the authors identified two levels of skin problem
determinants, those that were protective in nature, and those that were considered
“provocative” (Meulenbelt et al., 2009). The protective determinants most closely
associated with respondents who were older, male, and had a dysvascular amputation—a
finding that correlates well with the results of the Dudek study discussed previously and
suggestive that inactivity among older persons with dysvascular amputations tended to
result in fewer skin problems (Dudek et al., 2005). On the other hand, Meulenbelt also
noted that the provocative determinants were use of antibacterial soap, smoking, and
washing the residual limb four times a week or more often, challenging the premise that
mechanical forces in association with activity level are the primary reason for residual
limb skin problems. Additionally, the researchers noted that: (a) suspicion for eczema or
skin problems due to occlusion significantly correlated with the use of walking aids; and
(b) suspicion for mechanically induced skin problems, occlusions or subsequent of PVD
were significantly correlated with washing the residual limb more than four times a week
(Meulenbelt et al., 2009). While such correlations do not necessarily infer causation, it is
interesting to consider that a significant correlation with “walking aids” suggests poor
gait, perhaps due to weakness or a comorbid condition (possibly such as older age), and
frequent washing suggests good hygiene in response to accumulated sweat and/or
possible infection.
Several aspects of the authors’ findings are somewhat counter-intuitive, especially
in regard to hygiene and the use of antimicrobial soap. Frequent, or at least, regular
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washing of a body part is generally accepted as good health practice. Given the moist
environment in which the residual limb is typically trapped (due to sweating and
impervious materials such as liners and the artificial limb socket), frequent washing with
an antimicrobial soap would seem a protective determinant against certain skin problems,
specifically fungal or bacterial infections. The fact that it was considered a “provocative”
determinant instead and that infection was one of the most frequent skin problems
reported by the respondents, leads one to (a) question the accuracy of the respondents’
perception of the skin problem, (b) question their interpretation of the survey question, or
(c) question if there is some sort of skin chemical sensitivity to the soap. While the
methodology employed by the authors was a viable means to reach a larger and broader
sample, such self-designed and delivered surveys are fraught with validity issues and
sample bias such as the results demonstrated— the sample was not representative of the
older dysvascular amputee that they reported accounted for nearly 94% of the entire
Netherlands amputee population; and without the guidance of a trained interviewer,
standardized and validated survey questions, or a practitioner’s skilled eye at identifying
specific skin problems, it is difficult to quantify and measure outcomes. Thus the findings
of this study further support the concept that not only are skin problems of the residual
limb a consistent and problematic issue for the lower limb amputee that need further
investigation beyond mere case reports, but that some other means besides subjective
survey should be employed to assess such, for example: standardized medical coding

109
such as ICD-9-CM, HCPCS, or CPT codes universally accepted and utilized extensively
by most healthcare facilities and providers.
An Alternative Source of Evidence
The high quality clinical database. In those cases where the conduction of a
clinical trial may be unfeasible or unethical, many disciplines have turned to the
development of high-quality clinical databases (HQCD) as a means for consolidating
evidence-based medicine in a systematic manner (Arlet et al., 2008). An HQCD is
typically a relational database that focuses on an intervention and the related patient
outcome. It allows for the generation of large samples that improve statistics, promote
generalizability of analyses, and allow for subgroup identification to include the
aggregation of rare cases and/or interventions for study (Black, 1997; Hlatky, 1991;
Sacristan & Galende, 1999).
While databases such as the Thoracic Surgery database may exemplify the gold
standard for an HQCD, most such databases are limited in scope or site (hospital specific)
and take considerable time, forethought, and expertise to develop (Arlet et al., 2008).
Nonetheless, it is exactly this specificity and direct clinical application that makes an
HQCD so powerful, whereas other databases such as the Cancer Registries may offer
important population-based data that is disease specific and can be used to identify trends
and patterns of associations, but they do not necessarily link an intervention outcome
with the disease or support long-term follow-up of specific cases or cohorts of interest
that could lead to policy change (Black & Tan, 2013; CDC, 2013).

110
Healthcare administrative databases. In the absence of an appropriate HQCD
(or to facilitate the development of such), a healthcare administrative database may serve
as a viable alternative. Despite being broad in scope, and even though a healthcare
administrative database typically does not contain direct clinical information beyond
diagnosis and procedural codes, such a database is nonetheless useful for clinical research
when used for calculating population disease incidence/prevalence and/or health service
practices (Boyko et al., 2000). Further, when the administrative database is linked to a
systematic patient follow-up, and/or outcomes are directly related to medical coding,
what emerges is a framework with which to study patient outcomes and disease or
intervention prognosis (Boyko et al., 2000; Hlatky, 1991; Miller & Pogach, 2008; Rosato
et al., 2008). An example of such is presented by Rosato, D'Errigo, Badoni, Fusco,
Perucci, & Seccareccia (2008) in which they compared data from the Coronary Artery
Bypass Graft (CABG) project clinical database with that obtained from administrative
hospital discharge records of individuals identified in both data sources. They then
applied a risk model to the CABG data, the hospital discharge data, and the hospital
discharge data supplemented with a few key variables from the CABG database. Analysis
and comparison of the three data sources for the assessment of hospital/surgical
performance revealed that the clinical CABG and administrative hospital discharge
records were quite similar in outcome (Rosato et al., 2008). However, when the
administrative dataset was supplemented with clinical data, the assessment improved and
became more accurate (Rosato et al., 2008).
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Other studies demonstrate a similar value of administrative databases for
assessing disease treatment protocols such as foot care management for diabetic patients
(Moreland et al., 2004); yet others have demonstrated their value as effective tools that
facilitate quality assurance among professionals, actually improving communication
between such persons (de Bont, Stoevelaar, & Bal, 2007). Perhaps a key reason for the
continued value of healthcare administrative databases is their dependence on
standardized, easily accessible, well-defined and accepted medical coding systems—a
feature that has been developed over many years, and has been refined and expanded and
utilized internationally.
Medical Coding Systems
Coding for disease and diagnoses. The International Classification of Diseases,
9th Revision, Clinical Modifications (ICD-9-CM) is a standardized classification of
disease, injuries, and causes of death, by etiology and anatomic location. The combined
information is assigned a unique, searchable six-digit number, allowing for the easy
exchange of information and organization of detail (CDC, 2012). Historically, the
International Classification of Diseases evolved from the need to track mortality and
morbidity rates, primarily for the declaration of property rights and insurance payments
(Moriyama, Loy, & Robb-Smith 2011). In 1948, the World Health Organization
published the initial International Classification of Disease, a listing of the known
diseases at the time, to be used as a means to statistically track morbidity and mortality
(Moriyama et al., 2011). The ninth revision of this listing (ICD-9) was published in 1977,
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and having attained considerable international acceptance, the U.S. National Center for
Health Statistics decided to modify the disease listing so as to accommodate the statistical
analysis of clinical and morbidity information (Moriyama et al., 2011). This resulted in
the publication of the ICD-9-CM, which contains information sufficient to precisely
delineate the clinical picture of each patient, beyond that needed merely for disease
groupings and the statistical analysis of healthcare trends. Subsequently, in 1989, the
United States Congress passed a mandate that required the use of ICD-9-CM codes on
each Part-B Medicare claim submitted by physicians (Moriyama et al., 2011).
To date, these codes have become a standard for both public and private company
insurance claims and health records, warranting the need for trained, professional coders,
because failure to use or to improperly use ICD-9-CM codes can lead to serious
repercussions (Moriyama, et al., 2011). In fact, the Centers for Medicare and Medicaid
Services provides specific guidelines to aid in standardizing coding practices across the
United States and these are summarized in Table 3 (Centers for Medicare & Medicaid
Services [CMMS], 2012b). These rules are useful for helping one understand the
organization and implications of the codes as they appear in healthcare administrative
records.
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Table 3
Basic Standardized ICD-9-CM Coding Practices as Extracted from The Centers for
Medicare and Medicaid Services (CMMS) Guidelines (CMMS, 2012b)
Rule
Additional explanation
Identify each service, procedure, or supply To describe the diagnosis, symptom,
with an ICD.9 code from 001.0 through
complaint, condition, or problem.
V82.9.
Identify services or visits for
Example: follow-up care after
circumstances other than disease or injury, chemotherapy.
with V codes.
Code the primary diagnosis first, followed
by the secondary, tertiary, and so on.

Code any coexisting conditions that affect
the treatment of the patient for that visit or
procedure as supplement information.
Do not code a diagnosis that is no longer
applicable.

Code to the highest degree of specificity.

Carry the numerical code to the 4th or 5th
digit when necessary.
There are only approximately 100 valid
three-digit codes; all other ICD.9 codes
require additional digits.

Code a chronic diagnosis as often as it
is applicable to the patient’s treatment.
When only ancillary services are
provided, list the appropriate V code first
and the problem second.

For example, if the patient is receiving
physical therapy, list the V code first, then
the diagnosis code.

For surgical procedures, code the
diagnosis applicable to the procedure.

If the postoperative diagnosis is different
than the preoperative diagnosis, use the
postoperative diagnosis.
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Coding for treatment and services. While ICD-9-CM codes describe an
individual’s condition, they provide little to no indication of what treatment or service
was provided, a necessary component for billing and accounting services. Current
Procedural Terminology (CPT) is a listing of descriptive terms and identifying codes for
reporting medical services and procedures (American Medical Association [AMA],
2013). The codes “provide a uniform language that accurately describes medical,
surgical, and diagnostic services…" (Footnote AMA website at http://www.amaassn.org/med-sci/cpt/template.htm). First published in 1966, Current Procedural
Terminology (CPT) is trademarked by the American Medical Association (AMA), and
used for reporting in both public and private health insurance systems, primarily for
reimbursement and claims processing purposes (AMA, 2013). Such a coding system also
allows for the monitoring of services provided relative to a diagnosis (as indicated by
ICD-9-CM codes) and thus, ultimately, cost control and health care management (AMA,
2013). In fact, the Health Care Financing Administration (HCFA) has adopted CPT as
part of its Healthcare Common Procedure Coding System (HCPCS) for use in reporting
medical services in Medicare and Medicaid, as well as the VHA (CMMS 2012). An
important and notable difference between CPT and HCPCS codes is that CPT codes are
only for services provided, while HCPCS codes may include durable medical equipment
(DME) provided as part of that service (CMMS, 2012). Therefore, HCPCS codes rather
than CPT codes are particularly useful to represent services rendered in hospitals and
skilled nursing facilities, outpatient clinics, and rehabilitation centers to include physical
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and occupational therapy services as such services frequently include the administration
of such items as canes, walkers, braces and other orthopedic DME (CMMS, 2012a).
Clearly a key strength of the above-mentioned coding systems (ICD-9-CM, CPT,
and HCPCS) is their uniformity of language and universal acceptance within the
healthcare and medical industry. However, the codes and definitions are often obtuse and
complex, such that it may be difficult to assign a patient’s condition and service with a
single code, nor does the typical patient have a single condition. The accuracy of the
codes is only as good as the person doing the coding, be that person a professional coder,
an office manager, or the physician. Also, whereas the ICD-9-CM code is specific per
diagnosis, the CPT/HCPCS codes are considerably more general, as a single “procedure”
may actually be appropriate for multiple diagnoses or conditions; that is, CPT codes
indicate the treatment procedure to treat a particular condition and thus, it seems then, are
considerably more non-specific as a research outcome variable, and more appropriate as
confirmation or validation of the condition being accounted.
The Veterans Health Administration System of Care
A Public health system at work. The Department of Veteran Affairs attained
cabinet-level status under President George H. Bush in 1989 (Brown, et al., 2003). The
VHA is a section thereof and accounts for nearly half the budget (in Fiscal Year 2010,
estimated Congressional appropriation for the VA was $127.0 billion, of which the
VHA’s portion was $48.1 billion). As of 2010, the VHA was serving over 8.6 million
Veterans, nearly twice the number served in 2001 (Department of Veteran Affairs,
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2010a). During times of war, the VHA provides health care for active duty military
personnel, as well as for the general civilian public during national disasters.
Subsequently, nearly 4% (285,103) of the Veterans served were rated 100% disabled, and
as of FY 2009, 981 were Operation Iraqi Freedom/Operation Enduring Freedom war
amputees (DVA, 2010).
Table 4
Sample Veteran Population Demographics as of 2009
(National Center for Veterans Analysis and Statistics, 2010)
Characteristic
Percentage
Gender
8% Female, 92% male
Over 65 years old 39.9%
Race
White 79.3%
Black 11.3%
Asian/Pacific Islander 1.5%
Hispanic 5.8%
American Indian/Alaska Natives 0.8%

The Veterans Healthcare Administration of the United States is one of the largest
centralized health systems in the world with 153 hospitals, more than 800 communitybased and facility-based clinics, 135 nursing homes, 43 domiciliaries, 206 readjustment
counseling centers, and various other facilities, and employing approximately 180,000
healthcare professionals (DVA, 2010). Further, as part of VHA policy, VHA hospitals are
aligned and affiliated with medical and dental schools throughout the United States such
that, as of FY 2009, approximately 114,685 healthcare professionals (residents and
students) rotated through VHA facilities (DVA, 2010). In fact, more than half of the
United States practicing physicians have received training in VA hospitals (Boyko et al.,
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2000). In part, due to this close association with graduate education institutions, the VHA
is a major contributor to medical and scientific research and is second to the National
Institutes of Health in funding biomedical research in the U.S (DVA, 2010; Boyko et al.,
2000). As is apparent from this accounting of VHA facilities, there is considerable
variability in scope and complexity within the VHA system. For example, a small facility
(such as a community outreach center) may provide only routine primary care and a
subset of specialties, whereas moderate-sized facilities, such as hospital satellite centers,
may provide outpatient clinics to facilitate medical care access for large geographical
regions (Boyko et al., 2000). Typically, larger centers are affiliated with educational
medical centers and universities for collaborative clinical support (students and faculty
provide necessary manpower; clinical patients are an educational resource (Boyko, et al.,
2000). Such centers frequently provide expanded services to include inpatient and highly
specialized medical care units, for example, spinal cord injury, organ transplant,
traumatic brain injury, and polytrauma units (Boyko et al., 2000).
One of the key factors contributing to the VHA’s success and growing status as a
health care system is its early recognition and innovation in medical informatics.
Currently, medical documentation and ordering are computerized at every facility, with
national registries and databases being maintained since 1976; administrative and patient
information from all VA facilities is directed to a repository maintained at the VA Office
of Information, Austin Information Technology Center (Boyko et al., 2000; Murphy et
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al., 2002). At the core of this information system is the Veterans Health Information
Systems and Technology Architecture (VISTA).
The Veterans information systems technology and architecture program.
VISTA has its beginnings in the late 1970s, a time during which the VHA medical
centers began acquiring their own computing systems, largely for research purposes, and
from which emerged the Decentralized Hospital Computer Program (DHCP) (Brown et
al, 2003). The DHCP turned out to be a prototype for medical information systems being
based on a common data dictionary, common database, and sharing common tools and
needs such as scheduling, laboratory reporting, administrative records, pharmacy, mental
health applications, and radiology (Brown et al., 2003). By 1989, DHCP had expanded to
nationwide implementation and had expanded in scope to include dietetics, fiscal/supply,
medical center management, medical records tracking, nursing, and surgery (Brown et
al., 2003). Following a move toward “three-tiered architecture,” in 1996 DHCP was
renamed VISTA (Brown et al., 2003). By 2000, VISTA contained over 99 computer
software applications and, presently, most VHA medical centers run the program on
Compaq Alpha clusters ranging from 1 to 12 or more processors (Brown et al., 2003).
Given that the various applications supported by VISTA share a common infrastructure
(common database, common data dictionary, and so forth), this allows for (a) sharing of
common data, not replication thereof; (b) consistency of software application for the user
and developer; (c) simplified maintenance since the core code is centrally updated and
then distributed; and (d) stability between the operating system and applications—failure
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protection (Brown et al., 2003). Data sharing continues to improve. The Computerized
Patient Record System allows for near real-time, nationwide patient medical record
access, and similar access to the Department of Defense health care records for the
Veteran (while on previous active military duty) is now more easily available and
congruent (Brown et al., 2003).
The computerized patient record system. In the 1990s, the VHA launched their
Computerized Patient Record System (CPRS), shifting an emphasis from departmentalcentered clinical records to a more patient-centered clinical recordkeeping system, as well
as a departure from traditional paper charting to electronic charting (Boyko et al., 2000;
Brown et al., 2003; Murphy et al., 2002). CPRS is more than an electronic medical record
system; it is an umbrella program that organizes various clinical tools and applications in
a tabular and clinically relevant manner (Murphy et al., 2002). Virtually all clinical
documents are entered and accessed using CPRS, including all forms of clinical notes,
physician orders, consultations, procedure reports, and radiology and pathology
examinations - legacy paper medical records are no longer maintained on wards or
clinics, as virtually all necessary information is maintained and directly input through
CPRS (Brown, et al., 2003; Murphy et al., 2002). In fact, per VHA policy, clinicians and
practitioners are required to enter progress notes, orders, and reports directly into CPRS
at the time of the patient visit or as soon as possible thereafter. Upon completion of such,
and as part of the procedure to digitally sign the document, the signor must assign an
appropriate ICD-9-CM and/or CPT code, facilitated by a searchable lexicon available
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within the required data field (Murphy, et al., 2002). Additionally, other background
applications provide order checking, allergy checking, a notifications engine, patient
demographics and eligibility status, and clinical reminders (Brown et al., 2003; Murphy
et al., 2002). Of note: Although the clinician/provider is required to enter diagnosis and
treatment codes, professional coders are employed to review ICD-9-CM codes for their
appropriateness prior to weekly and monthly database roll-ups. CPT/HCPCS codes are
under the review of service chiefs and Medical Administration Service staff (Murphy et
al., 2002). It is through CPRS, facilitated by VISTA, that the various VHA national
clinical databases and registries obtain most (but not all) ICD-9-CM and CPT codes
(Murphy, et al., 2002). Additional clinical data may be acquired from pharmacy,
laboratory, admissions (demographic data), and scheduling applications as part of the
numerous administrative data files managed by VISTA and summarized in CPRS (Brown
et al., 2003; Murphy et al., 2002).
The national patient care database. Supported by VISTA, the National Patient
Care Database (NPCD) is a centralized relational Oracle database (Murphy, et al 2002). It
receives patient visit information from CPRS from all VHA facilities across the nation,
but is not directly accessible by interested parties or researchers. Instead, upon request
and approval, data is provided in the form of annual (per fiscal year) SAS datasets that
may represent inpatient, outpatient, extended care, inpatient short stay/observation care,
and health care provided for veterans outside the VA with VA funding (VIReC, 2012b).
Basically, all patients having a health care episode at a VA medical center, hospital, or
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clinic in a given fiscal year will have their demographic information, location, date, time,
and type of health service provided (that is, surgical or CPT code). The type of provider
and the purpose of the visit or reason for admission (diagnostic ICD-9-CM codes) are
recorded in the database (Murphy et al., 2002; VIReC, 2012b). The information is
organized as either inpatient or outpatient (ambulatory care) data files, from which more
specific SAS datasets may be extracted (VIReC, 2012b). Common to both data files is
demographic information to include age; sex; race; birth date; marital status; city, county,
and state of residence; period of military service; and selected special characteristics such
as spinal cord injury status, Agent Orange exposure, and service connected disability
status (Murphy et al., 2002; VIReC 2012b). Inpatient data includes the patient’s
admission date, specialty, provider, and facility; their primary diagnosis, patient care data
(as indicated by ICD-9-CM codes and diagnosis related groups, CPT codes); and
discharge date and type (for example, death or relocation) (Murphy, 2002; VIReC,
2012b). As such, the service provided is indicated by the date, provider/specialty, and
associated clinic, while the actual patient care is indicated by ICD-9-CM and CPT codes
(Murphy et al., 2002).
Data from the NPCD has been used extensively in VHA medical/clinical research.
Examples include a study to determine if race/ethnicity was an independent predictor for
dysvascular amputation versus lower limb vascular by-pass procedures (Collins, Johnson,
Henderson, Khuri, & Daley, 2002), the clinical utilization patterns of Traumatic Brain
Injury patients (Homaifar, Harwood, Wagner, & Brenner, 2009), and psychiatric
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comorbidities among Veterans diagnosed with epilepsy (Pugh, Zeber, Copeland, Tabares,
& Cramer, 2008). Relative to limb loss, Mayfield et al., (2001) published their findings
following a solid epidemiological analysis of Veteran patients, to identify factors
associated with survival following amputation. The authors identified amputee patients
from FY 1992 from the VA Patient Treatment File, a subset of the NPCD. The outcome
measure was death with information derived from the Beneficiary Identification and
Records Locator System (BIRLS), maintained by the Department of Veteran Affairs (not
a VHA data file) (Mayfield et al., 2001). All lower-limb amputations were evaluated—
toe (ICD-9-CM 84.11), transmetatarsal (ICD-9-CM 84.12), transtibial (ICD-9-CM 84.1384.17), and transfemoral (ICD-9-CM 84.18-84.19) (Mayfield, et al., 2001). Comorbid
conditions were identified from the ICD-9-CM codes associated with the hospitalization
for the amputation and included diabetes, renal disease, and PVD, as well as the presence
or absence of congestive heart failure (CHF) (Mayfield et al., 2001). The analysis
included descriptive statistics, cross tabulations, frequencies, and the Kaplan-Meier
Survival Curve analysis. From these analyses the authors determined that nearly half of
all amputations were performed on persons over the age of 65 years, most (60%) were
White, nearly all (99%) were male, and most had diabetes (62%) (Mayfield et al., 2001).
The primary diagnoses at the time of amputations were cardiovascular disease (23%),
CHF (11%), renal failure (9%), cerebrovascular disease (10%), and PVD (56%)
(Mayfield et al., 2001). Almost 20% of the persons undergoing transtibial amputation
died before discharge, and the three-year mortality rate for all amputations was calculated
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to be 41.5%, and the five-year mortality rate was 55.5% (Mayfield et al., 2001). KaplanMeier curves demonstrated worse survival outcomes with advancing age, proximal
amputation level, renal disease, and cardiovascular, cerebral vascular, and PVD
(Mayfield et al., 2001).
As can be concluded from the extensive results the authors were able to compile,
the NPCD contains a wealth of information suitable for epidemiologic studies to describe
and account for amputation. However, as the study utilized data strictly from the NPCD,
there was no way to ascertain if patients received an artificial limb following amputation
surgery, and, if they did, what type of artificial limb configuration they got, or if that
artificial limb contributed to their survival or death.
From the PSP to the national prosthetics patient database. The Prosthetics
Software Package/Prosthetics Suspense Program (PSP) (recently upgraded and renamed
the OWLS—Orthotic WorkLoad Software) is the Prosthetics and Sensory Aids Service’s
product accounting and information software packet that runs separately from CPRS. It is
supported by VISTA and serves as the interface between the user and administration of
prosthetic devices (Werner, 2010; G. W. Bosker CPO, personal communication, January
2011). The Prosthetics Software Package performs all aspects of prosthetics provision,
from ordering, to purchasing, to accounting, to reconciliation; allowing for the review of
past current and pending provisions (Werner, 2010). It is a necessary tool for, unlike the
process in the private sector wherein the patient selects a vendor to supply the assistive
devices, which are then billed to Medicare/insurance, the VHA provides the patient with
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assistive devices, purchasing or renting them using a competitive bid process (G. W.
Bosker CPO, personal communication, January 2011). The prosthetics–orthotics service
practitioner is responsible for entering product name, type, reason for purchase, and the
appropriate HCPCS (billing code, selected from an on-line lexicon) of the device
prescribed, allowing for limited interface with the National Prosthetics Patient Database
(NPPD), with a collection of tools to facilitate such (Werner, 2010).
NPPD is maintained by the U.S. Veterans Administration Prosthetic and Sensory
Aids Service Strategic Healthcare Group (PSAS). Originally developed to oversee and
monitor the VA Prosthetic Service, as well as to provide clinicians with information
regarding prosthetic prescription practices, the NPPD is a roll-up of all dispensed
prosthetic, orthotic, and durable medical equipment data extracted from the local VISTA
Prosthetics Suspense Package (PSP) for each VHA facility in the United States (Pape et
al., 2001). The database groups’ items/devices provided on the basis of HCPCS codes,
with subsequent groups being: wheelchairs and accessories, artificial limbs, braces and
orthotics, neurosensory aids, oxygen and respiratory, durable medical equipment, and
surgical implants (Pape, et al., 2001). There are a total of 25 data fields including visit
dates, device provided, reason for visit (provision, repair or replacement), product
identification (cost, type, and so forth), and contractor or vendor providing the device
(device usage or abandonment is not recorded) (Pape et al, 2001; VIReC, 2012a). The
database is maintained at the Austin Information Technology Center, and requested data
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is transferred as a flat text file or Excel spreadsheet with one record per device purchased
and dispensed (VIReC, 2012a).
The NPPD is a relatively new database, having been made available to
researchers only since 2001 (Pape et al., 2001). Unfortunately, the quality of the data
entry and data extraction process has not been evaluated fully, although significant
improvements and greater compatibility were put in place as of 2005 (VIReC, 2012a).
The key limitation of this database is its potential lack of reliability and validity in terms
of visit dates that should correspond with outpatient encounter dates as indicated by the
NPCD. In the study by Mark W. Smith (2010) it was determined that only about 40% to
60% of visit dates in the NPPD could be matched to corresponding outpatient care visits,
and only about 10% of related inpatient dates as per Patient Treatment Files from the
NPCD. Such discrepancies between the two databases would clearly impact research
having to do with the timing of patient response relative to receipt of a device, or when
tracking health care delivery practices, but would probably be accurate in regard to an
accounting of devices or components dispensed. However, in part due to problems with
data validity and reliability, the NPPD has not been exploited to the extent the NPCD
data files have, and thus few studies utilize the NPPD database.
Nonetheless, the NPPD has been shown to be valuable when attempting to assess
the national distribution of devices, or as a means to understand prescription practices.
For example, Hubbard, Fitzgerald, Vogel, Reker, Cooper, & Boninger (2007) used data
from the NPPD as an initial step toward devising prescription guidelines for wheelchairs
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and scooters, hypothesizing that “enhanced prescription guidelines would facilitate more
equitable cost distributions of wheelchairs,” while leading to enhanced clinician expertise
and more personalized prescriptions (p582). The authors endeavored to determine
patterns of wheelchair and scooter provision across the 23 Veteran Integrated Systems
Networks (VISN regional offices) to include what primary diagnoses were associated
with wheelchairs versus scooters, estimate mean number of devices per Veteran, and the
cost per VISN for the provision of devices (Hubbard et al., 2007). Data for fiscal years
2000 and 2001 were extracted from the NPPD, amounting to over 120,000 observations
(Hubbard et al., 2007). Although the data were found to have numerous errors suggestive
of data entry problems (for example, HCPCS code for manual wheelchair linked with a
cost more suitable for a powered wheelchair), the authors were nonetheless able to
determine that the most commonly prescribed wheelchair was the standard manual
wheelchair (53%) followed by the light rehabilitative manual wheelchair (17%), and then
the scooter (13%) (Hubbard et al., 2007). No patterns of relation to age or diagnosis were
discerned beyond geographical (by VISN) differences suggesting either over or under
prescription between regions (Hubbard et al., 2007). However, without additional clinical
information, it is difficult to clearly understand the trends noted. For instance, many times
a power wheelchair is prescribed for persons who have developed chronic shoulder pain
due to prolonged manual wheelchair use; scooters are frequently prescribed due to patient
preference and/or for patients dealing with complications of obesity (D. Barber MD,
personal communication, October 2013). Without the addition of ICD-9-CM codes to
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establish comorbid conditions, it is difficult to ascertain why the prescription patterns
noted by the authors actually exist. Finally, while cost was not assumed to be a driving
factor behind prescription, but rather was assumed to be an outcome or mere unit of
analysis, it would have been interesting to note or look for manufacturer or supplier
patterns among VISNs in relation to actual geographical regions (for example, Northwest
United States vs. New England; Southwest vs. Midwest United States). The author’s
conclusion that the differences in prescription trends may have been geographically based
begs the question of the impact of regional marketing/sales influence. Regardless, the
findings from this study highlight the advantages of linking NPPD data with NPCD
patient care data in order to draw more defined inferences, while also demonstrating both
the limitations and strengths of using administrative data to research health issues.
In a study that actually linked patient care data from the NPCD with the provision
of an artificial limb as indicated by the NPPD data, Kurichi et al., (2007) attempted to
identify factors related to lower limb artificial limb provision (transtibial, transfemoral,
and hip disarticulation among elderly veterans—specifically what factors seem to drive
clinical decisions as to who receives an artificial limb (the artificial limb configuration
was not considered. The authors utilized a grouping of patient-related factors available
from administrative records into clinically meaningful domains to predict patient
outcomes and patterns of artificial limb provision. Specifically, they used the PAQ (Post
Amputation Quality-of-life) framework, comprised of 6 domains (socioeconomic status
[SES], amputation etiologies, amputation level, co-morbidities, medical acuity, and
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functional performance outcome status) to explore patient factors, while a simple
binomial (yes/no) variable was used to indicate if the patient was provided an artificial
limb, as discerned from the NPPD (Kurichi et al., 2007). Utilizing data from FY 20022003, the authors combined inpatient and outpatient files from the NPCD to describe the
patient’s condition, amputation etiology and outcome (discharge or death), ultimately
identifying 2,375 Veterans with index amputations (Kurichi et al., 2007). Following
multivariate and logistic regression analysis, the authors determined that clinical factors
of CHF, neurological disorders, metastasis cancer, PVD, and renal failure are factors
most contributory to a patient not being provided an artificial limb (Kurichi et al., 2007).
They also ascertained that grouping of variables into relative domains of SES, etiology,
co- morbidity, functional, amputation level, and medical acuity (as per the PAQ
framework) are all predictive of artificial limb provision (Kurichi et al., 2007).
While this study was very comprehensive in its definition of the patient (in terms
of co-morbid conditions) and potential factors driving a clinician’s decision to prescribe
an artificial limb or not, there are other issues to be considered. Provision does not mean
the artificial limb was used, nor does it ensure a well-fitting, properly prescribed artificial
limb. The configuration of the artificial limb is not addressed nor the patient’s outcome
following provision, thereby limiting the ability to ascertain the effectiveness of the
clinician’s prescription decision.
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To Build a Better Database or Not
As has been stated and inferred throughout this review, at the time of this writing
there is (a) no systematic means for tracking or monitoring the incidence, prevalence, or
health of persons living with limb loss, (b) little literature and/or research on the
longitudinal impact of living with limb loss, (c) a low number of systematic studies that
directly assess the residual limb’s health, and (d) little incentive to conduct clinical trials
on artificial limb components, let alone configurations. While the development of a high
quality clinical database is one way to address or resolve many of these issues, the
development of such would be a very complicated and most likely expensive endeavor,
fraught with complications such as universal and standardized outcome measures,
decisions as to what constitutes a meaningful measure, and a means to collect unbiased
information/data (let alone disseminate it). Given the growing incidence and prevalence
of persons living with limb loss, which is expected to reach nearly four million people by
2050, some means of surveillance or monitoring of their condition seems imperative
(Ziegler-Graham et al., 2008).
The abundance of administrative healthcare records that are generated regularly
by healthcare institutions to include Medicare, private insurance, and state public health
programs seems a potential source with which to “build a better database” focused on
persons living with limb loss. Obvious advantages of such a database include large
numbers of observations, standard measures (that is, ICD-9-CM, CPT, and HCPCS
codes), pre-existent data systems, and data unbiased by recall or study design. The VHA
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comes close to having such a database at hand. By linking patient data from the NPCD
(ICD-9-CM, CPT codes and demographics) with artificial limb provision data (HCPCS
codes) from the NPPD, what emerges is a framework from which to build a database that
addresses many of these issues mentioned as currently lacking—a database from which to
derive evidence-based clinical guidelines.
Where’s the evidence? Evidence-based medicine became a feature of medical
and health care planning in the 1990s, being partly driven by significant advances and
accessibility in information technology, to include health informatics (Georgiou et al.,
2002). It may be defined as a process using the best evidence to make decisions on care
for patients, a process of decision-making that incorporates best practice medicine,
external, related scientific evidence, and social, economic, and cultural factors that
influence a patient’s quality of life, morbidity and mortality (Borg & Sunnerhagen, 2008;
Sackett et al., 2007). Within this paradigm, there is an emphasis on the randomized
control trial, especially the systematic review of several of such studies or the metaanalyses thereof, due to the belief that a randomized control trial is most likely to
promote greater validity and reliability but less bias (Charles et al., 2011; Giacomini,
2009). As such, this methodology has become the gold standard for judging whether a
treatment does more good than harm (Sackett et al., 2007). Unfortunately, in the medical
practice of prosthetics, and for various reasons, this aspect of evidence-based medicine is
lacking.
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In a clinical review by Groah, Libin, Lauderdale, Kroll, DeJong, & Hsieh (2009),
the authors presented an explanation and review of the dimensions of evidence-based
medicine through Knowledge Translation (KT) and into “best practices,” focusing these
paradigms on rehabilitation medicine practice and research. They argued that for research
in this field, required to embrace a wide variety of outcomes and diverse populations, the
exploitation of multiple data sources and study designs is preferable to randomized
control trials whose design may not be suitable for a specific question, is frequently
applicable only to a specific population and circumstance, and often has limited external
generalizability (Groah et al., 2009). Unfortunately, because of the paucity of randomized
control trials in rehabilitation medicine, the perception is that rehabilitation research
suffers from a lack of methodological rigor and hence, evidence (Groah et al., 2009). The
authors explain that the reasons for the lack of "high-quality" randomized control trials in
rehabilitation research are multifactorial, but can be aligned with two fundamental issues.
First of all, the practice is multidisciplinary such that an intervention is commonly
comprised of concurrent numerous treatments (for example, physical and occupational
therapy treatments and modalities, pharmacology, procedural interventions, nursing and
behavioral interventions, prosthetics, sensory, and mobility aids), making it difficult to
design and manage a high-quality randomized control trial (Groah et al., 2009). Secondly,
informative randomized control trials are typically most feasible in highly prevalent
conditions that allow for large, homogeneous study populations so as to maximize both
internal validity and the probability of demonstrating an effect that might otherwise be
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obscured by broader selection criteria (Groah et al., 2009; Sacket, et al., 2007). In
rehabilitation medicine (inclusive of prosthetics), such conditions and patient populations
are fairly limited to those with musculoskeletal disorders (for example, fractures and
dislocations), chronic pain, joint replacement, and stroke recovery, but the practice also
serves low-incidence, heterogeneous populations, such as those with spinal cord injuries,
burns, amputation, and many of the neuromuscular conditions such as multiple sclerosis
and amyotrophic lateral sclerosis (Groah et al., 2009; Iezzoni, 2004).
Therefore, in order to meet the requirements of the evidence-based medicine and
best practices paradigm, Groah, as well as others, suggests a shift toward using newer
methodological and statistical design techniques to better accommodate the unique
practice and patient population characteristics of rehabilitation medicine and similar
specialties (Borg & Sunnerhagen, 2008; Groah et al., 2009; Iezzoni, 2004). More
specifically, Groah and colleagues suggest a variant of the prospective observational
cohort design (a gold-standard for many epidemiologic health studies) referred to as the
practice-based evidence (PBE) model (Groah et al., 2009). The practice-based evidence
model basically seeks to systematically categorize patient interventions to determine
which interventions are most strongly associated with outcomes, while taking into account
a large number of patient characteristics that may be influential (Groah, et al., 2009). The
label practice-based evidence is rather self-explanatory as the model/design is focused on
actual medical practice. Specifically, hypotheses and inclusion criteria are rather general
(with more specific hypotheses being tested as warranted); selection criteria are broad so
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as to promote generalizability and external validity; and data collected includes patient
demographic and socioeconomic variables, co-morbid conditions, and functional status
measures that may account for the outcomes observed, and statistically controlled for
through multivariate analyses (Groah et al., 2009).
A “proof of concept.” The study proposed in this dissertation is clearly aligned
with the practice-based evidence model by relying heavily on clinical data such as CPT,
ICD-9-CM, and HCPCS codes as independent and dependent variables in a multivariate
analysis. Admittedly, a significant difference between the practice-based evidence model
and the methodology being proposed in this study is the use of retrospective data
acquired from national healthcare databases, as opposed to conducting a prospective
observational study with the advantage of direct clinical data, with perhaps greater detail.
While it is true that direct information is always better than second-hand or indirect data,
for the purposes of identifying trends and patterns for further study, perhaps indirect data
that is unbiased in its acquisition is nearly as powerful. However, in the field of
prosthetics, and at the crux of this study, such has not been addressed beyond the use of
diagnostic and procedural codes to describe patient conditions, and the absence or
presence of a prosthetic device (Kurichi et al., 2007) or wheelchair/scooter (Hubbard et
al., 2007). Nonetheless, perhaps a more significant hurdle of this proposed study is the
reliability of the NPPD. It is a relatively recent national database that has not been fully
tested, evaluated, or proven, certainly not to the same extent as the NPCD (VIReC,
2012a; Smith et al., 2010). Therefore, there is a definite possibility that the information to
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be drawn from the NPPD is insufficient to draw any conclusions or inferences relative to
the research questions.
The fact remains, however, that no other database of its nature (artificial limb
provision on a national level) exists at present and if any sort of surveillance or
monitoring of persons living with limb loss is to be advanced or advocated, it would be
highly beneficial to know (a) if such indirect data to represent patient care and residual
limb condition is sufficiently meaningful, (b) if residual limb condition is a suitable
outcome measure, and (c) if the concept of developing an amputee–artificial limb
database is feasible or worthwhile. In other words, the study conducted here was
designed as a proof of concept—a concept to be tested and challenged before investing
further time, resources, and stakeholders.
The development of the study database/dataset with residual limb condition as a
longitudinal outcome measure, and subsequent patterns of artificial limb provision
relative to such, served as a challenge to the proof of concept in regard to the actual
structure or design of a future database. However, a key component of the concept was its
viability as a tool to detect changes in outcome, given conditional input as factors
potentially contributing to outcome results.
For this particular study and subsequent dataset, the population (dysvascular
amputees) was actually fairly homogenous. All had a transtibial amputation due to
dysvascular complications; most were over the age of 50; given the etiology of the
amputation, their comorbid conditions (COPD, renal failure, diabetes, congestive heart
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failure, and so forth) had direct bearing on blood circulation and thus the outcome
measure; all were U. S. Veterans enrolled with the VHA and enjoyed the advantages of
socialized medicine, to include access to preventive care and the provision of artificial
limbs at no or minimal cost. As such, perhaps the more interesting test to the sensitivity
of the outcome measure and its relationship to artificial limb configuration was the
inclusion of variables more directly associated with a patient’s inferred ability to maintain
their artificial limb and healthy residual limb.
In keeping with the dataset design and data sources, the factor would need to be
one identifiable by diagnosis and/or procedural codes, and not as common among the
population as to overwhelm the sensitivity of the outcome measure. Further, it is always
beneficial to introduce a factor that will add to the body of knowledge, rather than merely
to duplicate or repeat what is already known. For these reasons, the test
factor(s)/variable(s) selected represented the mental health status of the amputee,
especially because of the dearth of research and literature currently available and its
implications toward the long-term success of the amputee utilizing an artificial limb.
Therefore, the following chapter on methodology will provide the details of data
acquisition, data manipulations, and plans for analysis, given a study dataset that
represented a cohort of Veterans having undergone a transtibial amputation for
dysvascular complications. In an effort to assess long-term residual limb outcomes, the
cohort was followed for three years following amputation and the comorbid condition of
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several mental health conditions included in the analysis to assess the influence, if any,
on the patient’s care of their residual limb (as indicated by outcome).
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Chapter 3: Methodology
Background
The purpose of this study was to address the utility of VHA administrative
healthcare records to discriminate determinants of residual limb skin outcomes relative to
the artificial lower limb configuration prescribed, as a source of information toward the
potential development of a suitable amputee-artificial limb database and future
surveillance system. The goal and purpose of the study was derived from the fact that the
number of persons living with limb loss (specifically that due to dysvascular
complications) is estimated to continue to rise over the next decades, reaching an
estimated three million individuals by 2050 (Ziegler-Graham et al., 2008). As presented
in Chapter 2, the lives of such persons are frequently modulated by factors related to their
amputation, ranging from mild discomfort (psychosocial and physical), to impaired or
restricted mobility, to significant residual limb complications that lead to reamputation
and even death. Some, though not all, of these factors may be attributable to poor or
inappropriate artificial limb prescriptions—prescriptions that are not sufficiently tailored
to the individual’s mental status, physical condition, or realistic capacity (Kurichi et al.,
2007; Nelson et al., 2006; van der Linde et al., 2004).
Further, and as also indicated in Chapter 2, prescription of an artificial limb is not
a simple matter and is hampered by a lack of quality evidence-based medicine (EBM)
literature, clinical trial results, or even surveillance/monitoring system reports, from
which to draw conclusions and facilitate decisions (Van der Linde et al., 2004). This lack
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of substantiated information is, in part, a consequence of the complex nature of the
patient/artificial limb interface, relative specificity of the population (compared to more
common conditions such as hypertension), and the resources required to conduct research
that meets EBM standards (Groah et al., 2009). It is a combination of these factors that
led to the second half of the stated study purpose: “exploring the utility of an integrated
amputee–artificial limb dataset as a means to fill informational gaps regarding artificial
limb prescription and amputee outcome,” and supports the underlying study goal of
exploring the feasibility of healthcare administrative data as a source and basis of EBM in
the field of prosthetics research.
This chapter describes the research plan, measures, and analyses that were
relevant to the goals presented above in a strategy that combined two phases: one
grounded in informatics principles, the other in epidemiology. The first phase,
“Developing an informatics tool,” focused on the compilation of a cohort study dataset
derived from multiple VHA national patient care databases. Given the uniqueness of such
a dataset, not only was its quality, validity, or reliability unknown, but so also was its
potential value as an informatics tool for the development of artificial limb prescription
guidelines or to provide evidence for policy makers. No matter how well or poorly
constructed the tool, its potential value, limitations, and weaknesses remain truly
unknown until challenged with thoughtful analyses. Such analyses may ascertain its
potential value for continued development and refinement, or to determine its demise,
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before expending limited resources. This strategy, specific to the compiled dataset and
epidemiological in structure, formed the basis of the second phase of the study.
At the time of this project, there were no known studies that utilize medical
coding to examine the relationships between artificial limb configuration, residual limb
conditions, and mental health. Therefore, this seemed worthy of a thoughtful analysis.
The second phase of the study, “An epidemiological study of a cohort of U.S.
Veterans with transtibial amputations,” utilized the derived cohort study dataset that
included two novel fields: artificial limb configuration (ALC), as the independent
variable, and Residual Limb Skin Problem Severity (RLSPS), as the repeated measures
dependent variable. These were examined in a series of statistical analyses in a study
designed to test the viability of the outcome/dependent variable that was based on
medical coding, while addressing significant factors relevant to success with an artificial
limb, namely certain mental health conditions and artificial limb configurations. Details
of the variables contributing to the epidemiological analysis are presented in the
Instrumentation and Materials section of this chapter.
The section entitled Research Design and Approach outlines each phase of the
study and presents the primary objective with associated tasks and explanatory
background information, thereby representing the logical flow of the overall
methodology. Phase 1 focused on the derivation, construction, and description of a
dataset as an example of a prosthetics practice-based informatics tool. Phase 2 focused on
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an epidemiological analysis of the previously defined cohort of U.S. veteran dysvascular
transtibial amputees, based on a retrospective observational cohort study design.
While the study methods utilized are not necessarily novel, the derived database
is, as is the epidemiological analysis, given its data source and selection of independentdependent variable focus. For this reason, a level of detail is presented regarding VHA
software applications that serve to interface the clinician with the VHA’s core
information system, VISTA (and ultimately the national databases from which the study
dataset was extracted), in order to more clearly explain data and study assumptions and
limitations. A fair amount of attention has also been given to matters of data acquisition
requirements and data security measures, as such factors are highly relevant to the
confidentiality of protected health information of our military veterans.
Ultimately, it is felt that in combination, the two study phases, objective, tasks,
analyses, and data quality serve to provide insight into the value of the study model for
future investigations, as well as provide an initial evaluation of practice-based evidence
relevant to the dysvascular lower limb amputee and their artificial limb prescription.
Research Design and Approach
Overview

Health planners have predicted that over the next 40 years the number of persons
living with the loss of a limb will rise from an estimated 2 million in 2007 and increase
dramatically to 3.6 million in 2050 (Ziegler-Graham, et al., 2008). Much of this increase
in amputations will likely be due to dysvascular conditions, most significantly diabetes
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and PVD, with a patient population increasing from just under 1 million in 2005 to 2.3
million in 2050 (Ziegler-Graham et al., 2008). For such persons with lower limb
amputations and an artificial limb, their success and quality of life is often modulated by
residual limb complications; however, little evidence-based research has been conducted
to explore this relationship. Without evidence-based outcomes research, this population
will and has remained especially vulnerable and at risk of poor quality of life, in
conjunction with excessive medical care and costs, subsequent of misguided artificial
limb prescription and resultant residual limb breakdown (Collins et al., 2006;
Hermodsson & Persson, 1998; Legro et al., 1998; Meulenbelt et al., 2006; ZieglerGraham et al., 2008).
Achieving the goal of establishing evidence based practices and outcomes based
care protocols for this growing patient population requires a thorough assessment of the
informatics tools and methods currently available for research. At the time of this writing,
there was no reported practiced-based evidence research to support residual limb
complications relative to artificial limb components—a status that may be, in part, due to
a lack of active surveillance/monitoring of amputees with artificial limbs. Such a practice
would facilitate the development of registries or high quality clinical databases (HQCD)
and provide direct clinical implications from which to derive prescription guidelines for
various populations of amputees (Groah et al., 2009; Black, 1999). Further, the
complexity of the patient condition and treatment (the provision of an artificial limb
being only one component thereof) renders evidence-based medicine difficult to pursue—
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prospective cohort studies are complex and costly, meaningful outcome measures
arguable, and randomized control trials veritably infeasible(Borg & Sunnerhagen, 2008;
Groah et al., 2009; Iezzoni, 2004). However, in the absence of prospective studies or
clinically specific databases, other medical specialties (for example, surgery,
endocrinology, and nephrology) have demonstrated the value of healthcare administrative
databases that record patient resource utilization, in the form of CPT codes and
HCPCS/billing codes, as reliable alternative resources(Boyko et al., 2000; Murphy et al.,
2002; Render et al., 2003). Thus, this study explored the value of a compiled and
integrated dataset derived from multiple national VHA health care datasets as a means to
provide observed practice-based evidence for the ascertainment of relationships
specifically relative to the lower limb amputee. What follows is an outline of that process.
Developing an Informatics Tool
The goal of this phase of the study was to derive a viable dataset composed of
healthcare administrative data from which to conduct an epidemiological analysis. A
compiled dataset was derived from the integration of subsets of the VHA’s NPCD (from
which were drawn pertinent patient health status information) with the NPPD (which
contained artificial limb components dispensed). Both databases maintain information on
the patient level that can be linked by a common variable, ”ScSSN,” the patient’s
encrypted Social Security Number, that is consistent throughout most VHA national
databases (VIReC, 2012b). The study dataset ultimately represented a cohort of United
States veterans having undergone a dysvascular transtibial amputation during FY 2007,
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selected clinical and demographic variables of interests from that time through FY 2010
(or death or loss) and included the artificial limb configuration (socket suspension system
and prosthetic foot combination) they were dispensed. From such a dataset, it was
possible to identify patterns of artificial limb prescription/disbursement relative to patient
clinical conditions and, in particular, RLSPS following disbursement and concurrent with
certain psychosocial conditions (the second phase of the study).
Aim 1. Integration of the multiple subsets. The first aim of this study was to
compile and integrate multiple subsets of the VHA’s NPCD and NPPD, that would
represent a cohort of veterans’ health statuses from the time of their amputation surgery
in FY 2007, to the date they were dispensed a definitive artificial limb (to include
identification of artificial limb components and configuration), and up to 3 years
thereafter. To accomplish this, the following tasks were performed:
•

Task 1.1 Data acquisition—The NPCD is the VHA’s centralized relational
database that receives patient encounter data from the VHA’s, CPRS. It is an
Oracle database that has been maintained at the Austin Information Technology
Center (AITC) on a UNIX platform (VIReC, 2012b). Therefore, data is not
accessible directly from the mainframe, but rather, upon approval and the
establishment of an account, is provided as medical SAS datasets per fiscal year
and preferred data file extract (see section entitled Setting and Sample). Approval
requires an approved IRB protocol, VA Research and Development Service
Subcommittee approval, Office of Information Security approval, and application
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through the on-line Data Access Request Tracker (VIReC, 2012b). Inpatient and
outpatient medical SAS datasheets for fiscal years 2007 through 2010 were
retrieved from the AITC and stored on a South Texas Veterans Health Care
System (STVHCS) secure server for further manipulation. NPPD data are under
the stewardship of the VHA’s Office of Patient Care Services (PCS). Data are
available for use in IRB-approved research studies and are provided as an Excel
worksheet or flat text file extract (VIReC, 2012a). Data requests require
submission of the PCS Data Transfer Agreement Request Form and associated
documentation to include proof of IRB and VA Research and Development
Subcommittee approval, certification of VA data security training, and
employment status (VIReC, 2012a). Flat text files extracts for FY 2007 through
2010 were stored on a STVHCS secure server for further manipulation.
•

Task 1.2 Compile/construct dataset (identify the cohort)—In-patient FY 2007
medical SAS datasets were examined and all cases with ICD-9, CPT and/or
surgical codes for transtibial amputation and a diagnosis code for diabetes
mellitus, PAD, or PVD were extracted to include available demographic data. The
extracted data formed the initial study dataset/cohort. Text file extracts from the
NPPD were then searched for cases having the same ScSSn as those identified
above, with HCPCS codes indicative of a dispensed definitive artificial lower
limb, as well as the date the limb was dispensed. The identified information was
then extracted and linked to the initial study dataset by ScSSn. Finally,
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representing the follow-up period, data from the NPCD outpatient encounter and
event datasets, per matched ScSSN and subsequent of the definitive artificial limb
provision date, procedural codes (V-codes and CPT codes), diagnosis codes (ICD9-CM codes) and associated visit dates were extracted from datasets representing
FY 2007 through 2010. Diagnosis codes representative of skin conditions such as
rashes, ulcering, blistering, allergic responses, or cysts/tumors, coexistent with Vcodes or CPT codes indicative of residual limb treatment, were linked to the
cohort study dataset under development, and used to define the outcome variable
RLSPS. Similarly, dates and diagnosis codes for MDD, PTSD and SUD, were
identified and used as psychosocial covariates, while dates and diagnosis codes
for cerebral vascular disease (CVD), chronic obstructive pulmonary disease
(COPD), obesity, renal failure, and congestive heart failure (CHF), were also
identified and served as explanatory variables in the epidemiological analysis of
the dataset (phase II). Further, dates and diagnosis and procedural codes
representative of residual limb revision and/or lower extremity amputation, as
well as discharge status (specifically death), were extracted from the NPCD
Inpatient Surgical and Main medical SAS datasets (FY 2007–FY 2010) and
served to calculate cohort mortality rates and serious outcomes. The specific
codes for which a search was conducted are listed in Table B27 in Appendix B –
Data dictionary.
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•

Task 1.3 Assess, describe and “clean” the study cohort dataset—Per fiscal year,
the study dataset was searched for nonsensical, superfluous, or missing data,
which was corrected or deleted depending on circumstances and best judgment.
Rules for data cleaning were devised accordingly and applied to subsequent fiscal
year extracts prior to compilation of the entire cohort dataset. A data dictionary of
the dataset was devised providing variable names, definitions, and characteristics
such as data types (date fields, categorical, binomial, continuous), data format
restrictions (that is, 1 = “yes”, 0 = “no”; date = mmddyy, and so forth), rules used
to extract necessary data, and any variable labels to facilitate data manipulations
and statistical analyses. Included in this data dictionary were new variables to
represent ALC categories (based on groupings of HCPCS codes) and RLSPS
categories (based on CPT, ICD-9-CM and DRG codes), as well as the rules or
algorithms used to define the variables. Figure 1 provides a schematic of the
derivation of the study cohort dataset.

147

NPCD Master Database
MedSAS inpatient & outpatient data
select for any major limb amputated in
FY07 – FY10

NPPD
artificial limb components
purchased and dispensed in
FY07 – FY10

Select for TTA in FY07 with dysvascular
condition, e.g. DM, PVD, PAD

Initial Cohort

Select for NPCD Initial Cohort members

Match & Link Records from
NPCD Initial Cohort and NPPD dataset

NPCD records only, no match:
excluded from study

No definitive artificial limb on record:
excluded from study

NPCD records linked with NPPD records

Definitive artificial limb purchased and dispensed

Study Cohort Dataset
FY07 TTA w/dysvascular condition and a definitive artificial limb by FY10
Independent Variable: artificial limb configuration derived from NPPD HCPCS billing codes
Dependent Variable: residual limb skin problem severity derived from NPCD ICD-9-CM and CPT codes
Figure 1. Derivation of study cohort dataset from NPCD and NPPD databases
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Aim 2. Independent and dependent variables. The second aim of this study
was to categorize the independent variable ALC and define the dependent variable
RLSPS. These are described as two separate tasks:
•

Task 2.1 from the cohort dataset, a categorical variable was derived to represent
ALC. As described above, the NPPD was the source for ALD descriptions in the
form of HCPCS codes, item descriptions and costs. Device transactions were
categorized as a first time issue, a repair, or a replacement. Additionally, there
was a specific HCPCS code for the definitive artificial limb (HCPCS L5301
definitive endoskeletal prosthesis) which, when present, defined the ALC to be
used for the study. In some cases, the so-called “temporary prosthesis” that is
prescribed and dispensed for an individual, may actually be their “definitive”
prosthetic limb configuration and only the socket will be modified as the residual
limb matures. In such cases, the L5301 code may be used in conjunction with an
HCPCS code for a new or modified socket and it was the date corresponding with
the dispensing of such a socket that was used to begin the “follow-up” assessment
of the patient. Initially, frequencies per fiscal year were run on the study dataset
for the various HCPCS codes associated with the known types of suspension
systems and prosthetic feet, separately and in combination, to ascertain the most
common components and potential configurations dispensed. From this initial
pass, an algorithm for categorizing the ALC was determined, an example of
which is described under the section Instrumentation and Materials. The rules
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defining the algorithm and categorization of the ALC were entered into the data
dictionary (Appendix B).
•

Task 2.2 Define the dependent (outcome) variable: RLSPS—Similar to the
independent variable, the actual algorithm to be used to define the dependent
variable was determined following an initial assessment of the study dataset per
FY 2007 through 2010. The focus of the assessment was on the frequency or
numbers of residual limb ulcerations and infections identified for the cohort
relative to the frequency of other skin conditions such as rashes, blisters, calluses
and cysts; and as identified by their corresponding diagnosis, procedural codes or
combinations thereof. Severe and less severe residual limb skin problems were
further categorized on the basis of an etiological classification suggested by Bui et
al., (2009). Ulcers and infection are a tipping point for the individual utilizing an
artificial limb—ulceration is typically associated with significant stress at the
interface of the socket and residual limb and frequently requires that the
individual not utilize the artificial limb until the ulcer has healed—a major impact
on quality of life (G. W. Bosker CPO, personal communication, January 2011).
Further, when the ulcer is compounded by infection, the risk of surgical revision
and/or sepsis may be increased (Salawu, Middleton, Gilbertson, Kodavali, et al.,
2006; DePalma et al., 2006). Rashes, blisters, calluses, and cysts are frequently
treated with topical agents, may be mildly uncomfortable, but rarely are life or
limb threatening; and although artificial limb use may be restricted, typically not
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for more than a day or two (ulcers may result in restricted usage for weeks and
even months) (G. W. Bosker CPO, personal communication, January 2011). An
example of a potential algorithm for this variable is presented in the section
Instrumentation and Materials. The rules and algorithm ultimately used were
entered into the data dictionary for the study dataset (Appendix B).
Epidemiological Analysis
Recommendations for improving the analytical usefulness of informatics methods
and tools are key, but require initial evaluations to identify potential weaknesses and
limitations. Therefore, the study included a retrospective observational cohort study
design and subsequent analysis of the compiled dataset, utilizing patient demographics
and extensive clinical histories in the form of medical, clinical, and billing codes,
contained therein. The focus of this phase of the study was limited to the ascertainment of
the relationships between artificial limb configurations dispensed, diagnosed
psychosocial conditions (for example, depression, alcohol/substance abuse, PTSD), and
the severity of long-term (up to three years) residual limb complications, for the cohort of
Veteran amputees. Subsequently, this study attempted to address aspects of residual limb
outcomes, subsequent of the artificial limb (mechanical)–human
(behavioral/psychosocial) interaction at the socket-residual limb interface. Mechanical
factors were those in which skin problems were considered the consequence of continued
biomechanical forces (for example, friction, pressure, and torque) acting on traumatized
skin tissue, and thus pertained primarily to the artificial limb configuration utilized
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(DeLisa & Kerrigan, 1998; DePalma et al., 2002). Behavioral factors were those in which
a similar exacerbation existed, but was driven by the actions of the user (for example,
poor self-care or disease management, activity/ambulation level, treatment noncompliance) theorized to be consequent of the biopsychosocial paradigm and
demonstrated by outcomes in association with diagnoses of MDD, PTSD, and SUD
(Engel, 1977; Hanley et al., 2004; The Management of MDD Working Group, 2009; The
Management of Post-Traumatic Stress Working Group, 2010; The Management of SUD
Work Group, 2009; Zinszer et al., 2011)
Primary Objective. Statistical analysis of the dataset and multivariate model
development. The primary objective of the study (Phase II) was the statistical analysis of
the refined study dataset and identification of the patterns and trends of the cohort in
regard to artificial limb provision and subsequent residual limb skin problems. Two
specific tasks for this objective were endeavored, one focused on defining the parameters
of the cohort data, and the other on determining relationships between ALC categories
dispensed, subsequent residual limb skin problem outcome severity, and the implications
of psychosocial, mechanical, and certain demographic factors on such outcomes. The
aims and tasks are as follows:
•

Aim 3.1 Descriptive analysis of the study dataset—In an effort to define the
dataset’s parameters, frequencies and percentages were calculated to include
proportion of the initial population study sample (new transtibial dysvascular
amputations in FY 2007) that did not receive an artificial limb, cohort mortality
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rates at 1 and 3 years post-amputation, frequencies of residual limb problems, and
percentages of types of socket suspension systems, prosthetic feet and artificial
limb configurations dispensed. Additionally the distribution of cohort members
nationally as per Veterans Integrated Service Network (VISN) were determined,
along with the types of artificial limb configurations and components dispensed.
Finally, the demographic characteristics of the cohort were defined—for example,
race, marital status, mean age, Veteran’s priority status, and so forth.
•

Aim 3.2 Development of multivariate models—To evaluate the interactions
between the independent variable ALC, dependent variable RLSPS, and
psychosocial covariates, General Estimating Equations (GEE) multivariate
modeling was used to address most of the research questions. Two main reasons
drove the preference for GEE over General Linear Modeling (GLM): (a) the
dependent variable was non-continuous with a Poisson distribution, and (b) it
was not necessarily linearly linked to the independent/predictor variable, in part
due to covariate confounding (Garson, 2008, 2011a). Poisson distribution of the
dependent variable was expected because the dependent variable is actually a
count of diagnosis or procedure codes per the given number of time units (3 year
follow-up in 6 month intervals), and because the “non-occurrence” of such codes
cannot be counted because a code is not removed when no longer applicable, but
typically remains until a new diagnosis is made or procedure performed (Garson,
2011b). Also it was expected to be censored data during the follow-up period,
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given the relatively high 3 year mortality rate associated with dysvascular
amputations (Dillingham & Pezzin, 2008;Dillingham et al., 2005; Mayfield et al.,
2001).
Specific research questions and hypotheses (discussed herein) addressed
mechanical and behavioral main effects as well as their interactions relative to RLSPS
medical coding as an outcome, and investigation of the implications of mental health
status on those outcomes. As such, the primary statistic of interest was statistical
significance of likelihood rather than odds ratios, and tested the sensitivity of the
dependent variable relative to different ALC while under the influence of mental health
disorders and physiological co-morbid conditions. Mental health disorders (or diagnoses)
were considered suggestive of behavioral influences such as non-compliance and poor
disease self-management, and physiological co-morbid conditions as suggestive of
decreased activity levels. Thus, at the completion of the study, two key and interrelated
goals were accomplished: (a) insights into the potential of the methodology as a tool to be
used as an alternative to the conduction of randomized control trials or prospective
observational cohort studies in the field of prosthetics evidence-based research, and (b)
an initial, objective, practice-based ascertainment of the implications of conditions of
mental health and artificial limb prescriptions, on residual limb outcomes.
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Setting and Sample
Data Sources
The dates selected for the cohort and analysis were selected on the basis of several
factors. Firstly, in 2005 the NPPD underwent significant upgrades to include structural
changes, consequent of data quality checks and limited data validation studies (VIReC,
2012a; Smith et al., 2012). It was felt prudent to acquire data from this database at least
one year post the upgrades to avoid problems with unstable data and acquisition time
constraints. Secondly, near the end of FY2011 (September 30, 2011), the VHA initiated
an archive data transfer from Oracle/Unix based platforms utilized at the Austin
Information & Technology Center (AITC) to a national Corporate Data Warehouse
system VIReC, 2012a. To avoid issues of timely and accurate data acquisition and
potential data destabilization, it was felt prudent to acquire data prior to the national
transfer. Thirdly, within these two time constraints, two other factors were given
consideration: (a) following surgery, it may take a given patient between 6 and 12
months for full rehabilitation potential to be achieved and the fitting of a definitive
prosthesis. Many of the factors driving this outcome were discussed in Chapter 2 and
include age, co morbid conditions, surgical outcomes, and stabilization of the residual
limb (DePalma et al., 2002; Kurichi et al., 2007). (b) Also as presented in Chapter 2, an
amputee with a definitive artificial limb will require a new prosthetic socket or artificial
limb approximately every 3 to 5 years, again depending on factors such as health status
and activity levels (Nair et al., 2008). Thus, based on these criteria and constraints, in
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order to contiguously follow a cohort of veterans who undergo a major limb amputation
one year, require as much as one year before being dispensed a definitive artificial limb,
and then followed for approximately 3 years thereafter, preferably using the same
artificial limb, it was determined that data should be collected beginning at the start of FY
2007 (October 1, 2006) through the end of FY 2010 (September 30, 2010)
Further, it was an overarching goal of the study to address the utility of VHA AHc
records to discriminate determinants of residual limb skin outcomes relative to the
artificial lower limb configuration prescribed, as well as the suitability of such data
toward the potential development of a viable amputee-artificial limb database and future
surveillance system (refer to Chapter 1, Nature of the Study.). Therefore, both in
preparation of this study and future analyses, a request to acquire the describe datasets
was initiated following the University of Texas Health Science Center at San Antonio
(UTHSCSA) IRB and STVHCS – Audie Murphy Research Subcommittee approval of a
protocol entitled “Practice based evidence on major limb amputation and artificial limb
prescription in a cohort of U.S. Veterans”, protocol number HSC20120047H, approved
on November 14, 2011. Following this approval, the acquisition process for the NPC was
initiated in Mid December 2011, access approved in March 2012, and data acquired in
May 2012. The process for retrieving data from the NPPD was initiated in mid –
December 2011, the application packet submitted Jan 19, 2012, approval received May
10, 2012, and the data received on November 20, 2012. In combination, these datasets
formed a master dataset and the data/cohort being analyzed for this study were a sub-
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group (dysvascular below-knee amputees) thereof. It is anticipated that the methodology
described within this proposal will be used to drive future studies and analyses of similar
cohorts within the master dataset (for example, a cohort of upper limb amputees, above
knee traumatic amputees, or above knee dysvascular amputees). The master data set was
stored on a South Texas Veterans health Care System Research Service secure server
under the oversight of the Veterans Evidence-based Research Dissemination and
implementation Center (VERDICT) research group.
The National Patient Care Database (NPCD). The NPCD is a centralized
relational database. It receives patient visit information from the VHA’s electronic
medical record system, CPRS, from all VHA facilities across the nation (Murphy et al.,
2002; Boyko et al., 2000). Requested data is provided in the form of annual (per fiscal
year) SAS datasets and those available include: inpatient, outpatient, extended care,
inpatient short stay/observation care, and health care provided for Veterans outside the
VA with VA funding (VIReC, 2012b). For this study, SAS datasets specific to inpatient
and outpatient care were utilized. The inpatient and outpatient care datasets are patientspecific, and thus lend themselves to be searchable by any variable (VIReC, 2012b).
The inpatient care dataset is further divided into four files: Inpatient Main,
Surgical, Bed Section, and Procedure (VIReC, 2012b). Only the Bed section file was not
explored as the primary reason for examining inpatient data was to identify the cohort as
of FY 2007. Inpatient variables of interest included: age, gender, race, marital status,
Veteran priority status (a proxy for Socioeconomic status; described further under the
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section Instrumentation and Materials); admission date with primary diagnosis (ICD-9CM code); type of discharge (for example, regular or death); date and surgical procedure
(as designated by ICD-9-CM and/or Diagnosis-Related Group (DRG code); and relevant
procedures (CPT codes) provided during an inpatient stay (VA Information Resource
Center [VAReC], 2011b)
The outpatient care dataset is further divided into two files: outpatient visits and
event files. Outpatient visit files represent “One day's occasions of service for an
outpatient,” while event files represent “One ambulatory encounter by a patient” (VIReC,
2012b). A third data file was extracted—inpatient encounter files—that represent an
inpatient’s clinical visits for outpatient procedures and diagnostics while designated as in
acute care, extended care, observation care, or non-VA care status (VIReC, 2012b). It
was anticipated that some amputees, particularly those in extended or observational care
not directly related to their amputation, would still require wound care or attend clinics
where residual limb skin problems were diagnosed and treated. Therefore, all three data
files were extracted from the NPCD, and outpatient data searches were focused on
procedures related to residual limb conditions/care, skin problem diagnosis codes, and
mental health diagnosis codes. The actual codes searched for are presented in Tables S4B17 in Appendix B - Data Dictionary, and event outpatient files were the primary source
of such information, as they include date and time of visit, associated CPT and ICD-9CM codes, as well as the type of clinic location where care was provided (VA
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Information Resource Center [VAReC], 2011a). The actual data fields where these codes
were found are presented in Table B27 in Appendix B - Data Dictionary.
The National Prosthetic Patient Database (NPPD). Maintained by the U.S.
Veterans Administration Prosthetic and Sensory Aids Service Strategic Health Care
Group, the NPPD is written in MS Access with one record per device transaction. It is a
roll-up of all prosthetic data extracted from the local VISTA Prosthetics Suspense
Package (PSP) for each VHA facility in the United States (VIReC, 2012a). The database
group items/devices provided on the basis of HCPCS codes. The subsequent groups
include: wheelchairs and accessories; artificial limbs; braces and orthotics; neurosensory
aids; oxygen and respiratory; durable medical equipment; and surgical implants (VIReC,
2012a). There are a total of 41 data fields (14 are for Service internal use only and are
unavailable to researchers) and are presented in Table B28, Appendix B – Data
Dictionary. Data is transferred either as a flat text file or Excel spreadsheet, and
permission from the Prosthetics and Sensory Aids Service (Patient Care Service) must be
acquired prior to transfer to a secure VA server (VIReC, 2012a).
The NPPD is a relatively new database having been made available to researchers
only since 2000. Unfortunately, the quality of the data entry and data extraction process
has not been evaluated fully, although significant improvements and greater compatibility
were put in place as of 2005 (VIReC, 2012a; smith et al., 2010). The key limitation of
this database is its reliability and validity in terms of visit dates that should correspond
with outpatient encounter dates as indicated by the NPCD. In a study by Mark W. Smith
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(2010) it was determined that only about 40% to 60% of visit dates in the NPPD could be
matched to corresponding outpatient care visits and only about 10% of related inpatient
dates, within a 14-day window (M. W. Smith et al., 2010). However, given the nature of
this study, such incongruences were not considered critical as the purposes of the NPPD
were to (a) identify those individual’s dispensed an artificial limb and (b) identify what
components comprised that artificial limb. There was no need or real purpose to match
dates the artificial limb was dispensed with outpatient clinic dates – it was only after the
artificial limb was dispensed that a patient’s residual limb status became noteworthy.
Further, it was highly unlikely that an artificial limb would be dispensed if the patient had
any evidence of a residual limb skin problem beyond scarring (G. W. Bosker CPO,
personal communication, January 2011). Other aspects as to the reliability and validity of
HCPCS coding, costs, and item descriptions have not been evaluated or at least not
reported.
Sample Population (Cohort Criteria) and Sample Size
From the FY 2007 NPCD Inpatient Surgical and Procedure datasets, Patients
having undergone a transtibial amputation for dysvascular reasons were extracted to
include their Subject identification number (encrypted social security number), date of
admission, date of discharge and discharge status. Dysvascular transtibial amputees were
identified as those with an ICD-9-CM code for diabetes mellitus (250-250.99), PAD
(443-443.9) or atherosclerosis of the extremities (440.20-440.29, 440.9); in conjunction
with the CPT code for amputate lower leg at knee (27598). On the basis of the encrypted
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Social Security Number, these same patients were extracted from the NPCD Inpatient
main dataset to retrieve pertinent demographic data including age, gender, marital status,
Means Test score, and race at time of admission. This then formed the initial cohort.
On the basis of matching encrypted Social Security Numbers, from the FY 2007,
2008, 2009, 2010 NPPD, any members of the cohort having been provided a definitive
artificial limb were identified, as well as the associated HCPCS codes specific to the
limb’s socket suspension system and prosthetic foot, date dispensed, and facility/VISN
that delivered the artificial limb. While the various components that comprise the total
artificial limb may have multiple HCPCS (billing codes), a definitive/permanent lower
limb prosthesis has a single specific and identifiable code: L5301 (G. W. Bosker CPO,
personal communication, January 2011).
Table B26 in Appendix B – Data Dictionary, presents HCPCS codes of interest.
Only those cohort members that received a definitive artificial limb (the independent
variable) were followed through FY 2010, the remaining accounted for through discharge
status (that is, death or transfer to hospice) as of FY 2010 and recorded in the NPCD
main file. For a diagrammatic summary of the derivation of the study cohort dataset, refer
to Figure 1.
Despite being a fixed dataset, the actual number of cases and variables were
unknown, being dependent on the number of individuals meeting the cohort inclusion
criteria, being dispensed an artificial limb, and having follow-up residual limb care visits.
Nonetheless, in a search of the FY 2009 NPCD inpatient records, over 2,321 above-knee
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and below-knee new amputations were identified (report by L. Copeland, PhD; (see
Appendix A). It was therefore anticipated, given the comparative incidence of transtibial
dysvascular amputations relative to transfemoral and traumatic transtibial amputations
(ratio of transtibial to transfemoral is 2:1; 75% due to dysvascular complications
(Mayfield et al., 2000), the initial cohort identified in FY 2007 would number
approximately 1,161 cases. Of these, based on a 30-day mortality rate of 7% and an
estimated 20% of cases dying before discharge, it was anticipated that about 929 cohort
members would be identified that met initial inclusion criteria (new transtibial
amputation, dysvascular comorbidity, eligible for artificial limb use). However, the
number of cohort members that would be dispensed a definitive artificial limb was
unknown. The literature suggested that approximately 50% of older dysvascular
amputees actually use an artificial limb for walking, suggesting that an estimated 464
members of the initial cohort would be dispensed an artificial limb and available for longterm follow-up (Dillingham & Pezzin, 2008; Fletcher et al., 2002). However, for
dysvascular transtibial amputees, Dillingham and colleagues reported a 3 year mortality
rate of 33% in 1996, suggesting that an estimated 311 cohort members would be
available for the duration of the follow-up period (Dillingham et al., 2005). Alternatively,
as the mortality rate reported was not specific to those amputees healthy enough to be
prescribed an artificial limb, and medical (specifically diabetes control and management)
and surgical advances have likely improved the survival rates over the past decade, a 3
year mortality/attrition rate of 20% may be more appropriate (suggesting 371 cohort
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members). Thus, it was conservatively estimated that the actual sample size for follow-up
would range between 300 and 400 cohort members.
Power Analysis
For most researchers, the challenge is being able to detect a true significant effect,
while balancing type I and type II errors in the face of limited resources, ethical
considerations, and optimal effects. Too small a sample expose research findings to type
II errors due to insufficient power. Too large a sample incurs unnecessary expense for the
research project and may reveal trivial significant differences that may cloud data
interpretation (Garson, 2011b). Whereas in most a priori power analyses the intent is to
estimate the sample size required to attain a given power (for example 80% at an alpha of
0.05) and thereby maximize the effective use of resources, in the case of a fixed dataset,
the purpose is more to ascertain what power can be attained given the sample size
available—the smaller the effect size (difference) from the null hypothesis value of the
dependent variable, the more likely the type II error, and thus the lower the power for a
given sample size (Garson, 2011b).
As described under “Research Approach,” this study was exploratory in nature
with a dual intent (that is, to develop a novel database and test its viability with an
epidemiological analysis), and utilized a retrospective observational cohort study design.
Thus the limitations associated with a fixed sample size applied to this study’s potential
power and statistical significance or relevance. As such, as presented in Chapter 2, there
is little to no literature that actually quantifies residual limb skin problems among a
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population (the repeated measure dependent variable), and thus no source from which to
estimate variance or an anticipated effect size. At best, a study by Dudek and colleagues
(2005) indicated that nearly 50% of the study population demonstrated at least one
residual limb skin problem, of which 27% were ulcers, and the remaining 73% were
comprised of various “less severe” conditions, but the actual variance in the frequency of
these conditions were not reported (Dudek et al., 2005). Similarly, there were no
identified studies that report the incidence of residual limb skin problems relative to
artificial limb components, although the aforementioned study by Dudeck and colleagues
did report no significant difference in the incidence of at least one skin problem among
the socket types and suspension systems used (Dudek et al., 2005). Further, there were no
identified studies that accounted for the frequency of residual skin problems over time to
suggest normal distribution thereof such that a Poisson distribution of the outcome
measure was projected and, given the unknown magnitude of effect size, example
response rate ratios of 15%, 20%, 25%, and 30% were used a priori to estimate power
(actual effect sizes were calculated post hoc on the basis of parameter confidence
intervals) (Garson, 2011b).
Additionally, research questions 1 through 4 utilized one or more factors, both
singularly and interactively, that ranged in levels from five (the anticipated number of
artificial limb configurations that could actually range between 3 and 12 configuration
types) to three (conditions of mental health), with outcomes potentially not influenced by
covariates. Thus, because of the complexity of the analysis required to address the overall
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goal and purpose of this study having multiple research questions and hypotheses that
utilize the same fixed sample/cohort, a power analysis was performed based on a Mixed
Model analysis and a single factor with five levels (likely the maximum number of factor
levels for an independent variable used for any of the sub-analyses).
Table 5 presents sample size and power calculations using the parameters
described above. The software power analysis and sample size system (PASS) (NCSS,
Kaysville, Utah) was used to perform the calculations and derive the values as presented,
based on the following equation:
𝑁𝑁 = ∅

(𝑍𝑍1−𝛼𝛼⁄2 �𝑉𝑉�𝑏𝑏1 �𝛽𝛽1

= 0�+𝑍𝑍1−𝛽𝛽�𝑉𝑉�𝑏𝑏1�𝛽𝛽1 = 𝐵𝐵1�)2
𝜇𝜇𝑟𝑟 𝑒𝑒 𝛽𝛽0 𝐵𝐵12

where α is type I error, β is type II error, B1 when X1 is the only covariate of interest, N is
sample size, ∅ is a measure of over-dispersion, 𝜇𝜇𝑟𝑟 is the mean exposure time and Z is the
standard normal deviate.

In summary, it can be stated that a Poisson distribution of the repeated measure,
catergorical dependent variable (RLSPS) from a three-year observational study of an
initial cohort of dysvascular below-knee amputees dispensed an ALC category (the
independent variable having five levels), a total sample size of 384 subjects (assuming a
20% attrition rate) would be required to achieve 80% power at a significant level of 0.05
and detect a response rate ratio of at least 20% for a two-sided test.
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Table 5
Power Analysis Results
Response rate
ratio

15%
20%
25%
30%

Unadjusted
sample size (N)

Adjusted
(20% attrition)
sample size

Adjusted
sample size per
factor level

526
370
204
147

658
384
255
184

132
77
51
37

Data Assumptions
Two primary assumptions were maintained throughout this study analysis: (a) that
the data provided and used for analysis was reliable and valid, and (b) that the prosthetic
socket provided to the Veteran amputee was of good quality.
Coding assumptions. Health care coding used in most administrative databases
(for example, ICD-9-CM, CPT, HCPCS codes) are prone to random and systematic error
resultant of physician judgment, communication failures, and/or coding procedures
(O'Malley et al., 2005). Therefore, they may not reflect precisely a disease condition or
appropriate treatment procedure. However, the VHA, through its dependence on the
VISTA and electronic medical record system (CPRS), has taken significant steps to
reduce this potential for error. Data that comprise both the NPCD and NPPD are derived
from roll-up applications from all VISNs, of which there are 23 across the nation. Each
VISN receives data from various facilities under its direction, and each facility is
responsible for compiling and maintaining its own administrative records (Murphy, et al.,
2002). In particular, CPRS, the electronic medical record system utilized by the VHA,
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has features specific to each VISN, although the data features and dictionary are
standardized across VISNs (Murphy, et al., 2002; Brown, et al., 2003).
At the time of the patient "encounter" or visit, the physician is responsible for
selecting the appropriate CPT code(s) from selection boxes. This information goes
directly into the facility’s administrative database and is not edited but rather reviewed by
coders (Szeto, Coleman, Gholami, Hoffman, & Goldstein, 2002). Ultimately, diagnostic
codes or many ICD-9-CM codes are edited by professional coders, although the
physician selected the code from another selection box as part of their clinical/medical
note. In both cases, procedural or diagnostic codes may have been poorly selected,
although the code values accurate because they are derived from selection boxes and
thus, have inherent data controls applied.
Similarly, the NPPD is a roll-up of fields from the Prosthetics Software Package
(PSP). They are integrated through an exchange of data. For every patient encounter with
the Prosthetics–Orthotics service, there is an accounting of that visit via various menus
and associated electronic forms, including one for purchasing prosthetic devices (Werner,
2010). The software application provides lists of “items” (device model and make), as
well as edit fields to provide additional information for the vendor, including a specific
model or type. To record a transaction, the practitioner selects the status of the device
(initial, repair, replacement, or spare) as well as the corresponding HCPCS code that is
provided based on the item selection (Werner, 2010). Most entries have lists from which
to select a response and thus there is inherent data control and accuracy. With such
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controls to minimize communication and systematic error, one can only assume that, for
both CPRS and PSP, the selection made by the practitioner was correct and appropriate.
As this study used de-identified data, it was not possible to ascertain the correctness of
coding selection (ICD-9-CM, CPT, OR HCPCS codes) against patient chart records and
thus accuracy could only be assumed.
Socket craftsmanship. The skill of the prosthetist is in their choice of socket
design, hand-crafting of the socket or mastery of Computer Aided Design/Computer
Aided Manufacture (CAD/CAM) socket software and hardware; fitting the socket to the
patient’s residual limb; configuring the artificial limb; and aligning the components (G.
W. Bosker CPO, personal communication, January 2011). Within the VHA system,
prosthetists must be certified (thus it is assumed that they are properly trained and
knowledgeable), but as discussed in Chapter 2, their level of experience and skill may
vary. Nonetheless, a key assumption regarding the artificial limb configurations being
analyzed in this study was that the socket was fitted properly to the patient’s residual
limb, and it is the configuration and design of the artificial limb, not merely the fit of the
socket, that was responsible for the “mechanical effects.”
Data Limitations
The outcome variable, RLSPS, was based on the presence or absence of certain
ICD-9 codes recorded during a cohort member’s visit to a VHA facility and treatment by
a clinician. Therefore, those conditions or incidents that are treated and managed by the
patient outside the VHA clinic were not captured. Typically, as part of their artificial limb
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training and rehab, patients are taught how to recognize and treat certain minor
conditions, to include rashes and blisters, without clinical intervention (G. W. Bosker,
CPO, personal communication, January 2011; The Rehabilitation of Lower Limb
Amputation Working Group, 2007). Therefore, the measure of residual limb skin
problems in this study may be skewed toward the more severe conditions and/or not
register the true incidence of “less severe” conditions that any one cohort member may
have experienced.
Finally, as discussed in Chapter 2, the gold standard for evidence based medicine
(EBM) is a randomized controlled trial, a format not easily adhered to in the field of
rehabilitation medicine, and a key reason for the observational practice-based evidence
/cohort design of the study (Groah et al., 2009).
Instrumentation and Materials
Data Files and Variables
Given that the data for this study was derived from VHA repository data, no
specific instrumentation or tools were required to collect the data other than
administrative permissions and PCL (Program Control Language) coding necessary to
transmit specified data from the VHA’s repository site (the Austin Information
Technology Center (AITC) to a local secure server for further data manipulation and
analysis. For this study, a master dataset containing the required cohort data was
previously transferred to reside on a South Texas Veterans Health Care System Research
Service secure server behind the VA firewall, accessible only with an appropriate user
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name and password directly via VISN17 VISTA network, or by an approved VPN from
outside the VA network. Data was stored on the server as Excel workbook or SAS
datasheets. The UTHSCSA IRB provided the necessary approval letter to acquire the
data. Most data management and manipulations, to include statistical analyses, was
performed using SAS software (Scientific Analysis Systems, SAS Institute, North
Carolina, USA) also situated behind the VA firewall on a secure server, or on a personal
computer with data access available only through an approved VPN and PC
configuration.
Residual limb skin problem severity. The primary dependent variable for the
epidemiological phase of the study was categorical representing three primary groups of
residual limb skin problems that a cohort member may develop after being dispensed
their definitive artificial limb: severe (skin ulcers and infections), less severe (calluses,
blisters, rashes) and no treatment. It was felt that such a division was warranted on the
basis of several factors: (a) an individual with a dysvascular condition such as Diabetes
Mellitus not only suffers from a compromised immune system, but also struggles with
poor healing capacity, making skin ulcers and skin infection particularly problematic and
even life-threatening; (b) under most conditions, an ulcer of the residual limb requires
that the individual not use, or minimize the use of, their artificial limb for the duration of
the healing process which, for many, may take weeks and even months, (c) most of the
“less severe” problems are treated with a topical agent and require only reduced use of
their artificial limb, and typically are not life-threatening. However, ulcers and infection
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frequently do not occur in isolation—blisters may evolve into ulcers or serious infection,
an ulcer may be present on one area of the residual limb and a rash may be present on
another, or a rash may be sign of deeper infection (Osteomyelitis). Therefore, in those
cases where an ulcer or infection was present, as well as a so-called “less severe”
condition, such was classified as severe. The presence of a residual limb ulcer and/or
infection of the residual limb places the artificial limb user at significantly higher risk of
surgical revision, reamputation, or death more so than do the other skin problems,
although the frequency of the less severe problems pose significant problems as well
(DeLisa & Kerrigan, 1998; G. W. Bosker, CPO, personal communication, January
2011).While both conditions impact the amputee’s quality of life, ascertaining which
condition more profoundly does so was beyond the scope of this study.
For those cohort members dispensed an artificial limb, the study dataset was
searched for relevant codes at 6 month intervals during the follow-up period, amounting
to six repeated measures for analysis. Representative codes for the RLSPS categories less severe residual limb skin problems and severe residual limb skin problems, are
presented in Tables B18 – B20 in Appendix B – Data Dictionary. Further, in order to
insure that the skin conditions were associated with the residual limb, it was intended that
only those detected while in the presence of the additional ICD-9-CM codes 997.60-.62,
997.69, V49.70, or V49.75 would be counted as problems definitely associated with the
residual limb. However, such defining codes were not found in the study dataset and an
alternative method was used as described in Chapter 4. Other relevant less severe and
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severe residual limb skin problem codes detected in the presence of certain CPT code
modifiers (for example , YG –“ Lower extremity ulcer risk assessment”) were searched
for but not found. For more definitions of codes, refer to Appendix B.
Studies have reported that 40-80% of individuals observed do develop some level
of skin problem when actively using an artificial limb (Bui et al., 2009; Dudek et al.,
2005; Meulenbelt et al., 2006; Meulenbelt et al., 2007). It should also be noted, though,
that many patients, especially later in the follow-up period, may no longer seek medical
care for skin problems as they become more competent and confident in treating
problems themselves. Therefore, while there may be individuals dispensed an artificial
limb who develop no skin problems, or those who self-treat and do not seek clinical
care/treatment (and thus are not captured by hospital care records), a third category, “no
treatment” was used to account for such situations.
Finally, the categories severe and Less severe were further sub-divided into four
categories relative to their etiology as suggested by Bui and colleagues (2009), the
categories were: surgical complications, repetitive trauma, occlusion: infectious, and
occlusion: non-infectious. These sub-categories were used to describe the study cohort,
however, as a goal of this study was to differentiate between those residual limb
conditions that are especially debilitating with the greatest impact on quality of life (such
as ulcers, osteomyelitis, or reamputation) versus those that are less so impactful, the three
primary categories (severe, less severe, and no treatment) were used for statistical
modeling, rather than just on etiology.
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Artificial limb configuration. As the primary independent variable of interest,
ALC represented the combinations of two key components of a lower limb artificial
limb—the socket suspension system and prosthetic foot, both of which were also
examined independently. The algorithm to be used to categorize ALC was determined
upon receipt and manipulation of the data, in order to ascertain exactly what models and
types of suspension systems and prosthetic feet were dispensed. Their identification was
based on the matching of subject ID numbers from the NPCD (identified as new
dysvascular transtibial amputees), with those in the NPPD, their corresponding HCPCS
codes, model type, and “new cost,” as well as date of dispensing, as per the HCPCS
billing codes. The various components searched for and used, along with their
corresponding HCPCS billing code, are presented in Table B1, Appendix B – Data
Dictionary. The HCPCS codes were the most reliable within the dataset and thus the
preferred means for identifying and categorizing artificial limb components. Whenever
possible, the codes were checked against model types, vendors, and item descriptions.
ALC were then categorized on the basis of combinations of the identified components.
For example, category A=socket suspension system 3 (out of 4 possible) + Prosthetic
Foot 8 (out of a possible 12). Further, given that the cost of these artificial limbs varied,
depending on the components prescribed and purchased, the NPPD variable “new cost”
was included in the algorithm as a summed value of the socket suspension system and the
prosthetic foot. A possible algorithm would be to identify combinations of suspension
system and prosthetic foot components, and then group them on the basis of their
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summed component cost. In almost all cases, as the cost/value of the component
increases, so does its sophistication and number of moving parts. For example, DePalma
and colleagues (2002), in their description of the categories of prosthetic feet available,
point out that the hybrid foot is significantly more expensive than the SACH foot, or even
the dynamic response foot (DePalma, et al., 2002).
Psychosocial covariates. From the main inpatient files, as well as outpatient data
files, per fiscal year (2007-2010), diagnosis /DRG ICD-9 codes representative of the key
covariates depression (309.81, V79.0, 296.2x, 296.3x, 311), PTSD (309.81), and
alcoholism/substance abuse (291, 292, 303, 304, 305 excluding 305.1) were searched for
within the cohort so as to capture psychosocial behaviors (or “proxies” thereof) that could
impact the type of skin problems associated with an ALC category and user.
The joint VA-DoD Clinical Practice Guidelines for Mental Health (available for
MDD, PTSD, bipolar disorder, and SUD online at http://www.healthquality.va.gov/)
describe pharmacological and psychotherapy recommendations for the disorders, each
with its own documentation. For each disorder, diagnosis paradigms are also provided:
•

MDD - the patient presents with depressed mood or loss of interest or pleasure,
along with at least 4 additional MDD diagnosis criteria symptoms (as per the
DSM-IV-TR) for a duration of at least 2 weeks (The Management of MDD
Working Group, 2009);
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•

PTSD - patients test positive on a screening survey tool (presented to all VHA
Veteran patients ) and then assessed by a mental health professional (The
Management of Post-Traumatic Stress Working Group, 2010); and

•

SUD - patients test positive on a screening tool (administered to all Veteran
patients)and present with contraindications as determined through interview with
a mental health professional or primary doctor (The Management of SUD
Working Group, 2009). For more complete definitions of these mental health
conditions, please refer to the section Definitions and Terms in Chapter 1 of this
document.
The guidelines also describe frequency of psychotherapeutic encounters in terms

of monitoring response to treatment and symptom improvement or exacerbation as well
as potentially weekly meetings, but at least the need to “evaluate periodically” and to
continue to follow up until the patient is symptom-free for at least two months.
Based on these definitions and criteria, it is recommended by clinicians in the
field that the diagnosis of MDD appear in a patient record at least twice successively (at
least two visits) and similarly, with PTSD and SUD, to account for false positives from
the screening tools (L. Copeland, Ph.D., personal communication, March, 2013).
Therefore, for this study, the presence of a code for a particular condition was
detected at least twice on different outpatient visit dates within a fiscal year to be counted
as a comorbid condition for any cohort member during the follow-up period.
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The covariates depression, PTSD, and SUD were explored in support of the
biopsychosocial theoretical model that the health of the mind is connected to the health of
the body—in this case, the residual limb. For example, a person suffering from any one
of the three conditions may lack the impetus to seek medical care and treatment of a
residual limb problem in a timely manner such that ulcers are more likely to evolve from
a lack of preventive measures, and once evolved become infected for similar reasons. On
the other hand, a significantly depressed individual may engage in less physical activity,
thereby incurring fewer biomechanical forces on the residual limb–artificial limb
interface, and thus may simply not develop skin problems that require treatment and
therefore no evidence of skin problems will appear in the clinical record. Similarly, the
person with PTSD and/or SUD may be more active and thus potentially more likely to
incur “mechanical effect” residual limb skin problems, but as these conditions are
frequently associated with community withdrawal (social isolation), as well as poor
healthcare and disease management, by the time treatment is sought, a “less severe” skin
problem may have evolved into a “severe” problem.
Socio-demographic covariates. Additionally, available from the NPCD inpatient
and outpatient files, demographic factors to include age (by age group), gender, race,
marital status, and VA Priority status (as an indicator of economic status) were explored
as a means to describe the cohort and potentially identify those characteristics that
associate with particular ALC categories prescribed and dispensed, and/or associated
with residual limb skin problems. The values and categories associated with each of these
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variables are presented in Appendix B - Data dictionary, Table B27 under the Variable
names : AG8R for age group, “SEX” for gender, “RACE”, “MS” for marital Status, and
“MEANS” for a patient’s Means Test score / VA Priority status.
For example, as reported in a study by Kurichi (2007), more elderly cohort
members (over the age of 74 years) may have a higher one year mortality rate , not
prescribed an artificial limb, or be prescribed an artificial limb for transitions only (for
example from bed to chair or toilet) (Fletcher et al., 2001; Kurichi et al., 2007). Further,
the older dysvascular amputee is typically less active due to reduced energy levels,
advanced complications, and less balance confidence; thus the artificial limb prescribed
and dispensed will likely be one more suitable for a household ambulator rather than for a
community ambulator (if an artificial limb is prescribed at all) (Kurichi et al., 2007;
Miller & Deathe, 2004; Remes, et al., 2009).
VA priority status was used as an indicator of socioeconomic status. It is a
measure incorporating economic need and disability status, and has been examined
among VA patients and subsequently validated in VA administrative data in numerous
studies (Kazis et al., 1998). VA priority status ranges from a ranking of “priority 1,” in
which the Veteran is not asked to make any payments for health care or pharmacy, to
“priority 8,” in which co-payments are required. It was anticipated that an individual with
priority 1 status suffers from greater disability and thus the artificial limb configuration
would reflect such; or a Veteran with a Priority 8 status will have the capacity to care for
their health sufficiently that residual limb skin problems would be less frequent and/or
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less severe, despite a lifestyle that may incur more activity and thus a residual limb more
at risk for mechanically induced problems (Meulenbelt et al., 2009).
Marital status (MS) was a variable available from the Inpatient files that was used
primarily to characterize the cohort. For example, those marital status values suggestive
of an individual living alone (such as single, never married, or divorced)would be
indicative of less oversight as to the management of their disease and care of their
residual limb and thus, demonstrate a pattern of more ulcers over the follow-up period.
In contrast, a married individual would likely have some level of oversight as to the
management of their health and care of their residual limb and demonstrate a pattern of
less severe residual limb skin problems (Remes et al., 2009).
Comorbid conditions, such as chronic obstructive pulmonary disease (COPD),
obesity, congestive heart failure (CHF), cerebrovascular disease (CVD), and renal failure
ICD-9-CM codes) were used primarily to characterize the cohort. Additionally, these
conditions were used as covariates (either present or absent) to help explain differences in
RLSPS levels between and among ALC categories.
In the study by Kurichi and colleagues (2007) and mentioned above, the authors
conducted a retrospective cohort analysis of lower limb amputees discharged for
amputation surgery during FY 2003, to ascertain those clinical factors relative to artificial
limb prescription (whether they were prescribed an artificial limb or not). The authors
concluded that medical conditions (such as renal failure and dysvascular disease) and
functional limitations (such as COPD, stroke, and obesity) adversely affect an
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individual’s level of energy, ability to move independently, or ability to exercise
judgment, and thusly reduces the likelihood of artificial limb prescription (Kurichi et al.,
2007). Thus it was relative to determine the frequencies of cohort members having such
comorbid conditions and actually dispensed an artificial limb, the ALC categories
dispensed (anticipated to be low cost, low technical sophistication) and patterns of
residual limb skin outcomes (severe/less severe) that developed over the course of the
follow-up period. For example, a cohort member with a comorbid diagnosis of COPD
may not be prescribed/dispensed an artificial limb due to the exertions required to
ambulate with such; an obese individual may be more difficult to fit, be less physically
active, and be more likely to struggle with proper hygiene (if without assistive care) and
thus prone to mechanical skin problems compounded by infection; a cohort member that
suffers a debilitating stroke may simply stop using their artificial limb or their
prescription may need to be reconsidered, and a cohort member with advanced
dysvascular disease (as indicated by CHF and renal failure) may have significantly
compromised skin healing capacity as demonstrated by chronic ulcer treatment or
surgical revision during the follow-up period.
Data Analysis
Overview
Data analysis for this observational study was primarily descriptive, as a novel
knowledge base was explored, specifically the NPPD (which at the time was yet not fully
validated), and long-term patient outcomes relative to ALC category dispensed.
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Frequencies, means and standard deviations, ranges, and adjusted models were
employed to describe the parameters of the integrated dataset. Chi square analyses and
multivariate analysis models of variance and covariance, specifically general estimating
equations (GEE), were used to examine the influence of comorbid conditions on amputee
and artificial limb outcomes. More specifically, multivariate modeling was specific to the
research questions with an emphasis on differences between ALC categories and the
subsequent incidence of severe and less severe residual limb skin problems
reported/treated in a clinical setting.
Defining the Integrated Study Dataset and Cohort
Upon compilation of the integrated study dataset that reflected the clinical history
of U.S. Veterans having undergone a transtibial amputation for dysvascular
complications during FY 2007 and followed through FY 2010, efforts were made to
identify erroneous data, duplications, and nonsensical codes. Data across fiscal years and
data files were linked by ScSSN (scrambled/encrypted Social Security Number) and
aggregated to the patient level.
The initial statistical analyses of the dataset were descriptive and included:
frequencies, rates, means, and standard deviations of the cohort’s demographics (age,
gender, marital status, race, VA priority status, comorbid conditions, and geographical
/VISN distribution); one year and three year mortality rates during the follow-up period;
percentage and frequency of different codes indicative of dysvascular complications
associated with the amputation (those ICD-9-CM codes used to identify the initial cohort
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of new transtibial dysvascular amputations in FY2007); and frequencies, percentages, and
geographical/VISN distribution of residual limb skin problem codes and categories
(severe/less severe) during the follow-up period, as well as the various artificial limb
components dispensed. Additionally, univariate and bivariate analyses of the various comorbid conditions relative to the dependent variable (RLSPS levels) were conducted to
identify those conditions (or combinations thereof) demonstrating an alpha of 0.25 or
less, and therefore warranting their use in the multivariate modeling analyses.
In regard to artificial limb configurations dispensed, it was expected that while the
potential combinations of socket suspension systems and prosthetic feet that constitute an
artificial limb configuration could be as many as 60 (based on 5 different HCPCS billing
codes for socket suspension systems and 12 for prosthetic feet), the actual number of
different combinations/configurations dispensed would be relatively few (less than 10)
and predominately those of low function and moderate technical sophistication. The
primary factor driving such an expectation was the overall poor health status of the
dysvascular amputee.
A common characteristic of most dysvascular conditions, that is, type 2 diabetes
mellitus and PAD that lead to amputation is their relatively late onset—both diseases are
typically associated with the older adult (65 years and above) (CDC, 2011a; Criqui,
2001). Additionally, the complications that ultimately resolve into the need for
amputation may occur over a relatively long period of time such that prior to amputation,
the patient likely becomes progressively less active due to chronic pain from neuropathy
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of the lower limb, foot ulcers, and limb revascularization surgeries (Boutoille et al., 2008;
Sprengers et al., 2007). For example, the individual with PAD will likely undergo
multiple stent and bypass surgeries of the lower limb vascular system prior to the onset of
critical limb ischemia and the need for amputation; the diabetic with peripheral
neuropathy may contend with multiple foot ulcers and toe or partial foot amputations
prior to transtibial amputation (Mayfield, et al., 2004; Boutoille, et al., 2008). Such
individuals are not likely to benefit from hi-tech, complicated, and costly artificial limb
configurations that are more designed for the highly active, athletic individual. Two
exceptions to this concept are the Vacuum Assisted Suspension System (VASS) (L5781,
L5782), which is marketed to actually improve blood flow in the residual limb, and the
Proprio-Foot (L5973), which is designed to reduce the amount of energy needed to
ambulate and is actually recommended for the household and limited community
ambulator (Chitragari et al., 2014; Hoskins, Sutton, Kinor, Schaeffer, & Fatone, 2014).
To specifically address this conjecture, descriptive statistics were used to describe
patterns of artificial limb provision, to include frequencies and rates of artificial limb
configurations, socket suspension systems, and prosthetic feet codes and categories
dispensed. Low rates of VASS socket suspension systems (L5781, L5782), multiaxisdynamic response Flex Foot or Flex Walk systems prosthetic feet (L5979, L5980, or
L5981, respectively), or configurations comprised of the VASS with the multiaxisdynamic response, Flex-foot, or Flex walk system would support the expectation that
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most of the artificial limb configurations or components dispensed were of low function
and technical sophistication.
The Epidemiological Analysis
Utilizing the parameterized dataset and cohort, several further research questions
were addressed that focused on the relationship between artificial limb use and the
development of residual limb problems. As stated in Chapter 2, two key factors tend to
drive most (if not all) residual limb problems experienced by the lower limb artificial
limb user: mechanical effects and behavioral effects, and the interaction thereof.
Mechanical main effects. Research Question 1 addresses the issue of the
artificial limb configuration as the main effect influencing the variability in residual limb
skin problems. So-called “mechanical” effects as described previously are those in which
undue biomechanical forces act on the residual limb-artificial limb interface (at the
contact point of the socket and skin of the residual limb). Such undue forces may be
consequent of poor socket fit, poor artificial limb alignment, an artificial limb
configuration not suitable or congruent with the user’s activity level, or simply excessive
forces generated given the user’s body type, residual limb shape, and activity level and
type—the more active the user, the more potential for skin problems (DePalma et al.,
2002; DeLisa & Kerrigan, 1998). Given the predicted demographics of the study
population (that is, older, less active with significant comorbid conditions), coupled with
the poor healing capacity of individuals with dysvascular disease, it was expected that the
predominance of the cohort dispensed artificial limbs would be for limited household and
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minimal community ambulation (functional levels high K1 to low K3, as defined in
Chapter 2) with artificial limbs dispensed that reflect such, for example, a SACH foot
(L5970) with cuff suspension (L 5666) or suction suspension (L5647)—all considered
low to moderate technical sophistication. Further, because of the cohort member’s
predicted low activity level, and predominately unvaried terrain (in house, few unlevel
surfaces such as grass or unpaved paths), “mechanical” effects, as indicated by rates of
RLSPS, would not vary significantly among artificial limb configurations, regardless of
sophistication, simply because the skin at the socket-residual limb interface would not be
overly stressed by undue or excessive biomechanical forces associated with high
repetitive impact. Nonetheless, due to the relatively poor vascular system this population
is characterized with, the risk of skin problems is heightened due to poor healing
capacity. When such is coupled with skin fragility consequent of the normal aging
process, the residual limb becomes especially vulnerable to abrasion, bruising, cellulitis,
and blisters that can very quickly become slow healing ulcers. Therefore, despite the
predicted low activity level of this population, the likelihood of skin breakdown is greater
and, when combined with certain demographics (that is, socioeconomic status, age,
comorbid conditions, and marital status), the chances for more severe skin problems are
increased to not uncommon. In fact, in the chart review study by Dudek, Marks,
Marshall, and Chardon (2005) among a population attending a Canadian outpatient rehab
center, over 40% of the population were found to have at least one skin problem treated,
of which 27% were ulcers. Therefore, it was hypothesized (Hypothesis 1) that severe
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residual limb skin problems would be significantly more frequent among artificial limb
configurations/components of higher function or technical sophistication because of
inappropriate prescription, and least for low function, low technically sophisticated
configurations. It was also hypothesized that over 50% of all the cohort members would
have at least one “less severe” residual limb skin problem treated during the three-year
follow-up period, regardless of the ALC category they were dispensed.
To address this research question and hypothesis, the key variables of interest
were: ALC and RLSPS (as described in the section entitled Instrumentation and
Materials). Subsequent study research questions included: (a) what was the frequency of
dispensation for each of the categories /levels of ALC, the independent categorical
variable? This would be needed to better understand patterns of variance; (b) for each
category of ALC, what was the summed count of severe as well as less severe residual
limb skin problem per 6 month interval over the follow-up period? This would be needed
to ascertain when variability of the dependent variable was greatest; and (c) following the
dispense of a definitive Artificial limb to cohort members, over a 3 year period, was there
a statistically significant (p-value < 0.05)difference in RLSPS levels (the
dependent/outcome variable)given the factor “Artificial limb” (independent category
variable) and the demographic constants age group, marital status, gender, and VA
Priority status, and if so, how do the factor levels compare? Descriptive statistics defined
the percentage of types of artificial limb configurations dispensed, as well as the
frequency and type of skin problems treated per year and over the course of the follow-up
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period. Additionally multivariate modeling (general estimating equations—GEE) was
performed with ALC as the categorical independent variable/ factor and the dependent
variable RLSPS (severe/less severe; repeated measure), age group, VA priority status
(categorical: 1-8), marital status (never married, married, divorced, widowed) and gender
(as covariate constants). Pairwise contrast tests analysis of the independent /factor (ALC)
was used to help determine which of the configurations were associated with significantly
more or less frequency in residual limb skin problems. Mean values helped determine
which configuration or component was associated with more severe residual limb skin
problems. A p-value of less than 0.05 for the category deemed most sophisticated, for
example, VASS suspension system (L5781, L5782), with multiaxis-dynamic response
foot (L5979) would support the hypothesis that more sophisticated artificial limb
configurations were associated with more residual limb skin problems.(HA1a)
Mechanical effects as a covariate. Research question 2 attempted to address a
larger issue, namely the need for universal prescription guidelines.
As stated previously in this chapter and further described in Chapter 2, the fit of
the prosthetic socket has direct bearing on the residual limb's condition. A poorly crafted
or poorly fitted socket may cause not only pain and discomfort for the amputee, but also
may exacerbate forces and frictions exerted on the residual limb, leading to residual limb
breakdown of skin and soft tissue (De Palma et al., 2002). Further, the prosthetist is
frequently not only responsible for crafting the artificial limb socket, but also for
configuring, building, and aligning the finished product. A well-crafted and fitted socket
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may still be associated with residual limb problems if the configuration of the artificial
limb is ill-suited to the activity level, mental capacity, or various socio-demographic
characteristics of the user (as discussed in Chapter 2). While not all prosthetists
associated with the VHA may be licensed in their particular state of residence, all are
certified by the American Board of Certification and thus are trained in the fit and
manufacture of prosthetic sockets. Therefore, it is fairly safe to assume that all prosthetic
sockets provided are fitted and crafted to the best of the ability of the prosthetist, but the
craftsmanship and knowledge base of artificial limb components may vary between
prosthetists. If there was no significant difference in residual limb skin outcomes between
prosthetists regardless of artificial limb configuration (H02), then it could be argued there
is no real need for prescription guidelines. If, on the other hand, there were significant
variability in the outcome measurement among prosthetists, the argument could be made
that the knowledge base is unequally distributed, and that universal prescription
guidelines (or at least updated ones) were needed to standardize care. The corresponding
hypothesis (Hypothesis 2) was stated to reflect this concept within the bounds of the
dataset (that is, the actual identification of the dispensing prosthetist is not available and
thus the VISN served as a proxy thereof).
It could then be argued, given characteristics of the cohort and the hypothesized
greater incidence of severe residual limb problems associated with higher function
technically sophisticated artificial limb configurations (Hypothesis 1), that should such
conditions exist regardless of the prosthetist/VISN (Ha2), then perhaps those prescription
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guidelines that exist have not kept up with rapidly advancing technology (concurrent with
certain VHA policies), or perhaps guidelines were simply not adhered to. On the other
hand, if associations between artificial limb configurations and residual limb outcomes
differ with VISNs, then the need for universal prescription guidelines or, at least,
improved sharing of information among VISN prosthetists, would be of consideration.
The specific reason or cause why VISN outcomes may or may not vary is beyond
the scope of this study. The intent was merely to identify such. Subsequent research
questions included: (a) Per VISN, how many cohort members were there; (b) when
VISNs were grouped geographically, what were the representative cohort numbers and
how did the regions rank; (c) per region, what was the frequency of each ALC category
dispensed and how did the regions compare/rank; (d) to assess the overall effect of
who/where an artificial limb was crafted , was there a statistically significant difference
(p-value <0.05) in RLSPS with the factor “Artificial Limb” the categorical independent
variable ALC), the demographic variables age group, marital status, gender, and VA
Priority status as constants, and VISN region as a covariate; and (5)to assess how the
VISN regions compare, was there a significant difference (p-value <0.05) in RLSPS with
“region” as one factor (each geographical region as a level) and “artificial limb” as a
second factor (representing the categorical independent variable ALC), and the
demographic variables age group, marital status, gender, and VA Priority status as
constants, in order to explore factor interactions. To address these questions and
hypotheses, descriptive statistics were used to determine the distribution of the categories
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of ALC among the VISNs (as there are 23 VISNs, they were eventually grouped into
larger geographical regions to improve cell sizes). Multivariate modeling (GEE) was
conducted with ALC as the independent variable/factor, RLSPS as the dependent
repeated measure variable, and VISN/Region where the artificial limb was dispensed as a
covariate as a means to ascertain the overall influence of VISN/prosthetist on RLSPS
categories (as determined by the model’s z-score). Pairwise contrast tests analysis of
VISN/Region was used to help determine which of the VISN/Regions were associated
with significantly more or less frequency in RLSPS categories; comparisons of
significance (p-value ≤ 0.05) were supportive of the hypothesis that not only does the
type of artificial limb configuration influence residual limb outcome (mechanical main
effect), but the outcome is also influenced by (by proxy) the skill and expertise of the
prosthetist (mechanical covariate).
Behavioral main effects. Research question 3 addressed the issue of the impact
certain mental health and behavioral (coping strategies) disorders may or may not have
on the types of residual limb problems that are associated with the use of an artificial
limb for the dysvascular transtibial amputee. Specifically, diagnosis codes for the
conditions MDD, PTSD, or SUD detected during the three-year follow-up period were of
interest, not just the presence of such a diagnosis at the time of the amputation surgery or
immediately postoperatively. Studies have shown that psychosocial factors impact the
health and welfare of the artificial limb user and their success with an artificial limb. For
example, Williams and colleagues (2011) showed that depression was associated with a
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33% higher risk of major lower limb amputation among diabetic Veterans; Darnell and
colleagues determined that just over 28% of persons in the general public living with
limb loss suffered from depression, with associated risk factors being marital status
(divorced or separated), living at the poverty level or lower, comorbid conditions, and
discomfort with the artificial limb; Livnech, Antonak, and Gerhard (1999), as well as
Desmond and MacLachlan (2006), showed that an individual’s coping strategies
significantly impacted their ability to adjust to major limb amputation and ultimate
success with an artificial limb.
The conditions in question (depression, PTSD, and SUD) are prevalent among
U.S. Veterans and have long lasting effects, particularly in their ability to manage chronic
disease such as diabetes, hypertension, and vascular problems. For the dysvascular
amputee, there is the additional complexity of managing the care of their residual limb as
well as care of the artificial limb. Based on the biopsychosocial theoretical model, a
person’s mental state has direct (and indirect) bearing on one’s physiology as well as
their ability to manage their disease (Bradley et al., 2002; Engel, 1977). Given the
apparent relationship between depression and incident amputation among diabetics, this
suggests an apathy toward foot care that ultimately ends in amputation due to infection.
This same apathy may lead to poor residual limb care and/or a low activity level, the
combination of which may result in frequent skin problems but of less severity than those
experienced by a more active individual. Behaviors associated with PTSD can range from
significant depression and withdrawal to violent outburst; from forgetfulness to paranoia
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(The Management of Post-Traumatic Stress Working Group, 2010). Any of these
behaviors can have a direct impact on one’s ability to manage physiological problems
including seeking treatment appropriately or following through with treatment protocols
(van der Kolk, 1994). Similarly, an individual diagnosed with SUD, frequently an
outcome of poor coping strategies, will have difficulty making decisions, following
through with health/disease management, and the substance being abused (for example,
alcohol) may compound an existing disease condition such as diabetes (Haase, 2009).
While potentially unable to maintain good health/disease management, the individual
with PTSD or SUD may remain relatively active seeking emotional solace, but not
necessarily seeking medical care. The activity increases biomechanical forces at the
artificial limb–residual limb interface, increasing the likelihood of minor skin problems
that go undiagnosed or untreated, and ultimately become severe skin problems.
Therefore, it was hypothesized (Alternative Hypothesis 3) that cohort members
with a diagnosis of MDD would have fewer severe residual limb skin problems and fewer
residual limb skin problems treated overall (primarily due to a low activity level) as
compared to those members with no such depression diagnosis(Ha3a); cohort members
with a diagnosis of PTSD or SUD would have significantly more severe residual limb
skin problems (due to higher activity levels and/or poorer self-management) than those
members without PTSD or SUD, but not significantly more less severe residual limb skin
problems (Ha3b). The subsequent research questions included the following: (a) what was
the frequency of diagnoses for each of the “Mental Health” factors (PTSD, MDD and
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SUD) among the cohort members dispensed an artificial limb; (b) What percentage of
the cohort had a single diagnosis for any of the three mental health conditions; and (c) for
the period after being dispensed an artificial limb, was there a statistically significant
difference (p-value<0.05) for RLSPS (dependent/outcome variable) given the factor
mental health status (with three levels - PTSD, MDD, and SUD), and the demographic
constants age group, marital status, gender, and VA Priority status, regardless of the
artificial limb configuration dispensed?
The analysis plan for this research question and hypothesis included descriptive
statistics to determine the frequencies and rates of ICD-9-CM codes for MDD, PTSD,
and SUD among the cohort dispensed artificial limbs per the follow-up period (ICD-9CM codes used to identify each condition can be found in Appendix B). Additionally,
multivariate modeling (GEE) was conducted with mental health status as a factor, the comorbid conditions COPD, CHF, CVD and renal failure as covariates, ,RLSPS levels as
the dependent repeated measure, and demographic as covariate constants, to estimate
differences in outcome relative to a diagnosis of MDD, PTSD, or SUD. A significant
difference (p-value < 0.05) for a mental health disorder would support the hypothesis that
the frequency of a residual limb skin problem outcome is influenced by a behavioral
effect. A p-value less than 0.05 for depression (MDD) would support the hypothesis that
outcome patterns for depression differ from that for PTSD or SUD. Adjusted odds ratios
for the demographic variables will help explain the differences.
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Interaction effect, mechanical by behavioral factors. Continuing to work off
the premise that certain mental health conditions are characterized by behaviors
expressed by activity levels and that activity level is one of the driving forces behind
severe skin problems, this Research Question 4 and subsequent analysis attempted to
address this interaction. As presented in Hypothesis 2, it is anticipated that the depressed
individual will be more apathetic and less physically active, while the patients struggling
with PTSD or SUD will have a fairly normal activity level but will be confounded by
poor disease management and unwillingness to seek timely medical care. All will have
skin problems regardless of the ALC category (given their dysvascular condition) and
those prescribed a more sophisticated artificial limb configuration could have more
problems than those with a less sophisticated limb (Hypothesis 1), but perhaps for
different reasons and to different extents. A significantly depressed individual using a
highly sophisticated artificial limb would likely not use it as extensively as others, but
when they did, they could be less cognizant of mechanical factors. Subsequently, they
would more likely incur mechanically induced skin problems, but because of their low
activity level, most problems would not become severe (Ha4a). On the other hand, the
individual with PTSD or SUD would utilize a sophisticated artificial limb more
extensively, but when problems occur, they would likely be reluctant to seek help while
continuing to use the limb such that less severe problems would become severe (Ha4b).
Further, in the case of the individual with SUD, particularly alcoholism, the continued
consumption of alcohol would compound their pre-existing vascular disorder, causing
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their residual limb to be more at risk for skin breakdown (Ha4b). For all three mental
health conditions, their particular sociodemographics will help determine their outcome.
For instance, a younger individual would likely be more active and more likely dispensed
a mechanically sophisticated artificial limb; an individual living in near poverty and not
married, more prone to skin problems simply because of less capacity to seek help and/or
maintain a mechanically sophisticated artificial limb properly.
The corresponding research questions included: (a) as determined previously,
what percentage of the cohort presented with a single mental health condition (PTSD,
MDD, or SUD), what was the most frequently and least frequently dispensed ALC
category, and what percentage of the cohort had at least one comorbid condition(CHF,
CVD, COPD, renal failure or obesity); (b) was there a significant difference (p-value <
.05) in RLSPS for MDD, PTSD, or SUD given a specific ALC category and the
demographic variables age group, marital status, gender, and VA Priority status as
constants; (c) given a significant difference, what main effect (that is, artificial limb
configuration or mental health) drove the difference; and (d) were there any other
significant interactive or differences (p-value < .05) associated with any one of the comorbid conditions? The analysis plan to address these interactions included descriptive
statistics calculated to reveal frequencies of PTSD, MDD, and SUD diagnoses from the
date the artificial limb was dispensed through the follow-up period. Additionally, because
activity levels are closely associated with mechanical effects related to using an artificial
limb, the presence/absence of the comorbid conditions CHF, CVD, COPD, renal failure,
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and obesity, were accounted for in the cohort, regardless of whether the comorbid
condition ICD-9-CM code was registered before or after artificial limb dispensation.
Multivariate modeling (GEE) was conducted in which ALC category, mental health, and
activity (as suggested by comorbid conditions) served as factors, RLSPS as the dependent
repeated measures variable, and demographic constants as covariates. Significant main
effects for mental health status as a diagnosis code for MDD, PTSD, or SUD, support the
hypothesis of behavioral effects on RLSPS. Significant interactions between categories of
ALC and mental health status should indicate the relationship between more
sophisticated artificial limb configurations and patients with depression, PTSD, or SUD
relative to RLSPS levels.
Confidentiality
Cohort Member Confidentiality
For both national databases, each patient has a unique identifier that is an
encryption of the patient's Social Security Number, and thus allows for patient
identification across fiscal years and datasets without jeopardizing or compromising
patient confidentiality. The requested and extracted data was matched and linked by these
encrypted social security numbers, the code to which was not required nor requested.
Further, because the encrypted social security number was considered a unique identifier
by the VHA, as per VHA regulations, all protected health information (PHI), including
dates, was protected by (a) maintaining up-to-date training for all persons having access
to the data, (b) monitoring implementation of good data security practices by all such
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persons on an ongoing basis, (c) storing data behind the VA firewall on protected,
limited-access research servers at all times, (d) using secure data transfer methods to
obtain PHI, such as limited access password-protected and user-specific direct data
transfer behind the VA firewall, (e) limiting PHI requested/obtained to the minimum
needed to meet study objectives, and (f) reporting only aggregate results, with no ages
greater than 90 years.
Data Security
The source data that comprised the master dataset and from which data were
extracted to form the study cohort dataset, was available due to a protocol approved by
the UTHSCSA (which serves as the oversite IRB for the South Texas Veterans Health
Care System Research Service) and STVHCS Research Service Subcommittee approval.
After obtaining the necessary permissions, a simple code was prepared, using SAS
programming language that established data selection criteria. This code was then
transmitted to the Austin Information Technology Center (AITC) housing the archived
data and where the investigator established a temporary account. The requested SAS
dataset was then prepared and results of any manipulations transmitted to the STVHCS
Research Service secured server. All electronic data were stored in accordance with the
VHA’s information security policy and encryption standards to include that any
subsequent data results reported be fully de-identified as summary (statistical) or
aggregate data.
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IRB approval from the UTHSCSA, as well as the STVHCS – Audie Murphy
Research Service Subcommittee, to acquire the master dataset was obtained in November
2011; the data requested and received as of November 2012. Prior to initiation of this
dissertation study, Walden University Institutional Review Board approval was obtained
(approval number: 08-11-14-0047713) on August 11, 2014. The extracted data used to
develop the study dataset was stored and manipulated on a secure server behind the
STVHCS firewall)
Summary
As presented in Chapter 2, the process of determining what artificial limb
configuration is to be prescribed for anyone living with limb loss is highly individualized,
being dependent on multiple and integrated factors. Despite the advances in materials and
engineering associated with the development of new artificial limb components, the
artificial limb remains imperfect relative to the intact human limb. This imperfection is
particularly notable at the interface of the mechanical artificial limb and the human
residual limb, and is expressed as residual limb skin problems. These residual limb skin
problems jeopardize the integrity of the residual limb, compromising the individual’s
mobility and quality of life, and range from the “less severe” (calluses, blisters, rashes,
and irritations) to the “severe” (ulcers, infection, limb breakdown). Ultimately two key
factors drive the likelihood of residual limb skin problems—mechanical effects in which
the design or configuration of the artificial limb creates forces and friction on the residual
limb resulting in “microtrauma” to tissue; and behavioral effects in which the actions of
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the user, particularly activity level and health self-management, incur or exacerbate
residual limb skin problems.
The methodology presented in this chapter was intended to address residual limb
skin problems resultant of mechanical and behavioral effects in the process of exploring
the viability of a novel dataset derived from AHc data. Specifically the study was
designed to explore the value of medical coding (to include ICD-9-CM diagnosis codes,
CPT procedural codes, and HCPCS billing codes) as a means to objectively describe the
clinical picture and outcomes, relative to the category of artificial limb dispensed, for a
cohort of U.S. Veterans with new transtibial amputations for dysvascular complications.
The research plan included the compilation of the cohort clinical and artificial limb
history over a period of three years, as derived from two VHA repository databases—the
NPCD and the NPPD. The compiled, integrated study dataset was used to calculate
descriptive and multivariate analyses in an effort to (a) describe the cohort in terms of comorbid conditions, artificial limbs dispensed, and demographic characteristics; (b) assess
the effects (main and interaction) of mechanical factors (ALC category, prosthetist
skill/knowledge base); (c) assess the effects (main and interactions) of assumed
behavioral factors associated with MDD, PTSD, and SUD; and (d) determine the value
and usefulness of residual limb skin problem diagnosis codes (ICD-9-CM codes) as
outcome measures. As with any research study involving humans, considerable effort
was made to ensure the confidentiality and protection of health information of all the
study cohort members. All source data was applied for and approved by VHA entities, all
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data retained behind the VHA firewall, source data only identifiable by an encrypted,
scrambled patient social security number that was not decoded, and a unique subject ID
per cohort member utilized in the derived dataset.
Given the relative novelty and questionable validity (see Data Limitations herein)
of both the source data from the NPPD and, subsequently, the study dataset, the study is
intended only to lay the methodological and descriptive analysis foundation for future
studies. For this reason, data analysis was primarily limited to descriptive and
multivariable analysis of the likelihood of differences as calculated by general estimating
equation procedures. In other words, the research plan and analysis was designed as a
“proof of concept”—that such a dataset of AHc medical coding of an individual’s clinical
history and artificial limb prescription (with a focus on implications of mental health
conditions) would provide sufficiently informative and valuable information for future
studies. Such studies may include those that derive different algorithms to categorize
artificial limb configurations, expand the clinical history of the cohort to include the
prescription of mobility aids and/or medications, apply the methodology to cohorts of
different amputation levels, or seek predictive relationships regarding ALC categories
and patient outcome, specifically in regard to medically coded indicators. Such studies
should, logically, lead to improved clinical prescription guidelines and/or artificial limb
component design, as well as offer support for the development of an amputee care
surveillance system or registry.
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The ensuing chapters present the data analyses as described and discuss the
findings in a manner that not only present the strengths and weaknesses of the study
dataset, but also lay the foundation for further analyses and application of the dataset
concept to other levels and causes of amputation.
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Chapter 4: Results
Introduction
The purpose of this study was to address the utility of VHA AHc records as a
source of information toward the potential development of a suitable amputee-artificial
limb database and future surveillance system. To accomplish this, there were two main
goals to be achieved: (a) derivation of a suitable dataset, referred to in the previous
chapter as Phase 1 – Developing an informatics tool, and (b) utilization of that dataset in
a meaningful epidemiological analysis, referred to as Phase 2 in the previous chapter and
based on a retrospective observational cohort study design. While the study methods used
were not necessarily novel, the derived database was, as was the epidemiological
analysis, given its data source and selection of independent and dependent variables.
Phase 1 focused on the extraction and integration of administrative data from the
VHA’s NPCD from which clinical histories of the cohort were ascertained on the basis
of diagnosis, surgical and procedure codes (ICD9-CM and CPT codes, respectively), and
the NPPD from which the cohort’s history of artificial limb components delivered and
procedures performed were recorded as HCPCS (billing) codes. On the bases of these
codes, the categorical variable ALC (representative of mechanical factors influencing
outcomes) was developed, certain comorbid conditions (representative of behavioral
factors influencing outcomes) were identified, and the outcome variable RLSPS was
constructed. Ultimately, the derived dataset represented a cohort of veterans having
undergone a transtibial amputation for dysvascular complications during FY 2007
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(October 1, 2006 through September 30, 2007), subsequently provided an artificial limb,
and followed through FY 2010. It was this dataset that was used for the epidemiological
analysis in Phase 2 of the study, and served to address the potential for a similarly
derived database as a prosthetics practiced-based informatics tool in the development of
an amputee-care surveillance system.
Exploring the feasibility of healthcare administrative data as a source and basis of
EBM in the field of prosthetics research is a necessary step and includes an initial
description of the steps and rules used to derive the study dataset. The section entitled
Phase1 – Developing the Informatics Tool, under the Data Preparation heading, includes
a list of those steps and rules and includes a data dictionary of variable definitions
pertinent to those rules, construction of the categorical variables ALC and RLSPS, and
characterization of the study dataset in terms of frequencies, ranges, and invalid/unusable
cases.
Statistical analysis of the refined dataset and identification of the patterns and
trends of the cohort with regard to artificial limb provision and subsequent RLSPS
outcomes follows in the section Phase 2 under the Results heading. The statistical
analyses used to address each research question reflect both the complexity of the case
histories of the cohort, as well as limitations of using unvalidated, archival data. Further,
the research questions focused on both mechanical and behavioral factors as main effects
or covariates and, as such, are reflected in the statistical model design and subsequent
data manipulations. Details of such manipulations are described as needed

202
Data Preparation
Phase 1 – Developing the Informatics Tool
Overview. From a master database located on a STVHCS secure server, 2240
observations were extracted representing the inpatient clinical histories of 1487 veterans
during FY 2007, all with an ICD9-CM or CPT code for below knee amputation and
concurrent with ICD9-CM codes for dysvascular conditions such as diabetes, PAD or
PVD. This was the initial cohort and served as the basis for the final study cohort.
Observations from the same master database containing extracts from the NPPD
was then searched for encrypted Social Security Numbers (variable name – ScrSNN) that
matched those identified in the initial cohort, extracted, cleaned, and prepared prior to
merging with follow-up clinical data. The NPPD has not yet been fully validated or
examined and thus presented with various data incongruencies, apparent missing data,
and unknown reliability, requiring extensive data cleaning and preparation.
Ultimately, outcomes from data preparation defined the study dataset were those
cases who in FY 2007 presented with a combination of ICD9-CM OR CPT codes
indicative of a dysvascular transtibial amputation or revision surgery, dispensed an
identifiable definitive artificial limb at some point during FY 2007 through FY 2011, and
after which (the date the artificial limb was dispensed) the patient’s clinical history would
be followed through to the end of FY 2011 (September 30, 2011). (Note: it was decided
to expand the follow-up period to FY 2011 from FY 2010 as the data were available and
the extension would allow for more data points.) Specific rules defining the data
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preparation and identification of the study cohort are presented in Appendix C: Data
Dictionary, and are summarized below.
Extraction of clinical data. NPCD data provides clinical (diagnosis and
procedure) codes at the patient level for all veterans visiting a VHA facility. The master
database housed at the STVHCS – Audie Murphy Hospital contains such data for
inpatient and outpatient visits during fiscal years 2007 through 2011. It was from this
database that all clinical data for the study was extracted to include identification of
cohort members, their comorbid conditions, demographics, and all follow-up residual
limb skin problems.
Identification of cohort members. The inclusion criteria and coding used to
identify persons having undergone a below knee amputation was expanded from the CPT
code 27598 to include the ICD9-CM codes 897.0, 897.1, 897.4, and 897.5 (definitions of
these codes are presented in Appendix B: Data Dictionary, Table B25). This expansion of
the cohort inclusion criteria was performed in an effort to maximize the number of cases
for analysis. Further, because of the complex disease conditions of many veterans,
especially those with dysvascular conditions, the ICD9-CM and CPT codes were
searched for throughout the FY 2007 NPCD inpatient datasets, rather than being limited
to a search in the dataset variable DXPRIME, the primary code and reason for hospital
admission. The other dataset variables/fields from the NPCD datasets included: DXB2DXB5, DXF2-DXF13, DXLSB, and DXLSF, all of which indicate the primary and
secondary ICD-9-CM diagnostic codes that apply to the inpatient files (bed section or full
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stay) for the patient (see Appendix B, Table B27 for a full list of dataset fields/variables).
In so doing, cases were not limited to those veterans undergoing an index transtibial
amputation in FY 2007, but included veterans with existing below-knee amputations
undergoing a revision surgery of the residual limb, a reamputation of the same limb (for
example, from Syme’s to transtibial; from transtibial to transfemoral), or a veteran with a
pre-existing unilateral lower limb amputation undergoing a below-knee amputation of
their intact limb. Ultimately, a total of 1487 unique cases were identified and formed the
initial cohort.
Extraction of artificial limb data. NPPD patient level data were the source for
artificial limb data and provided all patient prescribed equipment and device transactions
conducted nationally at VHA facilities, including artificial limb components. The master
database housed at the STVHCS-Audie Murphy Hospital contains all such data for fiscal
years 2007 through 2011. It should be noted that, unlike the NPCD data which is
composed of multiple MedSAS data files for inpatient and outpatient clinical data per
fiscal year, the NPPD dataset was a single Excel worksheet containing all requested data
for fiscal years 2007-2011. The dataset was structured as one row per patient transaction
and amounted to 319,119 records with 34 variables, representing 6,590 unique cases.
Transactions included those for any durable medical equipment (such as hospital beds or
grab bars), wheelchairs, sensory aids (such as eyeglasses and hearing aids),oxygen tanks
and portable ventilation systems, surgical implants (such as hip and knee joints), orthotics
(such as shoe inserts and diabetic shoes), and prosthetic devices and components.
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From this master database of NPPD data, a first pass for data extraction was made
based on the presence of HCPCS codes indicative of an artificial limb to include the code
L5301(used to indicate permanent/definitive artificial limb from temporary or
immediate post-operative artificial limb), the codes for prosthetic feet (L5970, l5974,
L5972, L5975, L5978, l5973, L5976, L5979, L5980, L5981, and L5987) and the codes
for socket suspension systems (L5680, L5682, L5684, L5688, l5690, L5666, L5685,
L5670, L5671, l5673, L5647, L5781, and L5782). Appendix B provides a full definition
for each of these codes in Table B26. This first pass was performed to eliminate those
potential cohort members who may have received wheelchairs or other durable medical
equipment (DME) but no artificial limb components, and resulted in the identification of
3,394 unique cases and 18,526 records.
The scrambled SSNs of the 1487 unique cases identified from the clinical data
were then compared with the scrambled SSNs of these NPPD cases, and matching cases
with associated observations extracted for further analysis. The matching accounted for
597 cases and 3327 associated observations from the NPPD data file. The following
inclusion/exclusion criteria were then applied to the 597 cases (artificial limb data only):
1.

Inclusion criteria - The presence of HCPCS code L5301, expanded to
include L5700, L5100, and L5629 (code labels are presented in Appendix
B, Table B26). The expansion was made in order to include Veterans with
pre-existing below-knee amputations, reamputations, and revision
surgeries (as described above). Also required were HCPCS codes for
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prosthetic feet and socket suspension systems as indicated above; delivery
date, quantity, description, and VISN for each HCPCS code; and
calculated cost for each L5301 code. A cohort member dispensed a
below-knee preparatory socket (HCPCS codesL5510, L5520, L5530,
L5540) but no definitive socket/limb code l5301 noted, was included only
if the code l5700 (“replace socket below knee”), was dispensed at least
one year post surgery. This modification to the inclusion/exclusion criteria
was made in order to capture for analysis those cases where a definitive
artificial limb was dispensed but possibly improperly coded as a
replacement socket.
2.

Exclusion criteria – The presence of HCPCS codes indicative of a
Syme’s amputation (an amputation through the ankle rather than
transtibial) to include L5632, L5634, and L5636; those HCPCS codes
indicative of an above-knee amputation to include L5321, L5560, L5580,
L5585, and L5590 (Labels for each of these codes can be found in
Appendix B, Table B26). It is not uncommon for a unilateral above-knee
dysvascular amputee to undergo a below-knee amputation of the intact
limb, subsequent of continued poor vascularization, foot ulceration, and
infection (Dillingham, et al., 2005; Izumi et al., 2006). Exclusion of such
individuals despite the below-knee amputation, was required because
ICD9-CM codes for residual limb skin problems do not differentiate
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between left and right (above knee and below-knee amputation ) limb and
therefore, residual limb outcomes could not be tracked accurately. This
same factor was relevant to persons who became bilateral below-knee
amputees following amputation surgery in FY 2007.
3.

Additional exclusions - Cases that presented with no Delivery Date for
the artificial limb of interest were excluded as it was impossible to
determine if the date were merely missing, not recorded , or the
component not delivered. Cases that included the l5301 code but missing
codes for either a prosthetic foot or socket suspension system were
excluded from the cohort as it was impossible to assign a category for the
independent variable ALC.

The data extracts from the NPPD master database were then inspected for data
quality and useability on a case by case basis, whereupon a temporary variable,
DataStatus, was created to encode cases as to their useability: a value of 1 to indicate
useable data (met all inclusion/exclusion criteria), a value of 88 to indicate a bilateral
amputee (either above-knee/below-knee or bilateral below-knee), a value of 92 to
indicate a case with missing relevant delivery dates or otherwise incongruent data (such
as the HCPCS code l5301 used to denote repair or modification to a pre-existing
definitive artificial limb), the value 93 for a case presenting with an HCPCS code for
above-knee artificial limb (preparatory, definitive, or replacement), the value 94 when a
case presented with a missing HCPCS code for prosthetic foot or suspension system in
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association with a definitive artificial limb (HCPCS code l5301, l5100, or L5700), and
the value 95 for delivery of a Syme’s artificial limb.
Assessment of the data revealed three coding strategies for the HCPCS code
L5301. One strategy was to use the code to indicate a definitive (versus a preparatory or
replacement socket and limb) and typically included a monetary amount in the NPPD
variable CalCost reflective of multiple components (greater than $3,000) and a delivery
date the same as that for an associated prosthetic foot and suspension system. A second
apparent strategy was to use the L5301 code to indicate that some repair was made to the
patient’s pre-existing definitive artificial limb, and apparently used in lieu or ignorance of
the codes L7510 or L7520 (code labels can be found in Appendix B, Table B26). Such
cases were identified on the basis of monetary values for the NPPD variable CalCost
being less than $2,500 (the new cost of a below-knee socket), the value $0 for this same
variable, or a particular component was identified in the NPPD variable field
ConsultDesc or Item, but instead of using the HCPCS code appropriate for that part, the
l5301 code was used along with a unit cost reflective of the part described. For example:
Table 6
Sample Data from NPPD to Illustrate Coding Strategies.
Study
_ID

Calc
Cost

HCPC
SPSAS

New
Cost

Qty

HCPCSDesc

142

50

L5301

0

1

BELOW KNEE,
MOLDED SOCK

Delivery
Date
04/28/2010
00:00:00

167

103.68

L5301

103.
68

1

BELOW KNEE,
MOLDED SOCK

07/24/2007
00:00:00

925

68

L5301

68

1

BELOW KNEE, MOLDED SOCK

Item

ConsultDesc

PROSTHESIS
BELOW KNEE

RIGHT BK
REPAIRS
REPAIR TO
BK
PROSTHETI
C
STUMP
SOCK

1
PROSTHESIS,
BK
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As indicated previously, 1487 dysvascular below-knee amputees were identified
in the FY 2007 inpatient data files, of which 597 (39%) cases had scrambled social
security numbers that matched those extracted from the NPPD artificial limb data. The
890 unmatched cases (59.9% of the initial cohort) were not used any further in the study
and can be supposed to be persons who died within the fiscal year or were simply not
recommended or prescribed an artificial limb. In fact, of these 890 unmatched amputees,
245 (16.5%) died during the fiscal year, suggesting that the remaining 645 (43.4%) were
not prescribed an artificial limb. This number/ percentage is not without merit as it has
been estimated that nearly 60% of lower limb dysvascular amputees will not progress
beyond use of a rudimentary or k2-level artificial limb (Smith et al., 2003; Uustal, 2009).

Of the 597 Veteran below-knee amputees identified and matched with artificial
limb data, only 279 cases (47%) met all inclusion /exclusion criteria and could be used
for epidemiological analysis. The remaining 318 cases (53%) could not be used, of which
39 cases were coded as 88(7%), 55 coded as 92 (9%), 121 coded as 93 (21%), 76 coded
as 94 (13%), and 21 coded as 95 (4%). Definitions for each of these codes are presented
above and can also be found in Appendix B Data Dictionary, Table B3.
Development of the Independent Variable – Artificial Limb Configuration
In an effort to detect an inherent categorizing strategy, frequencies were run on
the extracted artificial limb data (from the master database) comprised of 597 cases and
1752 observations, in order to determine the most commonly prescribed socket
suspension systems and prosthetic feet (frequency tables can be found in Appendix D,
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Tables D8 and D9. While this first pass at the data was not exclusive to the study cohort
to be used in the epidemiological analysis, the study cohort was inclusive and the larger
N, despite missing dates or bilateral amputations, was reflective of prescription patterns
across the VA system.
Results revealed the following: The most frequently prescribed suspension
systems were the L5671and L5685, each with 422 and 420 prescribed respectively and
accounting for nearly 77% of all suspension systems prescribed for below-knee
amputees. Suction sockets (L5647; N = 111), supracondylar (L5670 N = 54), cuff
suspension (L5666; N = 45), straps and belts (L5680, L5682, L5684, L5688, L5690; N =
34) and vacuum assisted systems (VASS; L5781, L5782; N=8) accounted for the
remaining 23%. The most frequently prescribed prosthetic feet were the Flex walk
system (L5981; N=262) followed by the Flex-foot System (L5980; N = 192) accounting
for 23% and 18% respectively.
Table 7 below presents the top ten combinations of prosthetic feet and suspension
systems prescribed and, based on the prosthetic foot types, suggests that the redominance of the Veterans were considered community ambulators or better (K3-K3-4).
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Table 7
Top Ten Most Frequently Prescribed Prosthetic Foot and Suspension System
Combinations
Combination

Frequency

Percent

106

9.67%

101

9.22%

78

7.12%

70

6.39%

67

6.11%

65

5.93%

48

4.38%

47

4.29%

41

3.74%

39

3.56%

L5981 Flex Walk System
L5674 suspension sleeve with locking mechanism
L5980 FlexFoot System
L5685 Below knee suspension sleeve
L5980 Flex foot system
L5685 Below knee suspension sleeve
L5976 Energy Storing Foot
L5674 suspension sleeve with locking mechanism
L5976 Energy Storing Foot
L5685 Below knee suspension sleeve
L5980 Flex foot system
L5674 suspension sleeve with locking mechanism
L5987 shank foot system with vertical loading pylon
L5674 suspension sleeve with locking mechanism
L5987 shank foot system with vertical loading pylon
L5685 Below knee suspension sleeve
L5972 Flexible keel foot
L5674 suspension sleeve with locking mechanism
L5974 single axis ankle/foot
L5674 suspension sleeve with locking mechanism

Because a plausible categorization of the artificial limb configurations that would
include all the combinations prescribed was not made evident by this first pass, two
alternative algorithms were considered, one based primarily on the total cost of the
artificial limb using the NPPD dataset variable CalCost, and the other more aligned with
the category of prosthetic foot (for example, K1, K2, K3).
Algorithm one for development of the ALC variable. CalCost is a
variable/field provided by the NPPD and part of the dataset extracted from the master
database as described above. It is a currency type field and represented the total cost
associated with the HCPCS code L5301 and includes cost beyond that of the socket
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suspension system and prosthetic foot. As a rule of thumb, the more high-tech, more
complex an artificial limb, the more expensive (DePalma, et al., 2002). However, also as
described above, the CalCost frequently did not represent the total cost of the artificial
limb, but rather some part or component not otherwise identified except in the Item
and/or ConsultDesc variables/fields which are truncated free text fields and inherently
unreliable. An alternative may have been to simply sum the NewCost (another NPPD
variable/field) for the suspension system and prosthetic foot, but this summing does not
include the cost of the socket, additional fittings (such as rotators), or the use of special
materials) (DePalma, et al., 2002; Cigna Health Care, 2010). Regardless, in most cases,
the higher the k-level, the more complex and high-tech the prosthetic foot (DePalma et
al., 2002). The exception to this is the Proprio Foot (HCPCS l5973) which is a
microprocessor controlled ankle/foot system recommended for the K2 level amputee (G.
W. Bosker CPO, personal communication, January 2015). HCPCS codes associated with
prosthetic foot functional levels used to fill the temporary variable ALC foot in this study
include: k1 functional level (HCPCS codes L5970, L5974); K2 (HCPCS codes L5972,
L5978); K3 (HCPCS codes L5976, L5979), and, in order to indicate the more complex,
technically sophisticated feet within the K3 level, K3-4 (HCPCS L5979, L5980, L5981,
and L5987. Descriptions of each of these codes are presented in Appendix B Data
Dictionary, Table B26.
Unlike that for prosthetic feet, there is no particular categorization of socket
suspension systems discussed in the literature that is based on the amputee’s functional
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level. Rather, as described by DePalma and colleagues (2002) suspension systems are
typically organized in to differential pressure, anatomical, and simple. The differential
pressure systems are the most popular and range in sophistication from a pin lock gel
liner to a Vacuum Assisted Suspension System (VASS); the most popular anatomical
suspension system is the supracondylar; and among the simple suspension systems, cuff
suspension system is the most popular (DePalma et al., 2002). As may be expected, cost
ranges from the VASS as the most expensive (being the most sophisticated) through the
pin-lock liners which, though not mechanically complicated, utilize specialized materials
such as urethane and silicon to construct the liners; to the simple suspension systems
which other than the cuff suspension, amount to straps and belts that wrap around the
socket and attach to a waist belt (G. W. Bosker CPO, personal communication, January
2011). Table 25 in Appendix B provides the description and costs (as determined by the
Centers for Medicare-Medicaid Services) for each of the prosthetic feet and suspension
systems.
To facilitate the development of a viable ALC variable, another temporary study
dataset variable was created, ALCss, and suspension system HCPCS codes were
categorized on the basis of mechanical complexity. Simple suspension systems (L5680,
L5682, L5684, L5688, l5690, L5666) were grouped as low-tech (L); suspension sleeves
and anatomical systems (L5685, L5670) were grouped together as mid-tech (M) with a
subset , LOCK, dedicated to suspension sleeves with pin-lock mechanism(L5671, l5673)
as these were so popular. Finally, the differential pressure suspension systems, which
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include the below-knee suction socket (L5647) and the VASS (L5781, L5782) were
categorized as high-tech (H) based on their sophistication and cost. Because of the
exceptional cost and reports of healing properties associated with the VASS, these
components were SUB-categorized as Hv for descriptive statistics only.
Codes from ALCfoot and ALCss were then combined to form the independent
variable ALC per unique case and amounted to a total of 18 combinations/values. Table
D1 in Appendix D presents these combinations and frequencies. However, as can be
noted, many of the cells had very low frequencies that would not lend themselves to
accurate statistical analysis, and thus the various artificial limb configuration
combinations were further categorized into 7 groups as presented in the same table. The
frequencies and percentages reported represent the 279 cases with viable data only and
include the categories transfers (N =12, frequency = 4%); household-high tech suspension
system (N = 10, frequency = 3%); household-mid to low tech suspension system (N = 16,
frequency = 5%); household-locking suspension system (N = 25, frequency = 8%);
community-high tech suspension system (N = 49, frequency = 16%); community-mid to
low tech suspension system (N = 53, frequency = 17%); and community-locking
suspension system (N =150, frequency = 48%). A complete description of the coding
system used for the independent variable is described in Appendix B Data Dictionary,
Table B2.
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Development of the Dependent Variable, Residual Limb Skin Problem Severity
(RLSPS)
The variable RLSPS was comprised of three categories: severe (Severex), less
severe (Lseverex), and No Treatment. The categories severe and less severe were
further subdivided into four subcategories each, representative of those suggested by Bui
et al (2009). Because the subcategories were based on the potential causes or etiologies
of the skin problem, both severe and less severe skin problems could be categorized into
the same sub category or etiology. The exception to this rule was for those skin
problems felt to be caused or related to skin occlusions, in which those that were
infectious were placed in the severe category and those that were not, placed in the less
severe category. Thus the subcategories included: residual limb skin problems in
reaction to a foreign body (Foreignbx, less severe; Foreignb2x, severe); residual limb
skin problems in response to non-infectious occlusions (Occlusionx, less severe only);
residual limb skin reaction to repetitive injury or microtrauma (Repetitivetx, less severe;
Repetitivet2x, severe); residual limb complication directly consequent of limb surgery
(Surgicalx, less severe; Surgical2x, severe); residual limb complication not otherwise
categorized (Otherlsx, less severe; ,Otherls2x, severe); and residual limb skin problems
in response to an infectious occlusion (Occlusion2x, severe only). The ICD-9-CM codes
that comprised each of these subcategories are presented in tables B18 (Less severe
category) and B19 (severe category) of Appendix B, Data Dictionary. Table 8 below
presents an accounting of the RLSPS category and subcategory outcomes.
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Because ICD-9-CM codes do not necessarily discriminate between body parts or
locations, it was not always possible to be assured that the skin problem was actually on
the residual limb, strictly on the basis of code. In an attempt to correct for this problem, it
was initially planned to count only those RLSPS ICD-9-CM codes that were detected
within the same encounter record as the ICD-9-CM codes 997.6 (Late amputation stump
complication), 997.60 (Unspecified complication), 997.62 (Infection of stump, chronic),
997.69 (Other complication of stump), or V49.75 (Lower limb amputation status, below
knee). However, a review of the cohort dataset revealed no cases in which any of these
codes were present and thus could not be used to assure residual limb involvement.
Therefore, RLSPS category ICD9-CM codes with descriptions that included mention of
head, neck, torso, arms, hands, genitals, pelvis or feet were not included; those with
specific mention of lower limb, thigh or shank were; and those that were non-specific to a
body part were also included as long as they reasonably fit into one of the five
subcategories described above or indicated by Bui et al. (2009).
Additionally, because it is common for a skin problem to be labeled as a less
severe problem (according to the ICD-9-CM code) but be severe in nature, an attempt
was made to utilize CPT codes indicative of treatments used to distinguish as a severe or
less severe RLSPS category. The CPT codes used included those representative of
wound drainage, wound debridement, and lesion removal (table B21, Appendix B – Data
Dictionary presents the actual codes) but were not used in the categorization because of
complications of associating procedural codes with the appropriate ICD-9-CM code.
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Nonetheless, among the cohort 5 (2%) cases were noted to have undergone wound
drainage, 95 (34% cases for wound debridement, and 9 (14%) for lesion removal.
Table 8
Frequencies for Residual Limb Skin Problem Severity Variables with Subcategories
Variable & Subcategories
Residual Limb skin problem
severity (RLSPS)

Less severe (total)
Surgical
Foreign Body
Repetitive
Occlusion (non-infectious)
Other Less severe

Severe (total)
Surgical
Foreign Body
Repetitive
Occlusion (infectious)
Other severe

No Treatment (total)

Frequency
(percent)
------

131 (46.5)
2 (0.7)
12 (4.3)
56 (19.9)
84 (29.8)
38 (13.5)

141 (50.0)
26 (9.2)
0 (0.0)
56 (19.9)
96 (34.0)
42 (14.9)

10 (3.5)

Comments
The dependent/outcome
variable; categorical (severe/less
severe/no treatment); repeated
measure.
Skin problems considered nonlife threatening with minimal
restrictions on artificial limb use;
includes callouses, noninfectious rashes or blisters,
cysts, disorders of sebaceous or
sweat glands and dermatoses.
Severe Residual Limb Skin
Problems that are life/limb
threatening or infectious, and
may require extensive
restrictions on artificial limb use.
Includes skin ulcers, infectious
rashes, or lesions, neuromas,
osteomyelitis, cellulitis,
malignant neoplasms.
Represents those cases in which
neither a less severe nor a severe
skin code was recorded.

The Mental Health Status Variables and Codes
As discussed in Chapter 3, many skin problems associated with the residual limb
and use of an artificial limb are related to the amputee’s activity level (mechanical
effects) or disease/condition self-management and care compliance (behavioral effect).
Also, as discussed, these two effects are not necessarily independent of each other. For
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example, an individual with major depression not only may be inactive, but they may
also lack the impetus for required personal hygiene or self-care of their residual limb; an
amputee with anxiety issues associated with PTSD may exhibit normal activity but be
reluctant to seek medical care of a skin problem in a timely manner; an amputee dealing
with SUD may exhibit non-normal activity levels and poor self-care, but also be
exacerbating their dysvascular condition with alcohol and drugs.
The three mental health conditions being included in this study all have specific
ICD-9-CM codes associated with them as per guidelines supplied by the VHA and
Department of Defense working groups specific to each condition and are presented in
tables B14 MDD, B15 PTSD, and C16 SUD in Appendix B, Data Dictionary.
Consideration was given to include diagnosable conditions not listed in these guidelines
but clearly associated given their ICD-9-CM code descriptive label, especially in the
case of MDD (such as depressive states of bipolar disease) and PTSD as an adjustment
disorder. Subsequently, secondary variables labeled Otherdepx (in association with
MDD) and Otheradjdisx (for PTSD) were created and are also described in tables B14
and B15 of Appendix B, respectively. Given the ICD-9-CM codes for Otherdepx, only
five cases were identified, of which two cases also were diagnosed with MDD, increasing
the number of cohort members with depressive symptoms from 38 (13%) to 41 (15%).
Similarly, based on ICD-9-CM codes descriptive of behavior adjustment disorders in the
variable Otheradjdisx, 22 cases were identified of which 12 were also diagnosed with
PTSD, increasing the total number of cases with some behavioral adjustment disorder
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from 53 (19% - Ptsdx only) to 67 (24% - Ptsdx and otheraddax combined). Nonetheless,
since the selected ICD-9-CM codes for Otherdepx and Otheradjx were based on their
label rather than definition or guidelines, only the variables Majordepx for MDD and
Ptsdx for PTSD (along with Sudx for SUD), were used for statistical modeling in order to
preserve accuracy. Table 9 presents these outcomes as part of a characterization of the
cohort.
Variables Representative of Physical Comorbid Conditions
As per study cohort inclusion criteria, all 279 members (transtibial amputees) had
a diagnosis of concurrent dysvascular disease. More specifically, 188 (67%) had a
diagnosis of diabetes, 123 (44%) diagnosed with PVD, and 49 (18%) were diagnosed
with PAD.
ICD-9-CM codes used for the comorbid condition variables congestive heart
failure (Chfx), renal failure (renalfailx), cerebral vascular disease (Cvdx), and chronic
obstructive pulmonary disease (Copdx) were those identified by Kurichi et al., (2007) as
being significantly related to a patient’s clinical outcome post lower limb amputation.
Actual codes were searched for on the website http://www.eicd.com/EICDMain.htm
using key terms such as heart failure, renal failure, respiratory disease and cerebral
vascular disease.
COPD is described by groups of ICD-9-CM codes indicative of specific disorders
that are associated with obstruction or difficulty with lung and respiratory function. The
intent of the inclusion of the condition is because of the extra effort required to utilize an
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artificial limb and thus, the need for good exchange of gases as a consequence of
metabolic increases (The Management of Chronic Obstructive Pulmonary Disease
Working Group, 2011; Winter & Sienko, 1988). A secondary variable, Otherrespx, was
created to include those respiratory conditions that were not necessarily obstructive in
structure or function, but could, nonetheless, significantly impair oxygen/carbon dioxide
gas exchange. Within the cohort, 64 (23%) of the members had a diagnosis of COPD, 13
(5%) had a significant pulmonary disease other than COPD, for a total of72 (26%)
suffering from a pulmonary disease likely to impact their energy levels and gas exchange.
The comorbidity variables for CHF, renal failure (Renalfailx) and malnutrition
(Malnutritx) were identified with ICD-9-CM codes because of their indication of overall
poor health; CVD and obesity (Obesitx) were included because of their potential
mechanical effects due to hemiparesis and weight bearing gait abnormalities. The codes
used to describe each of the comorbid conditions selected are presented in Tables B4 for
CHFX, B5 for COPDx and Otherespx, B6 for CVD, C6 for Renalfailx), and B8 for
Malnutritx and Obesitx in Appendix B, Data dictionary. Given the chronic and lifethreatening nature of these conditions, only inpatient files from FY 2007 through FY
2011 were reviewed. As binomial variables, the presence of at least one ICD-9-CM code
for a condition in a cohort member’s record was sufficient to be counted. Table 9
presents the outcome of this accounting in detail and indicates that CHF was diagnosed in
129 (46%) of the cohort members, CVD in 17 (6%) of the members, renal failure in 52
(18%), obesity in 7 (2%, and malnutrition in 1 (0.4%).
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Demographic Variables Used in the Study
Demographic variables Gender, Age, Marital Status, Race, and VA Priority are all
found in the Main section of NPCD inpatient files. The primary intent of these variables
is to characterize the cohort and secondarily to help explain residual limb outcomes in the
multivariable analysis. To help improve cell sizes, the variable marital status was
condensed from 5 categories (not married, married, widowed, divorced, and unknown) to
2 categories - married of which there were 143 (53%) cohort members and other with 128
(47%) members. The variable VA priority (socioeco) was also condensed from 7
categories (VA Priority Status group 1 through 5, Group 7, and Group 8; no VA priority
Group 6 cases were found within the cohort) to 3 new categories – Unemployable
(frequency = 228 or 84%); Employable (frequency = 32 or 12%); and Co-pay Eligible
(frequency = 13 or 5%).
Reduction of the original variable values to fewer values was based primarily on
the projected influence or importance of the demographic on residual limb outcome. For
example, in regard to the variable socioeco, the decision to categorize the VA Priority
Groups into employable, unemployable, and co-pay eligible was based on the assumption
that an employed individual was likely to be more active and healthier, a co-pay eligible
individual of sufficient income and socioeconomic status to afford such (a co-payment)
and thus of potential moderate health and activity, and unemployable individuals
potentially less healthy and less active. Marital status was used as a proxy for the
presence of a caregiver or personal help for the amputee; and the variable Age was a
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numeric type variable and used only to describe the cohort, in part because such a
significant proportion of the cases were grouped within one age range (55 years to 75
years), and because there was 30% missing data (87 cases) for the variable Age from the
NPCD Inpatient MedSAS FY 2007 data extracts. Attempts were made to use the
variable AGE8 from the same data set and was found to have no missing data, and when
age groups/values were combined to reduce the number of categories from 8 to 3 (54
years or less, 55-74 years, and 75 years or greater), data integrity was preserved.
Ultimately it was determined that within the cohort 49 (18%) cohort members were 55
years or younger, 173 (62%) were between 55 and 74 years old, and 60 (22%) were 75
years or older.
Details regarding the formation of each of these demographic variables are
presented in Table B9 through Table B14 of Appendix B, and a detailed accounting of
each variable in Table 9 below.
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Table 9
Variable Frequencies and Cohort Characteristics
N*
Variable
Gender:
Male
Female
Age:
<25 years old
25 - 34 years old
35 - 44 years old
45 – 54 years old
55 – 64 years old
65 – 74 years old
75 – 84 years old
>84 years old
Race:
White
Black
Asian
Missing Data
Marital status:
Divorced
Married
Never married
Unknown
Widowed
Missing data

282

282

282

271

Frequency
(percent)
280 (99.29)
2(0.72)
1 (0.35)
6 (2.13)
9 (2.13)
33 (11.7)
110 (39.01)
63 (22.34)
42 (14.89)
18 (6.38)

Comments
Reflective of VA population (refer to Table 4, Chapter 2, p.117)

Mean Age = 62.4 ± 9.8; median = 60; minimum = 24, maximum
= 98; mean age 1st quartile = 56years, 3rd quartile = 73 years.

181 (69.1)
72 (27.5)
9 (3.4)
20 (7.1)
73 (26.94)
143 (52.77)
39 (14.39)
2 (0.74)
14 (5.17)
8 (2.83)

Variable condensed to Married = 143 (52.77%), Not-married =
128 (47.23%).

(table continues)
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N*
Variable
Socioeconomic (VA Priority
group):
Unemployable (1,4,5)
Employable, disabled (2, 3, 6)
Copay eligible (7,8)
Missing data:
Major depressive disorder (MDD)
Other depressive disorders
Total with depressive conditions
Cases with no matching codes
Post traumatic stress disorder (PTSD)
Other adjustment disorders
Cases with adjustment disorders
cases with no matching codes
Substance use disorder (SUD)
Cases with no matching codes
Chronic obstructive pulmonary
disease (COPD)
Other chronic respiratory disorders
Total with respiratory/pulmonary
disorders
Cases with no matching codes

279

282

282

282

282

Frequency
(percent)
195 (75.3)
34 (13.1)
30 (11.6)
20 (7.2)
38 (13.48)
5 (1.77)
41 (14.54)
241 (84.56
53 (18.79)
22 (7.8)
67 (23.76)
215 (76.24)
42 (14.89)
240 (85.11)
64 (22.7)
13 (4.61)
72 (25.53)

Comments
VA Priority groups are designated on the basis of degree of
service-connected or incident disability, adjusted income (means
test), and age/retirement status. For a more detailed description
of Priority Groups, refer to Appendix B – Data Dictionary.
Total number of cohort members with a depressive condition
represents those with either an ICD-9-cm CODE for MDD or
another depressive disorder; those with both are counted only
once. Frequencies indicate that only 2 (0.71%) had a depressive
disorder other than MDD.
The total number of cohort members with an adjustment disorder
may have both andICD-9-CM code for PTSD and another
adjustment disorder, but they are counted only once.
Frequencies indicate that 14 (4.97%) had both categories of
codes; 8 (2.83%) had an adjustment disorder other than PTSD.
Includes both drug and alcohol abuse.

Frequencies indicate that only 5 (1.77%) of the cohort suffered
from a chronic respiratory/pulmonary disorder other than COPD

210 (74.47)
(table continues)
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N*
Variable
Congestive heart failure (CHF)
Cases with no matching codes
Cerebral vascular disease (CVD)
Cases with no matching codes
Renal failure
Cases with no matching codes
Nutrition:
Obesity
Malnutrition
Cases with no matching codes
Death:
Year 2008
Year 2009
Year 2010
Cases with no matching codes

282
282
282

282

279**

Frequency
(percent)
129 (45.74)
153 (54.26)
17 (6.03)
265 (93.97)
52 (18.44)
230 (81.56)
7 (2.48)
1 (0.35)
274 (97.16)
2 (0.71)
2 (0.71)
2 (0.71)
273 (97.8)

Comments
This large number is to be expected given the concurrent
diagnoses of diabetes, peripheral vascular disease and peripheral
arterial disease.
Includes strokes and cerebral bleeds.
Renal failure is a comorbid condition for both diabetes and
congestive heart failure.
Given that all the cohort members had diagnosis code for
diabetes, peripheral vascular disease or peripheral arterial
disease, the low frequency of a diagnosis code for obesity is
unexpected.
Of the initial cohort, 41% died in 2007 (or were not accounted
for); of the surviving 358, 279 (80%) were captured as members
of the study cohort. Of the study cohort, a total of 6 (2.1%) died
during their follow-up period

*: data extracted from inpatient/outpatient clinical files, except for socioeco/VA Priority which was extracted from NPPD
data.
**: N = 279 represents cohort members with sufficient clinical and artificial limb data.
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The variable VISN was identified from the NPPD extracts and served as an
indication of where the amputee received their artificial limb and, by proxy, who decided
on the configuration of components and crafted the socket. To improve cell sizes, the 22
VISNs across the nation were condensed into 4 Regions as described by the Veterans
Administration Central Office, Office of Information Technology, Washington DC.
Based on the locale of the VISNs, the regions fairly well divide the United States into
four geographic areas: Region 1 – northwest and western U.S; Region 2 - north- and
south-central U.S. (includes Texas); Region 3 - eastern mid-west and southern U.S.
(includes Ohio); and Region 4 - mid-atlantic and northeast U.S. (includes Washington
DC/Maryland) (http://www.va.gov/directory/guide/division.asp?dnum=1#main-content).
Table D2, Appendix D presents the distribution of cohort members across the VISNs and
subsequent regions, as well as the distribution of ALC categories delivered to cohort
members per region. The total number of artificial limbs dispensed exceeds the total
number of cohort members because some were dispensed more than one type of ALC
during the follow-up period. The frequency per ALC category dispensed reflects not so
much the total number of limbs dispensed for the cohort, but rather the different
categories dispensed per cohort member. For example, a cohort member may have been
dispensed a K3LOCK limb in FY 2008 and another in FY 2009 and be counted only
once, whereas another may have been dispensed a K3m in FY 2007 and a K3LOCK in
FY 2009 and thus be counted twice.
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In summary, Region 3 was represented by 112 (40%) cohort members, followed
by Region 2 with 62 (22%) cohort members, Region 4 with 57 (20%) members, and
Region 1 with 48 (17%) members. The community-locking suspension system was the
most frequently dispensed ALC category with 65 dispensed in Region 3 (53% of all
ALCs dispensed within the region), followed by Region 1 with 30 (56% of all ALCs
dispensed within the region), Region 2 also with 30 (42% of all ALCs dispensed within
the region) and 25 in Region 4 (38% of all ALCs dispensed within the region). The ALC
categories Transfers and Household-high-tech suspension system were the least
frequently dispensed with a total of 12 and 10, respectively, across all four regions.
One of the underlying questions in this study has to do with the need for or
enforcement of standardized prescription guidelines - that the Prosthetist’s would practice
the same prescription patterns across the nation. However, the distribution of ALC
categories across the four regions was not homogeneous - in the case of ALC category
household-locking mechanism suspension system, two of the regions dispensed only 1
such artificial limb and the other 2 nearly 10 times that amount. Similarly, regions one,
two, and four dispensed 25-30 community-locking mechanism artificial limbs, whereas
Region 3 dispensed twice that amount. Certainly, these findings may suggest some
preference for certain types of artificial limb componentry per region; however, it is
purely speculation without further analysis to include cohort member demographics and
comorbid conditions that may influence a Prosthetists decision.
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Data Quality Assessment and Selection of Variables for the Multivariate Analysis
Frequency tables and chi square analyses were run on the variables described
above to check for missing data and significance of the variable relative to the dependent
variable category severe (Severex) or less severe (lseverex) skin problems (RLSPS).
Table D3 Appendix D presents the results of these calculations and reveals that the
variables ALC, MDD, PTSD, SUD, marital status, region, age, CHF, COPD, and renal
failure all met criteria (Chi-square p-value of 0.25 or less for at least one of the dependent
variable categories) and thus , were to be included in the epidemiologic analysis
statistical models. The variables for obesity and malnutrition were not included in the
univariate analysis given their very low frequencies. Based on the univariate analyses, the
variables socioeco, race, gender, and cerebral vascular disease (CVDx) could be removed
from the multivariate analysis, given Chi-square p-values of greater than 0.25. However,
only gender was removed because socioeco/VA priority as well as race, were constant
covariates as demographic variables, and CVD particularly interesting because of its
potential significance as a mechanical effect covariate.
Further, frequency tables and a univariate analysis were conducted using the
variables Region (being used as a proxy for the Prosthetist that configured and dispensed
the cohort member’s artificial limb) and ALC to ascertain if there was a significant
difference in artificial limbs dispensed across the regions. The findings indicated that,
while the calculated p-value for the Chi-Square analysis is not significant at an alpha of
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0.05, Region was included because of its relevance in addressing research question 2, as
well as an indicator of national prescription guidelines.
Similarly, the variables severe (Severex) and Less severe (Lseverex) (categories
of the dependent outcome variable RLSPS) were tested against the primary independent
variable, ALC, to detect if any significant relationships existed without the influence of
covariates. The findings indicated that severe skin problems were significantly associated
with the type/category of artificial limbs used (Chi-square N = 315, p-value = 0.0428,
while Less severe skin problems were less so (Chi-square N = 315, p-value = 0.26).
More specifically, Table 10, presents the frequencies for severe and less severe
categories of RLSPS per ALC category, and reveals that, overall, the frequency of severe
RLSPS was only about 3% more than that for less severe RLSPS. Additionally, problem
frequencies were greatest for the Community-Locking Suspension System ALC category
(severe RLSPS: frequency = 84 [27%]; less severe: frequency = 69 [22%]), but this was
also the most frequently dispensed ALC category; the transfers and Household-High
Tech Suspension System ALC categories demonstrated the least frequencies of severe
and less severe RLSPS (transfers: severe frequency = 2 [0.6%], less severe – frequency =
6 [2%]; household-high tech suspension system: severe – frequency = 5 [2%], less severe
– frequency = 2 [1%]), but were also the least frequently dispensed ALC categories.
Finally, in regard to the ratio of severe RLSPS to less severe RLSPS, the ALC categories
household-high tech suspension system and Household-mid to low tech suspension
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systems each had a rate of 2.5, while the ALC category transfers had a rate of 0.33 and
ALC Category Community-mid to low-tech suspension system a rate of 0.7.
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Table 10
Frequencies per ALC Category per Dependent Variable (RLSPS) Categories Severe and Less Severe
ALC Category

Severe Skin
Problems
Freq (%)*

Less Severe Skin
Problems
Freq (%)*

Comments

Transfer

2 (1.28)

6 (4.14)

Household-high-tech
suspension system
Household-mid to low-tech
suspension system
Household-locking
suspension system
Community-high tech
suspension system
Community-mid to lowtech suspension system
Community-locking
suspension system
Totals

5 (3.21)

2 (1.38)

10 (6.41)

4 (2.76)

14 (8.97)

13 (8.97)

21 (13.46)

23 (15.86)

20 (12.82)

29 20.0)

84 (53.85)

68 (46.9)

156 (49.52)

145 (46.03)

Total of 12 ALC units distributed across all four regions; ratio of severe to less severe
problems cases = 0.33
Total of 10 ALC units distributed across all four regions; ratio of severe to less severe
problems cases = 2.5
Total of 16 ALC units distributed across all four regions; ratio of severe to less severe
skin problem cases = 2.5
Total of 25 units distributed across all four regions; ratio of severe to less severe
problems cases = 1.1
Total of 49 units distributed across all four regions; ratio of severe to less severe problems
cases = 0.9
Total of 53 units distributed across all four regions; ratio of severe to less severe problems
cases = 0.69
Total of 150 units distributed across all four regions; ratio of severe to less severe
problems cases = 1.2
**Total of 315 units distributed across all four regions; ratio of severe to less severe
problem cases = 1.07

* Frequency = number of the RLSPS category codes counted (not the number of cases); a single case may have had none,
one, or more RLSPS codes during their follow-up period. Percent = number of RLSPS codes counted per ALC category.
** Cohort N = 282; a single case may have been distributed more than one ALC category during their follow-up period.
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The Epidemiological Analysis
Overview. The purpose of this phase of the study was to explore the value of a
compiled and integrated dataset derived from multiple national VHA health care datasets
as a means to provide observed practice-based evidence for the ascertainment of
relationships specifically relative to the lower limb amputee. More specifically, the goal
was to identify patterns of artificial limb prescription/dispensing relative to patient
clinical conditions and, in particular, residual limb skin problem severity following
dispensing and concurrent with certain psychosocial conditions, namely MDD, PTSD,
and SUD.
For each research question, relevant frequency tables were created (as every
variable was categorical and not conducive to other simple descriptive statistics), and as
described above, unadjusted univariate analyses conducted to guide model development.
However, demographic variables (such as married, race, age, and socioeco/VA priority)
were included regardless of their unadjusted significance because of their explanatory
value and basic importance. The remaining relevant variables (based on Chi-Square,
Univariate Analyses Statistical Significance) were then used to develop a multivariate
model using generalized estimating equations (GEE), logistic regression function
(LOGIT), an independent correlation structure, and assuming a binomial distribution. The
structure of the model included that the subject effect be the cohort member’s study ID
per repeated measure interval (6 month observation) and the cluster size not exceed one
nor be less than one such that the number of clusters equaled the number of observations.
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GEE was used rather than generalized linear modeling (GLM) because of the dependent
(response) variable being a categorical repeated measure with discrete values (frequency
counts of no treatment/severe/less severe RLSPS at six month intervals); because many
of the covariates contained small cell sizes and there were significant missing data
(considered inappropriate for GLM), and because the intent of the analysis was to
estimate variability/differences, not risk ratios.
Using the described GEE model structure, estimates of covariance were
calculated, but instead of attempting to model the within-subject covariance structure (as
in GLM), errors were treated as a nuisance and the mean response modeled instead
(Garson, 2008; Garson, 2011a). Ultimately, the p-value represents the statistical
significance of the odds that the characteristic/covariate is present in an observation
(Garson, 2008; Garson, 2011a).). This model type and structure was used for all four
research questions, with only the covariates of interest used relevant to each research
question. Of note, in an effort to simplify interpretation by establishing only binomial
outcomes, for those variables having more than one category (other than the ALC
independent variable) a category therein was identified as the reference category. For the
demographic variable Socioeco, there were 3 categories – employable, unemployable,
and copayment eligible, wherein the category unemployable was the reference category;
Age Group (Agex) categories were those less than 55 years of age, those aged 55 to 74
years, and those older than 74 years, with the reference category being the youngest
group; and for the variable Race categorized as White, Black and Asian, White was
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selected as the reference category. For the covariate Regionx, there are four regions
encompassing all 21 VISN, Region 1, Region 2, Region 3, and Region 4. Region 2 was
selected as the reference category as it is at a VISN within the Region that this study was
conducted and findings could prove to be particularly relevant. Finally, in an attempt to
track changes in residual limb skin problem frequencies over time, the three year followup period was divided into six month intervals/windows, with the reference interval being
the first 6 months.
Research question 1 - mechanical main effects. Research Question 1 addressed
the issue of the ALC as the main effect influencing the variability in residual limb skin
problems. So-called “mechanical” effects as described previously are those in which
undue biomechanical forces act on the residual limb-artificial limb interface (at the
contact point of the socket and skin of the residual limb).
Initial analysis. Frequency tables were created wherein the number of cohort
members having a severe or less severe RLSPS was accounted per ALC category as
well as 6 month observation interval and is presented in Table 11 below. The values for
percentage represents the percentage of cohort members identified per category among
all the artificial limbs dispensed (315 artificial limbs) per time point. The values under
the Total column represent the number of cohort members evaluated per ALC category,
and total values per column represent the total number of residual limb skin problem
condition/category per six month interval.
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Table 11
Frequency Tables for Research Question One
6 Month Follow-Up

12 Month Follow-Up

18 Month Follow-Up
Total**

ALC category

Statistic*
10

1

0

10

1

0

9

Less
Severe
1

3.58

0.36

0

3.58

0.36

0

3.23

6

0

2

6

0

2

8

2.15

0

0.72

2.15

0

0.72

10

0

3

12

1

3.58

0

1.08

4.3

16

1

6

5.73

0.36

2.15

No Tx
Transfer

Freq

Household-high tech suspension system

Freq

percent

percent
Household-mid to low tech suspension
system

Freq

Household-locking suspension system

Freq

percent

percent
Community-high tech suspension system

Freq
percent

Community-mid to low tech suspension
system

Freq

Community-locking suspension system

Freq

percent

percent
Freq
Total

percent

Less
Severe

Severe

No Tx

Less
Severe

Severe

No Tx

Severe
1

…

0.36

0.36

…

0

0

…

2.87

0

0

…

0

11

2

0

…

0.36

0

3.94

0.72

0

…

16

5

2

18

3

2

…

5.73

1.79

0.72

6.45

1.08

0.72

…

31

4

7

34

4

4

33

4

5

…

11.11

1.43

2.51

12.19

1.43

1.43

11.83

1.43

1.79

…

38

5

5

37

5

6

36

6

6

…

13.62

1.79

1.79

13.26

1.79

2.15

12.9

2.15

2.15

…

110

11

13

110

7

17

116

9

9

…

39.43

3.94

4.66

39.43

2.51

6.09

41.58

3.23

3.23

…

221

22

36

225

23

31

231

25

23

…

79.21

7.89

12.9

80.65

8.24

11.11

82.8

8.96

8.24

…

(table continues)
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6 Month Follow-Up

12 Month Follow-Up

18 Month Follow-Up
Total**

ALC category

Statistic*

Less
Severe
Severe
24 Month Follow-Up
Less
No Tx
severe
severe
9
1
1
No Tx

Transfer

Freq
percent

Household-high tech suspension system

Freq
percent

Household-mid to lowtech suspension
system

Freq

Household-locking suspension system

Freq

percent

percent
Community-high tech suspension system

Freq
percent

Community-mid to low

Freq
percent

Community-locking SS

Freq
percent
Freq

Total

percent

Less
Severe
Severe
30 Month Follow-Up
Less
No Tx
severe
severe
10
0
1
No Tx

Less
Severe
Severe
36 Month Follow-Up
Less
No Tx
severe
severe
11
0
0
No Tx

Total
11

3.23

0.36

0.36

3.58

0

0.36

3.94

0

0

3.94

8

0

0

8

0

0

8

0

0

8

2.87

0

0

2.87

0

0

2.87

0

0

2.87

13

0

0

12

0

1

13

0

0

13

4.66

0

0

4.3

0

0.36

4.66

0

0

4.66

21

1

1

19

1

3

22

1

0

23

7.53

0.36

0.36

6.81

0.36

1.08

7.89

0.36

0

8.24

35

3

4

38

1

3

39

2

1

42

12.54

1.08

1.43

13.62

0.36

1.08

13.98

0.72

0.36

15.05

40

2

6

44

1

3

43

3

2

48

14.34

0.72

2.15

15.77

0.36

1.08

15.41

1.08

0.72

17.2

115

8

11

123

4

7

126

4

4

134

41.22

2.87

3.94

44.09

1.43

2.51

45.16

1.43

1.43

48.03

241

15

23

254

7

18

262

10

7

279

86.38

5.38

8.24

91.04

2.51

6.45

93.91

3.58

2.51

100

*Frequency = number of cases per RLSPS category per ALC category; percent = number of cases per cohort N of 279.
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In general, based on the total frequency of all the ALC categories, less severe
RLSPS peaked at the 18 month interval with a frequency of 25 (9%) that diminished
fairly rapidly to a frequency of 10 (4%) by the 36 month interval, the lowest frequency
being 7 (3%) during the 30 month interval. severe RLSPS followed a similar trend but
peaked during the six month interval with a frequency of 36 (13%) that more gradually
diminished to a frequency of 7 (3%) during the 36 month interval. As a significant
proportion of the cohort utilized the community-locking suspension system ALC
category, the greater frequency and percentage of skin problems were associated with this
artificial limb configuration.
The unadjusted analysis utilized Fisher’s Exact Test instead of Chi-Square test as
there were several cells with frequencies below 5, and was used to determine if there was
a significant relationship between the type of ALC dispensed and the presence or absence
of a less severe RLSPS and separately, the presence or absence of a severe RLSPS;
frequency was based on the identification (or not) of cases with at least one residual limb
skin problem ICD-9-CM code during their follow-up period. It did not compare the
frequency of less severe problems to severe problems, and individuals may have been
counted in both categories (lseverex, and Severex) as they were treated as separate
dependent variables. Table D3, Appendix D presents the results of this unadjusted
analysis,, indicating that the frequency of severe residual limb RLSPS differed
significantly between the seven categories of artificial limbs (p = 0.042), but for less
severe RLSPS there was no such significant finding (p = 0.2636).
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GEE model analysis. Using the GEE model structure as described above, in
order to most directly address the issue of mechanical main effects in relation to the
outcome/response variable, the following covariates were included in the model:
demographic (explanatory) variables married, race, socioeco/VA Priority, and age group.
Three of the ALC categories – Transfers, household-mid to low suspension system, and
household-high tech suspension system – as their dispensing rate and outcome
frequencies were so low (compared to the other ALC categories) as to add little to the
model outcome if included individually, were instead, combined to form a single ALC
category, ‘others’. This category represented 38 (12%) of the 315 artificial limb
configurations dispense, and effectively preserved the sample size of 279 cases per
model. In this and ensuing GEE analyses wherein the ALC variable was a contributing
factor, each of the remaining 4 ALC categories were treated as binary and compared to
the ‘others’ category (for example, community-locking suspension system versus others;
household –locking suspension system versus others, and so forth). Table D2, Appendix
D, presents the distribution of ALC categories.
The model also included the dependent variable, RLSPS as a repeated measure at
6 month intervals following the dispensing of a cohort member’s definitive artificial
limb, and represented three categories/conditions: no treatment, less severe, and severe.
Table 12 presents the results of the GEE model analysis and reveals that only the
community-mid to low suspension system ALC category significantly contributed to the
likelihood of a cohort member developing a less severe RLSPS at some point during the
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3 year follow-up period (Estimate = 1.89, p = .02), but that this same ALC category plus
the community-high tech suspension system and community-locking suspension system
ALC categories also contributed significantly to the likelihood of a cohort member
developing a severe RLSPS during the entire follow-up period (Estimate = 1.91, p < .001;
Estimate = 1.17, p = .04; and Estimate = 1.05, p = .045, respectively). Of note, though
not statistically significant, a potential association was evident for cohort members using
a Household-locking suspension system ALC category who were likely to have a less
severe residual limb RLSPS during the follow-up period (Estimate = 1.59, p = .06), as
were those cohort members using a community-locking suspension system ALC category
(Estimate = 1.26, p= .10).
Review of the demographic parameters/variables revealed that cohort members
between the ages of 55 and 74 were less likely (compared to cohort members less than 55
years of age) to develop a less severe RLSPS during the follow-up period (Estimate = 0.93, p = .01), as well as in regard to a severe RLSPS (Estimate = -.73, p = .01), with the
addition that cohort members older than 74 were also less likely than members aged less
than 55 to develop a severe RLSPS (Estimate = -1.29, p = .002). Because of the structure
of the model, it is not possible to declare what age group and ALC category was more
likely to develop a less severe or severe RLSPS, only that the two conditions significantly
influenced the outcome. Additionally, race as a main effect was only relevant in the case
of severe RLSPS developed over the 36 month follow-up period, wherein Blacks were
significantly less likely to develop a severe RLSPS compared to Whites (Estimate = -.63,
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p = .02). A potential association was evident for socioeco/VA priority and, though not
statistically significant, , suggested that cohort members able to make a co-payment were
less likely to have a less severe RLSPS during the follow-up period than were cohort
members that were classified as unemployable (Estimate = -1.11, p = .08); and
similarly, marital status was potentially associated with severe RLSPS, and indicated that
married cohort members were less likely than other cohort members to have a severe
RLSPS during the follow-up period (Estimate = -.37, p = .09).
Finally, only during the thirty-month follow-up window and the thirty-six month
follow-up window was there a main effect evident for less severe RLSPS, the number of
cases diminishing significantly during both windows as compared to the reference six
month window (Estimate =-1.46, p = .01; Estimate = -.95, p = .04, respectively).
These findings indicate:
1.

That the null hypothesis (H01) - RLSPS categories (frequency and type)
will not vary significantly on the basis of the ALC category dispensed,
was rejected. Unadjusted Chi-square analyses revealed that there was a
significant association between type of ALC category and the number of
cases with a severe RLSPS (p = 0.0428), but a similar association did not
exist relative to less severe RLSPS; and results of the GEE analysis
confirmed this finding by demonstrating that not every ALC category was
significantly related to a RLSPS, especially in the case of the less severe
category.
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2.

The alternative hypothesis Ha1a - more severe RLSPS (such as ulcers) will
be significantly more frequent among ALC categories of higher function
or technical sophistication and will be least for low function, low
technically sophisticated configurations, is true in so far as the ALC
categories analyzed; the ALC category household-locking suspension
system did not attain statistical significance relative to the likelihood of
having a severe RLSPS during the follow-up period, and assuming that
the functional sophistication of an ALC category is based primarily on the
complexity of the prosthetic foot. The household ALC categories utilize
K1 or K2 functional level prosthetic feet (the remaining ALC categories
utilize K3 and K3-4 functional level prosthetic feet, all of which did attain
statistical significance).

3.

The alternative hypothesis Ha1b - over 50% of all the cohort members will
have at least one RLSPS treated during the three-year follow-up period,
regardless of the ALC category dispensed to them, is unclear; frequency
tables indicate that of the 279 cohort members analyzed, there were 102
cases of less severe RLSPS during a six month observation interval, and
138 cases of severe RLSPS for a total of 240 cases of residual limb skin
problems within the cohort. The structure of the model prohibits
determining how many of the skin problems were unique to a cohort
member; a single cohort member may have been counted once for a less
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severe problem, and again for a severe RLSPS during a different time
interval. Furthermore, while a secondary analysis would have been to
track the number of multiple residual limb skin problems per cohort
member, such an analysis is confounded by a diagnosis code being entered
every time a wound is treated, even if it is the same wound. Table 3,
Chapter 2 presents ICD-9-CM coding practices as defined by the Centers
for Medicare Medicaid Services, and states “Code a chronic diagnosis as
often as it is applicable to the patient’s treatment” (CMMS, 2012b).

243
Table 12
General Estimating Equations Model Output for Research Question One – Mechanical (ALC category) as the Main Effect.
Less Severe Residual Limb Skin Problems – Analysis of GEE Parameters
Empirical Standard Error Estimates
Parameter

Estimate Standard
Error

Intercept

95% Confidence Limits

Z Pr > |Z|

-2.9184

0.7569

-4.4019

-1.4350

-3.86 0.0001

12 month

0.0826

0.3979

-0.6973

0.8624

0.21 0.8356

18 month

0.1226

0.3862

-0.6344

0.8796

0.32 0.7509

24 month

-0.2662

0.4162

-1.0820

0.5495

-0.64 0.5224

30 month

-1.4616

0.5794

-2.5971

-0.3260

-2.52 0.0116

36 month

-0.9511

0.4731

-1.8784

-0.0239

-2.01 0.0444

0.0000

0.0000

0.0000

0.0000

*Household1:yes
locking suspension
0:no
system

1.5941

0.8463

-0.0646

3.2529

0.0000

0.0000

0.0000

0.0000

Community-high
tech suspension
system

1:yes

1.1701

0.8171

-0.4314

2.7717

0:no

0.0000

0.0000

0.0000

0.0000

Window

(reference)

6 month

1.88 0.0596
.
1.43 0.1521
(table continues)
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Less Severe Residual Limb Skin Problems – Analysis of GEE Parameters
Empirical Standard Error Estimates
Parameter
Community-mid
to low tech
Suspension
system

Estimate Standard
Error

Age group

Z Pr > |Z|

1:yes

1.8902

0.7901

0.3418

3.4387

0:no

0.0000

0.0000

0.0000

0.0000

1.2591

0.7638

-0.2378

2.7561

0.0000

0.0000

0.0000

0.0000

married

-0.0053

0.2633

-0.5214

0.5107

Others

0.0000

0.0000

0.0000

0.0000

55-74

-0.9297

0.3539

-1.6232

-0.2361

-2.63 0.0086

74 older

-0.0986

0.3743

-0.8322

0.6350

-0.26 0.7922

0.0000

0.0000

0.0000

0.0000

-1.1052

0.6338

-2.3473

0.1370

-1.74 0.0812

0.9903

0.72 0.4717

*Community1:yes
locking suspension
0:no
system
Marital status

95% Confidence Limits

(reference)

55 younger

*Socioeco / VA
Priority

*co-pay eligible
Employable

0.2660

0.3696

-0.4583

(reference)

unemployable

0.0000

0.0000

0.0000

2.39 0.0167
.

.

1.65 0.0992
.

.

-0.02 0.9838

.

.

0.0000 .

(table continues)
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Less Severe Residual Limb Skin Problems – Analysis of GEE Parameters
Empirical Standard Error Estimates
Parameter
Race

Estimate Standard
Error

95% Confidence Limits

Z Pr > |Z|

Asian

0.1288

0.6663

-1.1771

1.4347

0.19 0.8467

Black

0.2152

0.2735

-0.3208

0.7512

0.79 0.4313

Severe Residual Limb Skin Problems – Analysis of GEE parameters
Intercept
Window

(reference)

-1.6022

0.6271

-2.8313

-0.3731

-2.55 0.0106

12 month

0.0585

0.3310

-0.5903

0.7072

0.18 0.8598

18 month

-0.2562

0.3511

-0.9444

0.4319

-0.73 0.4655

24 month

-0.3257

0.3494

-1.0105

0.3591

-0.93 0.3512

30 month

-0.5976

0.3714

-1.3256

0.1303

-1.61 0.1076

36 month

-1.5702

0.4722

-2.4958

-0.6447

-3.33 0.0009

0.0000

0.0000

0.0000

0.0000

0.6328

0.6635

-0.6677

1.9333

0.0000

0.0000

0.0000

0.0000

6 month

Household-locking 1:yes
suspension system
0:no

.

.

0.95 0.3402

(table continues)
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Less Severe Residual Limb Skin Problems – Analysis of GEE Parameters
Empirical Standard Error Estimates
Parameter
Community-high
tech suspension
system

Estimate Standard
Error

95% Confidence Limits

Z Pr > |Z|

1:yes

1.1717

0.5606

0.0730

2.2705

0:no

0.0000

0.0000

0.0000

0.0000

Community-mid 1:yes
to low tech
suspension system 0:no

1.9093

0.5460

0.8392

2.9794

3.50 0.0005

0.0000

0.0000

0.0000

0.0000

.

Community1:yes
locking
suspension system 0:no

1.0468

0.5232

0.0214

2.0723

2.00 0.0454

0.0000

0.0000

0.0000

0.0000

-0.3720

0.2175

-0.7983

0.0544

others

0.0000

0.0000

0.0000

0.0000

55-74

-0.7282

0.2872

-1.2911

-0.1652

-2.53 0.0112

74 older

-1.2948

0.4102

-2.0988

-0.4909

-3.16 0.0016

0.0000

0.0000

0.0000

0.0000

*Marital status

Age group

(reference)

married

55 younger

2.09 0.0366

.

.

-1.71 0.0873

(table continues)

.
.
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Less Severe Residual Limb Skin Problems – Analysis of GEE Parameters
Empirical Standard Error Estimates
Parameter

Estimate Standard
Error

95% Confidence Limits

Z Pr > |Z|

Socioeco /VA
Priority

co-pay eligible

-1.0491

0.4795

-1.9888

-0.1093

-2.19 0.0287

Employable

-0.6726

0.4212

-1.4982

0.1530

-1.60 0.1103

(reference)

unemployable

0.0000

0.0000

0.0000

0.0000

Race

Asian

-0.5958

0.8412

-2.2445

1.0529

-0.71 0.4788

Black

-0.6318

0.2632

-1.1477

-0.1159

-2.40 0.0164

White

0.0000

0.0000

0.0000

0.0000

(reference)

.

.

Estimate indicates direction of correlation; bolded text indicates statistical significance of 95% probability, alpha of 0.05; * indicates statistical
significance at 90% probability, alpha of 0.10.
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Research question 2 – mechanical effects as a covariate. The craftsmanship
and knowledge base of artificial limb components may vary between Prosthetists. The
extent to which this variability in skill and knowledge effects a patient’s outcome is the
basis for research question 2.
The actual identification of the dispensing Prosthetist was not available and thus
the Veterans Integrated Service Network served as a proxy thereof, but because of small
cell sizes and missing data, the broader variable, Regionx, was used wherein four
categories (Region 1, region 2, region 3, and region 4) represent groupings of VISNs.
Table D2, Appendix D, indicates VISN groupings per region and the number of cohort
members per VISN.
Initial analysis. Frequency tables and unadjusted Chi-square analyses were
conducted to detect statistically significant differences in the number of ALC categories
dispensed per region. Region 1 accounted for 54 (17%) of all the ALC categories
dispensed, Region 2 72 (23%) artificial limbs, Region 3 123 (39%), and Region 4 66
(21%); Chi-square analysis was not significant given an alpha of 0.05 with a p-value of
0.17. The least frequently dispensed ALC category across all four regions was the
household-hi tech suspension system with only 10 (3%) delivered followed by (in order)
transfers with 12 (4%) delivered, household-mid to low tech suspension system artificial
limb configurations with 16 (5%) delivered, household-locking suspension system with
25 (8%), community-high tech suspension system with 49 (16%) limbs delivered,
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community-mid to low suspension system with 53 (17%) limbs delivered, and
community-locking suspension system with a total of 150 (48%) limbs delivered.
Additionally, frequency tables and unadjusted Chi-Square analyses were
conducted to determine if there was a statistically significant difference in the frequency
of less severe and severe residual limb skin problems across the four regions. In regard to
less severe RLSPS, of the 145 cases detected among the 279 cohort members, in order of
frequency, Region 1 had 27 (9%) cases, Region 2 had 29 (9%) less severe residual limb
skin problem cases, Region 4 had 33 (10%) cases, and Region 3 had 56 (18%); chisquare analysis was not statistically significant at an alpha of 0.05 with a p-value of 0.63,
suggesting that Region was not a driving factor behind less severe RLSPS. For severe
RLSPS, of the 156 cases detected among the 279 cohort members, in order of frequency,
Region 1 had 29 (9%) severe residual limb skin problem cases, Region 2 had 30 (10%)
such cases, Region 4 had 32 (10%) cases, and Region 3 had 65 (21%) cases; Chi-Square
analysis was not statistically significant at an alpha of 0.05 with a p-value of 0.44,
suggesting that Region was also not a driving factor behind the frequency of severe
RLSPS within the cohort. However, as these analyses did not include demographic
variables, nor did they treat the dependent variable as a repeated measure, to better
address the research question, GEE modeling was employed using the same structure as
described above.
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GEE model analysis. For this analysis, the sample size was 279 and ALC
category was not a parameter of the model. The variables included in the model were: the
dependent variable RLSPS; Region (Table D2, Appendix D, provides the geographical
description of the regions); and the demographic parameters/variables Marital Status,
Race, Age Group, and Socioeco/VA priority.
Table 13 below provides the results of this analysis. In summary, as with the
unadjusted analysis, for the less severe residual limb skin problem condition, Region did
not attain statistical significance, suggesting that no one region was likely to be
responsible for more less severe RLSPS than another. However, the analysis revealed
that cohort members between the ages of 55 and 74 were less likely to develop a less
severe RLSPS during their follow-up period than their younger counter parts (Estimate =
-.90, p = .01) regardless of the region from which their artificial limb configuration was
dispensed; and, socioeco/VA priority attained near significance indicative of a possible
trend that cohort members able to make a co-payment were less likely to have a less
severe RLSPS than their unemployable cohort members (Estimate = -1.20, p = .07).
Finally, during the 30 month observation interval, as well as the 36 month observation
interval, cohort members were less likely to have a less severe RLSPS as compared to
their six month interval, and regardless of the region that delivered their ALC category
(Estimate = -1.46, p = .01; Estimate = -.95, p = .04, respectively). However, for the
severe RLSPS condition, region did have a significant effect. Cohort members having
their ALC categories dispensed from Region 4 were significantly more likely to develop
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a severe RLSPS during their follow-up period, than cohort members delivered ALC
categories from Region 2 (Estimate = .93, p = .009). Further, cohort members between
the ages of 55 and 74 years, as well as those over 74 years, were significantly less likely
to develop a severe RLSPS during their follow-up period (regardless of the Region
delivering their ALC category) than those cohort members younger than 55 years
(Estimate = -.64, p = .02; Estimate = -1.34, p = .001, respectively). Additionally, cohort
members that were of a socioeconomic and VA priority status as to be required to make
co-payments for treatment (co-pay eligible) were significantly less likely to have a severe
RLSPS (regardless of the Region delivering their artificial limb) than those cohort
members categorized as unemployable (Estimate = -1.07, p = .02); and cohort members
who were Black were less likely to have a severe RLSPS during their follow-up period
than their White cohort members (Estimate = -.59, p = .02), regardless of the Region
where their artificial limb was configured and dispensed.
These findings suggest:
1.

The null hypothesis (Ho2) – residual limb skin problems categories
(frequency and type) will not vary between VISNs, regardless of ALC
category dispensed – is rejected, assuming that Region is a suitable proxy
for VISN Prosthetists; the GEE analysis identified a statistically
significant relationship between the frequency of severe RLSPS the cohort
experienced in that cases associated with Region 4 were significantly more
likely to have a skin problem than cohort members from Region 2. This
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same association did not exist for less severe RLSPS in which case, the
Region from whence an artificial limb was configured and dispensed, had
no real effect on outcome. However, given the lack of granularity in the
variable Region, it is difficult to associate the skills of any prosthetists
with the outcomes and rather, the variable may be a better proxy for
climate and geography (discussed further in Chapter 5).
2.

The alternative Hypothesis (Ha2) - Significantly more severe RLSPS will
be noted among cohort members with higher function or more technically
sophisticated artificial limb configurations, regardless of the responsible
Prosthetist, although overall variability will be greater among Prosthetists
than within a single Prosthetist – is unclear on the basis of the same lack
of granularity within the variable Region. As can be noted in Table D2,
Appendix D, each region accounted for up to 5 VISNs, within which the
number of actual practicing prosthetists was unavailable for this study, but
based on personal experience is at least 2 certified practitioners.
Additionally, it is not uncommon for a veteran to have their artificial limb
actually built by a prosthetist within the veteran’s local community rather
than at a VHA facility. However, what is clear is (a) severe RLSPS did
vary significantly among the Regions with Region 4 demonstrating
significantly more such conditions; (b) findings from research question 1
(mechanical main effects) determined that the community-high tech
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suspension system was significantly associated with a likelihood of such
cohort member users to have a severe RLSPS during their follow-up
period, and (c) according to Table D2, Appendix D, Region 4 represented
20% of the cohort population (57 members) and 15 (23%) of the
community-high tech suspension system ALC categories dispensed, For
Region 4, this amount to a ratio of approximately 1 such artificial limb per
4 regional cohort members, as compared to Region 1 (1 limb per 8
regional cohort members), Region 2 (approximately 1 limb per 6 regional
cohort members), and Region 3 (approximately 1 limb per 7 regional
cohort members), suggesting a greater frequency of severe RLSPS relative
to Region 4 and dispensed community-high tech suspension system ALC
category. A secondary analysis in which ALC was included in the model
with Regions as a covariate was not run, as if was felt that such an analysis
would do little to address the question of the association between ALC
type and the prosthetist, given the gross granularity of the variable Region
and the unbalanced distribution of ALC categories across the regions (as
discussed above).
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Table 13
General Estimating Equations Model Output for Research Question Two – Mechanical
Effect by Region.
Less Severe Residual Limb Skin Problem – Analysis of GEE Parameters
Empirical Standard Error Estimates
Parameter

Estimate

Standard
Error

Z

Pr > |Z|

Intercept

-1.5726

0.4770

-2.5075

-0.6376

-3.30

0.0010

12 month

0.0767

0.4008

-0.7089

0.8624

0.19

0.8482

18 month

0.1259

0.3877

-0.6339

0.8857

0.32

0.7454

24 month

-0.2862

0.4131

-1.0959

0.5234

-0.69

0.4884

30 month

-1.4571

0.5812

-2.5962

-0.3180

-2.51

0.0122

36 month

-0.9545

0.4751

-1.8857

-0.0233

-2.01

0.0445

(reference)

6 month

0.0000

0.0000

0.0000

0.0000

.

.

Region

1 – region 1

-0.2030

0.4077

-1.0021

0.5960

-0.50

0.6184

2 – region 3

-0.3967

0.3543

-1.0911

0.2977

-1.12

0.2628

3 – region 4

0.2671

0.4185

-0.5531

1.0874

0.64

0.5233

0 – region 2

0.0000

0.0000

0.0000

0.0000

.

.

0.0696

0.2596

-0.4393

0.5785

0.27

0.7886

Others

0.0000

0.0000

0.0000

0.0000

.

.

55-74

-0.8963

0.3487

-1.5797

-0.2128

-2.57

0.0102

74 older

0.0076

0.3635

-0.7047

0.7200

0.02

0.9832

(reference)

55 younger

0.0000

0.0000

0.0000

0.0000

.

.

* Socioeco /
VA Priority

*co-pay eligible

-1.1953

0.6590

-2.4870

0.0964

-1.81

0.0697

Employable

0.2518

0.4024

-0.5369

1.0406

0.63

0.5315

(reference

Unemployable

0.0000

0.0000

0.0000

0.0000

.

.

Race

Asian

0.4546

0.7151

-0.9469

1.8561

0.64

0.5249

Black

0.3389

0.2783

-0.2066

0.8844

1.22

0.2234

White

0.0000

0.0000

0.0000

0.0000

.

-0.7731

0.4373

-1.6302

0.0840

-1.77

Window

(reference)

Marital status Married

Age group

(reference)
Intercept

95% Confidence Limits

0.0771
(table
continues)
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Less Severe Residual Limb Skin Problem – Analysis of GEE Parameters
Empirical Standard Error Estimates
Parameter
Window

Estimate

Standard
Error

95% Confidence Limits

Z

Pr > |Z|

12 month

0.0679

0.3280

-0.5749

0.7107

0.21

0.8359

18 month

-0.2371

0.3466

-0.9163

0.4422

-0.68

0.4940

24 month

-0.3026

0.3496

-0.9878

0.3827

-0.87

0.3868

30 month

-0.5752

0.3652

-1.2909

0.1405

-1.58

0.1152

36 month

-1.5694

0.4789

-2.5080

-0.6308

-3.28

0.0010

(reference)

6 month

0.0000

0.0000

0.0000

0.0000

.

.

Region

1 – region 1

0.3836

0.3377

-0.2783

1.0454

1.14

0.2560

2 – region 3

-0.1231

0.3133

-0.7372

0.4910

-0.39

0.6944

3 – region 4

0.9320

0.3551

0.2360

1.6280

2.62

0.0087

0 – region 2

0.0000

0.0000

0.0000

0.0000

.

.

-0.3417

0.2210

-0.7749

0.0914

-1.55

0.1220

others

0.0000

0.0000

0.0000

0.0000

.

.

55-74

-0.6441

0.2816

-1.1960

-0.0922

-2.29

0.0222

74 older

-1.3385

0.3936

-2.1098

-0.5671

-3.40

0.0007

0.0000

0.0000

0.0000

0.0000

.

.

(reference)

Marital status married

Age group

(reference)

55 younger

Socioeco /
VA Priority

co-pay eligible

-1.0685

0.4639

-1.9777

-0.1593

-2.30

0.0213

*Employable

-0.7330

0.4409

-1.5972

0.1311

-1.66

0.0964

(reference)

unemployable

0.0000

0.0000

0.0000

0.0000

.

.

Race

Asian

-0.2712

0.7832

-1.8063

1.2638

-0.35

0.7291

Black

-0.5905

0.2579

-1.0959

-0.0851

-2.29

0.0220

White

0.0000

0.0000

0.0000

0.0000

.

.

(reference)

Estimate indicates direction of correlation; bolded text indicates statistical significance at 95% probability, alpha of
0.05; * indicates statistical significance of 90% probability, alpha of 0.10.
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Research question three-behavioral effect. Research question 3 addresses the
issue of the impact certain mental health and behavioral (coping strategies) conditions
may or may not have on the types of residual limb problems that are associated with the
use of an artificial limb for the dysvascular transtibial amputee. Specifically, diagnosis
codes for the conditions MDD, PTSD, and SUD, detected during the three-year follow-up
period were of interest.
Initial analysis. Frequency tables and unadjusted chi-square analyses were
conducted for the three mental health conditions MDD, PTSD, and SUD, as well as
physiologic conditions that influence activity levels – chronic obstructive pulmonary
disease (COPD), congestive heart failure (CHF), , cerebral vascular disease (CVD, and
Renal failure. Table D3, Appendix D, displays the results wherein it can be seen that all
the above mentioned conditions, except CVD, achieved a p-value of less than 0.25 and
thus were included in the multivariable analysis. Because of the significant
biomechanical impact a stroke and subsequent paresis can have on gait, CVD was
included. However, as mentioned previously, these analyses did not include
demographic variables, nor did they treat the dependent variable as a repeated measure
and thus, to better address the research question, GEE modeling was employed using the
same structure as described above under the section Overview.
GEE model analysis. For this analysis, the sample size was 279 as the ALC
category was not a parameter/factor. The parameters/variables included in the model
were: the dependent variable, RLSPS , demographic variables Marital status,
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Socioeco/VA priority, Age group, and Race; the mental health conditions MDD , PTSD,
SUD; comorbid conditions COPD, CHF, CVD, and Renal Failure. The variables ALC
and Region were not included as the intent of the question was to ascertain if behavioral
conditions (psychological and physiological – especially in regard to affecting energy,
endurance, and activity levels), were directly related to the outcome measure, RLSPS,
regardless of mechanical effects as suggested in the two previous research questions and
analyses.
Table 14 below provides the results of the analysis. The GEE analysis revealed
that cohort members with diagnoses of SUD, COPD, CHF, or CVD were all likely to
have less severe RLSPS at some point during their follow-up period (Estimate = 0.89, p <
0.05; Estimate = 0.59, p < 0.05; Estimate = 0.52, p = 0.04; and Estimate = 0.82, p = 0.02,
respectively). Cohort members with diagnoses of MDD, SUD, and COPD were likely to
have a severe RLSPS at some point during their follow-up period (Estimate = 0.86, p <
0.001; Estimate = 0.76, p < 0.05; and Estimate = 0.45, p = 0.02, respectively).
Furthermore, cohort members with either a less severe or severe RLSPS were less likely
to have such problems during their 30 and 36 month follow-ups (less severe – Estimate =
-1.31, p < 0.05; Estimate = -0.98, p = 0.02), thirty and 36 months respectively; severe –
Estimate = -0.84, p < 0.05; Estimate = -1.83, p < .0001), thirty and 36 months
respectively).
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The findings suggest:
1.

The null hypothesis (Ho3) - Cohort members with a diagnosis of MDD,
PTSD, or SUD will have no greater or less variability in RLSPS
(frequency or type) than members of the cohort with no such diagnosis –
is rejected. Cohort members with a diagnosis of SUD were significantly
likely to develop a less severe or severe RLSPS, and cohort members with
a diagnosis of MDD were significantly likely to have a severe RLSPS;

2.

The alternative hypothesis (Ha3a) - Cohort members with a diagnosis of
MDD will have fewer severe RLSPS and fewer RLSPS treated overall, as
compared to those members with no such depression diagnosis) – is
rejected. As indicated in Table 14 below, as part of the GEE analysis
model, cohort members with no MDD diagnosis code were used as a
reference to compare outcomes with those cohort members with a
diagnosis of MDD (as was similarly true for all the parameters). In the
case of severe RLSPS outcomes, cohort members with an MDD diagnosis
were significantly more likely to develop such a problem (as indicated by
a positive Estimate value and a p-value less than 0.05), but were not
significantly likely to develop more less severe RLSPS outcomes (as
indicated by a negative Estimate valued and a p-value greater than 0.05).

3.

The alternative hypothesis (Ha3b) - cohort members with a diagnosis of
PTSD or SUD will have significantly more severe RLSPS (such as ulcers)
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than those members without PTSD or SUD, but no significant difference
in frequency of less severe RLSPS compared to those cohort members
with no such diagnosis. This alternative hypothesis is unclear. As seen in
Table D3, Appendix D cases with PTSD accounted for approximately
one-third of all cases with a less severe RLSPS and attained statistical
significance in the Chi-square analysis, but not in the GEE model,
suggesting other factors influenced the significance of the model outcome.
Similarly, approximately one-third of all cases with a severe RLSPS were
also diagnosed with PTSD, but did not attain statistical significance (p <
0.05) in the Chi-square analysis, nor in the GEE model analysis. Further,
in the case of cohort members with a diagnosis of SUD, approximately
one-quarter of all cases with a less severe or severe RLSPS were also
diagnosed with SUD, but in neither condition was statistical significance
attained using a Chi-square analysis, but for both conditions(less severe
and severe RLSPS) statistical significance was attained using the GEE
model analysis (less severe - Estimate = 0.89, p = .006; severe - Estimate
= 0.76, p = .004). These findings suggest that behavioral factors such as
PTSD and SUD are clearly not the only reason a cohort member
developed a residual limb skin problem, and that cohort members with
SUD were more likely to develop some sort of residual limb skin problem
than a cohort member with a diagnosis of PTSD.
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Table 14
General Estimating Equations Model Output for Research Question Three – Behavioral (Mental Health and Comorbid
Conditions) as the Main Effect.
Less Severe Outcomes - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard
Error

Intercept

-3.0942

0.2907

-3.6640

12 month

0.0188

0.3216

18 month

0.0872

24 month

Window

(reference)

Z

Pr > |Z|

-2.5244

-10.64

<.0001

-0.6116

0.6492

0.06

0.9535

0.3151

-0.5305

0.7048

0.28

0.7821

-0.4791

0.3542

-1.1733

0.2152

-1.35

0.1762

30 month

-1.3066

0.4489

-2.1864

-0.4268

-2.91

0.0036

36 month

-0.9820

0.4038

-1.7733

-0.1906

-2.43

0.0150

0.0000

0.0000

0.0000

0.0000

.

.

-0.4909

0.3777

-1.2312

0.2494

-1.30

0.1937

0:no

0.0000

0.0000

0.0000

0.0000

.

.

1:yes

0.4369

0.2810

-0.1139

0.9876

1.55

0.1200

0:no

0.0000

0.0000

0.0000

0.0000

6 month

Major depressive disorder 1:yes

Post-traumatic stress
disorder

95% Confidence Limits

.
(table continues)
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Less Severe Outcomes - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard
Error

1:yes

0.8946

0.3235

0.2606

1.5286

0:no

0.0000

0.0000

0.0000

0.0000

Chronic obstructive
pulmonary disorder

1:yes

0.5946

0.2226

0.1584

0:no

0.0000

0.0000

Congestive heart failure

1:yes

0.5160

0:no
Cerebral vascular
disease
Renal failure

Substance use disorder

Z

Pr > |Z|

2.77

0.0057

1.0308

2.67

0.0076

0.0000

0.0000

.

.

0.2543

0.0175

1.0145

2.03

0.0425

0.0000

0.0000

0.0000

0.0000

.

.

1:yes

0.8184

0.3414

0.1491

1.4876

2.40

0.0165

0:no

0.0000

0.0000

0.0000

0.0000

.

1:yes

0.4350

0.2558

-0.0664

0.9364

1.70

0.0890

0:no

0.0000

0.0000

0.0000

0.0000

.

.

-2.3325

0.2317

-2.7867

-1.8783

-10.07

<.0001

12 month

-0.1457

0.2682

-0.6714

0.3800

-0.54

0.5869

*18 month

-0.4726

0.2881

-1.0372

0.0921

-1.64

0.1009

*24 month

-0.5269

0.2900

-1.0953

0.0415

-1.82

0.0692

Intercept
Window

95% Confidence Limits

(table continues)
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Less Severe Outcomes - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard
Error

95% Confidence Limits

Z

Pr > |Z|

30 month

-0.8405

0.3070

-1.4423

-0.2387

-2.74

0.0062

36 month

-1.8294

0.4308

-2.6738

-0.9850

-4.25

<.0001

(reference)

6 month

0.0000

0.0000

0.0000

0.0000

.

.

Major depressive
disorder

1:yes

0.8578

0.2347

0.3978

1.3178

3.66

0.0003

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Post-traumatic stress
disorder

1:yes

-0.1386

0.2511

-0.6308

0.3535

-0.55

0.5809

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Substance use disorder

1:yes

0.7582

0.2654

0.2380

1.2783

2.86

0.0043

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Chronic obstructive
pulmonary disease

1:yes

0.4505

0.1942

0.0699

0.8312

2.32

0.0204

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Congestive heart failure

1:yes

0.2671

0.2109

-0.1463

0.6806

1.27

0.2054

0:no

0.0000

0.0000

0.0000

0.0000
(table continues)
.
.
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Less Severe Outcomes - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter
Cerebral vascular disease

Renal failure

Estimate

Standard
Error

95% Confidence Limits

Z

Pr > |Z|

1:yes

-0.0208

0.3866

-0.7785

0.7369

-0.05

0.9571

0:no

0.0000

0.0000

0.0000

0.0000

1:yes

-0.0003

0.2433

-0.4772

0.4766

-0.00

0.9990

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Estimate indicates direction of correlation; bolded text indicates statistical significance at 95% probability, alpha of 0.05; *
indicate statistical significance at 90% probability, alpha of 0.10.
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Research question 4 – the interaction of mechanical with behavioral effects.
Continuing to work off the premise that certain mental health conditions are characterized
by behaviors expressed by activity levels and that activity level is one of the driving
forces behind severe skin problems, this research question 4 and subsequent analysis
attempts to address this interaction, in relation to the type ALC category dispensed.
More specifically, this analysis, using general estimating equations (GEE), Logit
function, and an independent correlation structure as described above in the section
Overview, identified those covariates that interacted sufficiently to significantly impact
the cohort’s response ( in terms of RLSPS outcome), and specific to each ALC category.
Initial analysis. Frequency tables and unadjusted Chi-Square analyses were
conducted on key variables and are presented in Table D3, Appendix D. Those variables
with a Chi-Square probability less than 0.20 (80%) were automatically included in the
model as long as statistical significance was attained under the less severe or severe
RLSPS condition/category. These variables included: MDD, PTSD, SUD, COPD, CHF,
CVD, Renal Failure; the demographic variables Marital Status, Age group, Socioeco/VA
Priority, and Race (regardless of their Chi-Square significance as they were constants
held throughout the analyses), and ALC categories household-high tech suspension
system, community-high tech suspension system, community-mid to low tech suspension
system, and community-locking suspension system, as these four categories were used
for research question 1 and identified as mechanical main effects. Additionally, the
parameter/variable region was included because of its significance as a mechanical
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covariate, as was CVD (although the variables Chi-Square probability did not attain
significance) because of the profound influence hemiparesis frequently associated with
stroke could have on gait biomechanics and hence the mechanical effects of the artificial
limb. As with the previous models and analyses, the dependent variable, RLSPS, was
comprised of three categories (no treatment, less severe, and severe) and was treated as a
repeated measure at six month interval for a total of a 36 month follow-up period. Also,
as described previously, each ALC category was treated as a binary variable with the
category ‘others’ as the reference category, as the intent was to seek associations between
ALC categories and RLSPS outcomes rather than compare ALC categories.
GEE model analysis. Table 15 (less severe RLSPS category) and Table 16
(severe RLSPS category) below summarize the findings of these Gee model analyses; the
full statistical analysis outcome can be found in Appendix D, tables D4, D5, D6, and D7.
To summarize, none of the four ALC categories analyzed achieved statistical significance
as covariates likely to be associated with cohort member’s development of less severe or
severe RLSPS. Neither was there any obvious pattern in the Estimates indicating a
positive or negative correlation other than the household-locking suspension system ALC
category was negative for both less severe and severe RLSPS conditions, indicating a
tendency toward being a less likely effect; the community-mid to low tech suspension
system ALC category Estimates were positive for both less severe and severe RLSPS
conditions and thus tending toward being a likely effect, while the community-high tech
suspension system ALC category tended toward being a less likely effect for the less
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severe RLSPS and a likely effect for the severe condition; and the community-locking
suspension system ALC category tended toward a likely effect (positive) for less severe
RLSPS and a less likely effect for severe RLSPS.
Household-locking suspension system. When the household-locking suspension
system ALC category was included in the model, cohort members with a diagnosis of
SUD were likely to have a less severe RLSPS (Estimate = 0.87, p = .05) but not so for the
severe condition, and similarly, cohort members with a diagnosis of CVD were likely to
have a less severe RLSPS (Estimate = 1.51, p < .001) but there was no significant effect
on the severe condition. COPD had a significant and likely effect on both the less severe
and severe RLSPS (Estimate = 0.70, p = .03; Estimate = 0.59, p = .02 respectively), but
no other disease or mental health condition had a significant effect on either RLSPS
condition. Demographic factors, however, did have significant effects: Cohort members
in the age group 55 to 74 years were less likely to have a less severe RLSPS than their
younger members (Estimate = - 0.95, p = .02), and cohort members older than 74 years
were less likely to have a severe RLSPS than those less than 55 years of age (Estimate = 1.15, p = .005); for both the less severe and severe RLSPS, cohort members required to
make co-payments (due to their VA Priority classification) were significantly less likely
to have RLSPSs than those cohort members classified as unemployable (Estimate = 1.56, p = .03; Estimate = -1.20, p = .01 respectively); and Black cohort members were
significantly less likely to have a less severe RLSPS than White cohort members
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(Estimate = -0.61, p = 0.03) but race had no significant effect on the likelihood of having
a severe RLSPS.
Finally, cohort members were less likely to have a less severe RLSPS during both
the 30 month and 36 month follow-up interval than during the six month interval
(Estimate = -1.76, p = 0.009; Estimate = -1.11, p = 0.03 respectively), while for the
severe RLSPS condition, only during the 36 month interval were they significantly less
likely to have any such RLSPS as during the six month interval (Estimate = -1.62, p <
0.001).
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Table 15
GEE Model Analysis – the Interaction of Mechanical and Behavioral Effects on Less
severe Residual Limb Skin Problems.
Less Severe Residual Limb Skin Problems
Community-high
Household-locking tech suspension
Parameter
suspension system
system

Less severe
residual limb
skin problems
Age group
55-74 years
> 74 years
<55 years
(reference)
Region
Region 1
Region 3
Region 4
Region 2
(reference)
Socioeco/VA
Priority
Co-pay
eligible
employable
unemployable
(reference)
Marital status
Race
Asian
Black
White
(reference)
MDD- Major
depressive
disorder
PTSD – Post
traumatic
stress disorder
Substance Use
Disorder

Community mid
to low suspension
system

p (Estimate = +/-)

p (Estimate = +/-)

p (Estimate = +/-)

Community-locking
suspension system
p (Estimate = +/-)
sub-category

0.58 (-)

0.24 (-)

0.74 (+)

0.30 (+)

0.02 (-)
(0.44 (-)
0.00

0.01 (-)
0.31 (-)
0.00

0.03 (-)
0.46 (-)
0.00

0.02 (-)
0.44 (-)
0.00

0.79 (-)
0.42 (-)
0.70 (+)
0.00

0.64 (-)
0.32 (-)
0.76 (+)
0.000

0.62 (-)
0.55 (-)
0.70 (+)
0.00

0.75 (-)
0.42 (-)
0.73 (-)
0.00

0.03 (-)
0.50 (+)
0.00

0.03 (-)
0.57 (+)
0.00

0.04 (-)
0.59 (+)
0.00

0.03 (-)
0.50 (+)
0.00

0.67 (+)

0.58 (+)

0.55 (+)

0.60 (+)

0.64 (+)
0.45 (+)
0.00

0.69 (+)
0.45 (+)
0.00

0.78 (+)
0.45 (+)
0.00

0.66 (+)
0.41(+)
0.00

0.29 (-)

0.31 (-)

0.32 (-)

0.41 (-)

0.41 (+)

0.43 (+)
*
0.053 (+)

0.35 (+)

0.45 (+)

*0.057 (+)

0.05 (+)
(table continues)

0.05 (+)
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Less Severe Residual Limb Skin Problems
Community-high
Household-locking tech suspension
Parameter
suspension system
system

COPD –
Chronic
obstructive
pulmonary
disease
CHF –
Congestive
heart failure
CVD –
Cerebral
vascular
disease

Community mid
to low suspension
system

p (Estimate = +/-)

p (Estimate = +/-)

p (Estimate = +/-)

Community-locking
suspension system
p (Estimate = +/-)
sub-category

0.03 (+)

0.03 (+)

*0.054 (+)

0.02 (+)

0.62 (+)

0.70 (+)

0.70 (+)

0.61 (+)

0.0002 (+)
<.0001 (+)
0.0002 (+)
0.0001 (+)
Renal failure
0.36 (+)
0.42 (+)
0.38 (+)
0.35 (+)
* indicates near significance where p < 0.06>.05;
Estimate =+indicates positive correlation, Estimate =- indicates negative correlation. bolded text
indicates statistical significance at 95% probability, alpha of 0.05

Community-high tech suspension system. When the community-high tech
suspension system ALC category was included as a covariate, none of the mental health
conditions (MDD, PTSD, or SUD) attained statistical significance as an effect on cohort
members likelihood to have a less severe RLSPS, although near significance was attained
for cohort members with a diagnosis of SUD to likely have a less severe RLSPS
(Estimate = 0.83, p = 0.06). In regard to other diseases, cohort members with a diagnosis
of COPD were significantly likely to have a less severe RLSPS (Estimate = 0.68, p =
0.03) or a severe RLSPS (Estimate = 0.61, p = 0.02), and cohort members with a
diagnosis of CVD were likely to have a less severe RLSPS (Estimate = 1.63, p < 0.0001),
but for the severe RLSPS condition, a diagnosis of CVD had no significant effect. As
with the household-locking suspension system ALC category, demographic parameters
co-varied significantly with the outcome: Cohort members aged 55 to 74 years were
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significantly less likely to have a less severe RLSPS as compared to those less than 55
years of age (Estimate = -0.10, p = 0.01), while cohort members over the age of 74 were
significantly less likely to have a severe RLSPS compared to cohort members less than
55 years of age (Estimate = -1.18, p = 0.005); cohort members whose VA Priority
classification required them to make co-payments for health care were significantly less
likely to have a less severe RLSPS (Estimate = -1.57, p = 0.03) compared to cohort
members with a VA Priority classification as unemployable, and similarly, the likelihood
of having a severe RLSPS (Estimate = -1.20, p = 0.014) was less likely for co-payment
cohort members than those classified as unemployable; and Black cohort members were
significantly less likely to have a severe RLSPS than White cohort members (Estimate =
-0.60, p = 0.03) whereas race had no apparent effect on the less severe condition. Of
note, Region was not a significant effect for the less severe RLSPS, but demonstrated
near significance and possible trending such that , cohort members treated at or living in
Region four were likely to have a severe RLSPS as compared to those treated or living in
Region 2 (Estimate = 0.71, p = 0.0). Finally, during their 30 month interval follow-up, as
well as their 36 month interval, cohort members were less likely to have a less severe
RLSPS as compared to the six month interval (Estimate = -1.54, p = 0.019; Estimate = 1.03, p = 0.04 respectively) whereas for the severe RLSPS condition, only the thirty six
month interval was significantly less likely (Estimate = -1.52, p = 0.005). None of the
other variables included in the model and analysis attained statistical significance.
Community-mid to low tech suspension system. Results of adding the ALC
category community-mid to low tech suspension system to the GEE model as a covariate
included the finding that the mechanical effect represented by the artificial limb did not
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attain statistical significance for the less severe nor the severe RLSPS conditions
(Estimate = -0.43, p = 0.24; Estimate = 0.27, p = 0.66 respectively). Further, none of the
behavioral effects as represented by the mental health conditions attained statistical
significance under either RLSPS condition, although SUD attain near significance to
indicate that cohort members with such a condition were likely to have a less severe
RLSPS during the follow-up period (Estimate = 0.83, p = 0.06), but a similar statistical
significance was not attained for this variable under the severe RLSPS condition.
Similarly, MDD attained near significance under the severe RLSPS condition (Estimate =
0.51, p = 0.06) indicating that cohort members with such a diagnosis were likely to have
a severe RLSPS during their follow-up period, a finding that was not mirrored for the less
severe RLSPS condition. Further, cohort members with a diagnosis of CVD were likely
to have a less severe RLSPS (Estimate = 1.53, p = 0.0002), but no similar statistical
significance was attained for the severe RLSPS condition; cohort members with a
diagnosis of COPD were likely to have a less severe RLSPS during their follow-up
period (Estimate = 0.60, p = 0.05), but a similar relationship was not evident under the
severe RLSPS condition; none of the other disease diagnoses attained statistical
significance for either less severe or severe RLSPS.
In regard to the demographic variables, cohort members between the age of 55
and 74 years of age were less likely to have a less severe RLSPS (Estimate = -0.89, p =
0.03) compared to cohort members less than 55 years of age, whereas cohort members of
the same age bracket (55-74 years), as well as those over the age of 74 years, were also
less likely to have a severe RLSPS compared to cohort members less than 55 years of age
(Estimate = -0.61, p = 0.03; Estimate = -1.25, p = 0.003 respectively). Marital status was
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not a contributing element to either less severe or severe RLSPS outcomes, but race did
contribute in that Black cohort members were significantly less likely to have a severe
RLSPS than White cohort members (Estimate = -0.60, p = 0.03), while race had no
significant effect on less severe RLSPS. Socioeconomic status(as indicated by VA
Priority classification, was a contributing element for both the less severe RLSPS
outcome as well as the severe ; cohort members categorized as co-pay eligible were
significantly less likely to have a RLSPS (less severe or severe) than those categorized as
unemployable (Estimate = -1.48, p = 0.04; Estimate = -1.15, p = 0.02 respectively) and
demonstrating a trend toward significance, cohort members categorized as employable
were also less likely to have a severe RLSPS than cohort members categorized as
unemployable (Estimate = -0.82, p = 0.07). Of note, Region became a contributing
element when in the presence of this ALC category in that severe RLSPS were more
likely to be associated with cohort members treated or living in region four as compared
to those treated/living in region two (Estimate = 0.80, p = 0.03), but was of no
significance toward less severe RLSPS outcomes.
Finally, as with the other analyses, cohort members were less likely to have less
severe RLSPS during the 30 month and 36 month follow-up interval/window than during
the six month interval (Estimate = -1.56, p = 0.02; Estimate = -1.13, p = 0.04), and for
severe RLSPS, cohort members were less likely to have RLSPS during the 36 month
interval/window than during the six month interval (Estimate = -1.87, p = 0.001). None
of the other variables/parameters included in the model achieved statistical significance
as a covariate and included PTSD, CHF, renal failure, and intervals/windows twelve,
eighteen and twenty-four months.
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Table 16
GEE Model Analysis – the Interaction of Mechanical and Behavioral Effects on
Severe Residual Limb Skin Problems.

Parameter
Severe residual
limb skin
problems
Age group
55-74 years
74 older
55 younger
(reference)
Region:
Region 1
Region 3
Region 4
Region 2
(reference)
Socioeco/VA
Priority
Co-pay eligible
Employable
Unemployable
(reference)
Marital status
Race
Asian
Black
White
(reference)
MDD- Major
depressive
disorder

Householdlocking
suspension
system

Community-high
tech suspension
system

Community-mid
to low tech
suspension system

Community-locking
suspension system

P (Estimate = +/-)

P (Estimate = +/-)

P (Estimate = +/-)

P (Estimate = +/-)

0.47 (-)

0.66 (+)

0.65 (+)

0.37 (-)

0.08 (-)
0.005 (-)
0.00

0.07(-)
0.005 (-)
0.00

0.03 (-)
0.003 (-)
0.00

0.07 (-)
0.003 (-)
0.00

0.66 (+)
0.48 (-)
*0.06 (+)
0.00

0.60 (+)
0.47 (-)
*0.053 (+)
0.000

0.76 (+)
0.50 (-)
0.03 (+)
0.00

0.55 (+)
0.55 (-)
0.04 (+)
0.00

0.01 (-)
0.14 -)
0.00

0.01 (-)
0.13 (-)
0.00

0.02 (-)
0.07 (-)
0.00

0.02 (-)
0.13 (-)
0.00

0.31 (-)

0.26 (-)

0.24 (-)

0.26 (-)

0.85 (-)
0.03 (-)
0.00

0.89 (-)
0.04 (-)
0.00

0.74 (-)
0.03 (-)
0.00

0.89 (-)
0.03 (-)
0.00

0.10 (+)

0.10 (+)

*0.06 (+)

0.1 (+)
(table continues)
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Parameter
PTSD – Post
traumatic stress
disorder
SUD –
Substance Use
Disorder
COPD –
Chronic
obstructive
pulmonary
disease
CHF –
Congestive
heart failure
CVD – Cerebral
vascular disease

Householdlocking
suspension
system

Community-high
tech suspension
system

Community-mid
to low tech
suspension
system

Communitylocking suspension
system

P (Estimate = +/-)

P (Estimate = +/-)

P (Estimate = +/-)

P (Estimate = +/-)

0.71 (-)

0.77 (-)

0.96 (+)

0.80 (-)

0.10 (+)

0.10 (+)

0.16 (+)

0.10 (+)

0.02 (+)

0.02 (+)

0.11 (+)

0.02 (+)

0.62 (-)

0.61 (-)

0.57 (-)

0.60 (-)

0.57 (-)

0.56(-)

0.60 (-)

0.60 (-)

Renal failure
0.98 (+)
0.99 (-)
0.87 (+)
0.99 (+)
* indicates near significance where p < 0.06>.05;
Estimate =+ indicates positive correlation, Estimate =- indicates negative correlation. Bolded text
indicates statistical significance at 95% probability, alpha of 0.05.

Community-locking suspension system. When the ALC category communitylocking suspension system was included as a parameter of the model ,of the behavioral
effects (mental health conditions), SUD attained statistical significance to indicate that
cohort members with such a diagnosis were likely to have a less severe RLSPS during the
follow-up period (Estimate = 0.86, p = 0.05), but this same parameter/covariate only
attained near significance for the severe RLSPS category, indicating that cohort members
with a diagnosis of SUD were likely to have a severe RLSPS during the follow-up period
(Estimate = 0.51, p = 0.10). Neither MDD nor PTSD attained statistical significance for
either the less severe or severe RLSPS outcomes. Of the disease covariates, COPD
attained statistical significance for both less severe and severe RLSPS outcomes , and
indicated that cohort members with such a diagnosis were likely to have a less severe or
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severe RLSPS at some point during the follow-up period (Estimate = 0.7039, p = 0.02;
Estimate = 0.5967, p = 0.02 respectively); CVD was also significant relative to the less
severe RLSPS indicating that cohort members with this diagnosis were likely to have a
less severe RLSPS during the follow-up period (Estimate = 1.53, p = 0.0001) but
significance at the 95% probability levels were not attained relative to severe RLSPS
outcomes.
Several demographic parameters contributed to the model outcomes. Cohort
members between the age of 55 and 74 were less likely to have a less severe RLSPS than
cohort members less than 55 years of age (Estimate = -0.95, p = 0.02), and further, cohort
members over the age of 74 years were less likely than cohort members under the age of
55 to have a severe RLSPS (Estimate = 1.18, p = 0.003). The age group 55 to 74 years
only attained near significance relative to severe RLSPS outcomes (Estimate = -0.51, p =
0.07). Additionally, Black cohort members were significantly less likely to have a severe
RLSPS than White cohort members (Estimate = -0.60, p = 0.03), but no such relationship
was evident for less severe RLSPS; and cohort members with a VA Priority level
categorizing them as co-payment eligible were less likely to have either a less severe or
severe RLSPS than those categorized as unemployable (Estimate = -1.58, p = 0.03;
Estimate = -1.20, p = 0.02 respectively).
The mechanical effect covariate, region, only attained statistical significance for
the severe RLSPS outcome, indicating that cohort members treated or living in region
four were more likely to have a severe RLSPS than those treated/living in region two
(Estimate = 0.73, p = 0.04). And finally, cohort members were less likely to have a severe
RLSPS during the 36 month interval/window than during the six month window
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(Estimate = -1.84, p < 0.05), although the same could not be said regarding less severe
RLSPS nor any other interval/window. The parameters/variables marital status, PTSD,
CHF and renal failure did not attain statistical significance as a RLSPS contributing
element, for either less severe or severe RLSPS outcomes.
Findings. The above findings suggest:
1.

The null hypothesis (Ho4) - residual limb skin problem (RLSPS)
categories relative to artificial limb configuration will not increase or
decrease for cohort members with a diagnosis of MDD, PTSD, or SUD,,
compared to cohort members with similar artificial limb configurations
and no such diagnoses – is actually unclear as it was not directly tested.
The model and analysis used did not estimate variance so much as it
estimated correlation - how likely a parameter was associated with the
dependent variable in the presence of other parameters. Further, the limits
of the dataset (missing data and small cell sizes) prevented comparison of
the various ALC categories, at least with the model used to address this
particular research question. However, in support of the alternative
hypothesis, what is known is that although these mental health conditions
definitely did not consistently play a major or singular role in the
likelihood of a cohort member having a less severe or severe RLSPS, for
each ALC category , at least MDD or SUD, attained significance at the
95% probability level or nearly so, suggesting that a cohort member with
such a mental health condition is more likely to have a residual limb skin
problem (less severe and severe RLSPS outcomes were each compared to
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cohort members that had no skin problem codes).Table 10 above presents
the frequencies of severe and Less severe RLSPS categories per ALC
category and reveals that The greatest frequency for both RLSPS
categories was associated with the Community-Locking Suspension
System (21.6% - Less severe; 26.7% - severe). Frequencies decreased
considerably (in order) for the Community-Mid to Low Tech Suspension
System, Community-High tech suspension System, Household-Locking
Suspension System, Household-Mid to Low Tech Suspension System,
Household-High Tech Suspension System, to the Transfers category – all
regardless of demographics, mental health or disease diagnoses.
2.

The alternative hypothesis (Ha4a) - cohort members with a diagnosis of
PTSD or SUD and an artificial limb of high function or technical
sophistication will have significantly more severe residual limb skin
problems (such as ulcers) than all other cohort members - could not be
accepted. The analysis revealed that regardless of the artificial limb
configurations sophistication or level of technology, having the diagnosis
of PTSD was not a significant contributing element, and a diagnosis of
SUD was only a contributing element for less severe RLSPS, not severe
RLSPS. More specifically, for the community-high tech suspension
system ALC category, the diagnosis for SUD trended toward a significant
association with the likelihood of having a less severe RLSPS (Estimate =
0.83, p = 0.05). The only comorbid condition associated with a severe
RLSPS and the community-high tech suspension system ALC category
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was COPD, in which cohort members were more likely to have a severe
RLSPS than those without such a diagnosis (Estimate = 0.61, p = 0.02)
3.

The alternative hypothesis (Ha4b) - cohort members with a diagnosis of
MDD and a lower function or less technically sophisticated artificial limb
configuration will have significantly fewer severe residual limb problems
than all other cohort members – can only be partially accepted, in part
because the three lowest technically significant ALC categories were not
included in the analysis and, as with the previous alternative hypothesis,
the structure of the model is not amenable. Nonetheless, relative to this
model, MDD was not a significant contributing element for less severe or
severe RLSPS for users of the household-locking suspension system or
community-mid to low suspension system ALC categories. Further, as
described above, and in support of Ha4b, frequency tables clearly indicate
that the least technically sophisticated artificial limb configurations
(transfers, household-mid to low tech suspension system, and householdlocking suspension system) had the lowest percentage of users with any
skin problem (less severe – 1.9%, 1.3%, 4.1%; severe – 0.6%, 3.2%, 4.4%
respectively) compared to more technically sophisticated artificial limb
configurations.
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Summary
The purpose of this study was multilayered: (a) to test the utility of healthcare
administrative data (such as ICD-9CM and HCPCS codes) in the development of an
infomatics tool in the field of prosthetics, (b) to identify determinants of severe and less
severe residual limb skin problems relative to the artificial limb used, and (c) ascertain
whether or not diagnoses of MDD, PTSD, or SUD were significant factors toward such
outcomes.
To accomplish such, Phase I of this study was directed at developing the dataset
derived from the merging of multiple VHA healthcare administrative database subsets,
and then extracting the study cohort on the basis of specified inclusion/exclusion criteria,
many of which were contrived post hoc, in order to preserve accuracy and a maximal
number of cohort members. A subsequent data dictionary was created (Appendix B) and
frequency tables prepared to define and characterize the study cohort. Subsequently, this
phase of the study and results not only established the study cohort, but in so doing,
identified various limitations of using AHc datasets, especially in regard to the NPPD and
the use of HCPCS codes to identify ALC categories; as well as the use of ICD-9-CM
codes to define RLSPS outcomes. These two issues address the useability of AHc data as
a tool in prosthetics practice-based medical research and as an infomatics tool, and will
be further discussed in the next chapter.
Phase 2 of the study was dedicated to an epidemiological analysis of the cohort
with the aim of ascertaining the significance of mechanical effects (the ALC category and
region where the configuration was made and dispensed) addressed by research question
1 and 2; behavioral effects (MDD, PTSD, SUD, and relevant comorbid conditions)
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addressed by research question 3; and the interaction of these two effects, as addressed by
research question 4. Aspects of the final study dataset (low cell frequencies, subsequent
binomial catergorization) required that the original intent of an analysis of variance with
interactive factors, be shifted to one of covariance and correlation, accomplished through
GEE modeling. GEE allows for the analysis and identification of patterns of relationships
within the cohort without the specificity of linear regression that the dataset could not
support.
Despite the limitations presented by the dataset (and ultimately, the analysis)
several of the above issues were clearly addressed. For example, mechanical factors,
specifically the ALC category, was not a statistically significant factor toward the
development of a severe or less severe RLSPS, suggesting that something other than the
type of artificial limb was at play. The parameter Region, originally intended to be a
proxy for the prosthetist responsible for the configuration of the artificial limb, was too
broad for such a definition, but still did influence the likelihood of cohort members
associated with Region 4 (primarily Northeastern United States) to be significantly more
likely to develop severe RLSPS. Further, behavioral effects MDD and SUD were
associated with the likelihood of developing a residual limb skin problem, regardless of
mechanical effects, although a diagnosis of PTSD had no similar influence; and the
medical comorbid conditions, COPD was associated with a significant likelihood of
developing severe and less severe RLSPS (in conjunction with the dysvascular conditions
of diabetes, PVD or PAD that also described a cohort member). While the demographic
factors age, race and socioeconomic status may not have been driving factors toward the
likelihood of the development of a residual limb skin problem, all three parameters
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statistically significantly contributed to the explanation thereof, either potentially as an
indicator of activity level, disease disparities, or social influences. These identified
patterns and findings will thusly be discussed in the next chapter.
In conclusion, the discussion will turn to suggested changes to the source database
(particularly the NPPD) to improve data quality and useability, overall implications of the
study in regard to practice-based medicine in the field of prosthetics, shortcomings in the
study itself, and potential future research endeavors to further refine a prosthetics
informatics tool.
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Chapter 5: Discussion
Introduction
The overarching purpose of this study was to explore the utility of an amputeeartificial limb database as a surveillance tool and as a means to improve prescription
guidelines, support policy, facilitate evidential research, and inform the user. To address
this purpose, this study attempted to achieve two goals: (a) to explore the viability of
medical coding from health care administrative records as an outcome measure for
artificial limb use in the field of prosthetics (an informatics perspective); and (b) to
ascertain what, if any, relative comorbid condition, especially depression, PTSD, or SUD,
has on those outcomes, (the epidemiologic perspective). These two goals are
interdependent of one another, as the informatics perspective is necessary to address the
epidemiological; the epidemiological perspective tests the informatics tool. In
combination, I believe that these two goals lead toward a third goal and the stated
purpose of the study: to address the utility of VHA AHc records to discriminate
determinants of residual limb skin outcomes relative to the artificial lower limb
configuration prescribed.
Prescription and configuration of an artificial limb is no simple matter, as multiple
factors must be considered. Persons living with limb loss, specifically lower limb
transtibial (below-knee) amputation, have multiple factors to overcome or contend with
to enjoy a quality of life that approaches that of a healthy able-bodied counterpart.
(Desmond et al., 2002; Desmond et al., 2008; Ephraim et al., 2006; Gallagher et al.,
2011). For many, these factors are confounded by varying degrees of mental illness and
becomes a matter of concern for the artificial limb provider, as it may influence a
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patient’s activity level, their capacity to heal, and their health care self-management
compliance including maintenance of their artificial limb.
Among the veteran population, MDD, PTSD and SUD are among the most
common mental health diagnoses. More specifically, the prevalence of MDD in the
veteran population is about 5 % to 13% and is frequently a comorbid condition with
PTSD (The Management of MDD Working Group, 2009; Veterans and PTSD, 2015).
PTSD is the third most prevalent psychiatric diagnosis among veterans utilizing VHA
hospitals, and 50% of the veterans suffering from PTSD do not seek treatment (Veterans
and PTSD, 2015). Vietnam veterans, who are likely represented by those cohort members
over the age of 65, report lifetime rates of PTSD ranging from 10% to 31% (Veterans and
PTSD, 2015). The rate of SUD among veterans, also frequently associated with PTSD,
range from 3.7% among pre-Vietnam-era veterans, to 4.7% for those who served during
the Vietnam conflict (1964 to 1975) to 7.7% for those who served between 1975 and
1990, to 12.7% among those who served in the military since September 2001 (Spotlight,
2015).
To complicate matters, an individual undergoing their first or index amputation
has limited resources for information beyond that provided by their provider or
prosthetist. Unfortunately, these same providers and prosthetists are hindered by a lack of
scientific/medical evidence regarding outcomes related to certain artificial limb
components and configurations, relying instead on manufacturer marketing and anecdotal
evidence (Meulenbelt, et al., 2006; van der Linde et al., 2004; G. W. Bosker CPO,
personal communication March 2014).
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In order for an amputee-artificial limb surveillance system and informatics tool to
be successful, all of these factors should be represented in one way or another. Therefore,
a key component to all three goals identified above is a standardized description of each
(as much as possible) in the form of a universally accepted code. In the case of the
artificial limb the amputee uses, this was accomplished with Healthcare Common
Procedure Coding System (HCPCS) codes, otherwise referred to as “billing codes”. The
Centers for Medicare Medicaid Services (CMMS) maintains such codes and updates
them regularly to accommodate new technologies and innovation. Devices are
categorized by common features of functionality and structure, but new devices may not
be differentiated except by make and model (CMMS 2012). For example, the code L5976
is described as “All lower extremity prostheses, energy storing foot (Seattle Carbon Copy
II or equal) ” and includes the S.A.F.E. foot by American Prosthetic, the “K Series” K2A
Assisted ADL foot, Quantum Truestep™ by Hosmer, the Steplite, the Impulse™ by Ohio
Willowood , the Seattle Carbon Lightfoot by Trulife, and many others (Prosthetic Foot
Reference Guide- Pel Supply: //www.pelsupply.com/related_files/978/315.pdf).
As will be discussed later, results of the study identified several similar
limitations and issues relative to the “informatics perspective” primarily driven by
shortcomings associated with the use of HCPCS codes (as described above) and ICD9CM diagnosis codes, especially to define and ALC category or identify and categorize a
RLSPS. Unfortunately, these shortcomings affected the results of the epidemiological
perspective by reducing quality data availability, forcing the use of broader or more
generalized variables that then could only offer limited interpretation. Regardless,
adjustments were made to the study design, specifically a shift from an analysis of
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variance with multiple factor levels to generalized estimating equations with a logit
function, to make best use of viable data, detect patterns of outcomes, and test the
feasibility and usefulness of a potential amputee-artificial limb informatics tool.
Preparing the Dataset
Development of the final study dataset required the merging of extracts from two
different databases, the link between the two being the patient’s scrambled social security
number. The VHA considers these scrambled social security numbers as identifiers and
thus, all data manipulations were performed behind the VHA’s firewall, even after the
scrambled SSNs were stripped and replaced with unique study ID numbers. While in
theory this merging seemed simple, in actuality it was cumbersome. This was due, in
part, to the number of records that were reviewed (over 1.6 million) and because of
differing cell formats between and within the extracted datasets, as well as differing
source database structures.
The inpatient and outpatient clinical datasets were from the same national archive
database (the NPCD) and shared the same platform and format, specifically MedSAS
files that were completely compatible with Statistical Analysis Software (SAS), used for
data cleaning and the study’s analysis. Complete and updated data dictionaries were
available online. On the other hand, the artificial limb component codes were registered
in the NPPD and used a different format and platform (Microsoft Excel Worksheet
comprised of 34 variables/columns and over 319,000 rows) that, though compatible with
the clinical data, was not immediately so. A fair amount of data manipulation (such as
cell reformatting) was required to render the extracted data sheets compatible with SAS
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and linked to the clinical data. There was no real data dictionary and only limited
information about variables and fields to facilitate manipulations.
Final preparation of the study cohort dataset was further challenged by a lack of
data integrity found in the NPPD extract. The source database and extracts frequently
contained variable values that were inconsistent with other variables in the same row,
truncated text fields that relayed little to no or contradictory information, missing values,
nonsensical data, and unexplained duplications. The NPPD is a fairly new database,
having only been established in 2000, and is not yet fully validated or evaluated (Downs,
2000; Pape et al., 2001; Smith et al., 2010). Data for the database is drawn from multiple
sources via the VA’s foundation software, VISTA originally called the Decentralized
Hospital Computer Program (DHCP). VISTA consists of nearly 180 applications for
clinical, financial, administrative, and infrastructure needs in VA integrated into a single,
common database, permitting all VA applications to share one single, authoritative data
source (Brown et al., 2003). Therefore, it is difficult to know the source of the missing or
inaccurate data, if from a secondary application, human input error, or glitches in the
associated input application.
Regardless of the source of data problems, best data interpretations were made on
a case-by-case basis and, subsequently, of an initial cohort with 597 matching study IDs
between clinical data from the NPCD and artificial limb component data from the NPPD,
315 could not be used because they did not meet inclusion/exclusion criteria (such as
incomplete component and data fields, bilateral amputations, or reamputations of the
ipsilateral limb). This significant reduction in the sample size led to smaller than expected
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cell sizes and required the compression of several variable categories to include the
independent variable, which was the ALC category.
Manipulation of the NPCD extracts (clinical data) also proved cumbersome,
primarily due to their size and necessary SAS programming strategies to insure accurate
accounting of numerous ICD-9-CM codes. RLSPS codes and categories (the dependent
variable) were complicated by the fact that few descriptions defined a particular
anatomical region. Efforts to insure that skin problems were definitely associated with the
residual limb of any case was thwarted when the code specific to stump complications
was not found in any of the records and thus could not be used in conjunction with any
RLSPS ICD-9-CM code. The alternative strategy for identifying RLSPS codes and
categories based strictly on the code label may have identified more skin problems than
may have been detected otherwise; however, it was felt that given the exploratory nature
of the study, over identification was better than under identification of residual limb skin
problems. Further, an objective of the study was to characterize the cohort to include
health conditions and, while some skin problems may have been detected that had
nothing overtly to do with the mechanical impact of the artificial limb on the residual
limb, they may have impacted the overall behavior and activity level of the amputee and
thus RLSPS outcomes.
Ultimately a study cohort of 282 cases was constructed containing copies of the
inpatient data extract of fiscal year 2007, outpatient data extracts from fiscal years 2008,
2009, and 2010; and the extract from the NPPD for fiscal years 2007, 2008, 2009, and
2010; all linked by common identification codes. To preserve data integrity, all the
extracts from the source data were left intact, and only copies thereof manipulated. These
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copies too were left intact, although as part of the coding process required to identify
categories of ALC (the independent variable), subsets of the extracts were used and then
reintegrated with the copied extract.
Key Findings
Phase 1 - the informatics perspective. The focus of the informatics perspective
(Phase 1) was to develop the study dataset, derived from multiple VHA archival national
database subsets, merged and linked together on the basis of common encrypted Social
Security numbers of a cohort of patients/cases. The derived study cohort dataset was then
used to address the epidemiological perspective and analysis.
Key findings associated with the development of this dataset include:
•

HCPCS codes proved to be a viable means of identifying and categorizing an
artificial limb configuration, but only in broad terms (that is, without specification
of make and model), and to insure accuracy, care should be taken to note the date
the component code was issued relative to the HCPCS codes available at that time
(further discussion of this matter will follow later in this chapter).

•

The use of ICD9-CM codes to create categories of RLSPS outcomes was
technically feasible but only moderately meaningful due to limitations of the
coding system – a matter likely resolved with the conversion to ICD10 codes that
will include anatomical laterality and metrics of condition severity.

•

The NPPD for the timeframe utilized for this study was weak in terms of data
quality and integrity, primarily due to inconsistent cell formats and matters of data
input to include timely updates to HCPCS codes, as well as human error at the
interfacing application software level.
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Phase 2 - the epidemiological perspective. Phase 2 of this study focused on an
epidemiological analysis of the study dataset representing a cohort of dysvascular belowknee amputees dispensed a definitive artificial limb. Because of the novelty of the
dataset, an objective of the epidemiological perspective was to characterize or describe
the cohort in terms of their demographic and medical status, as well as the categories of
ALC dispensed, and frequencies of RLSPS categories.
Characterization of the cohort. Descriptive statistics revealed the following:
•

Diabetes was the most frequent dysvascular diagnosed disease and accounted for
67% of the cohort.

•

Within the study cohort, the most frequently dispensed suspension system was the
L5671, a differential pressure suspension system with pin locking mechanism,
and dispensed to nearly 58% of the cohort; the most frequently dispensed
prosthetic foot among the study cohort was the l5980 Flex Foot, a prosthetic foot
suitable for the K3 level community ambulators and dispensed to nearly 46% of
the cohort. In combination, this suggests that the majority of the veterans were
considered community ambulators or better (K3, K3-4) and in fact, a total of 80%
of the artificial limbs dispensed were configured with K3 level (community
ambulatory) prosthetic feet.

•

Forty percent of the cohort members received their artificial limbs and care from
Region 3 (eastern Mid-West and Southern United States), with the remaining 60%
fairly equally distributed across the remaining three regions. This same region
was responsible for dispensing twice as many community-locking suspension
system artificial limb configurations as any of the other regions.
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•

The frequency of cases with less severe residual skin problems only (47% of the
cohort) was only slightly less than the frequency of cohort members that
developed severe residual limb skin problems (50% of the cohort).

•

The most common less severe RLSPS were noninfectious occlusion type (such as
dermatitis or diseases of hair and hair follicles) and accounted for 30% of all less
severe RLSPS; similarly, infectious occlusions (such as gas gangrene, carbuncles,
and cellulitis) were the most common severe RLSPS, accounting for over 34% of
the severe skin problems.

•

ALC category of transfers not only represented the least number of cases with
skin problems, but also the lowest ratio of severe to less severe RLSPS. The ALC
categories household-high tech, household-mid to low tech, and household –
locking suspension system all were associated with higher ratios of severe to less
severe RLSPS, compared to the other ALC categories.

•

PTSD was the most common mental health disorder of the cohort members
(24%), followed by SUD and MDD (both at 15%).

•

Sixty-four percent of the cohort was aged between 55 and 74 years of age with a
median age of 60 years.

•

Compared to 2009 veteran statistics, the cohort was represented by a lower
percentage of women and nearly twice the percentage of Black individuals,
although White and Asian percentages were similar

•

Over half (52%) of the cohort were married, suggesting the presence of a
caregiver.
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•

Eighty-four percent of the cohort were classified as disabled and considered
unemployable (VA Priority status 1,4, and 5)

•

Debilitating comorbid conditions were common with nearly a quarter of the
cohort suffering with a respiratory disorder (COPD), 45% had CHF, and 8% were
diagnosed with some stage of renal failure. CHF, renal failure and amputation are
all indicators of advanced diabetes.
The epidemiological analysis. The design of the analysis was intended to test the

usefulness of both the outcome variable (categories of residual limb skin problems) and
the independent variable (ALC categories) in detecting meaningful patterns of association
between them. Two elements of artificial limb use were of particular interest because of
their potential separate or combined influences on the development and frequency of
residual limb skin problems: mechanical affects in which a particular type of ALC
category was associated with more residual limb skin problems than other categories
(research questions 1 and 2); behavioral affects in which certain comorbid conditions (
including MDD, PTSD, and SUD) were associated with more frequent residual limb skin
problems than others (research question 3); and, given the combination of both affects
(which are not totally independent of one another) what associations persisted or evolved
(research question 4).
Further, in an effort to identify any temporal relationships regarding the
development of a less severe or severe RLSPS over the three year follow-up period,
frequencies of such were counted within the cohort at six month intervals/windows and
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each window compared to the frequency of the first window (six months) to determine if
any change was significant.
Mechanical effects. In regard to mechanical effects (research questions 1 and 2),
it was found that (a) not every ALC category was significantly related to a RLSPS
category, especially in the case of less severe RLSPS; (B) severe RLSPS (such as ulcers)
were significantly more frequent for cohort members dispensed ALC categories of
higher function or technical sophistication and least for low function, low technically
sophisticated configurations (in so far as the ALC categories analyzed); (c) Region was
not a main effect in the development of less severe RLSPS, but was in regard to severe
RLSPS with only Region 4 having significantly more severe residual limb skin problems
relative to Region 2. In Summary then, mechanical effects tended to be more profound
for cohort members using a K3 functional level prosthetic foot and, potentially,
prescription practices, especially in Region 4, may have been a contributing factor.
Behavioral effects. Behavioral effects included the mental health conditions
MDD, PTSD, and SUD; as well as several comorbid conditions that because of their
debilitating health effects were likely to affect a cohort member’s activity level or
capacity to heal. Similarly, mental health conditions are also posited to affect activity
levels (for example, inactivity due to depression) and healing capacity due to poor
nutrition or toxins (such as drugs and alcohol associated with SUD), as well as
difficulties with health self-management associated with anxiety, coping mechanisms,
and adjustment disorders (such as PTSD) (Desmond & MacLachlan, 2002; Desmond &
MacLachlan, 2006; Desmond et al., 2008; Hanley et al., 2004; The Management of MDD
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Working Group, 2009; The Management of Post-Traumatic Stress Working Group, 2010;
The Management of SUD Working Group, 2009; Zinszer et al., 2011). Based on these
behavioral effects and not including any mechanical parameters (research question 3), it
was found that: (a)cohort members with a diagnosis of SUD were significantly likely to
develop a less severe or severe RLSPS, (b) cohort members with a diagnosis of MDD
were significantly likely to have a severe RLSPS; (c) PTSD accounted for approximately
24% of the cohort but was not significantly associated with either less severe or severe
RLSPS; (d) COPD and CHF were both associated with the likelihood of a diagnosed case
developing a less severe RLSPS, but only COPD was associated with the likelihood of
severe RLSPS; and (e) CVD which frequently results in limb paresis and thus change
gait biomechanics as well as reduce activity, was found to be significantly associated
with the likelihood of developing a less severe skin problem, but not a severe one (the
actual number of cases with a diagnosis of CVD was 17). In summary, it was noteworthy
that only SUD and COPD were significantly associated with the likelihood of both severe
and less severe RLSPS, and that the other mental health conditions had relatively little
impact.
The interaction of mechanical and behavioral effects. Finally, as stated
previously, mechanical and behavioral effects are not independent of each other and thus,
one cannot simply sum the findings. Rather, it is the interaction of mechanical,
behavioral, and demographic effects that should be used to predict a residual limb
outcome, although in this study, prediction was not the goal, but instead a pattern of
relationship. Given these parameters, key findings included (research question 4): (a)
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none of the four ALC categories analyzed achieved statistical significance as parameters
likely to be associated with cohort members development of less severe or severe
RLSPS; (b) cohort members between 55 and 74 years of age were less likely to develop a
less severe RLSPS than younger cohort members, but older cohort members (aged 75
years or more) were less likely to develop a severe RLSPS compared to the same group;
(c) region was only a significant contributing factor in the case of cohort members
dispensed an artificial limb from Region 4 who had a greater likelihood of developing a
severe RLSPS than cohort members associated with Region 2; (d) cohort members
eligible to make co-payments for their health care were significantly less likely to
develop less severe or severe RLSPS than cohort members classified as disabled; (e)
Black cohort members were significantly less likely to develop a severe RLSPS than
White cohort members, but in regard to less severe RLSPS, race was not a significant
contributing factor; and (f) of the mental health disorders only SUD contributed to a
cohort member’s likelihood of developing a less severe RLSPS while, of the comorbid
conditions, COPD was significantly associated with both less severe and severe RLSPS,
regardless of the ALC category used. In summary then, the likelihood of a cohort
member having a less severe RLSPS was more closely aligned with behavioral effects
(namely a diagnosis of SUD or COPD), and not mechanical effects ( the type of
artificial limb configuration used or the region responsible for dispensing it), while the
likelihood of a cohort member having a severe RLSPS was significantly associated with
what region was responsible for the artificial limb (mechanical covariate), and/or a
diagnosis of COPD (behavioral effect). Demographic parameters had limited impact on
the likelihood of a cohort member having a residual limb skin problem, except that those
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cohort members assumed to be of a higher SES (copay eligible) were significantly less
likely to have skin problems. Age also was associated with RLSPS and may have been
more a behavioral effect than a physiologic relationship as the age range of those less
likely to have a residual limb skin problem shifted from 55 to 74 years for less severe
RLSPS, to over 75 years and the less likelihood of a severe RLSPS.
Temporal effects. For all research questions, only during the 30 month and 36
month windows were there a significant likelihood of fewer less severe RLSPS, the
exception being the mechanical by behavioral interaction for the community-locking
suspension system in which there was no significant comparisons. In regard to severe
RLSPS, all the research questions/conditions indicated a significantly less likelihood of
developing a problem by the 36 month window, the exception being for behavioral
effects analysis in which the 30 month window was similarly significant.
Interpretation of the Findings
Phase 1 - Derivation of the Study Dataset and Coding Systems
A key component of this study was the derivation of the study dataset and the
implementation of standardized health care coding systems to describe the artificial limb
configuration, the residual limb status, and potentially contributing comorbid conditions
including mental health disorders. While the two primary coding systems used (HCPCS
billing codes to identify and describe the ALC category, and ICD-9-CM codes to identify
residual limb skin problems and patient comorbidities) were fundamentally successful in
achieving their purpose as standardized measures with which to infer an amputee’s
history with a particular artificial limb, they were not without important weaknesses and
complication.
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HCPCS codes were highly useful to identify functional components of an
artificial limb, but said little about the overall limb whose more discrete functions can
only be determined on the basis of the makes and models of components used and the
skill of the prosthetist, especially in regard to socket craftsmanship, component
prescription, and fitting and alignment of the limb (DePalma et al., 2002, The
Rehabilitation of Lower Limb Amputation Working Group, 2007). Clinical expertise
remains a crucial component in prescribing an artificial limb configuration and is
dependent on the prosthetist’s (clinician’s) knowledge of the components available (van
der Linde et al., 2004). To this end, the use of HCPCS codes will describe an artificial
limb in fairly broad terms which, as part of an amputee-artificial limb surveillance
system, may prove useful to a policy-maker or review board, insurance company,
physician, or epidemiologist/researcher but will be less informative for the prosthetists,
component manufacturers, marketers, or the amputee user.
Further, in the derivation of the dataset, difficulties arose differentiating between
a definitive artificial limb and repair to one, based solely on HCPCS codes. This was a
reflection of the time period of the retrospective data (October 2006 through September
2010) in that the Centers for Medicare Medicaid Services did not approve and update
HCPCS codes that specifically indicated repair or modification to a component (such as
the codes L7520 - Repair prosthetic device, labor component, per 15 minutes or L7510 Repair of prosthetic device, repair or replace minor parts) until 2010. Had the source
database used to acquire HCPCS codes for the study (namely the NPPD) been fully
validated and the data therein deemed more reliable; had there been more data integrity,
an algorithm may have been derived based on multiple fields to include costs associated
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with the HCPCS code, to clearly differentiate between the index definitive limb, a repair
to a component thereof, or a modification of the limb or limb component. Instead, many
times the cost associated with the L5301 HCPCS code was indicative of a definitive
artificial limb, but a field in the database indicated that the type of service was a repair,
not a new limb, and conversely, the cost was frequently significantly less than that typical
for a definitive limb, but the type of service field was empty, giving no indication of why
the cost was lower than that typically associated with a definitive artificial limb. These
conditions demonstrate that, if using HCPCS billing codes as part of an amputee-artificial
limb surveillance database, it would be imperative that updates to the coding system be
noted regularly and in a timely manner (CMMS maintains such codes, and updates them
regularly to accommodate new technologies and innovation [CMMS, 2012]).
Additionally, it would be useful if a data field were included to indicate the
purpose of the artificial limb such as new, modified, secondary, or back-up. Many times
an amputee may be prescribed and dispensed multiple artificial limbs – a primary limb, a
back-up limb to use while the primary is repaired, and a specialized limb for a particular
activity such as swimming, running or showering (G. W. Bosker CPO, personal
communication, January 2011). All these types of artificial limbs may use the same
L5301 code as they are all definitive and not temporary limbs, and thus it is difficult to
know which component code (such as one for the prosthetic foot or suspension system)
goes for which purpose and/or artificial limb – information that would be valuable for
prosthetists, users, and vendors/marketers.
Determining the status of the artificial limb was further confounded by limitations
of ICD-9-CM surgical codes that did not differentiate between a total amputation, a
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reamputation, and a revision of the residual limb. A total amputation or a reamputation
would have required a new definitive limb (eventually) as described by a new socket,
appropriate suspension system, pylon, prosthetic foot and any other facilitating
components (DePalma et al., 2002; G. W. Bosker CPO, personal communication, January
2011). On the other hand, a revision most typically requires a modification to an existing
definitive limb (a new socket or suspension system), and therefore would have been
helpful toward the validation of seeming discrepancies in L5301 codes, costs, and repair
versus new limbs.
Further issues arose with the use of ICD-9-CM codes in the identification of skin
problems associated with the residual limb, but many of these problems may be resolved
with the implementation of ICD-10-CM codes. Few dermatological diagnoses codes are
defined by the part of the body and none are restricted to a residual limb. This fact posed
a problem in the identification of codes for categorization as well as a weakness in the
usefulness of diagnostic codes and RLSPS as an outcome measure. The original intent
was to use those dermatological ICD-9-CM codes that were concurrent with the ICD-9CM code 997.69 -Other amputation stump complication (a sub-division of the code 997
– Complications effecting other specified body systems, not elsewhere classified) , but
this strategy was abandoned when no such code was detected in any cohort member’s
clinical history. The three most likely explanations for this matter may have been: (a) this
investigator misinterpreted the meaning of the code label and the code was simply not
used; (b) the archival NPCD, the source for all clinical histories in this study, only allows
for 15 ICD-9-CM codes per patient event (outpatient day visit) and the code may have
been truncated, or (c) a clinician’s choice or error to not select the code from a
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procedural codes list in the electronic medical record system, a practice required for
outpatient clinic visits only. Consequently, the strategy used for identifying residual limb
skin problems dictated that any relevant code that included in its label a defined body
part was excluded unless that body part was lower leg, the code was one of those
identified by Bui et al. (2009) as a dermatological problem frequently associated with
residual limbs and artificial limb use, or a possible systemic problem that could appear
anywhere on the body but also fit into one of the categories of skin problem etiologies
modified from the Bui et al recommendations (refer to Appendix B, Tables B19 and B20
for a listing of codes and categories).
Given this strategy, there is a definite likelihood of over-identification of residual
limb skin problems. This may have been confounded by the use of outpatient
administrative records in which it has been shown, specifically regarding the VHA
electronic medical record system, that administrative data may be more sensitive than a
chart review, but the chart review more specific (Szeto et al., 2002). In other words, the
administrative files may have contained more diagnostic codes than a chart review may
have revealed, however, based on the numbers of cases (cohort members) with residual
limb skin problems and compared to results from other studies, over identification may
not have been excessive. For example, Dudek and colleagues (2005), based on a six year
retrospective chart review, reported that nearly 41% of their study population had at least
one skin problem. In the study being reported here, nearly 47% of the cohort was
identified as having at least one less severe RLSPS and 50% a severe RLSPS, of which
many (if not most) of the cohort members may have experienced both categories of skin
problems. While the data necessary to make such an accounting was available within the
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dataset, at the time of the analysis, to do so seemed beyond the scope of an this initial
exploratory assessment and thus, the percentage of cohort members that experienced both
less severe and severe RLSPS was not calculated. Nonetheless, two main factors explain
the difference in RLSPS category frequencies between this study and the study by Dudek
and colleagues: (a) study design – the Dudek study counted only the first skin problem in
a patient’s record whereas this study was a longitudinal design such that an individual
with a less severe RLSPS early on in the follow-up period, may have ultimately
developed a severe RLSPS later and effectively have been counted twice; (b) this study
included conditions such as chronic or acute osteomyelitis and systemic infections
because of their significant impact on quality of life and life-threatening potential,
conditions not included in the Dudek study.
Regardless, the use of ICD-10-CM codes will improve accuracy in the
identification of residual limb skin problems and thus, this method of using diagnostic
codes to identify residual limb outcomes in a surveillance system is not without merit. In
fact, the Centers for Disease Control and Prevention have specifically stated that ICD-10CM codes will improve public health surveillance systems with the codes increased
granularity allowing for indication of complications/severity and anatomical locations,
factors that are definitely relevant to a potential amputee-artificial limb database
(http://www.cdc.gov/nchs/icd/icd10cm_pcs_impact.htm). Further, the inclusion of
laterality and anatomical location will simplify the differentiation between an index
amputation, a reamputation (from transtibial to transfemoral or amputation of the
contralateral lower limb), or revision of the residual limb, and thus help insure proper
association between an artificial limb configuration and the limb status of the amputee.
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Characterization of the Cohort
In a study by Dillingham and colleagues (2002) that analyzed data from the
Health Care Cost and Utilization Project of 1988 to 1996, it was determined that 82% of
all limb loss hospital discharges were due to dysvascular complications, and that the
elderly and minorities were most at risk, especially with nearly 60% being major lower
limb amputations (Dillingham et al., 2002; Ziegler-Graham et al., 2008). In the United
States, of the dysvascular conditions, diabetes and diabetic complications account for the
largest proportion of below-knee amputations, typically subsequent to foot ulceration and
infection (Adler et al., 1999; Davis et al., 2006; Ephraim et al., 2003; Mayfield et al.,
2004; Rayman et al., 2004; Reiber et al., 1998). In fact, the CDC reported that in 2007,
the rate of below knee amputation per 1000 diabetic population was 1.1, and that nearly
25% of the U. S. population aged 60 years and older was diabetic (CDC 2010). It is
exactly because of these estimates that this study focused on a cohort of dysvascular
transtibial amputees, and the cohort followed in this study represented all of the above
statistics: predominately male and Caucasian, mean age of 64 years with 64% of the
cohort being between the ages of 55 and 70 years, and 67% of the cohort having a
diagnoses of diabetes. Further, while the cohort was represented by nearly twice the
number of Black individuals compared to 2009 VA statistics, this can be understood
given the report by the Centers for Disease Control and Prevention that, as of 2009, for
Black Americans, the risk of dysvascular lower limb acquired limb loss was estimated to
be 1.5 to 3.5 times that of non-Hispanic Whites (CDC, 2011a). Additionally, in a study
by Collins and colleagues (2002) it was found that within the VHA, Blacks suffering with
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peripheral arterial disease were at a greater risk for limb amputation (as opposed to limb
salvage) as compared to all non-Hispanic Whites.
Based on the cohort’s characteristics frequencies, the typical dysvascular
transtibial amputee veteran would be around 60 years of age, White, diabetic, married,
unemployed (VA Priority Status group 1, 4, or 5), possibly have a diagnosis of CHF, no
significant mental health disorders, and be a K3 functional level (community) ambulators
using a Flex Foot prosthetic foot with a pin-locking mechanism suspension system.
Relatively few members of the cohort were incapacitated to the point of only using an
artificial limb for transfers. The reason for this incapacity can only be speculated as due
to late age frailty or comorbid condition such as stroke and/or CHF. The low level of
activity for such persons would help to explain why someone in such a morbid condition
as to be prescribed and dispensed an artificial limb configuration suitable only for
transfers, would also have fewer less severe RLSPS that become severe ones.
This concept of activity level as a key factor toward the development of residual
limb skin problems becomes increasingly relevant as part of the epidemiological analysis,
but in terms of a descriptive analysis of the cohort, is further supported by the finding that
cohort members dispensed and artificial limb configuration suitable for a household
ambulation (for short walks on level surfaces such as in one’s home) were found to have
a higher ratio of severe to less severe RLSPS, relative to the K1 functional level (transfers
only) amputee. If the provider prescribed a K2 level prosthetic foot, it is likely that the
expectation was that the user would be sufficiently frail as to not progress to community
ambulation. Such a level of ill-health suggests equally frail residual limb skin and a
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greater propensity for skin breakdown or infection subsequent of increased pressures and
friction consequent of walking with an artificial limb (Mak et al., 2010).
Further evidence of the relationship between activity level and residual limb skin
problems is presented in the study by Dudek and colleagues (2005) mentioned above, in
which the authors reviewed over 700 lower extremity amputees using an artificial limb.
The investigators determined that nearly 41% of the residual limbs examined had at least
one skin problem (if a patient had more than one skin problem during the study period of
six years ,only the first problem was recorded), and that the majority of the amputations
were due to PVD of which 60% were subsequent of diabetes. (Dudek et al., 2005).
Further analysis of the data revealed that a primary risk factor for a residual limb skin
problem was activity level, however a comorbid condition of diabetes or coronary artery
disease did not contribute to the likelihood of a skin problem (Dudek et al, 2005).
While such findings support a relationship between activity levels and skin
problems but no similar relationship with a dysvascular condition, such may be a
consequence of the study design as it offered no real categorization of the patient’s
overall health status relative to their activity level. More specifically, socket types and
suspension systems were noted but not included in the analysis, nor was the functional
level of the patient at the time of recording, and thus no association with personal
capacity as an indicator of health status could be made. Because the study being reported
here categorized the artificial limb used by functional level of the prosthetic foot, cohort
members were by default similarly categorized. Although their categorization may not
have been perfect, it did allow for some rudimentary groupings that could be used as
indicators of a cohort member’s overall capacity, most likely dependent on the cohort
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member’s health and living status. In fact, in a study by Kurichi and colleagues (2007)
that reviewed the medical records of over 900 U.S. Veterans one year after a lower limb
amputation, it was reported that “Medical and functional conditions that adversely affect
level of energy, ability to move independently, or ability to exercise judgment”
influenced not only the type of artificial limb prescribed, but the likelihood of being
prescribed an artificial limb in the first place (Kurichi et al., 2007, p 904).
To further characterize the cohort, less severe and severe RLSPS were divided
into sub-categories representative of those suggested by Bui and colleagues (2009) as
potential etiologies of common residual limb skin problems. Among the cohort members
being reported here, the most common severe RLSPS was infectious occlusions to
include cellulitis and carbuncles, with the occlusions being thought to be a consequence
of the residual limb/socket suspension system interface environment. This environment is
typically warm and humid, under levels of physical pressure not typical for the anatomy
of a lower limb, exposed to unnatural elements and materials (such as plastic, nylon,
silicon and so forth), and frequently not very hygienic (DePalma et al., 2002; Mak et al,
2010). Further, the circulatory system of the residual limb is compromised in part due to
surgical outcomes, but also because of disease (diabetes, PAD or PVD) progression. At
the time of amputation, only “healthy” tissue remains, but over time the residual limb of a
dysvascular amputee can become increasingly fragile, especially under conditions of poor
glycemic control and advancing age (Brown, Crone, & Attinger,2012; Chitragari et al.,
2014)
. The opportunity for occlusion of a sweat gland, hair follicle, capillaries, or
lymph vessels are regular if not frequent – a problem compounded by the fact that
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diabetes is associated with a higher incidence and/or severity of infection due to a
hyperglycemic environment (Casqueiro and Alves, 2012). Hyperglycemia associated
with poorly controlled diabetes favors immune dysfunction to include reduced response
of T cells, neutrophil function, and disorders of humoral immunity (Casqueiro and Alves,
2012). Some skin and soft tissue infections (such as the less severe residual limb skin
problems folliculitis, furunculosis/boils, and subcutaneous abscesses) may break out
during the course of the disease or may be the first sign of diabetes presentation
(Casqueiro and Alves, 2012). It is also not uncommon for these less severe problems to
develop into severe problems if not properly cared for, such as blisters becoming ulcers
and abscesses becoming infectious and gangrenous. Such infections become lifethreatening given that they may trigger further diabetic complications such as
hypoglycemia, ketoacidosis, the possibility of sepsis, and diabetic coma (Casqueiro and
Alves, 2012). Furthermore, significant infection of the residual limb frequently results in
reamputation. It is not uncommon for a dysvascular amputee to undergo reamputation
(from transtibial to transfemoral or amputation of the contralateral limb) within a three
year time frame (Dillingham et al., 2005; Izumi et al., 2009). Izumi et al., (2009)
reported cumulative amputation rates per person as 48% at three years, a rate of 12% for
the ipsilateral limb, and 44% for the contralateral limb. Such grave outcomes subsequent
of residual limb skin problems makes it difficult to accept the Dudek study conclusion
that there was no real relationship between activity level, a dysvascular condition and the
presence of a residual limb skin problem.
Unfortunately, the design of this study dataset did not lend itself to a full
characterization of the cohort to include frequencies and percentages of cohort members
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with two or more comorbid conditions, other serious comorbid conditions (other than
those associated with dysvascular conditions), service connected or combat related
injuries that may compound health issues (such as agent orange exposure), cancers, joint
osteoarthritis and so forth, nor is there a direct measurement of activity level (such as
distance walked or steps taken) but instead the level of activity must be inferred.
However, in an effort to address the interplay between a mechanical artificial limb and
the health status of the user, research questions were designed to address the influence of
mechanical factors (such as the ALC category used and the region responsible),
behavioral factors (such as mental health conditions that impact activity and/or self-care
and disease management), and the factors resulting from the interaction of mechanical
and behavioral factors. What follows is a discussion thereof.
Phase 2 – the Epidemiological Analysis
The relevance of mechanical and behavioral factors. In the same study by
Dudek and colleagues as mentioned above, the investigators determined that activity
level was a contributing factor toward the development of a residual limb skin problem,
but that the type of socket or suspension system was not (or at least was not considered)
(Dudek et al., 2005). Nonetheless, in the Dudeck study, most of the transtibial amputees
used a supracondylar suspension system and nearly 12% used a pin locking mechanism
(with a silicon liner) suspension system. In contrast, 58% of the study cohort used for
analysis in this study used a pin-lock mechanism suspension system and less than 10%
used a supracondylar suspension system. The reason for this difference is unknown but
may be a reflection of prosthetist preference as the Dudek study was limited to a single
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outpatient rehabilitation center, whereas the results of this study were national and
reflected the preference of many prosthetists.
Further, nearly 80% of the cohort were dispensed a K3 (community ambulator)
level prosthetic foot - the type prosthetic foot used was not reported in the Dudek study.
As such, this describes by definition a cohort of below-knee amputees able to walk longer
distances through a community landscape (to include steps and curbs, ramps, and variable
surfaces) and able to walk at variable speeds; in other words, an individual of relatively
normal activity level and, on the surface, supports the relationship of more activity –
more residual limb skin problems, but without consideration of artificial limb
componentry.
It is the mechanics and functionality of the prosthetic foot that is most likely to
influence the stresses and forces on the residual limb, while the purpose of the suspension
system is not so much to protect the residual limb from these forces, but rather to connect
the residual limb to the artificial limb (DePalma et al., 2002; Versluys et al., 2009). As
discussed and eluded to throughout this document, not only is the type of components
used to configure the artificial limb important, but equally so is the prosthetist.
Research questions 1 and 2 address these “mechanical” factors in which it was
hypothesized that cohort members dispensed and using a more technically sophisticated
artificial limb combination, such as one with a k3 prosthetic foot and a differential
pressure suspension system, would be more likely to develop severe RLSPS than users of
a less technically sophisticated configuration. The primary premise behind this
hypothesis was that such technically sophisticated apparatus would require attention as,
having more moving parts, be more prone to mechanical breakdown, and failure of the
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device would inflict more harm than not on the residual limb (in other words, lead to a
higher incidence of severe residual limb skin problems) (DePalma, et al., 2002; G. W.
Bosker CPO, personal communication, January 2011). Thus, such an artificial limb
configuration would be best suited for the capable user – someone of sufficient health and
mental status to recognize problems and take appropriate action, be that to seek medical
care, stop wearing the artificial limb, and/or take it in for repair or adjustment. In fact, it
has been reported that cognitive ability is a significant patient factor to be considered as
part of the prescription decision process in part due to the complexity of newer artificial
limb components (to include those that are computer aided such as the ProprioFoot) as
well as an individual’s ability to learn how to use a prosthesis and maintain their
independence (Coffey, O'Keeffe, Gallagher, Desmond, & Lombard-Vance, 2012). This
suggests that activity level is more a reflection of behavior and not a function of the
artificial limb configuration itself. In other words, an individual of physical status only
capable of household ambulation, would not benefit from a K3 level artificial limb
configuration (it would not make them walk more or better) and, given a potentially more
fragile residual limb (due to poorer health) might be more prone to breakdown from
biomechanical forces generated by a more technically sophisticated artificial limb (Mak
et al., 2010). A better approach is to adapt the artificial limb configuration to the ability
of the user, with some exceptions such as the Vacuum Assisted Suspension System
(VASS), a technically sophisticated artificial limb component that has been demonstrated
to actually facilitate the healing of ulcers and improve the overall healing capacity of a
dysvascular residual limb (Traballesi et al., 2012; van der Linde et al., 2004).
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While the premise and alternative hypothesis for research question 1 was borne
out (the community level artificial limb configurations were associated with a greater
likelihood of development of a severe RLSPS) the reason for the association is beyond
the scope of this study. It can be speculated, however, that based on the findings by
Dudek et al., (2005) and Meulenbelt et al., (2011), both of which determined activity
level to be a significant contributing factor toward residual limb skin problems, that the
greater likelihood of the community level ALC categories to associate with severe
RLSPS, is due to the greater activity level of such persons as compared to the K1 and K2
level ambulators.
A secondary premise was that, the more technically sophisticated ALC category
would require greater skill in fitting and aligning, such that there would be greater
variability in the quality of fit as performed by the various prosthetists across the nation
and would be manifest as greater incidence of severe RLSPS in one Region and fewer in
another, relative to the ALC category dispensed. This particular issue was addressed in
research question 2 in which it was asked if the frequency and type of residual limb skin
problems associated with an ALC category would vary significantly between prosthetists
in which Region was used as a proxy thereof. The null hypothesis, that there would be no
such significant variability, would then suggest that across the VA system, prosthetists
were of similar skill, followed similar guidelines, or, while they may have practiced their
preferences, did so successfully with no more residual limb skin problems than another
prosthetist. The alternative hypothesis was that there would be significant variability,
suggesting that the quality of service was not consistent across the VHA system and that
perhaps there needed to be greater adherence to prescription guidelines, additional
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training for prosthetists, or that geographical aspects such as terrain, population
demographics and even climate affected a cohort member’s likelihood of developing a
residual limb skin problem.
A similar issue was addressed by Connally, Airey, and Chell, (2001) regarding
the question of variability in rates of lower limb amputation across and within countries
despite similar needs, hypothesizing that differences in clinical decision making might
explain the variability. Six cases were each examined by 10 different vascular surgeons
as to the decision to amputate or salvage the limb, whereupon only moderate agreement
was attained among the surgeons. The authors ultimately concluded that the variations in
limb amputation rates could be explained, at least in part, by differences in clinical
decision making rather than just geographical differences (Connally et al., 2001). One
caveat to this conclusion is that it would be expected that the clinician, especially in the
case of prescribing an artificial limb, would necessarily take into consideration
geographical factors such as terrain, rural versus urban, wet versus dry climes, and so
forth, that is the environment the patient lives in. In fact, in a study of secondary data
from National Physical and Sensory Disabilities Database of Ireland, it was determined
that climate was a significant barrier for the lower limb amputee (Gallagher et al., 2011).
It is likely that wet climates, either in the form of rain, snow or ice, would be especially
treacherous for a lower limb amputee as the biomechanics of their gait and their
prosthetic limb are less adaptable to sudden changes as that required to prevent a slip
from becoming a fall (Winter, 1988; G. W. Bosker, CPO, personal communication,
January 2011).
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The findings of the GEE analysis used to address research question 2, revealed
that cohort members who received their artificial limb configuration from Region 4 (the
Mid-Atlantic to northeastern section of the United States), were in fact more likely to
develop a severe RLSPS than the remaining 3 Regions, but Region 4 was only
represented by 20% of the cohort, compared to 40% from Region 3, 22% from Region 2,
and 17% from Region 1. Further, of the artificial limbs dispensed, for Region 4 19% were
of the K3/community level , compared to 35% for Region 3, 19% for Region 2, and 16%
for Region 1. If one assumes that the primary cause for severe residual limb skin
problems is related to activity level, then it would be expected that Region 3 with the
greatest number of cohort members and K3/community level ALC categories would have
significantly more severe RLSPS compared to the other regions. However, the GEE
analysis revealed that cohort members from Region 4 were significantly more likely to
develop a severe RLSPS than Region 2 which had the same percentage of K3/community
ALC categories dispensed. This suggests that something about Region 4 other than
activity level of the cohort members was driving the likelihood of developing a severe
residual limb problem and, while Region 4 was used as a proxy for the Prosthetists
preparing the artificial limb dispensed, given the lack of specificity of the Region
variable, it is not within the scope of the analysis to explain the phenomena. The variable
Region was used instead of VISN because of small cell sizes and thus the loss of
granularity, making it difficult to proclaim a problem with prosthetist expertise, the need
for universal prescription guidelines, or the influence of geographical factors, although
Region 4 and Region 2 do have distinctly different terrain and climates. More granular
information (such as the zip code of the organization prescribing or dispensing the

312

artificial limb)would likely be found valuable for policy makers or oversight agencies
potentially using an amputee-artificial limb database for reasons of registering fraud or
modifying policy.
Despite the above findings for research questions 1 and 2, it remains unclear if
residual limb skin problems are subsequent of prosthetist decisions or skill, a function of
a particular model or make of artificial limb component or some other aspect such as
patient residual limb health, usage patterns and care practices. As presented throughout,
mechanical factors or parameters are only one part of the equation that describes the
relationship between an amputee and their artificial limb. A significant component of a
provider’s artificial limb prescription is based on the amputee’s present and predicted
health status, as well as their (the amputee’s) goals and needs.
Studies by Desmond and colleagues (2002, 2005, 2006, and 2008), Callaghan,
Condie, and Johnston (2008); as well as Coffey and colleagues (2009, 2012, and 2013)
all reported findings that supported the importance of psychological and emotional wellbeing in the success of an amputee using an artificial limb, success being measured by
use of the limb and activity level (but not residual limb skin problems). In the late 1970s,
Engels posited the biosphychosocial model in which the health and quality of life for an
individual was dependent on the interaction between their physiologic status,
psychological condition and social barriers which, when applied to the transtibial
dysvascular amputee includes disease control through self-care and management,
psychological adjustments to changes in body image, independence, and mobility, as well
as care and maintenance of both their artificial and residual limb (Engels, 1977). Thus,
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based on this model, it is not likely that activity level is solely responsible for a lower
limb amputee to develop a residual limb skin problem, but rather a combination of factors
that define their activity level and their ability to self-manage care (Engels, 1977; Jack et
al., 2004; Hanley et al., 2004). To address this issue, research question 3 was intended to
ascertain the association between certain comorbid physiological diseases frequently
related to or in-line with dysvascular conditions (such as renal failure and CHF) with the
development of a residual limb skin problem, regardless of any so-called mechanical
factors. Other diseases of interest included those that would affect energy level such as
COPD and CVD, as well as the mental health conditions PTSD (because of its
association with anxiety and adjustment disorders- coping mechanisms), MDD (because
of associated decrease in initiative and impetus), and SUD (because of its association
with poor health care and maintenance).
The subsequent GEE model analysis revealed that SUD was associated with a
significant likelihood of developing, either a less severe or severe RLSPS, and MDD with
the likelihood of developing a severe RLSPS only. In both conditions, a lack of impetus
regarding personal health care may be a factor leading to poorer overall health and a
more fragile residual limb prone to breakdown when an artificial limb is in use –
regardless of the configuration.
Substance use disorder is defined as having a continuum of spectra – from regular
use to abuse to dependence (The Management of SUD Working Group, 2009). In the
case of alcohol consumption dependence may be otherwise categorized as alcoholism,
with which comes the increased possibility of cirrhosis of the liver, cancer, and other
chronic conditions (The Management of SUD Working Group, 2009). A key
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characteristic of substance abuse, regardless of the substance or level of use, is a
disregard for potentially harmful effects (The Management of SUD Working Group,
2009). In the case of substance dependence, a great deal of time is spent by the individual
in activities necessary to procure the substance, use it, and recover from its effects.
Social, occupational, or recreational activities are foregone in lieu of use of the substance
and, despite knowledge of having a persistent or recurrent physical or psychological
problem that is likely to have been caused or exacerbated by the substance; usage
continues (The Management of SUD Working Group, 2009). For example, a cocaine user
will continue despite knowledge and experience of cocaine-induced depression;
alcoholics will continue drinking despite acknowledgement that to do so exacerbates an
existing ulcer (The Management of SUD Working Group, 2009). Thus, in the case of
SUD, depending on the degree of usage, both activity level and personal health neglect
could explain its significant association with the likelihood of developing both less severe
and severe RLSPS.
However, in regard to MDD, the most likely explanation is personal health care
neglect or a lack of impetus. Current trends in diabetes control require the dogged
engagement of the patient to self-medicate (insulin or glucose control medications), selfcare (exercise and eat properly) and self-manage their disease (CDC, 2011b; Jack, 2004).
However, in a study of over 700 surveyed U.S. Veterans, it was found that while welleducated by their clinicians regarding the need for monitoring, exercise, and proper diet,
The mean self-efficacy score for diabetes self-care was low and only half of the sample
reported readiness to change their diet or level of exercise, whereas those with a high
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self-efficacy (confident and motivated) were successful in adjusting their lifestyle and
self-managing their disease (Nelson, McFarland, & Reiber, 2007).
Any chronic disease, including diabetes, PAD, or PVD, is associated with some
order of mood disorders and depression. In the case of the diabetic, the prevalence of
depression may be three times greater than that of the non-diabetic population (Harris,
2003). Moreover, individuals suffering from depression and diabetes frequently present
with poor glycemic control and a higher incidence of microvascular and macrovascular
complications, ostensibly setting them up for poor healing capacity and skin breakdown
(Harris, 2003; Williams et al., 2011). In fact, among a cohort of diabetic U.S. Veterans it
was found that those with a comorbid diagnosis of depression also had a 33% higher
incidence of major limb amputation (Williams et al., 2011).
Given that an individual diagnosed with diabetes is likely to suffer some level of
depression that is then compounded by amputation, (which itself is associated with
depression [Darnall et al., 2005]), it is not surprising that dysvascular amputees
especially struggle with glucose control and self-management of their disease, as well as
maintenance and usage of their artificial limb. In a prospective multisite study, Nelson
and colleagues (2007) determined that U.S. Veterans one year post a dysvascular major
limb amputation and fitted with an artificial limb, demonstrated poorer function given a
comorbid diagnosis of MDD. A diagnosis of MDD is based on the presence of depressed
mood or loss of interest or pleasure, with additional symptoms to include significant
change in weight or appetite, insomnia or hypersomnia, decreased concentration,
decreased energy, inappropriate guilt or feelings of worthlessness, psychomotor agitation
or retardation, and suicidal ideation (The Management of MDD Working Group, 2009).
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Given such states, interest in self-management of a chronic disease or the function of an
artificial limb is likely wane, and when combined with poor hygiene of the residual limb
or psychomotor agitation, the residual limb of a dysvascular amputee is prone to break
down, especially, perhaps, as an infectious occlusion, given the potential for poor hygiene
and personal neglect.
That PTSD was not associated with either a less severe or severe RLSPS may be
reflective of both its symptoms and the age of the predominance of the cohort. 82% of the
cohort was 55 years of age or older and the mean age was 64 years. Veterans of this age
were likely soldiers in the Viet Nam war of which it has been estimated that
approximately 9% still suffer from post-traumatic stress disorder, although the intensity
and duration has likely diminished (The Management of Post-Traumatic Stress Working
Group, 2010). Symptoms of the chronic version of the disorder include low energy,
memory problems, unfocused during daily activities; inability to make decisions, feelings
of irritability, agitation, resentfulness or anger; depression/despair, spontaneous crying;
emotionally numb, withdrawn, or isolated; overly protective of or fearful for safety of
loved ones; unable to face any reminders of the trauma (The Management of PostTraumatic Stress Working Group, 2010). Many times, PTSD is concurrent with
diagnoses for adjustment and mood disorders, pain, and sleep disturbances, as well as
psychological conditions such as MDD or SUD (The Management of Post-Traumatic
Stress Working Group, 2010). While this litany of symptoms seem to support the concept
of an amputee with and increased likelihood of developing a residual limb skin problem,
as mentioned above, most of the cohort members were middle - to older age, likely
having dealt with such symptoms for decades, rendering the symptomology to a highly
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manageable state through treatment and time. However, while age is potentially an
explanation for PTSD’s lack of significant association with a RLSPS category, another
explanation may be that a diagnosis of PTSD with no concurrent psychological disorder
(such as mentioned above) does not present itself with symptoms and characteristics that
would impact activity level or health self-care and management sufficiently to attain a
significant likelihood of a residual limb skin problem. Future studies that address the
outcomes associated with concurrent, multiples of mental health diagnoses may provide
considerable more insight useful for artificial limb prescription guidelines.
Finally, The GEE analysis of so-called “behavioral factors” also revealed a
significant association between COPD and the likelihood of developing a less severe or
severe RLSPS. COPD was selected as a comorbid condition of interest because of its
potential for low activity levels, as well as poorly oxygenated blood to inhibit rapid
healing (The Management of Chronic Obstructive Pulmonary Disease Working Group,
2011; Gea, Agusti, & Roca, 2013). Medically, COPD comprises a combination of
chronic and slowly progressive respiratory disorders including emphysema and chronic
bronchitis with symptoms such as shortness of breath, coughing, and an irreversible
worsening course (The Management of Chronic Obstructive Pulmonary Disease Working
Group, 2011). While COPD is primarily a respiratory condition, it is associated with
systemic inflammation and manifestations (especially impaired gases exchange and
hyperventilation) that can then exacerbate other conditions (The Management of Chronic
Obstructive Pulmonary Disease Working Group, 2011; Gea, Agusti, & Roca, 2013).
Veterans are at higher risk of COPD than those in the general US population, and it has
been shown that “within the VA population, patients with COPD have significantly
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higher all-cause and respiratory-related health care utilization than patients without
COPD.” (The Management of Chronic Obstructive Pulmonary Disease Working Group,
2011, p. 17). COPD was a diagnosis for approximately 25% of the cohort, whereas CHF
was a diagnosis for 46%. Why COPD and not CHF was significantly associated with the
likelihood of a RLSPS is unclear. Both conditions would likely be characterized by low
activity/low energy, as well as poor tissue oxygenation leading to poor healing capacity
(CHF due to poor blood circulation; COPD due to poor blood oxygenation), such that it
can only be suggested that COPD may be more treatable or have a longer progression
until incapacity than CHF or renal failure, both end-stage diseases. In concurrence with
these findings, in his multisite prospective study, Webster reported that dysvascular
amputees utilizing a prosthesis one year post amputation and with a concurrent diagnosis
for COPD, reported “greater functional restriction” than those with no such diagnosis,
and those with a diagnosis for renal failure demonstrated fewer hours of walking with an
artificial limb (Webster et al., 2012). Furthermore, as with the psychological disorders,
many of the cohort members may have had concurrent diagnoses of these physical
conditions (as well as others) and it may have been the combination of comorbid
conditions (COPD plus CHF) that was associated with residual limb skin problems – a
factor beyond the scope of this study.
As with most human conditions, rarely can they be explained by a single cause,
but rather more accurately by the interaction of systems. In the case of the dysvascular
transtibial amputee, for example, it is clear that the artificial limb configuration and the
prosthetist that dispensed it play a role, but also the overall health and behavior of the
user. Research questions 1 through 3 were intended to determine if any one factor
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(mechanical or behavioral) was more responsible or associated with a RLSPS category
more than the other, about which it can only be stated that proper fit of the artificial limb
and the corresponding activity level of the user is key, and less clearly but equally
important, the impetus of the user to self-manage their underlying (dysvascular) disease.
Research question 4 addressed this more realistic condition by addressing the outcome
when the interaction of mechanical and behavioral factors are at play in the face of some
demographic conditions. A sort of assessment of the biopsychosocial model and the
likelihood of developing a residual limb skin problem that could further impact quality of
life for the artificial limb user. As with research question 3, the behavioral aspects of the
analysis were focused on the psychological comorbidities with the physical comorbidities
serving as proxies for activity level potential and overall health status. The four most
popular of the seven ALC categories were included in the analysis, as were the
demographic variables Marital Status (as an indicator of the presence of a care giver),
Age (categorized by three age groups), Race (to detect any disparities), and VA Priority
status (as a proxy for socioeconomic status).
The subsequent GEE analyses revealed that mechanical factors, in terms of the
ALC category, had little to do with the development of a residual limb skin problem. This
suggests that manufacturers are doing a good job of developing artificial limb
components that are safe and appropriately categorized within the ambulatory functional
levels (k1 through K3) (The Rehabilitation of Lower Limb Amputation Working Group,
2007). However, as revealed in the analysis for research question 2, who and where the
artificial limb was dispensed played a significant role in the likelihood of a cohort
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member developing a severe RLSPS. Much of the information the prosthetist or provider
gather and incorporate in their practice is acquired from vendor representatives, anecdotal
evidence, experience, and select journal articles (G. W. Bosker, CPO; personal
communication, January 2011; Iezzoni, 2004). This is one of the key reasons for
exploring the development of an amputee-artificial limb database and surveillance
system, to provide the prosthetists with a source of evidence based data rather than that
from marketers or hearsay. Nonetheless, as mentioned previously, the variable Region is
such a broad proxy for the prosthetist dispensing the artificial limb, the best that can be
construed from its statistical significance in the model is that something was different
about Region 4 compared to the other regions. Further analysis may have revealed that
the demographics of the Region differed significantly, perhaps the predominance of
Black cohort members resided in Region 4 (Blacks have a higher incidence of diabetic
complications, especially amputation, and may therefore suffer from a poorer health
status and propensity for severe residual limb skin problems); or, perhaps, a greater
proportion of cohort members with COPD received care in Region 4 relative to the other
regions and thus, an increased likelihood of developing a residual limb skin problem
(Dillingham et al., 2002b); Webster et al., 2012). Both of these potential explanations are
beyond the scope of this study but give credence to the value of an amputee-artificial
limb database derived from a surveillance system utilizing ICD-10 codes, basic
demographic parameters, and some indicator of where the artificial limb configuration
was dispensed. The zip code or license of the individual actually responsible for building
the artificial limb would add another level of granularity to the database and be useful for

321

insurance companies and oversight agencies as a means to identify and protect against
insurance fraud, while providing researchers with a geographical marker.
In regard to demographic parameters, only socioeconomic status (as defined by
VA priority) and age appeared to be associated with the development of a residual limb
skin problem. As indicated in Table B14 of Appendix B, VA priority categorizes
veterans on the basis of the degree of their disability, whether it is connected to the
duration or time of their military service or not, and their average adjusted income
(means test score) or capacity for employment. This categorization is necessary because
funding for the veterans is appropriated by Congress and thus is a finite amount (for all
intents and purposes); to insure that those veterans most in need receive the care required,
they are prioritized into eight categories (VIReC, 2011b; VIReC 2012b). Because of
small cell sizes, for this analysis, the eight categories were collapsed into three, based on
the likelihood that a particular priority group would or could be employed. Furthermore,
categorization by employment level was used as it was assumed that an employed
Veteran was likely to be of a reasonable health status (able to work, fewer comorbid
conditions, relatively active), and a veteran able to make co-payments, if not employed,
was of financial status sufficient to afford such as well as likely to be of a reasonable
state of health. Supporting this assumption and definitions, several studies have reported
significant associations between limb amputation and socioeconomic status - that living
in poverty presents more barriers to success with using a prosthetic, that comorbidity is a
common characteristic (especially in regard to U.S. Veterans and adults older than 65
years), and that rates of limb amputation are greater for those living in poverty than not
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(Ephraim et al., 2006; Wachtel, 2005; Selim et al., 2007; Ferguson, Nightingale, Pathak,
and Jayatung, 2010).
Given such definitions, 75% of the cohort was categorized as unemployable, 13%
as employable, and approximately 12% as co-pay eligible. The GEE analysis for this
research question 4 indicated that co-pay eligible cohort members were significantly less
likely to develop a residual limb skin problem compared to those cohort members
categorized as unemployable. It seems fairly safe to assume that a Veteran deemed
unemployable because of their disability/health status, is more likely to develop a
residual limb skin problem due to comorbid conditions than due to activity level, as
compared to the veteran who is employed (in which activity level would likely be of
greater relevance) or someone of the financial means (required to make co-payments).
However, this assumption does not fully address differences in activity levels between
employment categories as some jobs are more sedentary than others (lesser activity
level), certain behavioral disorders are associated with physical activity but not
employment (such as PTSD or SUD), and financial means may be related to retirement
and less activity. Therefore, for this study and variable (Socioeco/VA Priority) perhaps it
is more indicative of a cohort member’s health status than their actual socioeconomic
status, and seems to suggest that activity level for an albeit dysvascular amputee, is not
necessarily the driving factor as is suggested by Dudek et al., (2005) and Meulenbelt et
al, (2008). That being said, it should be remembered that the Veteran population is not
generalizable to the general public, that the data in this study represents national
conditions, and that both the Dudek and Meulenbelt studies were drawn from the records
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of a single outpatient clinic or survey of an amputee support group (Dudek et al., 2005;
Meulenbelt et al, 2008; Selim et al., 2007).
Age may actually have a dual representation – one as an indicator of
demographics and another as a proxy for health or activity level. For this research
question, age was a significant parameter given its association with the likelihood of
developing a residual limb skin problem. As with several of the other variables utilized in
this study, the original eight age groups were compressed into three age groups in order
to adjust for otherwise small cell sizes. The three groups were: (a) cohort members under
the age of 55 and representing 17% of the cohort, (b) cohort members between the age of
55 and 74 representing approximately 64% of the cohort, and (c) cohort members over
the age of 74 years representing approximately 20% of the cohort. As part of the analysis,
outcomes for the 55 to 74 year age group and the over 74 age group were compared to the
under 55 group. The selection of the younger group for comparison was based on the
assumption that such individuals would likely be of better health status and subsequent
fewer residual limb skin problems. At the time, the consideration of potentially greater
activity was not considered. The results revealed, however, that the over 74 age group
was significantly less likely to develop a less severe or severe RLSPS than the youngest
age group, suggesting that older age group was either healthier or less active (based on
the results from the previous research questions). Given the significance of COPD and its
tendency to worsen with age, as well as the cumulative/progressive effects of dysvascular
disorders over time, it is likely that the less likely development of RLSPS among the
older group is a function of less activity to exacerbate poor residual limb health and
fragility.
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Summarization of the epidemiological analysis. A key finding resulting from
the analyses of this study is the confirmation that activity level alone, does not explain the
incidence or prevalence of residual limb skin problems in this cohort of transtibial
amputees. Rather, activity level is closely associated with the health and well-being of
the artificial limb user and, factors less tangible than the mechanical superiority of an
artificial limb, contribute as much if not more to an amputees success with an artificial
limb and the likelihood of residual limb skin problems. The findings further indicate that
MDD, SUD, and COPD are such key factors that also interact with age and energy and
activity levels. Further, while the expertise and knowledge base of the prosthetist and
provider are paramount, the analyses in this study and the variable Region did not
sufficiently address the matter, leaving it unclear why the outcomes for one region would
be significantly different than the others.
Temporal effects. The premise or hypothesis underlying the influence of temporal
effects on the development of residual limb skin problems was that early on in the
follow-up period (for example between 6 months and 12 months) cohort members would
have predominantly less severe RLSPS as they began using their artificial limb and minor
adjustments were made to its alignment or configuration. As time progressed (months 12
to month 24) the number of severe RLSPS would increase as less severe problems failed
to heal or activity levels increased; and as the end of the follow-up period ensued (month
30 to month 36), the predominance of residual limb skin problems would be severe as
active users learned to self-treat, not coming in for clinic appointments until the problem
had become severe.
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The results of the GEE analyses revealed that there was little significant
association between time and developing a less severe RLSPS throughout the follow-up
period, except during the last 6 months of follow-up (months 30 and 36) in which cohort
members were significantly less likely to develop a less severe RLSPS. However, in
regard to severe RLSPS, only during the 36 month window was there less likelihood of
developing such a skin problem. The exception to these findings was in regard to
behavioral effects only in which both less severe and severe RLSPS were associated with
less likelihood of development during the 30 and 36 month windows, and in regard to the
interaction of behavioral and mechanical effects for the artificial limb category
community-locking suspension system in which at no time was there a significant
association for less severe RLSPS and only a significantly less likelihood of a severe
problem.
In truth, though fairly consistent between conditions and analyses, these findings
are inconclusive in terms of the proposed premise, but do support the suggestion that, at
the very least, toward the end of the 36 month follow-up, cohort members were less
likely to seek and receive treatment (no need for clinic visits an thus not registered on
hospital records), for residual limb skin problems, although the need for treatment of
severe residual limb skin problems lingered beyond that of less severe problems.
This analysis actually demonstrates a significant shortcoming of a database
review as opposed to surveys or even a chart review as residual limb skin problems are
only registered if the patient comes for treatment and then only as a single code thereof.
As discussed by van Walraven and Demers (2001) a chart review might include a history
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of problems as reported by the patient to the physician that were self-treated, and as
suggested by Meulenbelt et al., (2009) a survey may give a clearer indication of problems
but, being self-diagnosed, be in correct or less specific than that presented by an ICD-9CM (or ICD-10) code. Clearly further analysis is required to ascertain (1) the likelihood
of the progression of a less severe residual limb skin problem to a severe problem, (2)
what skin problems are most likely to progress, and (3) if the frequency of less severe
skin problems actually diminish over time or, as suggested from this study, they are
simply not recorded in a healthcare record system.
Limitations of the Study
Limitations Imposed by the Coding Systems
The use of HCPCS billing codes to identify ALC categories. The Centers for
Medicare Medicaid Services (CMMS) maintains HCPCS codes, and updates them
regularly and, new products are categorized by common features of functionality and
structure. A device is then placed under an existing code or, after careful consideration,
research and petition, a new code may be derived (CMMS, 2012).
A limitation of this approach is that innovative designs or new materials that
improve performance but. not function, are not differentiated from others of the same
category other than by model and Manufacturer name – data fields that were available in
the NPPD dataset extract but not always containing appropriate data (for example, the
vendor’s name rather than the manufacturers). This created problems in validating the
components used to configure the artificial limb (internal validity)and may also impact
future studies in that the use of HCPCS codes will provide only limited information about
the prosthetic device, and more subtle differences between products that may or may not
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impact the user will not be detectable. Additionally, there is anecdotal evidence that the
user interface application used by the VHA Prosthetics and Sensory Aids Service to
select/record the HCPCS code per device is not updated as frequently and thus, unless the
provider/user inputs the code directly rather than depending on the drop-down list
provided, codes used may inaccurately reflect the device delivered (G. W. Bosker CPO,
personal communication, March 2015). In other words, the accuracy of the codes are only
as good as the coder. The end result of depending on HCPCS codes to categorize
artificial limbs is a lack of specificity. Not only is it impossible to distinguish between
makes and models of components, or determine the purpose of the component (that is,
whether for backup limb or a sports limb) but, in some cases, it is not a single HCPCS
code that defines the functional capacity of the limb (or even the prosthetic foot) but
rather a combination of codes. The lack of specificity made it veritably impossible to
explain differences in residual limb outcomes within an ALC category (such as due to a
particular model or manufacturer). Additionally, the fairly broad categorization of the
ALC variable may explain the lack of significant association between ALC categories
and residual limb outcomes. In general, the reliability of the dataset used in this study is
questionable, primarily due to data integrity problems evident in the data acquired from
the NPPD (from which the independent variable was derived).
Suitability of ICD-9-CM codes as an outcome measure for artificial limb use.
This study’s use of RLSPS as indicated by categories of ICD-9-CM codes was based on
the premise that residual limb skin problems directly impact an amputee’s use of their
artificial limb – the more severe the problem, the less likely they will use the limb; the
less they use the artificial limb, the greater toll on their mobility, independence, and
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quality of life. A distinct limitation of using ICD-9-CM codes as an outcome measure of
this sort, is that the code alone gives no indication of the cause or extent of the disorder,
only that the disorder was detected. Without a chart review (review of progress notes) or
patient interview, it is impossible to know the extent of a problem (such as how much of
the residual limb was covered with a rash, how large or deep an ulcer was, or how much
discomfort the problem caused the patient). As to the cause of the disorder, for some, the
etiology may be easily inferred or implied by the disorder itself (for example, calluses
[ICD-9-CM code 700 - corns and callosities] as a consequence of repetitive microtrauma
related to artificial limb fit), whereas others may be less easily inferred (such as
Folliculitis [ICD-9-CM code: 704.8 - Other specified diseases of hair and hair follicles]).
To this end, Bui et al. (2009) recognizing the need for standard categorization of
residual limb problems frequently associated with the use of an artificial limb, devised a
categorization of residual limb skin problems either on the basis of etiology or
morphology that could be used in conjunction with ICD-9-CM codes. However, the skin
problems Bui and colleagues referenced did not include their associated International
Codes for Diseases (ICD) and only included those conditions most commonly associated
with artificial limb use (Bui et al., 2009). For this dissertation, the Bui categories were
modified to account for additional conditions related to artificial limb use such as
osteomyelitis and gas gangrene because of their debilitating effect on the user. However,
without any indication of the extent of a problem, it is difficult to properly assign a ICD9-CM code to a particular category. For example, a rash (categorized as a less severe
problem) that covers most of the residual limb may better be categorized as severe; an
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ulcer (categorized as a severe problem) that is small in size and heals rapidly may better
be categorized as a less severe problem.
This limitation of ICD-9-CM codes is further confounded as the codes themselves
do not indicate where the disorder or condition is located. The actual location of the skin
problem was inferred from the ICD-9-CM code label only. For example code labels that
indicated body parts such as head, face, neck, trunk, foot, ankle, etcetera, were not used;
those that indicated lower leg, shank, or below knee, were included, as were those
conditions that were non-specific such as irritant dermatitis (ICD-9-CM: 692.9).
Subsequently, residual limb skin problems may have been inappropriately assigned to a
category. The relatively arbitrary categorization of RLSPS, though based on educated and
informed decisions, likely diminished the reliability of the associations and both internal
and external validity of the study.
The VHA will be transitioning to ICD-10-CM codes during Fiscal Year 2016; this
upgraded coding system will include laterality (that is, left or right limb) as well as more
detailed information about the condition. For example, in the case of pressure ulcers,
ICD-9-CM codes include: 707.0 - Decubitus ulcer; 707.1 - Ulcer of lower limbs, except
decubitus; 707.8 - Chronic ulcer of other specified sites; 707.9 - Chronic ulcer of
unspecified site. ICD-10-CM codes will include the extent (depth) of the sore/ulcer, as
well as its location. Examples include: L89.131 – Pressure ulcer of right lower back,
stage 1; L89.134 – Pressure ulcer of right lower back, stage 4; L89.141 – Pressure ulcer
of left lower back, stage 1; L89.144 – Pressure ulcer of left lower back, stage 4 (CDC,
2016).
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The Categorization of the Independent Variable, Artificial Limb Configuration
As discussed in previous chapters 3 and 4, the artificial limb that a patient
ultimately uses is comprised of multiple parts configured to meet the anticipated or
expected needs of the patient. This study focused only on two parts of the total
configuration, the socket suspension system and the prosthetic foot which, in
combination, may not reflect the complexity or true functional level of the artificial limb.
For example, a patient may use an artificial limb comprised of a SACH foot, a multiaxis
ankle, a rotator, and a pin-lock suspension system with a patella-bearing socket; and be
categorized as a K1LOCK user as the SACH foot (L5970) is classified as suitable for K1
functional level users. The K1 functional level implies an individual that uses their
artificial limb for minimal walking and/or transfers only. However, with the addition of
the multiaxis ankle (a separate component that sits on top of the SACH foot) effectively
creates a system more suitable for a K2 functional level user (household ambulatory), and
the addition of the rotator (a device that sits on top of the pylon and just below the socket
to allow for a degree of twist of the shank portion of the limb and greater ease of turning
during walking) effectively makes the artificial limb configuration suitable for a K3
functional level user (community ambulator) (DePalma et al., 2002; G. W. Bosker CPO,
personal communication, January 2011). Therefore the categorization of the artificial
limbs in this study may be inaccurate as to the actual functional level/capacity of the
cohort member amputee and thereby threatens the internal validity of the results.
However, the intent of the study was explorative, the use of GEE modeling robust, and
insofar as the categorization was based on the component types and not the functional
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capacity of the cohort member, internal validity is fundamentally preserved as all causal
relationships were considered estimates.
In regard to the categorization of the independent variable, another shortcoming
of the study is the decision to combine the three ALC categories Transfers, HouseholdHigh Tech Suspension system, and Household- Mid to Low Tech suspension system, and
have the combined categories serve as a single reference category for comparison with
the remaining four. The decision was made on the basis of low cell sizes and a
subsequent unbalanced model, but to have retained the categories in the model may have
improved external validity by representing an important cohort of dysvascular amputees
– those of lesser activity (walking) levels. Such an analysis may also have offered insight
as to outcomes associated with activity or no activity.
Generalizability of the Cohort Dataset and Veteran Population
Several factors inhibit generalizability of the study findings to include
demographics of the U.S. Veteran population, their access to health care, and aspects of
the study design and its scope.
The U.S. Veteran population is unique , especially when Comparing 2009 U.S.
Veteran statistics with 2010 U.S. census statistics: the Veteran population was comprised
of 92%males and 8% female while U.S. census reported 49.8% male and 50.8% female;
Among Veterans,39% were over the age of 65 years, whereas the Census reported 13%
of the population as being over the age of 65 years; and in regard to race, the Veteran
population was comprised of 7% more Whites, 1% fewer Blacks, 3%fewer Asian, 9%
fewer Hispanic, but about the same percentage of American Indian .(DVA, 2010a; U.S.
Census Bureau, 2016). Furthermore, in a cross-sectional survey of 887,775 veterans
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conducted by Selim and colleagues in 2004, using a valid and reliable survey, it was
determined that elderly veterans were of poorer health quality than similar demographic
older persons enrolled with Medicare, ranging from 0.5 to 1 standard deviations worse.
Another factor rendering studies with the US. Veteran population nongeneralizable to the overall U.S. population is the veterans access to healthcare,
especially during the time period of this retrospective study that utilized data from 2007
through 2010 – prior to the Patient Protection and Affordable Care Act of 2010 (O’Bama
Care). The VHA is often noted as the largest public health system in the world, and
where disabled veterans (representing 75% of the cohort) receive all health care,
including their artificial limb, at no cost. Only 12% of the cohort were required to make
co-payments. It is likely that the similar non-veteran, non-military, on-institutionalized
individual living in the U.S. during that same period of time would not have had the same
access, even with the support of Social Security Disability Insurance, Medicare, or
Medicaid. While not all Veterans take advantage of the VHA (for whatever reason)
those that do receive medical and surgical care, durable medical equipment, housing
modifications (if required) and clothing allowances at no charge or a minimum copayment (Department of Veteran Affairs, 2010b). Such elements of the U.S. Veteran
population typically makes disease risk ratios and the like less relative to the general
public, but for studies that are less concerned with predicting disease rate and more
oriented in testing a hypothesis regarding an informatics tool (such as an amputeeartificial limb database), demographic issues as described above become less of a
limitation.
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This study was intended to test the feasibility and usefulness of an amputeeartificial limb database utilizing HCPCS codes (to define the artificial limb) and ICD-9CM codes to defined comorbid conditions and the outcome variable – residual limb skin
problem. The informatics phase basically tested the feasibility of designing such a
database, and the epidemiological phase tested the usefulness of the data. The source data
was the NPCD (clinical histories) with a long history and reports of data validity and
reliability, and the NPPD (artificial limb component data) with a short history, very few
reports of data validity and reliability and few reports of utilization in research (Smith et
al., 2010; VIReC, 2012b). Unfortunately, no other similar database is maintained within
the United States, and even thus, is only accessible to VHA personnel and researchers.
Because of the relatively unknown quality of the NPPD data, the study design was
structured to limit the scope of the study to only estimations of likelihood rather than risk
ratios. Missing data, and data incongruencies resulted in a smaller sample size than
predicted, and several variables had to be compressed into fewer categories because of
small cell sizes leading to variables of low specificity and less meaning. The reason for
such data quality is unknown at this point , as the data that fills the various fields within
the NPPD are drawn from multiple other sources within the VHA (such as the purchasing
and contracts service, clinical records, and decision support systems) via the VIST-A
software (Pape & Reiber, 2001). If data from any of these other applications/systems is
corrupted or poor, than so shall be the NPPD data.
The end result is that the informatics phase of the study has limitations
subsequent of data type, regardless of the study population, and the epidemiological
phase has limitations because of the data. Extrapulating or generalizing results from the
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epidemiological phase to the general public is not recommended as the U. S. veteran
population has both unique health problems and benefits that separate them from the
general public.
Summary
The Utility of Administrative Healthcare Data. The fundamental concept of
utilizing standardized coding such as Health Common Procedural Coding System
(HCPCS) billing codes and International Classification of Diseases codes, to identify
relationships between artificial limb use and comorbid conditions, is clearly not only
feasible but valuable. Many studies and case reports describe skin problems of the
residual limb, but very few describe such problems relative to the artificial limb in use
(Meulenbelt et al., 2007). At the same time, providers are being directed toward artificial
limb prescription guidelines or standards as put forth by various institutions to include the
Veterans Healthcare Administration, the Military Health system, the Centers for
Medicare Medicaid Services, and private insurance companies (DePalma et al, 2002; The
Rehabilitation of Lower Limb Amputation Working Group, 2007; Centers for Medicare
Medicaid Services, 2015; Cigna Health Care, 2010).
As an example of a prosthetics surveillance database in action, in Great Britain
surveillance measures by the various Prosthetic and Amputee Rehabilitation Centers
(PARCs) of the British Health System are strongly encouraged to collect, maintain, and
provide statistical data relative to amputee rehabilitation and prosthetics to the National
Amputee Statistical Database (NASDAB) (British Society of Rehabilitation Medicine,
2003). A stated goal of the BSRM’s standards and guidelines for data collection and
analysis (surveillance) is to serve as a means to audit the service practices and outcomes
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of the PARCs as well as to provide future and present evidence of patient outcomes
(British Society of Rehabilitation Medicine, 2003). It is this sort of surveillance that is
lacking in the United States and likely contributes to the high healthcare costs and
questionable quality of life for the amputee. Without artificial limb prescription
guidelines, without a means to monitor patient outcomes, and without easy access to such
information, the individual living with limb loss is, by necessity, at the mercy of their
own resources.
This study was able to demonstrate the value of an amputee-artificial limb
database as derived via a surveillance system based on healthcare administrative records.
Two main aspects thereof are particularly relevant: (1) the study cohort dataset
successfully served as a means for evaluating prescription practices and outcomes
through the use of standardized coding systems and a clinical database, as opposed to
localized chart reviews, and (2) the significance of comorbid conditions relative to an
amputee’s use of an artificial limb versus purely mechanical influences.
While it is evident that database structure and format problems still exist for the
NPPD, this study could not have been conducted without it as no similar database exists
within the United States. It is believed that modifications toward improvement of the
database are fairly straightforward and could be accomplished through thoughtful
upgrades of the primary input applications (namely the Prosthetics Software Package
[PSP]), as well as focused validation and reliability studies similar to that conducted by
Smith et al., (2010). Basically, the more studies that exploit features of the NPPD, the
more weaknesses or limitations can be identified and potentially rectified, increasing its
value and usefulness. Some feature improvements might include a variable/field that

336

indicates the manufacturer of a component (such as Otto Bok or Ohio Willowwood) and
not just the local vendor; the model number of the component dispensed (not just
ordered); a variable/field that indicates the purpose of the component (for example,
primary limb, back-up limb, or sports limb); and regular updates with date notation of
HCPCS codes. To this end, despite various problems and limitations of the VHA’s NPPD
and despite the fact that the U.S. veteran population’s health condition and care system is
not entirely generalizable to the general public, the NPPD deserves further development
and improvement as a sole source of national prosthetics information.
In respect to the use of residual limb skin problem categories of ICD-9-CM codes
as an outcome measure, primarily due to limitations with ICD-9-CM codes, there existed
the potential for over or poor identification of problems. However, indications are,
compared to a chart review study by Dudek and colleagues (2005), the overall frequency
of skin problems may not be significantly more or less. With the implementation of ICD10 codes, more accurate accounting of skin problems restricted to the residual limb are
likely, given the greater granularity/specificity of the codes. Hence, more meaningful
categories thereof (such as that suggested by Bui et al., (2009) may be implemented as
standards, improving the robustness of a surveillance system and lead to more
meaningful causal inferences between and within subcategories of outcomes and
associated artificial limbs.
Determinants of Residual Limb Skin Problems. The results of the
epidemiological analysis were as revealing as the development of the study cohort
dataset. A common expectation and regularly identified determinant of residual limb skin
problems is the activity level of the user (Dudek et al., 2006; Meulenbelt et al., 2009).
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Conversely, in an observational study by Salawu and colleagues (2006), it was reported
that continued use of an artificial limb despite the presence of an ulcer on the residual
limb, resulted in only 2% of the population demonstrating deterioration of the ulcer over
a six week period. However, the actual activity level of the population was not measured,
comorbid conditions not recorded or reported and, as with the studies by Dudek and
Meulenbelt, the type of artificial limb used not recorded or not included in the analysis
(Dudek et al., 2005; Meulenbelt et al., 2009; Salawu et al., 2007). Perhaps one of the
greatest advantages of the study cohort dataset used for analysis in this study was the
ability to test for associations between multiple factors, especially the ALC categories
and patient comorbid conditions (otherwise referred to as mechanical and behavioral
factors, respectively). While the study design did not truly lend itself to causal inferences,
it did reveal a fairly interesting outcome – that residual limb skin problems may be more
closely associated with the user’s comorbid conditions than with their actual activity
level, as there was no significant mechanical effect but multiple behavioral effects related
to their comorbid conditions. The finding of no significant associations between ALC
categories and residual limb skin problems is promising as it helps to demonstrate that
manufacturers and prosthetists are designing artificial limbs that are both functional and
safe for the user, however, the remaining results suggest that perhaps more attention
needs to be given to the psychosocial influences that drive a user’s compliance in the care
and maintenance of both their artificial limb and comorbid condition. In other words, that
behavior (which drives activity) related to a disease is an equally important consideration
when prescribing an artificial limb configuration as the actual components used. The
significant association between COPD (frequently associated with smoking habits and
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resulting in poor oxygenation of tissue) and substance use disorder (including alcohol
use, dependency, and abuse; associated with hyperglycemia among diabetics), were both
significantly associated with the likelihood of developing a severe residual limb problem,
regardless of the ALC category used, giving credence to this concept. Further, the
association between MDD and severe residual limb skin problems, plus cited
associations between MDD, COPD, and diabetes (let alone with amputation) strongly
supports the need for providers to recognize and acknowledge the import of such
parameters when estimating the best artificial limb for an individual. The so-called
determinants MDD, SUD, and COPD support Engel’s theory of the biopsychosocial
model - that the mind-body connection exists and plays a significant role in an amputee’s
success with an artificial limb, not only in terms of self-management and medical
compliance, but on activity/energy levels. The demographic variables Age Group,
Socioeconomic/VA priority, and Race, all co-contributed to the outcomes of the final
model, but less clearly so. The youngest age group (less than 55 years of age) were
consistently more likely to have residual limb skin problems relative to the other age
groups, the primary assumption and explanation being more activity; Cohort members of
a higher socioeconomic status (required to make co-payments) were less likely to develop
residual limb skin problems; and Blacks more likely than Whites to develop residual limb
skin problems, assumed to be related to their greater susceptibility to complications of the
underlying dysvascular condition (Dillingham et al, 2002b).

Unfortunately, the use of a

database such as the one developed for this study, is not conducive to more declarative
statements regarding demographics in part due to the nature of the study (healthcare
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records instead of survey tools) and the fact that all Veterans are eligible for healthcare
with at most, a co-payment
For these reasons and to further validate the usefulness of an amputee-artificial
limb surveillance system and database, further manipulations of the existing dataset is
warranted. Such manipulations may include the analysis of different amputee
subpopulations, different or clusters of comorbid conditions, or a different statistical
model. Of course, given sufficient resources, a prospective study of a cohort of amputees
is preferred and the gold standard for practice-based evidence medicine, but because of
the complexity of the functional amputee with an artificial limb and their relative scarcity
compared to other chronic conditions, the concept(s) put forth by this study becomes
more and more relevant, especially with the current trends toward population and public
health practices.
Recommendations
Recommended Improvements and Modifications to the NPPD
As stated previously, a key component of this study was creating the study dataset
using extracts from the NPPD, a repository of prosthetics transactions maintained by the
VHA’s Prosthetics and Sensory Aids Service. This database has only been in
development since 2000, with a major adjustment made in 2005 and modifications to the
primary input application in 2012 (G. W. Bosker CPO, personal communication, March
2015). Of course, validity and reliability studies involving the NPPD are recommended
and will be accomplished with the continued use of the database. However, to facilitate
its use, based on the experiences of this study, a few modifications could go far to
improve its usability:
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•

Replace text fields (such as Item) with formatted fields that will reduce ambiguity
and improve data integrity. This modification may be more a matter of improving
the input application to include checkboxes or selection boxes. An example would
be a checkbox to indicate if the component is for the amputee’s left or right limb
and for what level of amputation (for example, left above knee, right symes, or
bilateral transtibial), which could then be validated against the ICD-10 surgical
codes from the NPCD clinical histories. This modification would not only
improve validity, but resolve conditions encountered with the present database of
2007-2010 wherein the Item NPPD variable would indicate “AKA” (above knee
amputation) associated with the HCPCS code for a distinctly transtibial artificial
limb component; or a prosthetic foot that could be used by either an above-knee
or below knee amputee. Such clarifications become relevant when attempting to
associate a particular component with a physical outcome as was addressed in this
study.

•

Another selection box (with each HCPCS code) that indicates the purpose of the
limb the code is a part of such as primary, back-up, or other. Many times there
were multiple related components (as indicated by HCPCS codes) for a single
individual, dispensed within less than three months of each other, making it
unclear if the patient had one or two artificial limbs (possibly suggesting a
bilateral amputee), if the components were being replaced, or if there was a
duplication in the records (sometimes the dispense date was missing). On
occasion but infrequently, the NPPD field Item or Notes would indicate that one
set of components was for a back-up/secondary artificial limb, or for a particular
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purpose such as swimming or running. Again, this information becomes relevant
when associating an artificial limb configuration or component to a specific
outcome, especially as this study supported the import of activity level on the
likelihood of developing a residual limb skin problem – knowing if the artificial
limb was being used for a particular sport or for everyday use thereby becomes
relevant.
•

To improve data usefulness and meaning to the clinician, it would be helpful if
the manufacturer of the component were included in the database. Presently, the
vendor is indicated which is likely input from the purchasing and contract service
but bears little meaning to a clinician or researcher from another VISN or region.
As indicated in the section Limitations of the Study above, a single HCPCS code
refers to a functional capacity or type of a component and may have multiple
manufacturers thereof. Given that many clinicians receive almost strictly
marketing information regarding a component, and that a purpose of an amputeeartificial limb informatics tool is to improve evidence-based medicine, identifying
the manufacture (such as Otto Bock, Ohio Willowood, or Endo-lite) becomes
especially relevant.
It is planned that the above information, as well as other problems encountered

with the NPPD and a summary of the results of the study will be prepared as a White
Paper and presented to the South Texas Veterans Health Care System Chief of
Prosthetics and Orthotics Service, with the request that the paper be reviewed. If so
desired, the contents will then be edited as deemed necessary and (hopefully) forwarded
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to the VISN 17 Prosthetic and Orthotics Service Chief for further consideration.
Additionally, as a courtesy to the NPPD Data Steward that approved access to the data, a
similar White Paper will be prepared and sent to that office.
Future Studies and Analyses
Based on the findings of this study and the apparent support from peer-reviewed
literature, it seems apparent that the study dataset derived and utilized has merit: a chart
review of residual limb skin problems had similar frequencies and types of problems
(Dudek et al., 2005); the same comorbid conditions found to be significant in the
likelihood of developing a severe residual limb skin problem (namely MDD, SUD, and
COPD) were also found to significantly impact an amputee’s functional ability at least
one year post amputation (Webster et al., 2012); and that activity level alone does not
explain the type and frequency of a residual limb skin problem among dysvascular U. S.
Veteran amputees (Williams et al., 2011; Hanley et al, 2004). It therefore seems
important to further assess the usability of the derived dataset by addressing
subpopulations of the initial cohort such as transtibial amputees without a dysvascular
comorbid condition (traumatic amputees). This would prove valuable not only medically
by potentially identifying differences in comorbid conditions, particularly MDD, PTSD
and SUD, their impact on a U. S. Veterans likelihood of developing a residual limb skin
problem and, potentially, their quality of life, but also help to discern the sensitivity and
specificity of the informatics tool by comparing results to that of the dysvascular amputee
(this dissertation). Using the same methodology as described in this study, other subpopulations to consider might be the above-knee amputee or the upper limb amputee. The
upper limb amputee is especially relevant in that one aspect of a clinical database (such
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as the one derived for this study) is its potential for assessing populations that would
otherwise be difficult and expensive to research because of their scarcity (Black, 1997;
Hlatky, 1991; Sacristan & Galende, 1999; Iezzoni, 2004). Upper limb amputees account
for only approximately four percent of all amputees, but the source data used in this study
was national in scope, with over three thousand unique amputees in 2007, a similar study
of approximately 120 cases is feasible (Limb Loss Resource Center, 2012). Significant
improvements in upper limb prosthetics that incorporate computerized control with
myographic input makes an epidemiological analysis of upper limb amputees intriguing.
Reanalysis of the Study Cohort
One of the questions that consistently arose in this dissertation but was beyond its
scope was the matter of the combined impact of comorbid conditions. This multivariable
analysis considered each of the selected comorbid conditions and their association with
the likelihood of an artificial limb user developing a residual limb skin problem.
However, as reported by Selim and colleagues (2004) older adult U. S. veterans suffer
from multiple comorbid conditions and all must act on an individual’s capacity to heal
and function in concert with each other rather than singly. The study by Webster et al.,
(2012) indicated that MDD and COPD were responsible for less functioning with an
artificial limb, and this doctoral study eluded to combinations of comorbid conditions
such as CHF and COPD, or PTSD or SUD as having a greater impact in combination
than as separate conditions. In fact, in the case of PTSD the conditions SUD and MDD
frequently go hand-in-hand (The Management of Post-Traumatic Stress Working Group,
2010). It is felt that combinations or ‘clusters’ of diseases will have a greater impact on
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the severity of a potential residual limb skin problem and thus could go far in helping
clinicians determine the best prescription and prognosis for an individual.
Another approach to the data might be to reanalyze the data used in this study first
to determine exactly which ICD-9-CM codes for residual limb skin problems were most
frequently identified, and secondly look for significant correlations between those codes
and a comorbid condition, regardless of the artificial limb used (especially as it was
determined that mechanical effects were minimal and non-significant). This would help
refine the list of dermatological ICD-9-CM codes and, as with the Bui study, provide a
more specific list of residual limb skin problems to use in future studies.
Finally, I identified Region 4 as having significantly more severe residual limb
skin problems than Region 2, while the other two Regions had no similar significance. It
was also demonstrated that the ALC category had no significant relationship with
residual limb skin problems, leading one to question what is so different about Region 4.
The first step might be to compare Region 4 to Regions 1 and 3 (same approach as that
used to address research question 2) by changing the reference category from Region 2 to
Region 4; if no other Region outcomes differ significantly from Region 4, it would then
be safe to state that there is something distinctly different between Regions 2 and 4. A
next step, then, might be to assess the variability in frequency of residual limb skin
problems among VISNs within the two regions using descriptive statistics – perhaps only
a couple VISNs within Region 4 are skewing the results and their respective rates of
comorbid conditions and demographic variables may be examined to help isolate the
difference as being driven by geographical location and subsequent conditions, patient
health status, or prosthetist’s practices. If no particular VISNs stand out as having results
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grossly different from the other VISNs within Region 4 then additional data is required,
which was not available in the dataset.
Toward A Surveillance System
To date, no national amputee registry exists within the United States, although
several entities recognize and are promoting the development of such to include the
Amputee Coalition of America (ACA), the Military Health System, and Veterans Health
System. As of 2014, a business plan was put forth to establish a VHA Amputee Registry
and efforts made to initiate its progression , but to date, no such unique Registry has been
made available (G. Reiber PhD, personal communication, May 2013). Additionally, the
Amputee Coalition of America has included the formation and implementation of a
National Limb Loss Registry as part of their five to ten-year strategic plan (Amputee
Coalition of America, 2015).
Conclusion.
For the growing amputee population, the utilization of AHc records comprised of
ICD-9-CM and HCPCS billing codes, is a viable means for identifying patterns of
association between the type of artificial limb used, psychosocial factors, comorbid
conditions, and the skin problems of the residual limb. However, at this stage and while
feasible and viable, limitations associated with each coding system and the databases
from which they are drawn, preclude a level of sensitivity and specificity to offer more
than pattern recognition and support of general prescription guidelines. Nonetheless the
significant associations identified demonstrated the key role of amputee behavior and
comorbid health conditions play in the likelihood of an artificial limb user to develop
residual limb skin problems that affect energy and activity levels of the amputee – further
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evidence of the strength of the biopsychosocial model and how difficult it is to separate
the mind from the body, especially in terms of health care (Engels, 1977).
Of particular note as the finding that the combination of the prosthetic foot and
suspension system had little to no effect on the likelihood of development of a residual
limb skin problem and suggests that external forces placed on a residual limb are well
contained by the artificial limb itself, but may be modulated by geographic conditions
faced by the user. Further, it was indicated that healing capacity of the residual limb
compromised by pre-existing dysvascular conditions of diabetes, PVD and PAD, was
particularly prone to residual limb skin problems in the presence of the comorbid
condition COPD (associated with poor blood oxygenation); and that behaviors associated
with MDD and SUD increased the likelihood of a dysvascular amputee to develop
residual limb skin problems, possibly consequent of poor disease self-management.
Despite these associations that elude to the import of activity level relative to the
development of residual limb skin problems, it was not possible to parameterize such
given the use of coding systems as well as the close relationship between psychological
status and the type and amount of activity. In other words, mechanical and behavioral
factors are truly integrated and difficult to separate, at least given this cohort of amputees,
and may continue to be a weakness of this type of evidence-based medicine technique.
Ultimately, this study demonstrated the value of healthcare administrative data,
manipulated to form a clinical database, as an effective tool in the field of prosthetics to
more comprehensively associate health parameters (both physical and mental) with
debilitating outcomes for the artificial limb user. Such determinants may have varying
implications within an amputee cohort, depending on the homogeneity or heterogeneity
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of the cohort, but provides focus for future research as well as the import thereof. While
an artificial limb need be customized to its user, that customization cannot be based on
biomechanics alone, but needs to incorporate the psychosocial conditions of the user as
well, in order to facilitate good quality of life.
Implications for Positive Social Change.
For those amputees using an artificial limb, their quality of life is often modulated
by residual limb problems resultant from the use of the device. It is not always clear if the
problems are due to the mechanics of the device or practices of the user. Unfortunately,
unlike a pair of shoes, it is not a simple matter to exchange one artificial limb for another,
nor does the typical artificial limb user have any prior experience, causing most to be
dependent on the decisions and recommendations of their practitioner.
However, multiple factors preclude quality EBM research in the field of prosthetics and
rehabilitative medicine, leading to prosthesis prescription ambiguity and associated
greater health risk (Borg & Sunnerhagen, 2008; Groah et al., 2009; Iezzoni, 2004).
Further, the field of prosthetics is not open to governmental control (such as by the FDA)
beyond the requirements of Good Manufacturing Practices and subsequently, marketing
information is a prime source for many practitioners and prosthetists (FDA, 2012).
Countering or supporting relative marketing information, through the acquisition,
evaluation and/or dissemination of objective evidence-based outcomes, promotes the
likelihood of a vulnerable population to receive unbiased educated medical care and
decision. To this end, various studies support utilization of AHc derived clinical
databases as a means to support improved quality of life, especially in the absence of
randomized control trials – the foundation for most (EBM) research and information
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(Guller, 2006; Nordio et al., 2009; Tseng et al., 2005; van Walraven et al., 2009) . The
findings of this study support such and give credence to development of a national
surveillance system, a proven means to drive product, policy, and medical decisions
toward an improved quality of life for the target, involved population (CDC, 2012a).
More specifically, especially given the current emphasis on patient-centered care,
stakeholders of an amputee-artificial limb national database and surveillance system,
could benefit from an unbiased resource (similar to the dataset used for this study) from
which to ascertain the combined influences of psychosocial and comorbid conditions
with artificial limb technology (a more holistic approach) and prescription guidelines
more applicable to individual cases. Furthermore, an artificial limb for the below-knee
amputee alone ranges in cost from $500 to over $10,000 (G. W. Bosker CPO, personal
communication, January 2011), making less ambiguous prescription guidelines a
veritable necessity in order to provide the most efficacious artificial limb for an
individual, regardless of marketing pressures.
This small step away from marketing and commercialism is one step toward
social justice for a vulnerable population (amputees), and any move towards social justice
is a move towards positive social change. Albeit small and incremental, this move toward
social justice is relative to many, not just in regard to racial or gender disparity, but more
towards that which governs disabled persons who struggle to assimilate with the ablebodied public. The amputee population includes persons with mental health disorders,
persons of all races, and persons of varying lifestyles, all of whom can be found on the
fringes of society regardless of any limb loss, and whose quality of life should not be
further compromised by the use of an artificial limb.
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Therefore perhaps the most significant implication for positive social change that
this study supports, is the feasibility of using easily accessible, standardized, evidencebased population data that can be transformed into meaningful information to improve
the quality of life for a growing population of amputees, without sacrificing device
innovation or technology, but rather by directing it toward the actual needs of an
amputee, other than what may be perceived without unbiased evidence.
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Appendix A: Pilot Study Results from Laurel Copeland, Ph.D.
From:
Sent: Saturday, February 20, 2010 8:27 AM
To: Walden, Judith G
Subject: fy09 leg amputations
Dear Gail,
I asked …, one of our data analysts (DA's), to determine the
number of unique patients who met any of the following criteria in FY09
nationwide. We found 2,321 persons who appear to be new AKA/BKA amputees in
FY09. I asked the DA to use 3 files, the inpatient discharge file (contains
diagnosis; netted 3 cases), the inpatient surgery file (contains diagnosis and
ICD9A codes; netted 1951 cases), and the inpatient encounter file (contains
diagnosis and CPT codes; netted 1338 cases). The DA then merged them to get 2321
unique persons.
Here are the criteria I used (having any of these codes causes the person to be included in
the count of AKA/BKA):
ICD9A:
'8414' = '8414 AMPUTATION OF ANKLE THROUGH MALLEOLI OF
'8415' = '8415 OTHER AMPUTATION BELOW KNEE
'8417' = '8417 AMPUTATION ABOVE KNEE

'
'

'

CPT:
'27590' = '27590 AMPUTATE LEG AT THIGH'
'27591' = '27591 AMPUTATE LEG AT THIGH'
'27592' = '27592 AMPUTATE LEG AT THIGH'
'27598' = '27598 AMPUTATE LOWER LEG AT KNEE'
Amputation ICD9 Dx Codes
896 Traumatic amputation of foot (complete) (partial)
897 Traumatic amputation of leg(s) (complete) (partial)
Interesting, huh?!
Center for Applied Health Research, Health Outcomes Core, Central Texas Veterans
Health System, Temple, Texas.
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Appendix B: Study Cohort Database Data Dictionary
Artificial Limb Component HCPCS Codes
Table B1
Component
Socket suspension systems:
Straps and belts
Cuff suspension
Suspension sleeve
Vacuum assisted
Suction suspension
Sleeve, pin-lock mechanism
Supercondyle
Prosthetic Feet:
SACH foot
SAFE foot (flexible keel)
Single axis ankle/foot
Flexible Keel
Multiaxial ankle/foot
Energy-storing (dynamic response
Dynamic response/multiaxis
Flex foot
Flex-walk system
Shank system with vertical loading pylon
Microprocessor-controlled ankle foot
prosthesis (for example, Proprio Foot®)
Multiaxis, flexible keel

HCPCS billing code(s)
L5680, L5682, L5684, L5688, l5690
L5666
L5685
L5781, l5782
L5647
L5671
L5670
L5970
L5972
L5974
L5972
L5978
L5976
L5979
L5980
L5981
L5987
L5973
L5975
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Table B2.
Artificial Limb Configuration (ALC)
ALC
Source
Type
Values

Comments

Category
definition:
1.transfers
Sub-category
K1H
K1lm
K1m
K1l
2.household
high-tech ss
K2H

3.household
mid to low

Artificial Limb Configuration
National Patient Prosthetics Database (NPPD) file extracts
Categorical
1.transfer, 2.household high-tech ss, 3.household mid to low, 4.household
locking ss, 5.community high-tech ss, 6.community mid to low, 7.community
locking ss
Each value/category is a combination of a prosthetic foot and socket
suspension system whose codes are presented below. The categories were
derived to reflect the K-level of the prosthetic feet and the technical
sophistication of the socket suspension system. “technically sophisticated”
can be defined as a device having multiple moving parts or advance materials;
as the k-level of prosthetic feet increases, so does the complexity of the design
and materials; straps, belts, and cuff suspensions are classified as low,
suspension sleeves and molded supracondylar suspension as moderate, and
suction or vacuum assisted suspension systems as high in their level of
technical sophistication.
HCPCS codes were identified from the Durable Medical Equipment,
Prosthetics/Orthotics, and Supplies Fee Schedule on the Centers for Medicare
Medicaid Services website at http://www.cms.gov/Medicare/Medicare-Feefor-Service-Payment/DMEPOSFeeSched/DMEPOS-Fee-Schedule.html

K1 level prosthetic feet (artificial limb used primarily for transfers such as
from bed to chair), combined with any type of socket suspension system.
HCPCS Code Combinations
L5970+L5647, L5781, or L5782
l5974+L5647, L5781, or L5782
L5970+L5671 or l5673
l5974+ L5671 or l5673
L5970+L5685 or L5670
l5974+L5685 or L5670
L5970+L5680, L5682, L5684, L5688, l5690 or , L5666
l5974+L5680, L5682, L5684, L5688, l5690 or , L5666
K2level prosthetic foot with a technically sophisticated socket suspension
system
L5972+L5647, L5781, or L5782
L5975+L5647, L5781, or L5782
L5978+L5647, L5781, or L5782
l5973+L5647, L5781, or L5782
K2 level prosthetic foot with a low to moderate technically sophisticated
socket suspension system
(table continues)
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ALC
K2L

K2m

4.household
locking ss
K2lm

5.community
high-tech ss
K3H

6.community
mid to low
K3l

K3m

7.community
locking ss
K3lm

Artificial Limb Configuration
L5972+L5680, L5682, L5684, L5688, l5690, or L5666
L5975+L5680, L5682, L5684, L5688, l5690, or L5666
L5978+L5680, L5682, L5684, L5688, l5690, or L5666
l5973+L5680, L5682, L5684, L5688, l5690, or L5666
L5972+ L5685 or L5670,
L5975+ L5685 or L5670,
L5978+ L5685 or L5670
l5973+L5685 or L5670
K2 level prosthetic foot with a locking mechanism socket suspension system
L5972+L5671 or l5673
L5975+L5671 or l5673
L5978+L5671 or l5673
l5973+L5671 or l5673
K3 level prosthetic foot with a technically sophisticated socket suspension
system
L5976+L5647, L5781, or L5782
L5979+L5647, L5781, or L5782
L5980+L5647, L5781, or L5782
L5981+L5647, L5781, or L5782
K3 prosthetic foot with a low to moderate technically sophisticated socket
suspension system
L5976+L5680, L5682, L5684, L5688, l5690, or L5666
L5979+L5680, L5682, L5684, L5688, l5690, or L5666
L5980+L5680, L5682, L5684, L5688, l5690, or L5666
L5981+ L5680, L5682, L5684, L5688, l5690, or L5666
L5987+L5680, L5682, L5684, L5688, l5690, or L5666
L5976+L5685 or L5670
L5979+L5685 or L5670
L5980+L5685 or L5670
L5981+L5685 or L5670
L5987+L5685 or L5670
K3 prosthetic foot with a locking mechanism socket suspension system
L5976+L5671 or l5673
L5979+L5671 or l5673
L5980+L5671 or l5673
L5981+L5671 or l5673
L5987+L5671 or l5673
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Table 3
Data Status
Data Status

Code assigned to study cohort members on the basis of NPPD
inclusion/exclusion criteria
Source:
NPPD datafile extracts
Type:
Numeric
Values:
1, 88, 92, 93, 94, 95
Comments: Values represent the useability of artificial limb data for analysis and are
described below
Code
Definition
1
Useable data; cohort member and delivered artificial limb meet all inclusion
criteria: (1) presence of both suspension system and prosthetic HCPCS codes
with delivery dates
(2) presence of HCPCS codes for definitive socket types L5301, l5100, or l5700,
(3) otherwise congruent data field values
88
bilateral amputee (BK/BK or BK/AK)
92
Delivery date for suspension system and/or prosthetic foot missing or outside
study parameters (before FY 2007 or after FY 2010).
93
Conversion to Above-knee amputee as indicated by associated text fields and/or
socket type HCPCS code
94
Missing HCPCS code for prosthetic foot, suspension system, or socket type
95
Syme’s amputation as indicated by HCPCS socket type and/or text fields.

Co-Morbid Conditions
Table B4
Congestive Heart Failure (CHF)
Chfx
Source:
Type:
Values:
Comments:

Diagnosis codes for congestive heart failure
NPCD Inpatient and Outpatient data file extracts
Binomial
1 = one or more codes present; 0 = no codes present
Codes in parentheses indicate that only select ICD9-CM codes were selected for
this topic of diagnosis code. Codes were searched for using the terms “heart
failure”, “congestive heart failure”, and “chronic heart failure” within the disease
category DISEASES OF THE CIRCULATORY SYSTEM (390-459 found on
the eICD website at http://www.eicd.com/EICDMain.htm).
ICD9-CM codes:
398.91
Rheumatic heart failure (congestive)
(402)
Hypertensive heart disease
402.01
Malignant with congestive heart failure
402.11
Benign with congestive heart failure
(table continues)
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Chfx
02.91
404.01
404.03
404.11
404.13
404.91
404.93
428.0
429.2
(414)
414.0
414.00
414.01
414.02
414.03
414.1
414.10
414.11
414.19
414.8
414.9

Diagnosis codes for congestive heart failure
Unspecified with congestive heart failure
With congestive heart failure (malignant Hypertensive heart and renal disease)
With congestive heart failure and renal failure
With congestive heart failure (benign heart and renal disease)
With congestive heart failure and renal failure
With congestive heart failure (Unspecified Heart and Renal Disease)
With congestive heart failure and renal failure
Congestive heart failure, unspecified
Cardiovascular disease, unspecified
Other forms of chronic ischaemic heart disease
Coronary atherosclerosis
Of unspecified vessel
Of native coronary artery
Of autologous biological bypass graft
Of nonautologous biological bypass graft
Aneurysm of heart
Of heart (wall)
Of coronary vessels
Other
Other specified forms of chronic ischaemic heart disease
Chronic ischaemic heart disease, unspecified

Table B5
Chronic Obstructive Pulmonary Disease (COPD)
Copdrespx

Diagnosis codes for Chronic obstructive pulmonary disease and allied
respiratory conditions
Source:
NPCD Inpatient and Outpatient data file extracts
Type:
Binomial
Values:
1 = one or more codes present; 0 = no codes present
Comments: Comprised of a combination of two categories of respiratory conditions: Copdx
and otherrespx
Copdx
Chronic obstructive pulmonary disease and allied conditions
Source:
NPCD Inpatient and Outpatient datafile extracts
Type:
Numeric
Values:
ICD9-CM codes
Comments: Codes in parentheses indicate that only select ICD9-CM codes were selected for
this topic of diagnosis code. Codes were searched for using the terms “lung
disease”, “obstructive pulmonary”, and “pulmonary disease” as well as within
the category DISEASES on the eICD website at
http://www.eicd.com/EICDMain.htm).
ICD9-CM codes:
(491)
Chronic bronchitis
491.0
Simple chronic bronchitis
491.1
Mucopurulent chronic bronchitis
491.2
Obstructive chronic bronchitis
(table continues)
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Copdrespx

Diagnosis codes for Chronic obstructive pulmonary disease and allied
respiratory conditions
491.20
Without mention of acute exacerbation
491.21
With acute exacerbation
491.8
Other chronic bronchitis
491.9
Unspecified chronic bronchitis
(492)
Emphysema
492.0
Emphysematous bleb
492.8
Other emphysema
(493)
Asthma
493.0
Extrinsic asthma
493.00
Without mention of status asthmaticus
493.01
With status asthmaticus
493.1
Intrinsic asthma
493.10
Without mention of status asthmaticus
493.11
With status asthmaticus
493.2
Chronic obstructive asthma
493.20
Without mention of status asthmaticus
493.21
With status asthmaticus
493.9
Asthma, unspecified
493.90
Without mention of status asthmaticus
493.91
With status asthmaticus
494
Bronchiectasis
(495)
Extrinsic allergic alveolitis
495.9
Unspecified allergic alveolitis and pneumonitis
496
Chronic airways obstruction, not elsewhere classified
Otherrespx Other respiratory disorders not otherwise specified in COPDx
Source:
NPCD Inpatient and Outpatient data file extracts
Type:
Numeric
Values:
ICD9-CM codes
Comments: Codes in parentheses indicate only select ICD9-CM codes were selected for this
topic of diagnosis code. Codes were searched for using the terms “pulmonary ”
, “respiratory “, and “lung disease” on the website:
http://www.eicd.com/EICDMain.htm
ICD9-CM codes:
501
Asbestosis
(506)
Respiratory conditions due to chemical fumes and vapours
506.0
Bronchitis and pneumonitis due to fumes and vapours
506.4
Chronic respiratory conditions due to fumes and vapours
506.9
Unspecified respiratory conditions due to fumes and vapours
(507)
Pneumonitis due to solids and liquids
507.0
Due to inhalation of food or vomitus
507.1
Due to inhalation of oils and essences
507.8
Due to other solids and liquids
(508)
Respiratory conditions due to other and unspecified external agents
508.1
Chronic and other pulmonary manifestations due to radiation
508.8
Respiratory conditions due to other specified external agents
508.9
Unspecified
(table continues)
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Copdrespx
(511)
511.0
511.1
511.8
511.9
513.0
513.1
514
516

Diagnosis codes for Chronic obstructive pulmonary disease and allied
respiratory conditions
Pleurisy
Without mention of effusion or current tuberculosis
With effusion, with mention of a bacterial cause other than tuberculosis
Other specified forms of effusion, except tuberculous
Unspecified pleural effusion
Abscess of lung
Abscess of mediastinum
Pulmonary congestion and hypostasis
Other alveolar and parietoalveolar pneumopathy

Table B6
Cerebral Vascular Disease (CVD)
Cvdx
Source:
Type:
Values:
Comments:

Diagnosis codes for cerebral vascular disease
NPCD Inpatient and Outpatient data file extracts; ICD9-CM codes
Binomial
1 = one or more codes present in patient record; 0= no codes present
Codes in parentheses indicate that only select ICD9-CM codes were selected for
this topic of diagnosis code. Codes were searched for and retrieved using the
terms: cerebral”, “stroke”, and “cerebral vascular disease” as well as within
DISEASES OF THE NERVOUS SYSTEM AND SENSE ORGANS (320-389)
on the eICD website at http://www.eicd.com/EICDMain.htm.
ICD9-CM codes:
430
Subarachnoid haemorrhage
431
Intracerebral haemorrhage
(432)
Other and unspecified intracranial haemorrhage
432.1
Subdural haemorrhage
432.9
Unspecified intracranial haemorrhage
(433)
Occlusion and stenosis of precerebral arteries
433.0
Basilar artery
433.00
without mention of cerebral infarction
433.01
with cerebral infarction
433.1
Carotid artery
433.11
with cerebral infarction
433.2
Vertebral artery
433.21
with cerebral infarction
433.3
Multiple and bilateral
433.31
with cerebral infarction
433.8
Other specified precerebral artery
433.81
with cerebral infarction
433.9
Unspecified precerebral artery
433.91
with cerebral infarction
(434)
Occlusion of cerebral arteries
434.0
Cerebral thrombosis
(table continues)
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Cvdx
434.01
434.1
434.11
434.9
434.91
(435)
435.0
435.1
435.2
435.8
435.9
(437)
437.0
437.1
437.2
437.4
437.5
437.6
437.
437.8
437.9
438

Diagnosis codes for cerebral vascular disease
with cerebral infarction
Cerebral embolism
with cerebral infarction
Cerebral artery occlusion, unspecified
with cerebral infarction
Transient cerebral ischaemia
Basilar artery syndrome
Vertebral artery syndrome
ubclavian steal syndrome
Other specified transient cerebral ischaemias
Unspecified transient cerebral ischaemia
Other and ill-defined cerebrovascular disease
Cerebral atherosclerosis
Other generalised ischaemic cerebrovascular disease
Hypertensive encephalopathy
Cerebral arteritis
Moyamoya disease
Nonpyogenic thrombosis of intracranial venous sinus
Transient global amnesia
Other
Unspecified
Late effects of cerebrovascular disease

Table B7
Renal Failure
Renalfailx
Source:
Type:
Values:

Diagnosis codes for renal failure
NPCD Inpatient and Outpatient data file extracts; ICD9-CM codes
Binomial
1 = one or more codes present in patient records; 0 = no codes present

Comments:

Codes in parentheses indicate that only select ICD9-CM codes were selected for this topic
of diagnosis code. Codes were searched for and retrieved using the terms: “renal failure”,
“kidney disease”, and
“renal disease”, as well as within DISEASES OF THE GENITOURINARY SYSTEM
(580-629) on the eICD website at http://www.eicd.com/EICDMain.htm.

ICD9-CM codes:
(403)
Hypertensive renal disease
403.01
Malignant with renal failure
403.11
Benign with renal failure
403.91
Unspecified with renal failure
404.02
Malignant Hypertensive heart and renal disease with renal failure
404.03
With congestive heart failure and renal failure
404.12
Benign Hypertensive heart and renal disease with renal failure
404.13
With congestive heart failure and renal failure
404.92
Unspecified Hypertensive Heart and renal disease with renal failure
404.93
With congestive heart failure and renal failure
(584)
Acute renal failure
(table continues)

392

Renalfailx
584.5
584.6
584.7
584.8
584.9
585
586
587

Diagnosis codes for renal failure
With lesion of tubular necrosis
With lesion of renal cortical necrosis
With lesion of renal medullary [papillary] necrosis
With other specified pathological lesion in kidney
Acute renal failure, unspecified
Chronic renal failure
Renal failure, unspecified
Renal sclerosis, unspecified

Table B8
Nutrition
Nutrition
Source:
Type:
Values:
Comments:

Diagnosis codes for obesity and malnutrition.
NPCD Inpatient and Outpatient data file extracts; ICD9-CM codes
Binomial
1 = one or more codes present in patient records; 0 = no codes present
Codes in parentheses indicate that only select ICD9-CM codes were selected for
this topic of diagnosis code. Codes were searched for and retrieved using the
terms: “obesity”, “nutrition”, and “malnutrition”, as well as within
ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES, AND
IMMUNITY DISORDERS (240-279) on the eICD website at
http://www.eicd.com/EICDMain.htm.
Obesitx ICD9-CM codes:
V77.8
Obesity
(278)
Obesity and other hyperalimentation
278.0
Obesity
278.1
Localized adiposity
278.2
Hypercarotinaemia
Malnutritx ICD-9-CM codes
V77.2
Malnutrition
260
Kwashiorkor
261
Nutritional marasmus
262
Other severe protein-calorie malnutrition
(263)
Other and unspecified protein-calorie malnutrition
263.0
Malnutrition of moderate degree
263.1
Malnutrition of mild degree
263.8
Other protein-calorie malnutrition
263.9
Unspecified protein-calorie malnutrition
(264)
Vitamin A deficiency
264.8
Other manifestations of vitamin A deficiency
264.9
Unspecified vitamin A deficiency
(266)
Deficiency of B-complex components
266.0
Ariboflavinosis
266.1
Vitamin B6 deficiency
266.2
Other B-complex deficiencies
266.9
Unspecified vitamin B deficiency
(table continues)
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Nutrition
(268)
268.0
268.1
268.2
268.9

Diagnosis codes for obesity and malnutrition.
Vitamin D deficiency
Rickets, active
Rickets, late effect268.2
Osteomalacia, unspecified
Unspecified vitamin D deficiency

Demographics
Table B9
Age
AgeXVariable:
Source:
Type
Values
Comments

Age at amputation
National Patient Care Database (NPCD)inpatient file
Numeric
18 through 89
A review of the data revealed that over73% of the cohort was between 45 and
74 years old with a mean age of 64 years, median of 62, minimum age of 22
and maximum age of 98. This variable was used only to describe the cohort
and not as part of the statistical model.

Table B10
Gender
Gender
Source:
Type:
Values:
Comments:

NPCD outpatient file extracts
Categorical
M – Male; F – Female; O – Other.
Within the cohort, only two females were identified, demonstrating VA trends of
over 98% male population; this variable was not used in the analysis, only for
description of the cohort
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Table B11
Marital Status
Marital
Status
Source:
Type:
Values:
Comments:

NPCD inpatient file extracts
Binomial
1-married; 0-not married
Over 50% of the cohort was categorized as married, the remaining as divorced,
widowed or never married (in order of highest to lowest frequency) with only 2
as unknown. To simplify the analysis, data was regrouped into only two
categories, married and not-married, as the intent of the variable was to indicate
the likelihood of the cohort member living alone. The 2 unknown status cohort
members were categorized as “not-married”. This variable was used as part of
the statistical model having a Chi square p-value of M0.25

Table B12
Race
Race
Source
Type
Values
Comments

NPCD inpatient file extracts
Categorical
1 - White, 2 - Black, and 3 - Asian.
Only 4 groups were identified: White, Black, Asian, and Hispanic. However,
since most Hispanics were also categorized as White, the Hispanic group was
merged with the White group to form 3 final race groups and values. This
variable was then further condense into two values: white and non-White and
will be used in the statistical model having a Chi Square p-value of <0..25

Table B13
Region
Region
Source:
Type:
Values:

Groupings of Veteran Integrated Service Networks (VISNs)
NPPD datafile extracts
1. Categorical
1(VISN 18, 19, 20, 21, 22); 2 (VISN 12, 15, 16, 17, 23), 3 (VISN 6, 7, 8, 9, 10,
11); 4(VISN 1, 2, 3, 4, 5)
Comments: The distribution of the VISNs among the four Regions was determined and
established by the Office of Information Technology (OIT) VHA Central
Offices, 2013. They may be loosely described in geographical terms as
referenced below. It should be noted that a single VISN may cover areas in
multiple states.
Region
Geographical description Veterans Integrated Service Network (VISN)
(table continues)
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Region
Region 1

Groupings of Veteran Integrated Service Networks (VISNs)
Northwest and Western
18.VA Southwest Healthcare Network; 19.Rocky
U.S.
Mountain Network; 20.Northwest Network;
21.Sierra Pacific Network; 22.Desert Pacific
Healthcare Network
Region 2
North- and South-Central 12.The Great Lakes Health Care System; 15.VA
U.S. (includes Texas)
Heartland Network; 16.South Central VA Health
Care Network; 17.VA Heart of Texas Health Care
Network; 23.VA Midwest Health Care Network
Region 3
Eastern Mid-West and
6.VA Mid-Atlantic Network; 7.The Atlantic
Southern U.S. Includes
Network; 8.VA Sunshine Healthcare Network;
Ohio)
9.Mid-South Veterans Healthcare Network; 10.VA
Healthcare System of Ohio; 11.Veterans In
Partnership
Region 4
Mid-Atlantic and
1.VA New England Healthcare System; 2.VA
Northeast U.S. (includes
Healthcare Network Upstate New York; 3.VA NY /
Washington
NJ Veterans Healthcare Network; 4.VA Stars &
DC/Maryland)
Stripes Healthcare Network; 5.VA Capitol Health
Care Network
Comments: VISNs 13 & 14 were combined to form VISN 23 in 2002. A VISN oversees the
VA hospitals and associated satellite centers and programs within its domain.

Table B14
Socioeconomic Status (VA Priority)
Socioeco
Source:
Type:
Values:
Comments:

Socioeconomic status as suggested by VA Priority status
NPCD data file extracts
Categorical
1.unemployable, 2.employable, 3.co-pay eligible
The intent of the inclusion of this variable was to identify those cohort
members’ socioeconomic status and/or employment capacity on the basis of
their VA Priority status group derived from a patient’s Means Test (adjusted
income). None of the cohort met Priority 6 criteria. Veterans in Priority 7
and 8 can be considered employable or non-disabled, Priority 1 through 4
disabled or minimally to unemployable, and Priority 5 living at the poverty
level, receiving VA pension benefits, but likely unemployable due to age.

Category Definitions
1.unemployable Priority Status groups 1, 4, and 5
2.employable
Priority status groups 2 and 3
3.copay eligible Priority status groups 7 and 8
VA Priority Status Group Definitions
“The number of Veterans who can be enrolled in the health care program is determined by the
amount of money Congress gives VA each year. Since funds are limited, VA set up Priority
Groups to make sure that certain groups of Veterans are able to be enrolled before others.”
(table continues)
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Socioeco
Group 1
Group 2
Group 3
Group 4
Group 5

Group 6
Group 7
Group 8

Socioeconomic status as suggested by VA Priority status
50% or more service connected disability and/or determined unemployable;
guaranteed enrollment and full health benefits).
30-40% service connected disability
former POWs, Purple Heart or Medal of Honor awardees, 10-20% service
connected disability
catastrophically disabled or receiving VA and attendance or housebound
benefits
non-service connected or non-disabled service connected veterans with
annual incomes below regional adjusted levels, receiving VA pension
benefits, eligible for Medicare
for service connected 0% compensable disability Veterans who served under
specified conditions
Veterans with gross household income below the geographically-adjusted
income limits (GMT) for their resident location and who agree to pay copays
Veterans with gross household income above the VA and the
geographically-adjusted income limits for their resident location and who
agree to pay copays.

(http://www.va.gov/healthbenefits/resources/priority_groups.asp).

Mental Health Conditions
Table B15
Depression (MDD and Other)
Depression

Cohort member having a diagnosis code for Major Depressive Disorder (MDD)
or other depressive condition during follow-up period
Source:
NPCD Inpatient and Outpatient data file extracts
Type
Binomial
Values:
1 = yes (one or more codes present); 0 = no (no codes present)
Comments: Comprised of a combination of two categories of depressive disorders: major
depressive disorder (Majordepx and clinical depression diagnosed as a condition
of other disorders such as bipolar disease (Otherdepx) This variable was used to
describe the cohort only.
Majordepx Major Depressive Disorder (MDD)
Source:
NPCD Inpatient and Outpatient files data extracts; ICD9-CM codes
Type
Numeric
Values:
ICD9-CM codes
Comments: ICD-9-CM codes as defined in The joint VA-DoD Clinical Practice Guidelines
for Mental Health, The Management of MDD Working Group, 2009). This
variable was used in the study’s statistical models.
ICD9-CM codes:
296.2
Major depressive disorder, single episode
296.20
Unspecified
296.21
Mild
296.22
Moderate
(table continues)
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Depression

Cohort member having a diagnosis code for Major Depressive Disorder (MDD)
or other depressive condition during follow-up period
296.23
severe, without mention of psychotic behaviour
296.24
severe, specified as with psychotic behaviour
296.3
Major depressive disorder, recurrent episode
296.30
Unspecified
296.31
Mild
296.32
Moderate
296.33
severe, without mention of psychotic behaviour
296.34
severe, specified as with psychotic behaviour
Otherdepx other depressive conditions not otherwise noted in the variable majordepx
Source:
NPCD Inpatient and Outpatient data file extracts
Type:
Numeric
Values:
ICD9-CM codes
Comments: Includes depressive states of bipolar conditions. Codes were searched for and
retrieved using the terms “depressive”, “depression”, and “depressive disorder”,
as well as within MENTAL DISORDERS (290-319) on the eICD website at
http://www.eicd.com/EICDMain.htm. This variable was used only to describe
the cohort.
ICD9-CM codes:
296.5
Bipolar affective disorder, depressed
296.50
Unspecified
296.51
Mild
296.52
Moderate
296.53
severe, without mention of psychotic behaviour
296.54
severe, specified as with psychotic behavior
296.82
Atypical depressive disorder
298.0
Depressive type psychosis
301.12
Chronic depressive personality disorder
309.1
Prolonged depressive reaction
290.13
Presenile dementia with depressive features
290.2
Senile dementia with delusional or depressive features
290.21
Senile dementia with depressive features
290.43
Arteriosclerotic dementia with depressive features

Table B16
PTSD and Other Adjustment Disorders
Ptsdadjx
Source:
Type:
Values:
Comments:

Ptsdx
Source:

Post-traumatic stress disorder and other adjustment disorders
NPCD Inpatient and Outpatient data files extracts
Binomial
1 = one or more codes present; 0 = no codes present
Comprised of a combination of two categories of adjustment disorders: posttraumatic stress disorder (Ptsdx) and those identified as relevant behavioral
adjustment disorders such as social anxiety (Otheradjdisx)
Post-traumatic stress disorder
NPCD Inpatient and Outpatient data file extracts
(table continues)
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Ptsdadjx
Type:
Values:
Comments:

Post-traumatic stress disorder and other adjustment disorders
Numeric
ICD9-CM codes
Diagnoses codes were selected as defined by the joint VA-DoD Clinical
Practice Guidelines for Mental Health, The Management of Post-Traumatic
Stress Working Group, 2010. This variable was used in the study’s statistical
model.
ICD9-CM codes:
309.81
Prolonged posttraumatic stress disorder
Otheradjdisx Behavior adjustment disorder diagnosis codes
Source:
NPCD Inpatient and Outpatient data file extracts
Type:
Numeric
Values:
ICD9-CM codes
Comments
Codes in parentheses indicate that only select ICD9-CM codes were selected for
this topic of diagnosis code. Codes were searched for using the terms:
“adjustment disorder”, “anxiety”, “anxious”, and “behavior disorder”, as well as
within MENTAL DISORDERS (290-319) on the eICD website at
http://www.eicd.com/EICDMain.htm. This variable was used only to describe
the cohort.
ICD9-CM codes:
(308)
Acute reaction to stress
308.0
Predominant disturbance of emotions
308.2
Predominant psychomotor disturbance
308.3
Other acute reactions to stress
308.4
Mixed disorders as reaction to stress
308.9
Unspecified acute reaction to stress
(309)
Adjustment reaction
309.2
With predominant disturbance of other emotions
309.21
Separation anxiety disorder
309.24
Adjustment reaction with anxious mood
309.28
Adjustment reaction with mixed emotional features
309.3
With predominant disturbance of conduct
309.4
With mixed disturbance of emotions and conduct
309.8
Other specified adjustment reactions
309.82
Adjustment reaction with physical symptoms
309.83
Adjustment reaction with withdrawal
309.89
Other
309.9
Unspecified adjustment reaction
312
Disturbance of conduct not elsewhere classified
312.0
Undersocialised conduct disorder, aggressive type
312.00
Unspecified
312.01
Mild
312.02
Moderate
312.03
severe
312.1
Undersocialised conduct disorder, unaggressive type
312.10
Unspecified
312.11
Mild
312.12
Moderate
(table continues)
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Ptsdadjx
312.13
312.2
312.20
312.21
312.22
312.23
312.3
312.30
312.8

Post-traumatic stress disorder and other adjustment disorders
severe
Socialised conduct disorder
Unspecified
Mild
Moderate
severe
Disorders of impulse control, not elsewhere classified
Impulse control disorder, unspecified
Other specified disturbances of conduct, not elsewhere classified

Table B17
Substance Use Disorder (SUD)
Sudx
Source:
Type:
Values
Comments:

Substance use disorder
NPCD Inpatient and Outpatient data file extracts
Binomial
1 = one or more codes present; 0 = no codes present
The codes selected were those as defined by The joint VA-DoD Clinical Practice
Guidelines for Mental Health, The Management of SUD Working Group, 2009;
codes in parentheses indicate only select ICD9-CM codes were selected for this
topic of diagnosis code. This variable was used as part of the study’s statistical
models.
ICD9-CM codes:
(291)
Alcoholic psychoses
291.0
Alcohol withdrawal delirium
291.1
Alcohol amnestic syndrome
291.9
Unspecified alcoholic psychosis
291.2
Other alcoholic dementia
(292)
Drug psychoses
292.1
Paranoid and/or hallucinatory states induced by drugs
292.11
Drug-induced organic delusional syndrome
292.12
Drug-induced hallucinosis
292.2
Pathological drug intoxication
292.8
Other specified drug-induced mental disorders
292.81
Drug-induced delirium
292.82
Drug-induced dementia
292.83
Drug-induced amnestic syndrome
292.9
Unspecified drug-induced mental disorder
(303)
Alcohol dependence syndrome
303.0
Acute alcoholic intoxication
303.00
Unspecified
303.01
Continuous
303.02
Episodic
303.9
Other and unspecified alcohol dependence
(table continues)
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Sudx
303.90
303.91
303.92
304
304.0
304.00
304.01
304.02
304.1
304.10
304.11
304.12
304.2
304.20
304.21
304.22
304.3
304.30
304.31
304.32
304.4
304.40
304.41
304.42
304.5
304.50
304.51
304.52
304.6
304.60
304.61
304.62
304.7
304.70
304.71
304.72
304.8
304.80
304.81
304.82
304.9
304.90
304.91
304.92
(305)
305.0
305.00

Substance use disorder
Unspecified
Continuous
Epzisodic
Drug dependence
Opioid type dependence
Unspecified
Continuous
Episodic
Barbiturate and similarly acting sedative or hypnotic dependence
Unspecified
Continuous
Episodic
Cocaine dependence
Unspecified
Continuous
Episodic
Cannabis dependence
Unspecified
Continuous
Episodic
Amphetamine and other psychostimulant dependence
Unspecified
Continuous
Episodic
Hallucinogen dependence
Unspecified
Continuous
Episodic
Other specified drug dependence
Unspecified
Continuous
Episodic
Combinations of opioid type drug with any other
Unspecified
Continuous
Episodic
Combinations of drug dependence excluding opioid type drug
Unspecified
Continuous
Episodic
Unspecified drug dependence
Unspecified
Continuous
Episodic
Nondependent abuse of drugs
Alcohol abuse
Unspecified
(table continues)
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Sudx
305.01
305.02
305.2
305.20
305.21
305.22
305.3
305.30
305.31
305.32
305.4
305.40
305.41
305.42
305.5
305.50
305.51
305.52
305.6
305.60
305.61
305.62
305.7
305.70
305.71
305.72
305.8
305.80
305.81
305.82
305.9
305.90
305.91
305.92

Substance use disorder
Continuous
Episodic
Cannabis abuse
Unspecified
Continuous
Episodic
Hallucinogen abuse
Unspecified
Continuous
Episodic
Barbiturate and similarly acting sedative or hypnotic abuse
Unspecified
Continuous
Episodic
Opioid abuse
Unspecified
Continuous
Episodic
Cocaine abuse
Unspecified
Continuous
Episodic
Amphetamine or related acting sympathomimetic abuse
Unspecified
Continuous
Episodic
Antidepressant type abuse
Unspecified
Continuous
Episodic
Other, mixed, or unspecified drug abuse
Unspecified
Continuous
Episodic
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Residual Limb Skin Problem Severity (less severe/ severe/no treatment)
Table B18
Residual Limb Skin Problem severity
RLSPS
Residual Limb Skin Problem Severity (dependent/outcome variable)
Source:
NPCD Outpatient datafiles extracts, ICD9-CM codes.
Type:
Categorical
Values:
0.no treatment, 1.less severe, 2.severe
Comments: This variable was derived from combining codes for less severe (Lseverex) and
severe (Severex) ICD-9-CM codes as described in the tables following. The
value 0.no treatment was assigned to those cases that did not have a severe or
less severe code identified during the follow-up period. This variable was used
in the study’s statistical models.

Table B19
Less severe Residual Limb Skin Problems
Lseverex:

Less severe Residual Limb Skin Problems considered non-life threatening with
minimal restrictions on artificial limb use
Source:
NPCD Outpatient datafiles extracts, ICD9-CM codes
Type:
Categorical, repeated measure
Values:
foreignbx, occlusionx, repetitivetx, surgicalx, otherlsx
(table continues)
Comments: Includes residual limb skin problems such as rashes, callouses, blisters, and
other non-infectious dermatoses; Codes in parentheses indicate only select
ICD9-CM codes were selected for this topic of diagnosis code. Codes were
selected on the basis of recommendations from Bui et al., (2007). Code
descriptions that included the terms head, neck, face, torso, arms, genitals,
pelvis, or foot were excluded; those with the terms lower leg, stump or shank
were included; codes with no body part mentioned were included if relevant to
artificial limb use. Codes were first searched for by category (such as
dermatoses) and then reviewed one-by-one, selected on the basis of description
and definition. Codes were search for and retrieved using terms such as
“dermatitis”, “erresthema”,”blister”, and callous, as well as within DISEASES
OF THE SKIN AND SUBCUTANEOUS TISSUE (680-709) on the eICD
website at http://www.eicd.com/EICDMain.htm.
Category definitions
Foreignbx
Residual limb skin problem in reaction to foreign body.
ICD9-CM codes:
706.2
Sebaceous cyst
709.4
Foreign body granuloma of skin and subcutaneous tissue
Occlusion
Residual limb skin problem in response to non-infectious occlusion.
ICD9-CM codes:
(691)
Atopic dermatitis and related conditions
691.8
Other atopic dermatitis and related conditions
(table continues)
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Lseverex:
(692)
692.0
692.1
692.2
692.3
692.4
692.8
692.82
692.83
692.89
692.9
694.5
(698)
698.2
698.4
698.8
698.9
(704)
704.0
704.00
704.01
704.09
704.1
704.2
704.8
704.9
(705)
705.0
705.1
705.8
705.81
705.82
705.89
705.9
(706)
706.1
706.8
706.9
(708)
708.0
708.1
708.2
708.3
708.4
708.5
708.8

Less severe Residual Limb Skin Problems considered non-life threatening with
minimal restrictions on artificial limb use
Contact dermatitis and other eczema
Due to detergents
Due to oils and greases
Due to solvents
Due to drugs and medicines in contact with skin
Due to other chemical products
Due to other specified agents
Dermatitis due to other radiation
Dermatitis due to metals
Other
Unspecified cause
Pemphigoid
Pruritus and related conditions
Prurigo
Dermatitis factitia [artifacta]
Other specified pruritic conditions
Unspecified pruritic disorder
Diseases of hair and hair follicles
Alopecia
Alopecia, unspecified
Alopecia areata
Other
Hirsutism
Abnormalities of the hair
Other specified diseases of hair and hair follicles
Unspecified disease of hair and hair follicles
Disorders of sweat glands
Anhidrosis
Prickly heat
Other specified disorders of sweat glands
Dyshidrosis
Fox-Fordyce disease
Other
Unspecified disorder of sweat glands
Diseases of sebaceous glands
Other acne
Other specified diseases of sebaceous glands
Unspecified disease of sebaceous glands
Urticaria
Allergic urticaria
Idiopathic urticaria
Urticaria due to cold and heat
Dermatographic urticaria
Vibratory urticaria
Cholinergic urticaria
Other specified urticaria
(table continues)
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Lseverex:

Less severe Residual Limb Skin Problems considered non-life threatening with
minimal restrictions on artificial limb use
708.9
Urticaria, unspecified
(709)
Other disorders of skin and subcutaneous tissue
709.8
Other specified disorders of skin
Repetitivetx Residual limb skin reaction to repetitive injury (microtrauma).
ICD9-CM codes:
(694)
Bullous dermatoses
694.0
Dermatitis herpetiformis
694.4
Pemphigus
694.5
Pemphigoid
694.8
Other specified bullous dermatoses
694.9
Unspecified bullous dermatoses
(695)
Erythematous conditions
695.0
Toxic erythema
695.1
Erythema multiforme
695.2
Erythema nodosum
695.8
Other specified erythematous conditions
695.89
Other
695.9
Unspecified erythematous condition
700
Corns and callosities
(701)
Other hypertrophic and atrophic conditions of skin
701.0
Circumscribed scleroderma
701.1
Keratoderma, acquired
701.2
Acquired acanthosis nigricans
701.4
Keloid scar
701.5
Other abnormal granulation tissue
701.8
Other specified hypertrophic and atrophic conditions of skin
701.9
Unspecified hypertrophic and atrophic conditions of skin
Surgicalx
Residual limb complication directly consequent of limb surgery.
ICD9-CM codes:
997.61
Neuroma of amputation stump
997.6
Late amputation stump complication
998.3
Disruption of operation wound
Otherlsx
Residual limb complication not otherwise categorized.
ICD9-CM codes:
683
Acute lymphadenitis
695.81
Ritter's disease
(696)
Psoriasis and similar disorders
696.0
Psoriatic arthropathy
696.1
Other psoriasis
696.2
Parapsoriasis
696.4
Pityriasis rubra pilaris
696.5
Other and unspecified pityriasis
696.8
Other
709.0
Dyschromia
709.00
Dyschromia, unspecified
709.01
Vitiligo
(table continues)
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Lseverex:
709.09
709.1
709.8
709.9
(739)
739.6

Less severe Residual Limb Skin Problems considered non-life threatening with
minimal restrictions on artificial limb use
Other
Vascular disorders of skin
Other specified disorders of skin
Unspecified disorder of skin and subcutaneous tissue
Nonallopathic lesions, not elsewhere classified
Lower extremities

Table B20
Severe Residual Limb Skin Problems
Severex

Severe Residual Limb Skin Problems that are life/limb threatening or
infectious, and may require extensive restrictions on artificial limb use.
Source:
Data from NPCD outpatient file extracts; ICD9-CM diagnosis codes
Type:
Categorical, repeated measure
Values:
foreignb2x, occlusion2x, repetitivet2x, surgical2x, others
Comments:
Includes ulcers, infectious skin and bone conditions; codes in parentheses
indicate only select ICD9-CM codes were selected for this topic of diagnosis
code. Codes were selected on the basis of recommendations from Bui et al.,
(2007). Code descriptions that included the terms head, neck, face, torso,
arms, genitals, pelvis, or foot were excluded; those with the terms lower leg,
stump or shank were included; codes with no body part mentioned were
included if relevant to artificial limb use. Codes were first searched for by
category (such as dermatoses) and then reviewed one-by-one, selected on the
basis of description and definition. Codes were searched for and retrieved
using the terms “ulcer”, “infection”, “cellulitis”, and “osteomyelitis”, as well
as within DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE (680709) on the eICD website at http://www.eicd.com/EICDMain.htm. This
variable was used only to describe the cohort.
Category definitions:
Foreignb2x
Residual limb skin problem in reaction to foreign body.
ICD9-CM codes:
006.6
Amoebic skin ulceration
037
Tetanus
040.3
Necrobacillosis
Occlusion2x Residual limb skin problem in response to infectious occlusion
ICD9-CM codes:
040.0
Gas gangrene
(680)
Carbuncle and furuncle
680.6
Leg, except foot
680.9
Unspecified site
(68)(
Other cellulitis and abscess
682.6
Leg, except foot
682.8
Other specified sites
682.9
Unspecified site
684
Impetigo
(table continues)
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Severex

Severe Residual Limb Skin Problems that are life/limb threatening or
infectious, and may require extensive restrictions on artificial limb use.
686.0
Pyoderma
686.8
Other specified local infections of skin and subcutaneous tissue
686.9
Unspecified local infection of skin and subcutaneous tissue
705.83
Hidradenitis
Repetitivet2x Residual limb skin reaction to repetitive injury (microtrauma)
ICD9-CM codes:
(173)
Other malignant neoplasm of skin
173.7
Skin of lower limb, including hip
173.8
Other specified sites of skin
(454)
Varicose veins of lower extremities
454.0
With ulcer
454.2
With ulcer and inflammation
707.1
Ulcer of lower limbs, except decubitus
707.8
Chronic ulcer of other specified sites
707.9
Chronic ulcer of unspecified site
Surgical2x
Residual limb complication directly consequent of limb surgery
ICD9-CM codes:
997.60
Unspecified complication
997.62
Infection (chronic)
997.69
Other
998.0
Postoperative shock
998.5
Postoperative infection
Others
Residual limb complication not otherwise categorized
ICD9-CM codes:
(038))
Septicaemia
038.0
Streptococcal septicaemia
038.1
Staphylococcal septicaemia
038.2
Pneumococcal septicaemia
038.3
Septicaemia due to anaerobes
038.4
Septicaemia due to other gram-negative organisms
038.40
Gram-negative organism, unspecified
038.43
Pseudomonas
038.44
Serratia
038.49
Other
038.8
ther specified septicaemias
038.9
Unspecified septicaemia
(172)
Malignant melanoma of skin
172.7
Lower limb, including hip
440.23
Atherosclerosis of the extremities with ulceration
440.24
Atherosclerosis of the extremities with gangrene
(451)
Phlebitis and thrombophlebitis
451.0
Of superficial vessels of lower extremities
451.1
Of deep vessels of lower extremities
451.11
Femoral vein (deep) (superficial)
451.2
Of lower extremities, unspecified
(table continues)

407

Severex
(730)
730.0
730.06
(730.10)
730.16
(730.2)
730.26
730.28
(730.3)
730.36
730.38
730.5
(730.8)
730.86
730.88
(730.9)
730.96
730.98
(733.4)
733.43
733.49

Severe Residual Limb Skin Problems that are life/limb threatening or
infectious, and may require extensive restrictions on artificial limb use.
Osteomyelitis, periostitis and other infections involving bone
Acute osteomyelitis
Lower leg
Site unspecified
Lower leg
Unspecified osteomyelitis
Lower leg
Other specified sites
Periostitis without mention of ostemyelitis
Lower leg
Other specified sites)
Tuberculosis of limb bones
Other infections involving bone in disease classified elsewhere
Lower leg
Other specified sites
Unspecified infection of bone
Lower leg
Other specified sites
Septic necrosis of bone
Medial femoral condyle
Other

Table B21
Procedural Codes for Skin Problem Treatments
Drainx
Source:
Type:
Values:
Comments:

CPT Code
10061
10080
10081
10140

Procedural codes for drainage of skin abscess or wound
NPCD Outpatient data file extracts
Binomial
1 = one or more codes present; 0 = no codes present
CPT codes to be used for further categorization of severe and less severe skin
problems, especially in the case of less severe problems transforming into severe
skin problems. Codes provided courtesy of Laurel A. Copeland, Ph.D. And are
in the form required by SAS statistical software.
This variable was not used in the statistical analysis as only 5 cases were
detected and to include was beyond the scope of the study (given skin problem
categorization by etiology)
Description
Drainage of skin abscess
Drainage of pilonidal cyst
DRAINAGE OF PILONIDAL CYST
DRAINAGE OF HEMATOMA/FLUID

10160
10180

PUNCTURE DRAINAGE OF LESION
COMPLEX DRAINAGE, WOUND
(table continues)
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Drainx
Woundx
Source:
Type:
Values:
Comments:

Cpt code
11000
11001
11010
11011
11012
11040
11041
11042
11043
11044
11055
11056
11057
1200112002
1200412007
12011
1201312016
12020
12021
13100
13101
13102
13120
13121
13131
13132
13133
1315013153
15738
1578015783

Procedural codes for drainage of skin abscess or wound
Procedural codes for wound treatment or debridement
Npcd outpatient data file extracts
Binomial
1 = one or more codes present; 0 = no codes present
Cpt codes to be used for further categorization of severe and less severe skin
problems, especially in the case of less severe problems transforming into severe
skin problems. Codes provided courtesy of laurel a. Copeland, Ph.D. And are in
the form required by SAS statistical software.
This variable was not used in the statistical analysis although 95 cases were
detected. To include in analysis was beyond the scope of the study given
categorization of skin problem codes by etiology.
Description
Debride infected skin
Debride infected skin
Debride skin, fx
Debride skin/muscle, fx
Debride skin/muscle/bone, fx
Debride skin, partial
Debride skin, full
Debride skin/tissue
Debride tissue/muscle
Debride tissue/muscle/bone
Trim skin lesion
Trim skin lesions, 2 to 4
Trim skin lesions, over 4
Repair superficial wound(s)
Repair superficial wound(s)
Repair superficial wound(s)
Repair superficial wound(s)
Closure of split wound
Closure of split wound
Repair of wound or lesion
Repair of wound or lesion
Repair wound/lesion add-on
Repair of wound or lesion
Repair of wound or lesion
Repair of wound or lesion
Repair of wound or lesion
Repair wound/lesion add-on
Repair of wound or lesion
Muscle-skin graft, leg
Abrasion treatment of skin
(table continues)
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Drainx
15781
15786
15999,
97597
97598
97601
97602
99183
Lesionx
Source:
Type:
Values:
Comments:

Cpt code
10120
10121
11450
11451
11462
11463
11470
17000
17001
17003
17004
17106
17107
17108
17110
17111
17250
1726017264
17266
1727017274
1728017284
17286
17340
64788

Procedural codes for drainage of skin abscess or wound
Abrasion treatment of skin
Abrasion, lesion, single
Removal of pressure sore
Active wound care/20 cm or <
Active wound care > 20 cm
Wound(s) care, selective
Wound(s) care non-selective
Hyperbaric oxygen therapy
Procedural codes for the treatment of skin lesion or sweat gland removal
Npcd outpatient data file extracts
Binomial
1 = one or more codes present; 0 = no codes present
Cpt codes to be used for further categorization of severe and less severe skin
problems, especially in the case of less severe problems transforming into severe
skin problems. Codes provided courtesy of laurel a. Copeland, Ph.D. And are in
the form required by SAS statistical software.
This variable was not used in the statistical analysis although 39 cases were
detected. To include in analysis was beyond the scope of the study given
categorization of skin problems by etiology.
Description
Remove foreign body
Remove foreign body
Removal, sweat gland lesion
Removal, sweat gland lesion
Removal, sweat gland lesion
Removal, sweat gland lesion
Removal, sweat gland lesion
Destroy benign/premalignant lesion
Destruction of additional lesions
Destroy lesions, 2-14
Destroy lesions, 15 or more
Destruction of skin lesions
Destruction of skin lesions
Destruction of skin lesions
Destruct lesion, 1-14'
Destruct lesion, 15 or more
Chemical cautery, tissue
Destruction of skin lesions
Destruction of skin lesions
Destruction of skin lesions
Destruction of skin lesions
Destruction of skin lesions
Cryotherapy of skin
Remove skin nerve lesion
(table continues)
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Drainx
96920
96921
96999

Procedural codes for drainage of skin abscess or wound
Laser treatment, skin < 250 sq cm
Laser treatment, skin 250-500 sq cm
Dermatological procedure

Rules for cohort inclusion/exclusion
Defining the Initial cohort.
The datafile extracts from the Fiscal Year (FY) 2007 National Patient Care Database
(NPCD) Inpatient medSAS files, representing all Veterans admitted to a VA facility for
treatment between October 1, 2006 through September 31, 2007, were searched for ICD9-CM diagnostic codes for diabetes mellitus, peripheral arterial disease (PAD), and
peripheral vascular disease (PVD).
All data manipulations were by a professional statistician (Shuko Lee, MS) using
Statistical Analysis System (SAS) software, Version 9.4 (SAS Institute, Research
Triangle, NC, and USA)
1. Codes were searched for in the following fields of the Inpatient files (bed section
and full stay):
DXPRIME

DXB2-DXB5, DXF2-DXF13,
DXLSB, DXLSF

Principal admitting ICD-9-CM diagnostic code; the condition
which after study, is determined to be
chiefly responsible for the admission of the patient to the hospital.
Primary and secondary ICD-9-CM diagnostic codes that apply
to the bed section or full stay of the patient
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Table B22
Initial Cohort Inclusion Criteria ICD-9-CM Codes for Diabetes Mellitus.
Code
Diabetes
250
Diabetes
mellitus
250.00
250.01
250.02
250.03
250.09
250.1
250.10
250.11
250.12
250.13
250.19
250.2
250.20
250.21
250.22
250.23
250.29
250.3
250.30
250.31
250.32
250.33
250.39
250.4
250.40

Description
Diabetes mellitus
Diabetes mellitus without mention of complication
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, not stated as uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], not stated as
uncontrolled
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], uncontrolled
Unspecified whether adult-onset or juvenile type
Diabetes with ketoacidosis
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, not stated as uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], not stated as
uncontrolled
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], uncontrolled
Unspecified whether adult-onset or juvenile type
Diabetes with hyperosmolarity
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, not stated as uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], not stated as
uncontrolled
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], uncontrolled
Unspecified whether adult-onset or juvenile type
Diabetes with other coma
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, not stated as uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], not stated as
uncontrolled
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], uncontrolled
Unspecified whether adult-onset or juvenile type
Diabetes with renal manifestations
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, not stated as uncontrolled
(table continues)
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Code
250.41
250.42
250.43
250.49
250.5
250.50
250.51
250.52
250.53
250.59
250.6
250.60
250.61
250.62
250.63
250.69
250.7
250.70
250.71
250.72
250.73
250.79
250.8
250.80
250.81
250.82
250.83
250.89
250.9
250.90

Description
Type I [insulin dependent type] [IDDM] [juvenile type], not stated as
uncontrolled
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], uncontrolled
Unspecified whether adult-onset or juvenile type
Diabetes with ophthalmic manifestations
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, not stated as uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], not stated as
uncontrolled
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], uncontrolled
Unspecified whether adult-onset or juvenile type
Diabetes with neurological manifestations
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, not stated as uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], not stated as
uncontrolled
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], uncontrolled
Unspecified whether adult-onset or juvenile type
Diabetes with peripheral circulatory disorders
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, not stated as uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], not stated as
uncontrolled
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], uncontrolled
Unspecified whether adult-onset or juvenile type
Diabetes with other specified manifestations
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, not stated as uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], not stated as
uncontrolled
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], uncontrolled
Unspecified whether adult-onset or juvenile type
Diabetes with unspecified complications
type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, not stated as uncontrolled
(table continues)

413

Code
250.91

Description
Type I [insulin dependent type] [IDDM] [juvenile type], not stated as
uncontrolled
Type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or
unspecified type, uncontrolled
Type I [insulin dependent type] [IDDM] [juvenile type], uncontrolled
Unspecified whether adult-onset or juvenile type

250.92
250.93
250.99

Table B23
Initial Cohort Inclusion ICD-9-CM Codes for Peripheral Arterial Disease.
Code
440.2
440.20
440.21
440.22
440.23
440.24
440.29
440.3
440.30
440.31
440.32
440.8

Description
[Atherosclerosis] Of native arteries of the extremities
Atherosclerosis of the extremities, unspecified
Atherosclerosis of the extremities with intermittent claudication
Atherosclerosis of the extremities with rest pain
Atherosclerosis of the extremities with ulceration
Atherosclerosis of the extremities with gangrene
Other
[Atherosclerosis] Of bypass graft of the extremities
Of unspecified graft
Of autologous vein bypass graft
Of nonautologous vein bypass graft
Of other specified arteries

Table B24
Initial Cohort Inclusion Criteria ICD-9-CM Codes for
Peripheral Vascular Disease.
Code
443
443.0
443.1
443.8
443.81
443.89
443.9

Description
Other peripheral vascular disease
Raynaud's syndrome
Thromboangiitis obliterans [Buerger's disease]
Other specified peripheral vascular diseases
Peripheral angiopathy in diseases classified elsewhere
Other
Peripheral vascular disease, unspecified

2. Using the same dataset fields, cases that met the above inclusion criteria were
then searched again for ICD-9-CM codes indicative of a unilateral below-knee
amputation; codes indicative of any other level of amputation (other than
“unspecified”) were ignored .
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Because codes were search for in fields other than DXPRIME (the primary reason for the
hospital stay), cases were not limited to those Veterans undergoing an index transtibial
amputation in FY 2007.
3. In order to capture all possible transtibial amputations, the ICD-9-CM codes for
“Traumatic amputation, unspecified level” was included in the search terms.
Specifically, the codes searched for included:
Table B25
Initial Cohort Inclusion Criteria ICD-9-CM Codes for Transtibial Amputation
Code
897
897.0
897.1
897.4
897.5
CPT code
278.80
278.81
278.82
278.84
278.86

Description
Traumatic amputation of leg(s) (complete) (partial)
Unilateral, below knee, without mention of complication
Unilateral, below knee, complicated
Unilateral, level not specified, without mention of complication
Unilateral, level not specified, complicated
Description
Amputation of lower leg
Amputation of lower leg
Amputation of lower leg
Amputation of lower leg follow-up surgery
Amputation of lower leg follow-up surgery

4. The codes 896-896.9, “Traumatic amputation of foot (complete) (partial)” were
not included to avoid partial foot amputations and Syme’s (through the ankle)
amputations.
5. Similarly CPT codes275.98 and 278.89 were excluded to avoid knee
disarticulation amputations and Syme’s through ankle amputations, respectively
6. The outcome from this search amounted to the “initial cohort’ - Veterans who
during FY 2007 underwent a below-knee amputation and who also had a
dysvascular condition.
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7. The scrSSN codes from this initial cohort were then searched for and matched to
cases in the NPCD Outpatient Event MedSAS datafiles for FY 2007, 2008, 2009,
2010, and 2011
8. Any matched scrSSN codes were extracted and merged with the initial cohort
dataset establishing the clinical history of each case from FY 2007 to FY 2011.
Defining the study cohort
From the National Prosthetics Patient Database (NPPD) datafile extracts, cases for
inclusion required the following:
1.

Must have matching ScrSSN with initial cohort.

2.

Must have HCPCSPSAS code for a prosthetic foot, socket suspension system,
and definitive/permanent below-knee socket or socket replacement (codes
L5301, l5100, l5700). Refer to Table B2 for HCPCS codes)

3.

Must have a Delivery Date for each HCPCSPSAS that is on the same date or
within 3 months of each other.

4.

Text for Item and/or ConsultDesc must reflect HCPCSPSAS code or
HCPCSDesc

Cases were excluded
1. Missing HCPCSPSAS code for a prosthetic foot, socket suspension system or
socket type.
2. No Delivery Date provided.
3. Presence of HCPCSPSAS code for Above-knee socket (l5150, l5160, l5200,
l5312 (knee disarticulate) or l5321 Indicates that individual is Above-
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Knee/Below-Knee (AK/BK) amputee or revised to Above-Knee (AK)from
Below-Knee (BK).
4. Presence of HCPCSPSAS code for Syme’s amputation (through ankle) (l5010,
l5050, or l5060) not a transtibial amputation.
5. Indicates bilateral or AK/BK amputee in Item or ConsultDesc (such as code for
left foot and code for right foot).
6. Has appropriate HCPCSPSAS code but Item or ConsultDesc indicates not
artificial limb for daily use (such as “swim leg” or “backup leg”)
7. on the basis of the above criteria, cases were then categorized as follows:
1
88
92
93
94
95

useable (met all criteria)(N=282)
bilateral amputee (BK/BK or BK/AK)
not useable due to invalid data or missing Delivery Date
conversion to AK (presence of AK HCPCS limb codes);
missing the HCPCSPSAS code for prosthetic foot, suspension system or socket type;
Syme’s amputation, not transtibial as indicated by HCPCSPSAS code, Item and/or
ConslutDesc.

8. All data was manipulated using Microsoft Office Excel 2010.
9. scrSNN codes of cases that met inclusion/exclusion criteria were then matched
and merged with those from the initial cohort using SAS statistical software as above.
10. These actions creating the study cohort dataset that was further manipulated for
data analysis using SAS statistical software.
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Healthcare Common Procedure Coding System (HCPCS).
HCPCS codes were identified from the Durable on the Centers for Medicare Medicaid
Services website at http://www.cms.gov/Medicare/Medicare-Fee-for-ServicePayment/DMEPOSFeeSched/DMEPOS-Fee-Schedule.html
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Table B26
HCPCS Codes, Descriptions, and Costs.
Hcpcs
code
L5100
L5301
L5321

Component

Long description

Cost (ea)

Definitive limb
(BK)
Definitive limb
(AK)

- Below knee, molded socket, shin, sach foot
- Below knee, molded socket, shin, sach foot, endoskeletal system
- Above knee, molded socket, open end, sach foot, endoskeletal system, single axis
knee
- Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover,
sach foot,
- Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover,
sach foot,
thermoplastic or equal, direct formed plaster socket, molded to model
- Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover,
sach foot,
thermoplastic or equal, molded to model
- Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover,
sach foot,
laminated socket, molded to model
- Preparatory, above knee- knee disarticulation, ischial level socket, non-alignable
system, pylon, no cover, sach foot, plaster socket, molded to model
-Preparatory, above knee - knee disarticulation, ischial level socket, non-alignable
system, pylon, no cover, sach foot, thermoplastic or equal, direct formed
- Preparatory, above knee - knee disarticulation ischial level socket, non-alignable
system, pylon, no cover, sach foot, thermoplastic or equal, molded to model
- Preparatory, above knee - knee disarticulation, ischial level socket, non-alignable
system, pylon, no cover, sach foot, prefabricated adjustable open end socket
- Addition to lower extremity, below knee suction socket

$2,859.38
$2,824.77

L5510

L5520

Temporary limb
(BK)

L5530

L5540
L5560
L5570

Temporary limb
(AK)

L5580
L5585
L5647

Suction suspension
(differential
pressure; high tech)

(table continues)

$4,043.58
$1,791.14

$1,769.22

$2,125.00

$2,226.77
$2,391.16
$2,485.96
$2,902.18
$3,147.76
$978.64
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Hcpcs
code
L5666
L5670

L5671

L5680
L5682
L5684

L5685

L5688
L5690
L5700

L5781

Component
Cuff suspension
(simple; Low-tech)
Supracondylar
(anatomical; midtech)
Sleeve, pin-lock
mechanism
(differential
pressure; mid-tech)
Straps and belts
(simple; low-tech)
Straps and belts
(simple; low-tech)
Straps and belts
(simple; low-tech)
Suspension sleeve
(differential
pressure; mid-tech)
Straps and belts
(simple; low-tech)
Straps and belts
(simple; low-tech)
replacement socket

Vacuum assisted
(differential
pressure; Hightech)

Long description

Cost (ea)

- Addition to lower extremity, below knee, cuff suspension

$86.12

- Addition to lower extremity, below knee, molded supracondylar suspension ('pts' or
similar)

$333.84

- Addition to lower extremity, below knee / above knee suspension locking mechanism
(shuttle, lanyard or equal), excludes socket insert

$611.95

- Addition to lower extremity, below knee, thigh lacer, nonmolded

$374.47;

- Addition to lower extremity, below knee, thigh lacer, gluteal/ischial, molded

$769.40;

- Addition to lower extremity, below knee, fork strap

$59.21;

- Addition to lower extremity prosthesis, below knee, suspension/sealing sleeve, with
or without valve, any material, each

$141.59

- Addition to lower extremity, below knee, waist belt, webbing

$75.15

- Addition to lower extremity, below knee, waist belt, padded and lined

$120.38

- Replacement, socket, below knee, molded to patient model
- Addition to lower limb prosthesis, vacuum pump, residual limb volume management
and moisture evacuation system
$4,423.02
(table continues)
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Hcpcs
code
L5970

L5972

L5973

L5974

L5975

L5976

Component

Long description

SACH foot
(recommended for
K1 functional
level)
SAFE foot ;flexible
keel
(recommended for
K2 functional
level)
Microprocessorcontrolled ankle
foot
(recommended for
k2/k3 functional
Level)

- All lower extremity prostheses, foot, external keel, sach foot

$249.86

- All lower extremity prostheses, foot, flexible keel

$433.59

Single axis
ankle/foot
(recommended for
K1 functional
level)
Multiaxis, flexible
keel
(recommended for
K2/K3 Functional
level)
Energy-storing
(dynamic response
(recommended for
K3 functional
level)

Cost (ea)

- Endoskeletal ankle foot system, microprocessor controlled feature, dorsiflexion
and/or plantar flexion control, includes power source

$19,290.71

- All lower extremity prostheses, foot, single axis ankle/foot

$286.69

- All lower extremity prosthesis, combination single axis ankle and flexible keel foot

$512.48

- All lower extremity prostheses, energy storing foot (Seattle carbon copy ii or equal)

(table continues)

$688.99
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Hcpcs
code

Component

L5978

Multiaxial
ankle/foot
(recommended for
K2 functional
level)

L5979

L5980

L5981

L5987

L7510
L7520

Dynamic
response/multiaxis
(recommended for
K3/K4 functional
level)
Flex foot
(recommended for
K3 functional
level)
Flex-walk system
(recommended for
K3 functional
level)
Shank system with
vertical loading
pylon
(recommended for
K3/K4 functional
level)
Repair
Repair

Long description
- All lower extremity prostheses, foot, multiaxial ankle/foot

Cost (ea)
$359.04

- All lower extremity prosthesis, multi-axial ankle, dynamic response foot, one piece
system

$2,807.21

- All lower extremity prostheses, flex foot system

$4,561.54

- All lower extremity prostheses, flex-walk system or equal

$3,543.43

- All lower extremity prosthesis, shank foot system with vertical loading pylon

$7,952.18

- Repair of prosthetic device, repair or replace minor parts
- Repair prosthetic device, labor component, per 15 minutes

Variable
Variable
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Code Sources
1. ICD-9-CM codes retrieved from:
Source:
Type:
Values:
Comments:
http://www.icd9data.com/2011/Volume1/default.htm

2. CPT codes provided by Laurel A. Copeland, PhD, Research Scientist, Associate Director, Center for Applied Health
Research, Baylor Scot & White Healthcare, Central Texas Veteran Health Care System, Temple, Texas.
3. 2012 HCPCS codes for Durable Medical Equipment (DME) and Prosthetics Orthotics (PO) were provided in a
searchable Excel file by Gordon W. Bosker, Chief Prosthetist, Prosthetics and Orthotics Service, South Texas Veterans
Health Care System (STVHCS) – Audie Murphy Division, San Antonio, Texas. These codes were also available at the
Durable on the Centers for Medicare Medicaid Services website at http://www.cms.gov/Medicare/Medicare-Fee-for-

Service-Payment/DMEPOSFeeSched/DMEPOS-Fee-Schedule.html. Long descriptions of the codes were searched for
and retrieved from
http://www.hipaaspace.com/Medical_Billing/Coding/Healthcare_Common_Procedure_Coding_System/HCPCS_Numb
er_Lookup.aspx

423

Table B27.
Key Inpatient and Outpatient MedSAS Dataset Fields/Variables Used for Compiling the Study Dataset (VIReC, 2011a, 2011b)
Variable Name
ADMITDAY

Definition/label
Date of admission of the inpatient
stay

Values
dd/mm/yyyy

VHA database file
Inpatient files, used to
identify cases of severe
infection and outcomes of
residual limb during
follow-up period.
Inpatient and outpatient
files; used to characterize
the cohort and as covariate
with dependent variable

AG8R

Categorical recoding of AGE
(patient age in years

1 - Less than 25 years old; 2 - 25 – 34 years old; 3 - 35 – 44
years old; 4 - 45 – 54 years old; 5 - 55 – 64 years old; 6- 65
– 74 years old; 7 - 75 – 84 years old; 8 - 85 years old.

DISTO

Type of location to which patient
was discharged

-3 – Irregular, -2 – Death, -1 – Community, 0 - VA
Hospital, 4 - Community Hospital, 5 - VA Nursing Home,
7 - Community Nursing Home, 9 - Same Community
Nursing Home, 10 - Other Community Nursing Home, 11 State Home Nursing, 12 - VA Domiciliary, 13 - State
Home Domiciliary, 15 - Foster Home, 16 - Halfway House,
17 - Boarding House, 19 - Penal Institute, 20 - Residential
Hotel/Reside, 21 - Other Placement, 22 - VA-Paid
Home/Community, 25 - Home-Basic Primary Care, 27 Sci Hcu Program, 29 – Respite, 30 – Hospice, 34
- Medicare Home Health, 35 - Other-Agency Home Health.

Inpatient files; used to
characterize the cohort;
potential covariate to
explain variability.

DISTYPE

Type of discharge

1 – Regular; 2 – Non-Bedcare; 3 – 6-Mo Limit; 4 –
Irregular; 5 – Transfer; 6 – Death-Autopsy; 7 – Death no
autopsy

Inpatient files; used to
characterize cohort
(table continues)
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Variable Name
DOD

Definition/label
Date of death

Values
Mm/yyyy

DXPRIME

Principal admitting ICD-9-CM
diagnostic code; the condition which
after study, is determined to be
chiefly responsible for the admission
of the patient to the hospital.
Primary and secondary ICD-9-CM
diagnostic codes that apply
to the bed section or full stay of the
patient

ICD –9-CM codes

Means Test Indicator Code. The
Means Test (MT) Indicator is used in
determining a patient's eligibility to
receive care. The assigned value
reflects Veteran status and percent
service-connected eligibility.
Marital Status

AS - Special category or Service Connected with at least
10% disability; AN – Poverty level Non-Service Connected
or Service Connected with 0% disability (no copayment);
CMT - Copayment required; N - Non-veteran; X Not applicable; U – Means test not done or incomplete; G Geographic-based Means Thresholds.
D – Divorced; M – Married; N - Never Married; S Separated; U – Unknown; W – Widowed.

PROCDAY

Date of procedure or procedures
performed at a given date and time
combination

dd/mm/yyyyy

PROCDE1PROCDE5

ICD-9-CM Procedure Codes for 1st 5th procedures performed on a given
date and time. Procedures include
dental services and are defined as
either diagnostic or therapeutic and
not occurring in an operating room.

ICD-9-CM codes

DXB2-DXB5,
DXF2-DXF13,
DXLSB, DXLSF

MEANS

MS

ICD-9-CM code

VHA database file
Inpatient files; used to
characterize cohort
(estimate mortality rate)
Inpatient and outpatient
files; used to identify
initial cohort (amputation
due to dysvascular
complications)
In patient files; used to
identify cohort
(dysvascular amputation)
as well as other comorbid
conditions
Outpatient files; used to
characterize cohort and
estimate SES; actual
variable used to indicate
VA Priority Status.
Inpatient and outpatient
files; used to characterize
cohort, potential covariate
to explain variance.
Inpatient files; used to
determine date of
procedures such as
treatment for
osteomyelitis.
Inpatient files; used to
identify severe residual
limb conditions during
follow-up period
(table continues)
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Variable Name
SEX

Definition/label
Gender of patient

Values
M – Male; F – Female; O – Other

VHA database file
Inpatient and outpatient
files; used to characterize
cohort.

SURG9CD1SURG9CD5

Surgical procedure codes

ICD-9-CM codes

SURGDAY

Date of surgery

Dd/mm/yyyyy

Inpatient files; used to
identify cohort with
transtibial amputation, or
revision during follow-up
period
Inpatient files; used to
indicate when a surgical
revision of residual limb
occurred during follow-up
period.

VISN

Veterans Integrated Service Network
(VISN)
where the hospital episode of care
occurred

CPT1-CPT20

Services and procedures performed
by a provider recorded in Current
Procedural Terminology (CPT-4)

1 - VA New England Healthcare System; 2 - VA
Healthcare Network Upstate New York; 3 VA NY / NJ Veterans Healthcare Network; 4 - VA Stars &
Stripes Healthcare Network; 5 - VA Capitol Health Care
Network ; 6 - VA Mid-Atlantic Network; 7 - The Atlantic
Network; 8- VA Sunshine Healthcare Network; 9 - Mid
South Veterans Healthcare Network; 10 - VA Healthcare
System of Ohio; 11- Veterans In Partnership; 12 - The
Great Lakes Health Care System; 15 - VA Heartland
Network; 16 - South Central VA Health Care Network; 17 VA Heart of Texas Health Care Network; 18 - VA
Southwest Healthcare Network; 19 - Rocky Mountain
Network; 20 - Northwest Network; 21 - Sierra Pacific
Network; 22 - Desert Pacific Healthcare Network; 23 - VA
Midwest Health Care Network
CPT codes

Inpatient and outpatient
files; used to characterize
cohort and as proxy for
prosthetist.

Outpatient files; used to
identify residual limb
procedures (e.g. wound
debridement) during
follow-up period.
(table continues)

426

Variable Name
DXF2-DXF10

Definition/label
Secondary ICD-9-CM diagnostic
codes for the visit

Values
ICD-9-CM codes

DXLSF

Primary ICD-9-CM diagnosis code
for this encounter

ICD-9-CM codes

HOMLESS

Character

RACE

Indicates the homeless status of
veteran. Psychiatric and substance
abuse disorders are prevalent among
homeless Veterans
Race or national origin

VIZDAY

Date of outpatient visit/encounter

1 - Hispanic, White; 2 - Hispanic, Black; 3 - American
Indian; 4 – Black; 5 – Asian; 6 – White; 7 – missing
Dd/mm/yyyy

VHA database file
Outpatient files; used to
identify severe and less
severe skin problems
during follow-up period
Outpatient files; used to
identify severe and less
severe residual limb skin
problems during follow-up
period.
Outpatient files; used as an
indicator of SES, potential
covariate to explain
variance
Outpatient files; used to
characterize cohort.
Outpatient files; used to
determine temporal
aspects of residual limb
skin problems during 6
month intervals of followup period.
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Table B28
NPPD Available Variables. Retrieved October 20, 2011
Variable Name

Type

Description

VISN *
STATION
NPPD LINE *

Integer
Text
Text

PATIENT ID *
SOURCE
HCPCS – PSAS *

Integer
Text
Text

VISN where device was prescribed and dispensed
Name of the VA facility
VA code that specifies the type of device within a
category
Patient identifier; unique to NPPD
Commercial or VA issued
Health Care Financing Administration Coding
System (HCPCS) Prosthetic and Sensory Aids
Service (PSAS) CODE

HCPCS CPT *
NEW COST*
USED COST
TYPE*
ITEM *
CALCULATED COST

Text
Currency
Currency
Text
Text
Currency

QTY
VENDOR*
FORM

Number
Text
Text

SHIP COST
PRIORITY *
CATEGORY

Currency
Integer
Text

HCPCS Common Procedure Code
Commercial cost for item or service
VA Cost for item or service
Service type
Description of service or item in IFCAP
Cost of multiple line items linked to a single
purchase order
Number of items issued per transaction
Name of company providing device or service
How item was procured or issued - VISA, Stock
Issue, and so forth
Cost of shipping
Priority Group of patient
Indicates where item was ordered for a Service
Connected (SC) or Non Service Connected (NSC)
Inpatient (IP) or Outpatient (OP)

SPECIAL CATEGORY

Text

Vista ID

Text

CREATE DATE
DELIVERY DATE *
ICD-9 *
HCPCS DESCRIPTION*
PA NAME

NSC/OP fall within one of four special categories:
Eligibility Reform, Post Hospital Care, Aid and
Attendance, and Special Legislation

Number assigned to a prosthetic order by the Vista
Prosthetic Package
Date/Time Date transaction entered into NPPD
Date/Time Date transaction completed with patient
Text
International Classification of Disease Code
Text
Text description of HCPCS PSAS Code
Text
Name of VA staff member who generated the
transaction
(table continues)
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Variable Name
TRANSACTION ID

Type
Text

GROUP ID *

Text

NPPD ID
GENDER *
SERIAL NUMBER
LOT NUMBER
PRODUCT
DESCRIPTION*
PRODUCT MODEL
NUMBER*
FISCAL YEAR*
SUSPENSE STATUS *
SUSPENSE TYPE

Integer
Text
Text
Text
Text

Description
Record number of purchase card order generated by
station
Number used to link multiple line items to a single
purchase order
Record number in the database
Sex of patient
Unique ID of item
Unique ID of item
Description of product

Text

Model number of product

Integer
Text
Text

CONSULT DATE
CONSULT
DESCRIPTION *
CONSULT EXTENDED
DESCRIPTION
WAIVER

Text
Text

Fiscal Year
Status of item - Open/Pending/Closed
Not Linked/Contact
Lens/Eyeglass/Manual/Oxygen/Routine
Date item/service prescribed
Free text description of item prescribed

Text

Free text description of item prescribed

Text

CONTRACT

Text

Indicates item has Waiver from purchasing off
national contract
Contract #

* indicates those variables that will be used to identify the independent variable, artificial limb
configuration as determined by HCPCS codes indicative of types of socket suspension systems
and prosthetic feet. This table was derived from similar information provided at the VIReC Data
Source and Description web page at
http://www.virec.research.va.gov/DataSourcesName/NPPD/NPPD.html.
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Appendix D: Tables of Statistical Results
Section I: Characterization of the Cohort
Table D1
Derivation of the Artificial Limb Configuration Categories
Final ALC values
Category Value
Transfer

Derived from ALC
values
Frequency
12

Percent
3.81

Category Frequency
K1 HV
2

Percent
0.63

K1 L

2

0.63

K1 M

2

0.63

K1
LOCK

6

1.91

Household high-tech ss

10

3.17

K2 H

10

3.17

Household mid to low

16

5.08

K2 L

6

1.91

K2 M

10

3.17

K2
LOCK

25

7.94

Household locking ss

25

7.94

Community high-tech ss

49

15.56 K3 H

7

2.23
(table
continues)
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Final ALC values
Category Value

Community mid to low

Community locking ss

Derived from ALC
values
Frequency

53

150

Percent

Category Frequency
K3 HV
1

Percent
0.32

K34 H

37

11.74

K34 HV

4

1.27

4

1.27

K3 M

24

7.62

K34 L

5

1.59

K34 M

20

6.35

47.62 K3
LOCK

50

15.79

100

31.84

16.83 K3 L

K34
LOCK
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Table D2.
Distribution of cohort members and Artificial Limb Configuration Categories
Region 1 - Northwest and
Western U.S.

Cohort
Members

VISN
18
19
20
21
22

Totals
Artificial limb
configuration Code
1. Transfer
K1(All)
2. Householdhigh tech ss
K2H, K2Hv
Artificial limb
configuration Code
K2M, k2l
3. Householdmid-low tech
ss

Frequency
(percent)
10 (3.58%)
1 (0.36%)
18 (6.45%)
5 (1.79%)
14 (5.02%)
48 (17.2%)
(Region 1)
Frequency
(percent)
2 (3.7%)
1 (1.85%)
(Region 1)
Frequency
(percent)
4 (7.41%)

Region 2 - North- and SouthCentral U.S. (includes Texas)

VISN
12
15
16
17
23

Frequency
(percent)
7 (2.51%)
9 (3.23%)
30 (10.75%)
11 (3.94%)
5 (1.79%)

62 (22.2%)
(Region 2)

Region 3 - Eastern MidWest and Southern U.S.
(Includes Ohio)

Frequency
(percent)
6 33 (11.83%)
7 9 (3.23)
8 19 (6.81%)
9 24 (8.6%)
10 12 (4.3%)
11 15 (5.38%)
112 (40.15%)
(Region 3)

VISN

Frequency(percent)
3 (4.17%)

Frequency (percent)
4 (3.25%)

3 (4.17%)

2 (1.63%)
(Region 3)

Frequency(percent)
4 (5.56%)

Frequency (percent)
3 (2.44%)

(Region 2)

Region 4 - MidAtlantic and
Northeast U.S.
(includes
Washington
DC/Maryland)
Frequency
VISN (percent)
1 9 (3.23%)
2 4 (1.43%)
3 4 (1.43%)
4 15 (5.38%)
5 25 (8.96%)
57 (20.43%)
(Region 4)
Frequency
(percent)
3 (4.55%)
4 (6.06%)
(Region 4)
Frequency
(percent)
5 (7.58%)

(table continues)
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Region 1 - Northwest and
Western U.S.

4. Householdlocking ss
5.
Communityhigh tech ss
6.
Communitymid-low tech
ss
7.
Communitylocking ss
Total

K2lock
K3H, K3HV,
K3-4H,K34Hv
K3M, K34M, K3L,
K3-4L
K3LOCK,K34LOCK

Region 2 - North- and SouthCentral U.S. (includes Texas)

Region 3 - Eastern MidWest and Southern U.S.
(Includes Ohio)

Region 4 - MidAtlantic and
Northeast U.S.
(includes
Washington
DC/Maryland)

1 (1.85%)

8 (11.11%)

15 (12.2%)

1 (1.52%)

6 (11.11)

11 (15.28%)

17 (13.82%)

15 (22.73%)

10 (18.52%)

13 (18.06%)

17 (13.82%)

13 (19.7%)

30 (55.56%)
54 (17.14%)

30 (41.67%)
72 (22.86%)

65 (52.85%)
123 (39.05%)

25 (37.88%)
66 (20.95%)
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Table D3.
Frequencies and Chi-Square Analyses per Study Cohort Variable Inclusion
Variable Name
Chi square p-value
Frequency (percent)
severe
Less severe
Artificial limb configuration (ALC)
0.0428
0.2636146 (146
150 (
Major Depressive Disorder (MDD)
0.034
0.0258
24 (8.6%)
23 (8.2%)

Variable used in
Multivariate Analysis
Yes
Yes

Post traumatic stress disorder (PTSD)

0.2296
33 (11.3%)

0.0069
52 (18.6%)

Yes

Substance use disorder (SUD)

0.1888
24 ((8.6%)

0.1371
42 (15.1%)

Yes

Marital Status

0.0123
Married: 62 (22.9%)
Other: 75 (27.7%

0.2544
Married: 66 (24.4%)
Other: 63 (23.3%))

Yes

Age

0.1564
<55 y/o: 19 (9.9%)
55-74 y/o: 64 (33.3%)
>74 y/o: 24 (12.5%)

0.6511
<55 y/o: 25 (13%)
55-74 y/o: 76 (39.6%)
>74 y/o: 21 (11%)

Yes

Region

0.1651
Region 1: 27 (8.6%)
Region 2: 29 (9.2%)
Region 3: 56 (17.8%)
Region 4: 33 (10.4%)

0.4357
Region 1: 29 (9.2%)
Region 2: 30 (9.5%)
Region 3: 65 (20.6%)
Region 4: 34 (10.2%)

Yes

(table continues)
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Variable Name

Socioeconomic status

Chi square p-value
Frequency (percent)
severe
0.9114
Unemployable: 86
(35.7%)
Employable: 15 (6.2%)
Co-pay eligible: 13 (5.4%)

Variable used in
Multivariate Analysis
Less severe
0.9949
Unemployable: 95 (
39.4%)
Employable:
16 (6.6%)
Co-pay eligible: 13
(5.4%

No

Race

0.632
White: 84 (32.8%
Black: 39 (15.1%)
Asian: 4 (1.5%))

0.0195

Chronic obstructive pulmonary
disease
Congestive Heart failure (CHF)

0.014

0.2293

Yes

45 (15.1%)
0.0467
69 (24.7%)

40 (14.3%)
0.0179
72 (25.8%)

Yes

Cerebral vascular disease (CVD)

0.462

0.5883
10 (3.6%)

No

Renal failure

0.0092
28 (10%)

0.1883
34 (12.2%)

Yes

White: 85 (32.8%)
Black: 44 (17%)
Asian: 7 (2.7%)

Yes
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Section II: Epidemiological analysis.
Table D4
General Estimating Equations Modeling Output for Research Question Four - the Interaction Of Mechanical (HouseholdLocking Suspension System Artificial Limb Configuration) with Behavioral Effects.
Less severe Residual Limb Skin Problems - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard Error 95% Confidence Limits

Intercept

-2.0803

0.5527

-3.1635

Z

Pr > |Z|

-0.9971

-3.76

0.0002

Household-locking
suspension system

1:yes

-0.7328

1.3166

-3.3133

1.8476

-0.56

0.5778

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Window

12 month

-0.2008

0.4487

-1.0802

0.6787

-0.45

0.6546

18 month

0.0738

0.4102

-0.7302

0.8778

0.18

0.8572

24 month

-0.3313

0.4444

-1.2022

0.5396

-0.75

0.4559

30 month

-1.7618

0.6720

-3.0790

-0.4446

-2.62

0.0088

36 month

-1.1098

0.5222

-2.1334

-0.0863

-2.13

0.0336

6 month

0.0000

0.0000

0.0000

0.0000

(reference)

.
(table continues)
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Less severe Residual Limb Skin Problems - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter
Age Group

Estimate

Standard Error 95% Confidence Limits

Z

Pr > |Z|

55-74

-0.9513

0.3970

-1.7295

-0.1731

-2.40

0.0166

74 older

-0.3555

0.4554

-1.2480

0.5371

-0.78

0.4351

0.0000

0.0000

0.0000

0.0000

.

.

(reference)

55 younger

Region

Region 1

-0.1238

0.4573

-1.0202

0.7726

-0.27

0.7866

Region 3

-0.2903

0.3608

-0.9973

0.4168

-0.80

0.4211

Region 4

0.1755

0.4616

-0.7292

1.0803

0.38

0.7038

(reference)

Region 2

0.0000

0.0000

0.0000

0.0000

.

.

Socioeco / VA Priority

co-pay eligible

0.7145

-2.9616

-0.1607

-2.18

0.0289

Employable

0.2939

0.4328

-0.5545

1.1422

0.68

0.4972

(reference)

Unemployable

0.0000

0.0000

0.0000

0.0000

.

.

Marital Status

Married

0.1283

0.2969

-0.4535

0.7102

0.43

0.6655

Others

0.0000

0.0000

0.0000

0.0000

.

(table continues).
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Less severe Residual Limb Skin Problems - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter
Race

Estimate

Standard Error 95% Confidence Limits

Z

Pr > |Z|

Asian

0.3345

0.7150

-1.0669

1.7359

0.47

0.6399

Black

0.2480

0.3282

-0.3952

0.8912

0.76

0.4498

(reference)

White

0.0000

0.0000

0.0000

0.0000

.

Major depressive disorder

1:yes

-0.4741

0.4472

-1.3507

0.4025

-1.06

0.2891

0:no

0.0000

0.0000

0.0000

0.0000

.

.

0.3192

0.3842

-0.4338

1.0722

0.83

0.4061

0:no

0.0000

0.0000

0.0000

0.0000

.

.

1:yes

0.8734

0.4399

0.0112

1.7357

1.99

0.0471

0:no

0.0000

0.0000

0.0000

0.0000

.

Chronic obstructive
pulmonary disease

1:yes

0.6967

0.3126

0.0841

1.3093

2.23

0.0258

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Congestive heart failure

1:yes

0.1689

0.3385

-0.4946

0.8325

0.50

0.6177

0:no

0.0000

0.0000

0.0000

0.0000

.
(table continues)

Post-traumatic stress disorder 1:yes

Substance use disorder

.
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Less severe Residual Limb Skin Problems - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Cerebral vascular disease

Renal Failure

Standard Error 95% Confidence Limits

Z

Pr > |Z|
0.0002

1:yes

1.5114

0.4031

0.7212

2.3015

3.75

0:no

0.0000

0.0000

0.0000

0.0000

.

1:yes

0.2809

0.3092

-0.3251

0.8868

0.91

0.3636

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Z

Pr > |Z|

Severe Residual Limb Skin Problem- Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard
Error

-1.0247

0.4540

-1.9144

-0.1349

-2.26

0.0240

1:yes

-0.3293

0.4597

-1.2302

0.5717

-0.72

0.4738

0:no

0.0000

0.0000

0.0000

0.0000

Intercept
Household-locking
suspension system

95% Confidence
Limits

.

(table continues)
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Less severe Residual Limb Skin Problems - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter
Window

Estimate

Standard Error 95% Confidence Limits

Z

Pr > |Z|

12 month

0.0473

0.3277

-0.5949

0.6895

0.14

0.8852

18 month

-0.2589

0.3421

-0.9294

0.4116

-0.76

0.4491

24 month

-0.3302

0.3538

-1.0236

0.3631

-0.93

0.3506

*30 month

-0.6158

0.3659

-1.3329

0.1013

-1.68

0.0924

36 month

-1.6230

0.4838

-2.5712

-0.6747

-3.35

0.0008

(reference)

6 month

0.0000

0.0000

0.0000

0.0000

.

.

Age group

*55-74

-0.4929

0.2799

-1.0415

0.0556

-1.76

0.0782

74 older

-1.1464

0.4049

-1.9400

-0.3528

-2.83

0.0046

(reference)

55 younger

0.0000

0.0000

0.0000

0.0000

.

.

*Region

Region 1

0.1553

0.3541

-0.5387

0.8492

0.44

0.6610

Region 3

-0.2241

0.3156

-0.8426

0.3945

-0.71

0.4777

*Region 4

0.6905

0.3640

-0.0230

1.4040

1.90

0.0578

Region 2

0.0000

0.0000

0.0000

0.0000

(reference)

.

(table continues)
.
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Less severe Residual Limb Skin Problems - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter
Socioeco / VA Priority

Estimate

Standard Error 95% Confidence Limits

Z

Pr > |Z|

Co-pay eligible

-1.1994

0.4922

-2.1641

-0.2346

-2.44

0.0148

Employable

-0.6472

0.4366

-1.5029

0.2085

-1.48

0.1382

0.0000

0.0000

0.0000

0.0000

.

.

(reference)

Unemployable

Marital status

Married

-0.2401

0.2373

-0.7051

0.2250

-1.01

0.3116

Others

0.0000

0.0000

0.0000

0.0000

.

.

Asian

-0.1486

0.8104

-1.7370

1.4398

-0.18

0.8545

Black

-0.6053

0.2740

-1.1422

-0.0683

-2.21

0.0271

(reference)

White

0.0000

0.0000

0.0000

0.0000

.

.

*Major depressive disorder

1:yes

0.4338

0.2656

-0.0869

0.9544

1.63

0.1025

0:no

0.0000

0.0000

0.0000

0.0000

.

.

-0.1065

0.2833

-0.6618

0.4487

-0.38

0.7069

0:no

0.0000

0.0000

0.0000

0.0000

.

.

1:yes

0.5050

0.3055

-0.0937

1.1037

1.65

0.0983

0:no

0.0000

0.0000

0.0000

0.0000

.
(table continues)

Race

Post-traumatic stress disorder 1:yes

*Substance use disorder

.
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Less severe Residual Limb Skin Problems - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard Error 95% Confidence Limits

Z

Pr > |Z|

Chronic obstructive
pulmonary disease

1:yes

0.5935

0.2612

0.0816

1.1054

2.27

0.0231

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Congestive heart failure

1:yes

-0.1276

0.2551

-0.6275

0.3724

-0.50

0.6170

0:no

0.0000

0.0000

0.0000

0.0000

.

.

1:yes

-0.3756

0.6655

-1.6801

0.9288

-0.56

0.5725

0:no

0.0000

0.0000

0.0000

0.0000

.

.

1:yes

0.0076

0.2785

-0.5383

0.5535

0.03

0.9781

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Cerebral vascular disease

Renal failure

Estimate indicates direction of correlation; bolded text indicates statistical significance at 95% probability, alpha 0.05; *
indicates statistical significance at 90% probability, alpha 0.10.
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Table D5
General Estimating Equations Model Output for Research Question Four – the Interaction of Mechanical (Community-High
Tech Suspension System) with Behavioral Effects.
Less severe Residual Limb Skin Problem - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard
Error

95% Confidence Limits

Intercept

-1.9411

0.5875

-3.0926

Z

Pr > |Z|

-0.7897

-3.30

0.0010

Community-high
tech suspension
system

1:yes

-0.4262

0.3651

-1.1418

0.2895

-1.17

0.2431

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Window

12 month

0.0382

0.4215

-0.7879

0.8644

0.09

0.9277

18 month

0.1032

0.4005

-0.6818

0.8882

0.26

0.7966

24 month

- 0.3402

0.4318

-1.1864

0.5061

-0.79

0.4308

30 month

-1.5375

0.5942

-2.7021

-0.3730

-2.59

0.0097

36 month

-1.0308

0.4940

-1.9990

-0.0626

-2.09

0.0369

(reference)

6 month

0.0000

0.0000

0.0000

0.0000

.

.

Age group

55-74

-0.9993

0.3883

-1.7603

-0.2382

-2.57

0.0101

74 older

-0.4471

0.4405

-1.3104

0.4162

-1.02

0.3100

0.0000

0.0000

0.0000

0.0000

(reference)

55 younger

.
(table continues)
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Less severe Residual Limb Skin Problem - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard
Error

Z

Pr > |Z|

Region 1

-0.2229

0.4742

-1.1523

0.7065

-0.47

0.6383

Region 3

-0.3638

0.3693

-1.0876

0.3600

-0.99

0.3245

Region 4

0.1397

0.4627

-0.7672

1.0467

0.30

0.7626

(reference)

Region 2

0.0000

0.0000

0.0000

0.0000

.

.

Socioeco / VA
Priority

co-pay
eligible

-1.5740

0.7146

-2.9747

-0.1734

-2.20

0.0276

employable

0.2588

0.4569

-0.6367

1.1543

0.57

0.5711

(reference

unemployable

0.0000

0.0000

0.0000

0.0000

.

.

Marital status

married

0.1601

0.2864

-0.4012

0.7214

0.56

0.5761

Others

0.0000

0.0000

0.0000

0.0000

.

.

Asian

0.2809

0.7069

-1.1047

1.6665

0.40

0.6911

Black

0.2400

0.3176

-0.3826

0.8626

0.76

0.4499

(reference)

White

0.0000

0.0000

0.0000

0.0000

.

.

Major depressive
disorder

1:yes

-0.4542

0.4507

-1.3376

0.4292

-1.01

0.3136

0:no

0.0000

0.0000

0.0000

0.0000

Region

Race

95% Confidence Limits

.
(table continues)
.
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Less severe Residual Limb Skin Problem - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard
Error

95% Confidence Limits

Z

Pr > |Z|

Post-traumatic stress 1:yes
disorder
0:no

0.2927

0.3742

-0.4407

1.0261

0.78

0.4341

0.0000

0.0000

0.0000

0.0000

.

*Substance use
disorder

1:yes

0.8315

0.4294

-0.0101

1.6731

1.94

0.0528

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Chronic obstructive
pulmonary disease

1:yes

0.6766

0.3136

0.0619

1.2912

2.16

0.0310

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Congestive heart
failure

1:yes

0.1308

0.3386

-0.5329

0.7945

0.39

0.6993

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Cerebral vascular
disease

1:yes

1.6301

0.4135

0.8197

2.4405

3.94

<.0001

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Renal Failure

1:yes

0.2523

0.3161

-0.3673

0.8719

0.80

0.4248

0:no

0.0000

0.0000

0.0000

0.0000

.

(table continues)
.
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Less severe Residual Limb Skin Problem - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard
Error

95% Confidence Limits

Z

Pr > |Z|

severe Residual Limb Skin Problem - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter
Intercept

Estimate

Standard
Error

95% Confidence Limits

Z Pr > |Z|

-1.0853

0.4764

-2.0191

-0.1515

-2.28

0.0227

Community-high
tech suspension
system

1:yes

0.2747

0.6176

-0.9357

1.4852

0.44

0.6564

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Window

12 month

0.1574

0.3583

-0.5449

0.8596

0.44

0.6605

18 month

-0.3080

0.3926

-1.0774

0.4615

-0.78

0.4327

24 month

-0.3295

0.3981

-1.1097

0.4507

-0.83

0.4078

30 month

-0.4667

0.4024

-1.2555

0.3221

-1.16

0.2462

36 month

-1.5233

0.5458

-2.5931

-0.4536

-2.79

0.0053

6 month

0.0000

0.0000

0.0000

0.0000

(reference)

.

(table continues)

.
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Less severe Residual Limb Skin Problem - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter
Age group

Estimate

Standard
Error

95% Confidence Limits

Z

Pr > |Z|

*55-74

-0.5183

0.2902

-1.0872

0.0505

-1.79

0.0741

74 older

-1.1831

0.4160

-1.9985

-0.3677

-2.84

0.0045

(reference)

55 younger

0.0000

0.0000

0.0000

0.0000

.

.

*Region

Region 1

0.1818

0.3469

-0.4981

0.8617

0.52

0.6002

Region 3

-0.2258

0.3117

-0.8366

0.3851

-0.72

0.4689

*Region 4

0.7119

0.3685

-0.0104

1.4342

1.93

0.0534

(reference)

Region 2

0.0000

0.0000

0.0000

0.0000

.

.

Socioeco / VA
Priority

Co-pay
eligible

-1.2037

0.4901

-2.1643

-0.2431

-2.46

0.0140

Employable

-0.6627

0.4425

-1.5299

0.2045

-1.50

0.1342

0.0000

0.0000

0.0000

0.0000

.

.

-1.12

0.2620

(reference)

Unemployabl
e

Marital status

Married

-0.2640

0.2353

-0.7252

0.1973

Others

0.0000

0.0000

0.0000

0.0000

.

(table continues)
.
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Less severe Residual Limb Skin Problem - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter
Race

*Major depressive
disorder

Estimate

Standard
Error

Asian

-0.1158

0.8139

-1.7110

Black

-0.6002

0.2759

1:yes

0.4370

0:no

Post-traumatic stress 1:yes
disorder
0:no

95% Confidence Limits

Z

Pr > |Z|

1.4794

-0.14

0.8869

-1.1409

-0.0595

-2.18

0.0296

0.2671

-0.0864

0.9605

1.64

0.1018

0.0000

0.0000

0.0000

0.0000

.

.

-0.0878

0.2868

-0.6498

0.4743

-0.31

0.7595

0.0000

0.0000

0.0000

0.0000

.

.

*Substance use
disorder

1:yes

0.5128

0.3124

-0.0995

1.1251

1.64

0.1007

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Chronic obstructive
pulmonary disease

1:yes

0.6058

0.2658

0.0848

1.1268

2.28

0.0227

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Congestive heart
failure

1:yes

-0.1316

0.2611

-0.6432

0.3801

-0.50

0.6142

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Cerebral vascular
disease

1:yes

-0.3812

0.6462

-1.6478

0.8854

-0.59

0.5553

0:no

0.0000

0.0000

0.0000

0.0000

.
(table continues)
.
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Less severe Residual Limb Skin Problem - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter
Renal failure

Estimate

Standard
Error

95% Confidence Limits

1:yes

-0.0019

0.2906

-0.5716

0:no

0.0000

0.0000

0.0000

Z

Pr > |Z|

0.5677

-0.01

0.9947

0.0000

.

.

Estimate indicates direction of correlation; bolded text indicates statistical significance at 95% probability, alpha 0.05; *
indicates statistical significance at 90% probability, alpha 0.10.
Table D6
General Estimating Equations Model Output for Research Question Four – the Interaction of Mechanical (Community-Mid-To
Low-Tech Suspension System) with Behavioral Effects.
Less severe Residual Limb Skin Problem - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard Error

Intercept

-2.1945

0.5799

-3.3310

0.2753

0.8375

-1.3662

1.9168

0.33

0.0000

0.0000

0.0000

0.0000

.
(table continues)

Community-mid 1:yes
to low tech
suspension
0:no
system

95% Confidence Limits

Z Pr > |Z|

-1.0580 -3.78

0.0002
0.7424
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Less severe Residual Limb Skin Problem - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard Error

18 month

-0.0478

0.4459

-0.9217

0.8262 -0.11

0.9147

24 month

-0.3061

0.4715

-1.2303

0.6182 -0.65

0.5163

30 month

-1.5563,m

0.6698

-2.8691

-0.2435 -2.32

0.0202

36 month

-1.1333

0.5541

-2.2193

-0.0473 -2.05

0.0408

(reference)

6 month

0.0000

0.0000

0.0000

Age group

55-74

-0.8884

0.4010

-1.6744

-0.1025 -2.22

0.0267

74 older

-0.3293

0.4430

-1.1977

0.5390 -0.74

0.4573

0.0000

0.0000

0.0000

(reference)

55 younger

Region

Region 1

-0.2375

0.4845

Region 3

-0.2105

Region 4
(reference)

Region 2

Socioeco / VA
priority

Co-pay
eligible

(reference)

95% Confidence Limits

0.0000

0.0000

Z Pr > |Z|

.

.

.

-1.1871

0.7121 -0.49

0.6240

0.3524

-0.9012

0.4803 -0.60

0.5504

0.1765

0.4620

-0.7289

1.0819

0.38

0.7024

0.0000

0.0000

0.0000

0.0000

.

.

-1.4777

0.7018

-2.8532

-0.1023 -2.11

0.0352

Employable

0.2494

0.4606

-0.6533

1.1522

0.54

Unemployabl
e

0.0000

0.0000

0.0000

0.0000

(table continues)

0.5882

.
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Less severe Residual Limb Skin Problem - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard Error

Married

0.1689

0.2841

-0.3879

0.7258

0.59

0.5521

Others

0.0000

0.0000

0.0000

0.0000

.

.

Asian

0.1909

0.6856

-1.1529

1.5347

0.28

0.7807

Black

0.2393

0.3148

-0.3777

0.8564

0.76

0.4471

(reference)

White

0.0000

0.0000

0.0000

0.0000

.

.

Major
depressive
disorder

1:yes

-0.4447

0.4517

-1.3300

0.4406 -0.98

0.3248

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Post-traumatic
stress disorder

1:yes

0.3521

0.3787

-0.3901

1.0944

0.93

0.3524

0:no

0.0000

0.0000

0.0000

0.0000

.

.

*Substance use
disorder

1:yes

0.8307

0.4365

-0.0247

1.6861

1.90

0.0570

0:no

0.0000

0.0000

0.0000

0.0000

.

.

*Chronic
obstructive
pulmonary
disease

1:yes

0.5966

0.3091

-0.0093

1.2025

1.93

0.0536

0:no

0.0000

0.0000

0.0000

0.0000

Marital status

Race

95% Confidence Limits

Z Pr > |Z|

.

(table continues)

.
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Less severe Residual Limb Skin Problem - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard Error

95% Confidence Limits

Congestive heart 1:yes
failure
0:no

0.1305

0.3378

-0.5314

0.7925

0.0000

0.0000

0.0000

0.0000

Cerebral
1:yes
vascular disease
0:no

1.5336

0.4161

0.7181

0.0000

0.0000

Renal failure

1:yes

0.2826

0:no

0.0000

Z Pr > |Z|
0.39

0.6991

2.3490

3.69

0.0002

0.0000

0.0000

.

.

0.3213

-0.3471

0.9124

0.88

0.3791

0.0000

0.0000

0.0000

.

.

-0.0490 -2.06

0.0390

Severe residual limb skin problems –Analysis of GEE parameter Estimates
Intercept

-0.9679

0.4689

-1.8869

0.2853

0.6301

-0.9495

1.5202

0.45

0.0000

0.0000

0.0000

0.0000

.

12 month

-0.0961

0.3598

-0.8014

0.6091 -0.27

0.7893

18 month

-0.4483

0.3835

-1.2000

0.3035 -1.17

0.2425

24 month

-0.5097

0.3999

-1.2935

0.2740 -1.27

0.2024

*30 month

-0.6622

0.3990

-1.4443

0.1199 -1.66

0.0970

36 month

-1.8656

0.5712

-2.9852

-0.7460 -3.27

0.0011

6 month

0.0000

0.0000

0.0000

Community-mid 1:yes
to low tech
0:no
suspension
system
Window

(reference)

0.0000

0.6506

.
(table continues)
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Less severe Residual Limb Skin Problem - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter
Age group

Estimate

Standard Error

95% Confidence Limits

Z Pr > |Z|

55-74

-0.6097

0.2834

-1.1650

-0.0543 -2.15

0.0314

74 older

-1.2536

0.4205

-2.0779

-0.4294 -2.98

0.0029

(reference)

55 younger

0.0000

0.0000

0.0000

0.0000

.

.

Region

Region 1

0.1140

0.3699

-0.6109

0.8390

0.31

0.7578

Region 3

-0.2107

0.3122

-0.8226

0.4012 -0.67

0.4997

Region 4

,p

0.3587

0.0945

1.5005

2.22

0.0262

(reference)

Region 2

0.0000

0.0000

0.0000

0.0000

.

.

Socioeco – VA
Priority

Co-pay
eligible

-1.1494

0.4756

-2.0816

-0.2173 -2.42

0.0157

*Employable

-0.8207

0.4483

-1.6993

0.0579 -1.83

0.0671

(reference)

Unemployabl
e

0.0000

0.0000

0.0000

Marital status

Married

-0.2780

0.2347

-0.7380

Others

0.0000

0.0000

0.0000

Asian

-0.2966

0.8968

Black

-0.6006

White

0.0000

Race

(reference)

0.0000

.

0.1821 -1.18
0.0000

0.2363

.

.

-2.0543

1.4610 -0.33

0.7408

0.2725

-1.1347

-0.0666 -2.20

0.0275

0.0000

0.0000

0.0000

.
(table continues)
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Less severe Residual Limb Skin Problem - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard Error

95% Confidence Limits

Z Pr > |Z|

*Major
depressive
disorder

1:yes

0.5051

0.2697

-0.0235

1.0337

1.87

0.0611

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Pot-traumatic
stress disorder

1:yes

0.0140

0.2831

-0.5408

0.5689

0.05

0.9604

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Substance use
disorder

1:yes

0.4458

0.3195

-0.1804

1.0720

1.40

0.1629

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Chronic
obstructive
pulmonary
disease

1:yes

0.4274

0.2694

-0.1006

0.9554

1.59

0.1126

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Congestive heart 1:yes
failure
0:no

-0.1491

0.2640

-0.6665

0.3684 -0.56

0.5723

0.0000

0.0000

0.0000

Cerebral
1:yes
vascular disease
0:no

-0.3699

0.7048

-1.7514

0.0000

0.0000

0.0000

0.0000

.

.

1:yes

0.0417

0.2926

-0.5318

0.6152

0.14

0.8867

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Renal failure

0.0000

.

.

1.0116 -0.52

0.5997

Estimate indicates direction of correlation; bolded text indicates statistical significance at alpha 0.05 (95%);
* indicates statistical significance at alpha = 0.10 (90%).
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Table D7
General Estimating Equations Model Output for Research Question Four – the Interaction of Mechanical (CommunityLocking Suspension System) with Behavioral Effects
Less severe Residual Limb Skin Problems - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard Error

95% Confidence Limits

Intercept

-2.5098

0.7244

-3.9295

Z

Pr > |Z|

-1.0901

-3.46

0.0005

Community-locking
suspension system

1:yes

0.6451

0.6190

-0.5681

1.8583

1.04

0.2973

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Window

12 month

0.6280

0.6110

-0.5696

1.8255

1.03

0.3041

18 month

0.3640

0.5987

-0.8093

1.5374

0.61

0.5431

24 month

-0.1717

0.6309

-1.4082

1.0649

-0.27

0.7856

**30 month

-1.3543

0.8410

-3.0026

0.2941

-1.61

0.1073

36 month

-0.4555

0.6615

-1.7520

0.8410

-0.69

0.4911

6 month

0.0000

0.0000

0.0000

0.0000

.

.

55-74

-0.9498

0.3978

-1.7296

-0.1701

-2.39

0.0170

74 older

-0.3384

0.4401

-1.2009

0.5241

-0.77

0.4419

0.0000

0.0000

0.0000

0.0000

Age Group

(reference)

55 younger

.

(table continues)
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Less severe Residual Limb Skin Problems - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard Error

Z

Pr > |Z|

Region 1

-0.1474

0.4629

-1.0547

0.7599

-0.32

0.7502

Region 3

-0.3051

0.3792

-1.0483

0.4381

-0.80

0.4210

Region 4

0.1599

0.4567

-0.7352

1.0550

0.35

0.7262

(reference)

Region 2

0.0000

0.0000

0.0000

0.0000

.

.

Socioeco / VA
Priority

Co-pay eligible

-1.5827

0.7269

-3.0074

-0.1580

-2.18

0.0295

Employable

0.2973

0.4459

-0.5766

1.1713

0.67

0.5049

(reference)

Unemployable

0.0000

0.0000

0.0000

0.0000

.

.

Marital status

Married

0.1511

0.2888

-0.4150

0.7172

0.52

0.6008

Others

0.0000

0.0000

0.0000

0.0000

.

.

Asian

0.3052

0.6895

-1.0461

1.6566

0.44

0.6580

Black

0.2621

0.3189

-0.3629

0.8872

0.82

0.4111

(reference)

White

0.0000

0.0000

0.0000

0.0000

.

.

Major depressive
disorder

1:yes

-0.4555

0.4491

-1.3358

0.4247

-1.01

0.3104

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Post-traumatic stress
disorder

1:yes

0.2988

0.3940

-0.4735

1.0711

0.76

0.4482

0:no

0.0000

0.0000

0.0000

Region

Race

95% Confidence Limits

0.0000 (table continues)
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Less severe Residual Limb Skin Problems - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard Error

95% Confidence Limits

Z

Pr > |Z|

Substance use
disorder

1:yes

0.8611

0.4318

0.0149

1.7074

1.99

0.0461

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Chronic obstructive
pulmonary disease

1:yes

0.7039

0.3129

0.0907

1.3171

2.25

0.0245

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Congestive heart
failure

1:yes

0.1713

0.3318

-0.4791

0.8216

0.52

0.6057

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Cerebral vascular
disease

1:yes

1.5273

0.3994

0.7445

2.3100

3.82

0.0001

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Renal failure

1:yes

0.2912

0.3094

-0.3152

0.8976

0.94

0.3466

0:no

0.0000

0.0000

0.0000

0.0000

.

(table continues)
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Less severe Residual Limb Skin Problems - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard Error

95% Confidence Limits

Z

Pr > |Z|

Z

Pr > |Z|

Severe Residual Limb Skin Problem - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard Error

Intercept

-0.8638

0.5058

-1.8551

0.1276

-1.71

0.0877

1:yes

-0.4282

0.4672

-1.3439

0.4875

-0.92

0.3594

0:no

0.0000

0.0000

0.0000

0.0000

.

12 month

-0.1620

0.4670

-1.0773

0.7534

-0.35

0.7287

18 month

-0.3969

0.4726

-1.3231

0.5293

-0.84

0.4010

24 month

-0.5565

0.4883

-1.5136

0.4005

-1.14

0.2544

30 month

-0.7721

0.5047

-1.7612

0.2171

-1.53

0.1261

36 month

-1.8417

0.6471

-3.1099

-0.5734

-2.85

0.0044

6 month

0.0000

0.0000

0.0000

0.0000

Community-locking
suspension system

Window

(reference)

95% Confidence Limits

.

(table continues)

.
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Less severe Residual Limb Skin Problems - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter
Age group

Estimate

Standard Error

95% Confidence Limits

Z

Pr > |Z|

*55-74 years

-0.5132

0.2851

-1.0720

0.0456

-1.80

0.0719

74 older

-1.1785

0.3983

-1.9592

-0.3979

-2.96

0.0031

(reference)

55 younger

0.0000

0.0000

0.0000

0.0000

.

.

Region

Region 1

0.2043

0.3448

-0.4715

0.8800

0.59

0.5535

Region 3

-0.2004

0.3345

-0.8560

0.4552

-0.60

0.5492

Region 4

0.7279

0.3584

0.0255

1.4304

2.03

0.0422

(reference)

Region 2

0.0000

0.0000

0.0000

0.0000

.

.

Socioeco / VA
Priority

Co-pay eligible

-1.1961

0.4943

-2.1650

-0.2273

-2.42

0.0155

Employable

-0.6552

0.4351

-1.5079

0.1975

-1.51

0.1321

(reference)

Unemployable

0.0000

0.0000

0.0000

0.0000

.

.

Marital status

Married

-0.2621

0.2344

-0.7215

0.1972

-1.12

0.2634

Others

0.0000

0.0000

0.0000

0.0000

.

.

Asian

-0.1143

0.8323

-1.7456

1.5169

-0.14

0.8907

Black

-0.6025

0.2776

-1.1466

-0.0584

-2.17

0.0300

White

0.0000

0.0000

0.0000

0.0000

Race

(reference)

.
(table continues)
.
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Less severe Residual Limb Skin Problems - Analysis Of GEE Parameter Estimates
Empirical Standard Error Estimates
Parameter

Estimate

Standard Error

95% Confidence Limits

Z

Pr > |Z|

Major depressive
disorder

1:yes

0.4302

0.2668

-0.0926

0.9531

1.61

0.1068

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Post-traumatic stress
disorder

1:yes

-0.0697

0.2814

-0.6211

0.4817

-0.25

0.8044

0:no

0.0000

0.0000

0.0000

0.0000

.

.

*Substance use
disorder

1:yes

0.5138

0.3102

-0.0942

1.1217

1.66

0.0977

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Chronic obstructive
pulmonary disease

1:yes

0.5967

0.2597

0.0876

1.1058

2.30

0.0216

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Congestive heart
failure

1:yes

-0.1377

0.2606

-0.6483

0.3730

-0.53

0.5973

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Cerebral vascular
disease

1:yes

-0.3794

0.6496

-1.6527

0.8938

-0.58

0.5592

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Renal failure

1:yes

0.0037

0.2904

-0.5655

0.5729

0.01

0.9898

0:no

0.0000

0.0000

0.0000

0.0000

.

.

Estimate indicates direction of correlation; bolded text indicates statistical significance at alpha = 0.05 (95%);
* indicates significance at alpha = 0.10 (90%).
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Section III: NPPD Initial cohort analysis
Table D8
Initial Cohort Artificial Limb Prosthetic Foot Frequencies
HCPCSPSAS
HCPCSPSAS

Frequency Percent Cumulative Cumulative
Frequency
Percent

L5970 SACH

25

2.28

25

2.28

L5972 SAFE

89

8.12

114

10.40

L5973 Micro

2

0.18

116

10.58

L5974 Single-axis

90

8.21

206

18.80

L5975 Multitiaxis Flex

16

1.46

222

20.26

L5976 Energy-storing

188

17.15

410

37.41

L5978 Multiaxial Ankle

42

3.83

452

41.24

L5979 Dynamic response

67

6.11

519

47.35

L5980 Flex foot

192

17.52

711

64.87

L5981 Flex-walk

262

23.91

973

88.78

L5987 Shank

123

11.22

1096

100.00

Table D9
Initial Cohort Artificial Limb Suspension System Frequencies
Socsus Frequency Percent Cumulative Cumulative
Frequency
Percent
cuff suspension

70

4.00

70

4.00

suction socket

169

9.65

239

13.64

supercondyle suspension

77

4.39

316

18.04

BK suspension sleeve

658

37.56

974

55.59

VASS

12

0.68

986

56.28

Sleeve

698

39.84

1684

96.12

Straps

68

3.88

1752

100.00

